Fragilidade : prevalência, fatores associados e tratamento através do treinamento de força by Coelho Júnior, Hélio José, 1990-
 
 
 
 
UNIVERSIDADE ESTADUAL DE CAMPINAS 
Faculdade de Educação Física 
 
 
 
 
 
HÉLIO JOSÉ COELHO JUNIOR 
 
 
 
FRAILTY: PREVALENCE, ASSOCIATED FACTORS AND TREATMENT THROUGH 
RESISTANCE TRAINING 
 
 
FRAGILIDADE: PREVALÊNCIA, FATORES ASSOCIADOS E                          
TRATAMENTO ATRAVÉS DO TREINAMENTO DE FORÇA 
 
 
 
 
 
 
CAMPINAS 
2019  
 
 
HÉLIO JOSÉ COELHO JUNIOR 
 
 
FRAILTY: PREVALENCE, ASSOCIATED FACTORS AND TREATMENT THROUGH 
RESISTANCE TRAINING 
 
 
FRAGILIDADE: PREVALÊNCIA, FATORES ASSOCIADOS E TRATAMENTO 
ATRAVÉS DO TREINAMENTO DE FORÇA 
 
 
 
 
 
 
 
 
Supervisor: MARCO CARLOS UCHIDA  
Co-supervisor: BRUNO RODRIGUES 
 
 
 
 
 
CAMPINAS 
2019  
Thesis presented to the Faculty of Physical Education of 
the University of Campinas in partial fulfillment of the 
requirements for the degree of Doctor, in the area of 
adapted physical activity. 
ESTE TRABALHO CORRESPONDE À VERSÃO 
FINAL DA TESE DEFENDIDA PELO ALUNO 
HÉLIO JOSÉ COELHO JUNIOR, E ORIENTADA 
PELO PROF. DR. MARCO CARLOS UCHIDA 
 
 
 
  
 
 
Comissão Examinadora 
 
 
Marco Carlos Uchida (Presidente) 
 
Emanuele Marzetti 
 
Reury Frank Pereira Bacurau 
 
Eduardo Lusa Cadore 
 
Lígia de Moraes Antunes Correa 
 
 
 
 
 
 
 
 
 
 
 
A Ata da defesa com as respectivas assinaturas dos membros encontra-se no 
SIGA/Sistema de Fluxo de Dissertação/Tese e na Secretaria do Programa da Unidade. 
 
 
AGRADECIMENTOS 
Prof. Dr. Marco Carlos Uchida. Sensei, há quase 10 anos o senhor me acolheu como 
um filho e me ajudou na escolha dos caminhos ao longo dessa jornada. Que orgulho em dizer 
que o senhor é, não só o meu orientador, mas o meu mentor: um pai científico, seja lá o que 
isso queira dizer. Obrigado por todo o companheirismo e carinho, por ter aceitado dividir 
comigo momentos em que o senhor podia apenas se abster. Obrigado pelas conversas 
incansáveis e por me presentear com uma amizade muita sincera, aceitando as minhas 
limitações. Aliás, me desculpe pelos momentos de fraqueza. Um doutor é muito mais que um 
“paper”, certo? Obrigado pelas reflexões em relação às minhas quedas, erros e fracassos, 
evitando que estes se tornassem motivo de autopiedade, e construindo um caráter mais 
resiliente. Eu me sinto treinado por um antigo samurai, o qual me ensinou o Bushidô, e cabe a 
mim usá-lo. É como se a primeira parte do treinamento tivesse terminado e agora receberei 
minha katana ou minha armadura de ouro para assim trilhar o meu caminho. Não sozinho! 
Porque sei que o senhor continuará comigo e sua sapiência e ensinamentos estarão comigo em 
minhas atitudes. Como Dohko de libra, o senhor me ensinou que o equilíbrio é necessário, a 
balança não pode pender muito para um lado, nem para o outro. A última década me moldou e 
o senhor é um dos responsáveis por isso. Muito obrigado! Oss!  
Mãe, Edna Antônia Refundine. Exemplo de garra, de trabalho, de foco. Uma ótima 
cozinheira, sempre me deixou muita claro a receita para conquistar os meus desejos: “Acordar 
muito cedo, trabalhar muito durante o dia, conversar pouco com aqueles que não tem o que 
fazer, e dormir muito tarde”. Minha primeira fornecedora de livros e café.  
Sr. Geraldo Refundine (Nego), in memorian. Meu primeiro orientador: passava 
horas me ensinando coisas que eu só consegui (creio eu) entender muito mais tarde. Que falta 
o senhor me faz. Gostaria de escutar sua reflexão sobre a minha tese. Infelizmente, foi o máximo 
que consegui, me desculpe. Obrigado por ainda hoje ser o meu Norte. 
A Heloá Cataria Coelho (Chata). Obrigado por toda a força! Não teria feito sem 
você.  
A Dejanira Terezinha dos Santos Refundine. Vó, o que seria de mim sem as suas 
orações? Tenho certeza de que são elas que me levam para frente. Muito obrigado por ser a 
minha amigona, “pau para toda obra”. Sei que posso contar sempre com a senhora.  
Dott. Emanule Marzetti, Bazzi, Heeman, Ema! Dai, Bazzi! Mamma mia, come sei 
stato carino con me. Mi hai abbracciato e capito i miei momenti de debolezze e necessità, anche 
se sono brasiliano, nero, povero e grasso. Grazie per me avermi ascoltato e rispettato sempre. 
 
 
Grazie per i viaggi, le cene, le chiacchierate. Non lo sai quanto mi hai fatto crescere “alla 
clinica” e come ricercatore. Grazie per la opportunità che mi hai regalato di lavorare con tante 
cose diversi, come i pazienti con Down. Grazie per la pazienza di insegnarmi e di scrivere 
insieme a me. Lo sai che quando sono tornato in Brasile, non riuscivo a scrivere senza ascoltare 
“ma si vede che si fa capire bene quando vuole...; tutte le sere ne accompagna a casa una 
diversa...”. Sarò un ricercatore eccezionale come te un giorno, fidati!  
Sra. Simone Malfatti Ganade Ide, responsável pela secretaria do PPG/FEF. Mais 
uma vez, não tenho palavras para agradecê-la por toda a atenção e paciência durante todo o meu 
doutorado. A senhora merece um busto na FEF. Muito obrigado por tudo, de coração. 
Prof. Ms. Samuel da Silva Aguiar. Negão, parceiro, você estava aqui desde o 
começo e sempre me ensinou muito. Obrigado não só pela ajuda nas coletas, mas pelos cafés e 
conversas. No fim, toda nossa filosofia e pragmatismo não nos levarão a lugar nenhum, mas 
nos fazem rir bastante. Muito obrigado, irmão.  
Prof. Marcos Cenedeze, amigo, tio, parceiro de documentários sobre a segunda 
guerra, pizzas, e vinho barato. Obrigado por todos os conselhos e força que o senhor me deu 
durante esse período. Seu acolhimento meu deu suporte nos momentos mais difíceis.   
Dott.ssa Picca, Pikles, Nanno di giardino! Come faceva bene arrivare lì e vedere il 
tuo sorriso. Sei sicuramente la dottoressa più bella e più bassa al sud di Roma. Grazie per la tua 
pazienza (o no) con me. Anche se con tutta questa cattiveria nel cuore, mi hai regalato momenti 
felicissimi. Grazie mille per tutto. Sei stata essenziale!  
Dott. Riccardo Calvani, Mano, Luigi! Ricca, mano, ma che figata conoscerti. 
Sempre preoccupato se io avevo da mangiare, se io avevo preso il caffè, se era tutto apposto. 
Grazie per insegnarmi il romano proprio, quello di Roma sud, le parolacce, e certo, come 
possiamo dimenticarci delle bestemmie. Madonna, come mi piacevano le nostre lezioni. Ricca, 
grazie per la pazienza con me. Grazie per fidarti del mio lavoro.  
Dott. Luca Mariotti. Dai che questa è tua, Lucca! Alla fine, sono sicuro che nessuno 
di noi è rimasto con la sfortuna delle suore. Principalmente perché io andavo sempre con la 
mano in tasca. Lucca, grazie mille per tutto che hai fatto per me. Sempre preoccupato se era 
tutto apposto, se io stavo conoscendo le cose che io dovevo. Se crescevo anche culturalmente. 
Sei troppo bravo, Lucca!  
Dott.ssa. Giulia Severa (Freeddeericcoooo) e Dott. Damiano Biscotti! Ma che 
coppia, Dio mio! Allora, voi siete stati bravissimi con me. Grazie per le cene, le chiacchierate, 
le serrate. Giulietta, grazie per la confidenza, per le sigarette, per ricordarmi di quello che io 
non potevo fare dopo il secondo bicchieri di vino. Bomberone, grazie per tutto! Che giocatore 
 
 
che sei! Non perdi questa l’anima per niente, va bene? “Mi dispiace devo andare...” o pure “ 
Mi ricordi che rivivo in tante cose...nananana“.  
Dott. Matteo Tosato. Grandissimo! Sempre pronto per un caffè. Matt, sempre carino 
con me. Grazie per tutti i caffè e chiacchierate. Ancora mancha la serata del vino... 
Dott.ssa. Marianna Broccatelli e Dott.ssa. Marihelena. Prima che siete bellissimi, e 
questo già mi faceva bene nella mattina. Grazie per tutte i momenti che mi avete scaldato il 
cuore e preso cura di me.  
Dott. Angelo Carfi. Grazie per la pazienza e per avermi insegnato tanto sui pazienti 
con Down. Porterò sempre con me il rispetto e la umanità che hai con i pazienti. Sicuramente, 
sei il dottore più bravo che io ho mai visto.  
Dott.ssa. Daniela Ronconi. Oh Dio! Va bene, è un po’ difficile ringraziarti dopo 
tutti gli schiaffi e calci che mi hai dato. Però, già che hai scelto io mio nome per tuo figlio ti 
perdono. Grazie per i momenti de risate e lavoro insieme.  
Signora Anna Maria. Ma come mi mancano questi bracci grassi, Mamma mia! 
Grazie per tutte le cose belli che mi dicevi. Grazie per tutto il cibo anche se errano per Riccardo, 
ma non mi importa.  
Claudio, Nonno. AVE CLAUDIUS! Nonno, vabbè, quante persone si conosci al 
mondo con 147 anni che ancora lavorano come te? Allora, guarda, mi Raccomando con troppo 
caffè che tu non sei più un ragazzino, ok? Prendi il vino, mangia la carbonara e non pensi tanto 
su le cose. Grazie per tutto!  
Dott.ssa. Cipriani, Dott.ssa. Lo Monaco, e Dott. Fusco, grazie per avermi accettato 
in quella stanza. Grazie per sempre avermi trattato con il massimo di rispetto. Siete sempre stati 
carinissimi con me. 
Dott. Graziano Onder. Grazie per permettere che io vedesse i pazienti con Down.  
Dott. Augusto. Augusto, sempre con una parolaccia nella mattina. Grazie per tutto!  
Prof. Francesco Landi. Grazie per avermi ricevuto e per tutto il rispetto che mi hai 
dato. 
Prof. Roberto Bernarbei. Professore, grazie mille per avere accettato la mia richiesta 
per studiare a Gemelli. Sono stato contentissimo nel suo dipartimento. La ringrazio per questa 
opportunità.     
Ai colleghi del dipartimento, ai baristi e a tutti quelli che mi hanno regalato 
momenti di felicità.  
Prof. Dr. Bruno Rodrigues. Obrigado pela confiança e pelas oportunidades que o 
senhor me deu no começo dessa jornada. O senhor foi um grande motivador para que eu 
 
 
crescesse. Que tenhamos aprendido com os erros e possamos amadurecer sempre, não só 
naquilo que diz respeito à pesquisa científica, mas como seres humanos.  
Prof. Edison Duarte. Obrigado pela honra em tê-lo na minha qualificação e 
obrigado pelas considerações na minha tese.  
Dra. Juliana Costa Zwarg, fisioterapeuta do Lar Mãe Mariana. Passamos das 
discussões acaloradas para uma homeostase relativa, verdade? Obrigado por todo o seu carinho 
comigo, desde o café que você me trazia até as exaustivas coletas de dados. Obrigado por toda 
a paciência, ensinamentos e motivação. Você se tornou uma amiga muito querida.  
Dra. Denise de Azevedo Carvalho, fisioterapeuta do Lar Mãe Mariana. Nós não 
conseguimos sair das discussões, né? Talvez porque sejamos muito parecidos. Obrigado pelas 
intermináveis caronas e pela sua dedicação em me ajudar no projeto, mesmo nos dias em que 
eu estava muito estressado (mais do que o costumeiro). Obrigado pelas vezes em que você me 
defendeu.  
Sra. Deise Andrade Máximo. Me sinto lisonjeado em ter recebido sua confiança 
para entrar no lar Mãe Mariana. Sei que o espaço é cuidado com muito zelo e os idosos são 
muito paparicados. Me senti realmente em casa e parte da equipe durante todo o tempo que 
estive ali. Seus idosos mudaram muita coisa em mim e serei sempre grato pela oportunidade 
que você me deu.   
Thaís Lourenço. Tha, muito obrigado por me ajudar nos trâmites burocráticos 
dentro do lar. Obrigado por todo o carinho que você deu.  
Ao Lar Mãe Mariana: Sra. Vânia Lazaneo, Sr. João, “tias da cozinha”, “tias da 
limpeza”, auxiliares de enfermagem, enfermeiros, porteiros, motoristas, funcionários do lar, e 
a Dra. Patrícia, nutricionista. Muito obrigado pelo café sem açúcar, pelas frutas, por trazerem 
os idosos até a reabilitação. Obrigado pela paciência com o meu projeto e por ajudar na 
logística.  
Prof. Ms. Ivan de Oliveira Gonçalves, obrigado pela confiança e por abrir as portas 
para que eu conduzisse meu projeto no cantinho do idoso. Obrigado por sempre me recomendar 
ao idosos e à outras instituições da cidade. A sua bondade permitiu que esse doutorado fosse 
realizado.  
Aos educadores físicos Fabiana e Renato por ajudarem na coleta dos dados dos 
estudos observacionais.  
Tuca, Regiane, e “tias da cozinha e limpeza” do Cantinho do Idoso da Cidade de 
Poá. Sempre com um sorriso, um elogio, um gracejo. Seu carinho permitiu que tudo se tornasse 
mais leve. Muito obrigado!  
 
 
Prof. Gabriella Ventura. Paciente e atenciosa com os idosos. Quantas madrugadas 
me ajudando apenas pelo prazer de aprender. Obrigado por tudo!  
Prof. Dr. Ricardo Yukio Asano e Prof. Rafael Palmeira. Grandes incentivadores. 
Obrigado! 
Renato Perreira. Irmão de coração. Valeu, mesmo, mano! Sem palavras!  
Heloiza Meireles Ferreira. Obrigado pelo companheirismo, pela atenção e pela 
compreensão nos momentos mais difíceis. Obrigado por sempre estar aqui.   
Aos professores Lígia Antunes-Correa, Eduardo Lusa Cadore, Reury Frank 
Bacurau, e Francisco Luciano Pontes Junior por aceitarem o convite para fazer parte da minha 
banca de doutorado. É uma honra tê-los aqui.  
Monsieur le Professeur Michel Audiffren. Merci de votre attention et de votre 
apprentissage à Rome. Merci de faire partie de ce comité.  
Aos colegas do coworking João, Michele, Jaqueline e Dani. Obrigado pelos cafés e 
atenção.  
A todos os meus inimigos, incluindo, mas não se limitando, à todas as malditas 
professoras, pedagogas, psicólogas, coordenadoras e diretoras que eu escutei ao longo da vida 
me dizendo que eu era um problema e me expulsando das escolas. Vocês são um lixo! Aos 
preguiçosos que eu fui obrigado a trabalhar, estudar ou “carregar nas costas” durante o mestrado 
e doutorado. Espero que vocês consigam posições de destaque onde não consigam realizar 
aquilo que deveriam, pois será muito mais prazeroso vê-los derrotados dessa forma. Aos 
bravíssimos amigos, que estão sempre dispostos a pedir os seus nomes nos artigos científicos. 
Eu sei quem vocês são e os odeio. Desejo a todos uma morte lente e dolorosa. Espero vê-los 
comigo no inferno. Muito obrigado por terem me presenteado sempre com mais vontade de 
crescer e ser melhor.  
Aos idosos. Obrigado pela oportunidade de aprender com a dor e o sofrimento dos 
senhores. Que prazer em escutá-los diariamente e saber que me esperavam. Obrigado por tanto 
aprendizado e paciência com as minhas limitações. Os senhores mudaram a minha vida e forma 
de viver. Não conseguirei nunca retribuir o que fizeram por mim. Desejo a todos muita luz em 
seu caminho e que possam encontrar toda a paz que desejam e o amor que merecem.   
O presente trabalho foi realizado com apoio da Coordenação de Aperfeiçoamento 
de Pessoal de Nível Superior - Brasil (CAPES) - Código de Financiamento 001  
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal 
de Nível Superior - Brasil (CAPES) - Finance Code 001 
 
 
A todos aqueles que colaboraram de forma direta ou indiretamente para que esse 
projeto acontecesse. 
  
 
 
 
 
 
 
 
 
 
 
Il restera de toi ce que tu as donné. 
Au lieu de le garder dans des coffres rouillés. 
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RESUMO 
A fragilidade é um estado potencialmente reversível de maior vulnerabilidade à desfechos de 
saúde negativos, o qual ocorre como resultado do comprometimento biológico multissistêmico 
e aspectos socioambientais. A prevalência de fragilidade na Europa e na Ásia já foi estabelecida 
e, mais recentemente, pesquisadores sugeriram que a incidência de fragilidade em três anos ao 
rendo do mundo é de 13,6%. Embora os países da América do Sul sejam uma economia 
emergente, ainda sofrem com a pobreza, desnutrição, moradia precária, falta de informação e 
baixa qualidade de vida, todas variáveis associadas ao desenvolvimento da fragilidade. No 
entanto, a prevalência de fragilidade na América do Sul ainda é pouco explorada. Portanto, o 
presente projeto de doutorado investigou a prevalência de fragilidade na América do Sul. 
A gênese e a progressão da fragilidade estão associadas à muitos desfechos negativos 
relacionados à saúde, como limitações da mobilidade e anormalidades cardiovasculares. Em 
contraste, o alto consumo proteico parece estar associado negativamente ao status de 
fragilidade. Notavelmente, a definição operacional de fragilidade ainda é difícil pela ausência 
de uma definição unívoca, e mais de 60 instrumentos diferentes para a sua avaliação estão 
atualmente disponíveis. Algumas investigações observaram que esses instrumentos não 
capturam necessariamente o mesmo construto, o que permite supor que a associação entre 
fragilidade e outros fatores possa ser dependente do instrumento utilizado. Com base nessas 
premissas, este projeto investigou a relação entre o status de fragilidade e a ingestão de 
proteínas, função física e parâmetros relacionados à hipertensão arterial sistêmica usando 
4 instrumentos diferentes. O estabelecimento da fragilidade como um problema de saúde 
pública levou pesquisadores a examinar terapias para colaborar com o tratamento dessa 
condição. Muita atenção tem sido dada ao exercício físico, principalmente ao treinamento de 
força (TF), dados os inúmeros estudos que relataram melhorias nos parâmetros relacionados à 
fragilidade em resposta aos programas de TF. No entanto, mesmo que os programas tradicionais 
de TF, ou também chamados treinamento de resistência a baixa velocidade (LSRT), pareçam 
ser uma ferramenta poderosa para melhorar a força muscular, seus efeitos da mobilidade são 
menos pronunciados. Nesse contexto, evidências que a potência muscular, a capacidade de 
exercer força em um curto intervalo de tempo, diminui precocemente e está mais associada à 
tarefas de mobilidade do que a força muscular, levou à suposição de que os protocolos de RT 
de alta velocidade (HSRT) poderiam causar maiores melhorias na mobilidade do que o LSRT. 
Ensaios clínicos randomizados, revisões sistemáticas e metanálises testaram essa hipótese e os 
resultados ainda são controversos. Além disso, as investigações são baseadas em idosos 
robustos, de modo que os efeitos dos programas de TF no status de fragilidade e no desempenho 
 
 
físico de idosos frágeis não foram descritos anteriormente. Assim, o presente projeto 
investigou os efeitos do HSRT e LSRT no status de fragilidade. Secundariamente, foi 
examinado os efeitos de ambos os programas de TF no desempenho físico, função 
cognitiva e pressão arterial, dada sua estreita associação com à fragilidade. 
Palavras-chave: Fragilidade; Sarcopenia; Treinamento de Força; Força Muscualr; Teste de 
Caminhada; 
  
 
 
ABSTRACT 
Frailty is a potentially reversible state of increased vulnerability to negative health-related 
outcomes that occurs as a result of multisystem biological impairment and environmental 
aspects. The prevalence of frailty in Europe and Asia has been estimated and more recently 
researchers suggested that the average 3-year incidence of frailty worldwide is 13.6%. Although 
South America countries an emerging economy, they are still suffering with the poverty, 
malnutrition, poor housing, lack of information, and low quality of life, all variables associated 
with frailty development. Nevertheless, the prevalence of frailty in South America is still poorly 
explored. Therefore, the current Ph.D. project investigated the prevalence of frailty in 
South America. The genesis and progression of frailty is associated with many negative health-
related outcomes, such as mobility limitations and cardiovascular abnormalities. In contrast, 
high protein consumption seems to be negatively associated with frailty status. Notably, the 
operational definition of frailty is still hampered by the absence of a univocal definition, and 
more than 60 different instruments for the assessment of frailty are currently available. Some 
investigations have observed that these instruments not necessarily capture the same construct, 
which allows the assumption that the association between frailty and associated factors may be 
instrument-dependent. Based on these premises, this project investigated the relationship 
between frailty status and protein intake, physical performance, and hypertension-related 
parameters using 4 different frailty instruments. The establishment of frailty as a public 
health problem led researchers to examining therapies to collaborate with management of 
frailty. Much attention has been paid to exercise training, mainly to resistance training (RT), 
given the numerous studies that have reported improvements in frailty-related parameters in 
response to RT programs. However, even if traditional RT programs, or also called low-speed 
resistance training (LSRT), seem to be a powerful tool to improve muscle strength, its effects 
of mobility are less pronounced. In this context, evidence has found that muscle power, the 
capacity to exert force in a short time interval, declines faster and is more associated with 
mobility tasks than muscle strength, which lead to the assumption the high-velocity RT (HSRT) 
protocols could cause greater improvements in mobility than LSRT. Randomized clinical trials 
and systematic reviews and metanalyses have tested this hypothesis and findings are still 
controversial. Furthermore, investigations are based on robust older adults the effects of both 
RT programs on frailty status and physical performance have not been described before. Thus¸ 
the present project investigated the effects of HSRT and LSRT on frailty status. 
 
 
Secondarily, we examined the effects of both RT programs on physical performance, 
cognitive function, and blood pressure, given its close association with frailty.  
Keywords: Frailty; Sarcopenia; Resistance Training. Muscle Strength; Walking Speed 
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INTRODUCTION 
 
Aging process and frailty: a brief perspective 
The aging process and mainly the old age have gone through many perceptions 
during human history. In ancient Greek, the god of old age was Geras (Senectus in ancient 
Rome), represented as a sad person who walked using a cane and accompanied the actions of 
Thanatos, the god of death (HAMILTON, 2019). Heh (i.e., million in Egypt) was the 
personification of eternity for Egyptians. He is commonly represented as a man holding one 
palm stem in each hand and with a palm stem in his head, indicating longevity (WILKINSON, 
2003). African polytheists adore Oxalufan as the representation of “old age”. This divinity is 
described as a wise old man with mobility limitations who wears white clothes and walks using 
a sacred cane (paxorô) (BARBOSA, 2014).    
 
Figure 1. Representation of a) Geras, b) Heh, and c) Oxalufan. In the first picture, a representation 
of Heracles who would have won Geras; Heh, in the middle, holds palm stems, representing longevity; 
in the last picture, Oxalufan is represented by a thin old man who walks hunched.  
 
In the bible, grow old is described as a divine blessing. Adam (930 years) and Moses 
(120 years), for example, lived more than 100 years, and Methuselah (969 years) is considered 
the oldest person in human history. According to psalms 91, longevity will be a gift for those 
who follow God’s footsteps: With long life, I will satisfy him and show him my salvation. More 
than that, long life would be a representation of morality, Gray hair is a crown of splendor; it 
is attained in the way of righteousness (Proverbs, 16:31).  
Nevertheless, also in the psalms, people showed their despair to not be abandoned 
by god when they become old and weak: “Do not cast me away when I am old; do not forsake 
me when my strength is gone” (psalms 71:9). 
Being old in ancient Rome allowed some perks. The Law of the Twelve Tables, 
Duodecim Tabulae, gave to the breadwinner permission to decide on the life of his slaves and 
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children (patres familias). Older men also composed the senatus, a council responsible for 
political decisions.  
At that moment, thinkers started to reflect on the aging process. Cicero, one of the 
most famous Roman thinkers, wrote a book expressing his ideas about how to grow old 
(CICERO, 103AD). According to him, four main problems are associated with getting old: 1st) 
that it withdraws us from active pursuits; 2nd) that it makes the body weaker; 3rd) it deprives us 
of almost all physical pleasures; and, 4th) that it is not far removed from death.  
In his point of view, remain intellectually active, instead of being worried about the 
decline in physical function may propitiate successful aging and counteract most problems 
associated with growing old. Nevertheless, the possible negative outcomes of aging have been 
described by many writers, philosophers, and poets throughout the centuries. 
In King Lear, Shakespeare recognizes that the old age may a moment of expressing 
wisdom (SHAKESPEARE, 1606). In the first act, Lear asks the fool about his behavior with 
his daughter, given that he showed signals of dementia, and the footman comments: “If thou 
wert my fool, nuncle, I’d have thee beaten for being old before thy time”. Samuel T Coleridge 
shares this perspective and portrays his ancient Mariner as an old man who learned with his 
mistakes. Dona Benta, character created by Monteiro Lobato who took care of children, was 
known to be old and wise. 
However, Gabriel García Márquez in Memories of My Melancholy Whores genially 
identified that be smart and cultured may not be enough for a complete old age and suggests 
that loneliness may trigger serious problems (MÁRQUEZ, 2004).  
Physical changes arising from old age are a common topic in the literature and many 
times a problem for the characters. In the magnun opus of Oscar Wilde (1890), Doryan gray, 
Prince Charming¸ remains young and handsome thanks to a full-length portrait in oil, which 
gets old instead of him. When he stabs the painting, Doryan died and his body became old, 
withered and decrepit. Would Wilde be indicating that evil makes us old? Is old age a 
punishment? 
In the myth of Tithonus, Eos, Goddess of the Dawn, asked Zeus to make her beloved 
immortal but forgot to ask that he be granted eternal youth. As a result, Tithonus kept growing 
old, lost his physical function and became a cicada.   
Santiago, Ernest Hemingway’s fisher, is described as thin and gaunt with deep 
wrinkles in the back of his neck and the author concludes that everything about him was old 
(HEMINGWAY, 1952). 
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Figure 2. King lear, Eos and Tithonus, and Doryan Gray. In the upper left corner of the figure, King 
Lear and his fool by William Dyce (1806–1864); In the picture below, Eos and Tithonus by Giulio 
Carpioni (Italian, 1613–1679); In the right corner of the figure, the picture of Doryan Gray by Ivan 
Albright (1897–1983). 
 
Aging was not forgotten by great painters. After dissecting the corpse of an older 
man, Leonardo da Vinci stated that muscles were consumed and reduced to the state of a thin 
membrane so that the cords, instead of being transformed into muscle were converted into a 
wide sheet (TONELLI, 2014).  
 
Figure 3. Dissected leg by Leonardo da Vinci (1452-1519). 
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The demographic transition made aging become a hot topic in science. Reports from 
the earlier 20’s indicated that become old was treated as a disease by some scientists. In the 
article The Pathology of the Aging Process, Warthin A. (1928) termed old age as “the period of 
involution”, given that men have fulfilled their biological duty and the human body slowly 
reduces the functioning of its vital functions. During the second world war II, Nazis performed 
secret experiments with hormones in an attempt to slow aging and make the Fuher and the so-
called Aryan race immortal (DE NÁPOLI, 2012).    
The first papers talking about frailty started to be published in the 80’s and 
recognized this condition as possible characteristic inherently associated with the aging process 
(GADOW, 1983) or a state associated with long-term hospitalization and high prevalence of 
comorbidities (WILLIAMS et al., 1989). However, there was the notion that aging could be a 
heterogeneous process (GADOW, 1983). In the 90’s, researchers (SPEECHLEY; TINETTI, 
1991; BORTZ, 1993; ROCKWOOD et al., 1999) had in mind that frailty was apparently 
associated with some elements, like aging, diseases, and behavioral factors, but a conceptual 
framework was not yet established. 
However, still in this period, some investigations (SPEECHLEY; TINETTI, 1991; 
ROCKWOOD et al., 1999) reported that be frail, according to definitions based on mobility, 
disability, and dementia, to quote a few, were associated with higher risk of falls and 
institutionalization.   
 
 
Figure 4. A long road to frailty. 
These compendia of evidence motivated researchers in the early 2000s to look for 
a conceptual framework and a clinical definition of frailty. The turning point occurred with the 
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investigation of Fried et al. (2001). First, researchers identified that a) weight loss, b) weakness, 
c) exhaustion, d) slowness and e) sedentary behavior were five elements fundamentally 
associated with frailty and could be used to clinically identify it. Subsequently, they used data 
from the Cardiovascular Health Study (CHS) to test the hypothesis that older adults with three 
or more of the five abovementioned features were at higher risk of adverse health outcomes.  
 
 
Figure 5. Five cardinal features of frailty according to Fried et al., 2001 
Baseline results deconstructed preliminary views by suggesting that frailty was not 
necessarily accompanied by disability or diseases, given that 27% of the frail participants had 
none of the conditions. Authors observed that their proposal of frailty phenotype was an 
independent predictor of incident falls, worsened mobility or activities of daily living disability, 
incident hospitalization, and death over 3 or 7 years, after adjustment for many covariates.   
This study opened an avenue for exploring the physiopathology of frailty (CLEGG 
et al., 2013; COELHO-JUNIOR et al., 2019b (Article 1); MARZETTI et al., 2019; PICCA et 
al., 2019), its associated factors (BEASLEY et al., 2010; BOLLWEIN et al., 2013; NADRUZ 
et al., 2016; GOBBENS, 2019), its development and adverse outcomes (KOJIMA, 2016a, 
2016b, 2017a, 2017b, 2018; KOJIMA et al., 2016), the best instruments for its identification 
(BUTA et al., 2016; APRAHAMIAN et al., 2017; LIN et al., 2018a), and the possible 
treatments (NEGM et al., 2017; JADCZAK et al., 2018). Indeed, many observational studies 
(NERI et al., 2013; PIRES CORONA et al., 2015) and randomized clinical trials (MARZETTI 
et al., 2018) have been performed to study the several strands of frailty around the world.   
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It should be mentioned that alternative phenotypes of frailty including other 
domains (e.g., social, religious, cognition) were proposed by research groups (ROCKWOOD 
et al., 2005; SEWO SAMPAIO et al., 2016a; BRECCIA et al., 2018; CHECA-LÓPEZ et al., 
2019), and have been exhaustively tested. However, the Fried frailty phenotype, also called 
physical frailty, is still the most used in research and clinical practice (CLEGG et al., 2013; 
MORLEY et al., 2013a). 
Nowadays, frailty is defined as a reversible state of increased vulnerability to 
negative health-related outcomes, including disability and mortality, which occurs separated 
and faster than normal aging process in response to a heterogenous multisystem impairment of 
the human body that presents high within-individual variability (FRIED et al., 2009; VAN KAN 
et al., 2010; CLEGG et al., 2013; MORLEY; MALMSTROM, 2013; CHOI et al., 2015; 
STOLZ; MAYERL; FREIDL, 2019). It means that frail patients are at higher risk for many 
unfavorable outcomes and early death. Their clinical presentation is composed of numerous 
age-related components (e.g., weakness), but not represent a product of the aging process. Its 
cause may and probably do vary across individuals so that two frail older adults might show a 
different combination of biological impairments and social issues. Finally, frail individuals will 
present fluctuations in their state, which has important implications in the treatment.   
Investigations have estimated the prevalence of frailty worldwide. In Europe, the 
overall prevalence was estimated at 7.7%, with lower occurrences identified in countries with 
higher Human Development Index (HDI), such as Switzerland, Sweden and Denmark 
(MANFREDI et al., 2019). Similar findings were found in Japan, where frailty accounts for 
7.4% (KOJIMA et al., 2017). A recent systematic review and meta-analysis identified that 
around 21.7% of older adults in South America are frail (Article 2). In Brazil, specifically, the 
mean prevalence of frailty is estimated in 26.1%, with the highest prevalence observed in 
nursing-home residents (55.8%), followed by hospitalized (39.6%), and community-dwelling 
people (24.8%). 
 
Frailty and associated factors: protein consumption, physical performance, and hypertension-
related parameters 
The main concern regarding frailty progression is its close association with adverse 
outcomes. Frail people are at higher risk for mobility limitations (VERMEIREN et al., 2016; 
LIN et al., 2018b), cardiovascular abnormalities (NEWMAN et al., 2001; NADRUZ et al., 
2016), cognitive impairment (GRANDE et al., 2019; MIYAMURA et al., 2019), falls 
(VERMEIREN et al., 2016),  fractures (ENSRUD et al., 2008; KOJIMA, 2016b, 2017b), 
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hospitalization (LIN et al., 2018b), and death (VERMEIREN et al., 2016; LIN et al., 2018b), 
which collaborates to a poor quality of life and high prevalence of depressive symptoms in this 
population (VAUGHAN; CORBIN; GOVEAS, 2015). This state of susceptibility increases 
private and public costs (BOCK et al., 2016). As such, frailty represents a major public health 
problem.  
On the other hand, good life habits, such as adequate nutrients intake (LORENZO-
LÓPEZ et al., 2017) and high physical activity levels (DE SOUTO BARRETO, 2010) may 
postpone or even prevent frailty’s development.  
 
 
Figure 6. Frailty and negative health-related outcomes. 
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The relationship between frailty and some of its associated factors will be discussed below.  
 
Frailty and protein consumption 
Proteins are macromolecules consisting of a linear polymer of amino acids (AA), 
which are responsible for numerous biological processes in the human body, including DNA 
replication, cell structure, enzymatic reactions, and transporting of molecules. Different from 
other macronutrients, protein has no inactive compound to serve as a reservoir and protein 
dietary intake must be kept constant so that skeletal muscle contractile proteins are rapidly 
utilized to supply the lack of AA during fasting and stress.  
The building of proteins begins with the acquisition of AA derived from dietary 
protein, given that the human body is not able to synthesize all essential AA (EAA). Different 
from carbohydrates, protein degradation, proteolysis, begins in the stomach, where the 
hydrochloric acid (HCl) exposes the peptide bonds to digestive enzymes and activates and 
converts pepsinogen into pepsin, which acts cleaving peptide bonds into small AA molecules. 
In the duodenum, the AA chains are metabolized into shorter molecules of AA (i.e., tripeptides 
and dipeptides) by digestive enzymes produced by the pancreas, such as trypsin, chymotrypsin, 
elastase, and carboxypolipeptidase. Finally, tripeptides and dipeptides are converted into AA 
and reach target tissues through the bloodstream.  
AA are organic compounds that contain amine (-NH2), carboxyl (-COOH) and R 
groups (side chain), which varies according to each AA. These variations on R groups have a 
key role in the structure of proteins by influencing the combination of AA during 
polymerization. Protein synthesis begins after DNA’s transcription into a messenger RNA 
(mRNA). This molecular structure involves a recipe with the sequence of AA to produce the 
protein. A complex composed by ribosomes adhered to the endoplasmic reticulum (ER), 
mRNA, and transfer RNA (tRNA) will produce proteins by dehydrating each single AA, 
forming a peptide bond, which results in an amide group, a functional group essential to connect 
many residues during polymerization in which nitrogen is close to a carbonyl.  
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Figure 7. Protein digestion.  
The current Recommended Dietary Allowances (RDA) of proteins for adults is 0.8 
g/kg body weight (BW)/d. However, RDA is under intense criticism  (DREYER; VOLPI, 2005; 
BAUER et al., 2013; VOLPI et al., 2013; BAUER; DIEKMANN, 2015; DEER; VOLPI, 2015; 
LANDI et al., 2016a; PHILLIPS; CHEVALIER; LEIDY, 2016), given that it is based on 
nitrogen balance studies and does not include specific recommendations for older adults, who 
seem to need higher amounts of protein to maintain basic functions of some biological process. 
In particular, muscle protein anabolism is blunted in the old muscle due to a reduced 
muscle protein synthesis (MPS) in response to hyperaminoacidemia (VOLPI et al., 2000; 
KATSANOS et al., 2005, 2006; WALL et al., 2015), which is known as anabolic resistance. 
Evidence have demonstrated that the rate of phenylalanine, an essential AA not produced in the 
body and not oxidized in the muscle tissue, taken up by the muscle after essential/mixed AA 
infusion (VOLPI et al., 2000) or ingestion (KATSANOS et al., 2005, 2006; WALL et al., 2015) 
is higher in young than in older adults. This phenomenon was accompanied by a reduced MPS 
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in the post-prandial, but no post-absorptive state (VOLPI et al., 2000; KATSANOS et al., 2005, 
2006; WALL et al., 2015).  
Moore et al. (2014) added to the aforementioned studies by observing that older 
adults required a 140% greater protein intake to maximally stimulate postprandial rates of MPS 
in comparison to young adults.    
 
 
Figure 8. Anabolic resistance. 
These premises lead researchers to propose that muscle loss with aging may be at 
least partially attributed to anabolic resistance to protein intake, given that skeletal muscle mass 
is maintained by the balance between MPS and muscle protein breakdown (MPB). Age-related 
muscle wasting is an important clinical aspect of older adults due to its close relationship with 
the development of sarcopenia.  
Sarcopenia, or also called muscle failure (SUETTA; MAIER, 2019), is a chronic 
neuromuscular degenerative disease involving substantial muscle loss, dynapenia, and reduced 
physical function (CRUZ-JENTOFT et al., 2019). This condition has been considered a public 
health problem, given its possible adverse outcomes (e.g., disability, institutionalization, death) 
(HIRANI et al., 2015; LOCQUET et al., 2019), high prevalence in older adults (ETHGEN et 
al., 2017; SHEN et al., 2019; SU et al., 2019) and people with premature aging (COELHO-
JUNIOR et al., 2019a; Article 3), and costs for public health (BEAUDART et al., 2014).  
The atrophic process is characterized by a significant reduction in muscle area and 
preferably occurs in type II muscle fibers (LEXELL; TAYLOR; SJÖSTRÖM, 1988; 
KLITGAARD et al., 1990; NILWIK et al., 2013). These fibers are the main responsible for the 
production of maximal force and power, which occurs due to the larger availability and higher 
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activity of myosin ATPase and glycolytic enzymes, in comparison to type I muscle fibers 
(SCOTT; STEVENS; BINDER-MACLEOD, 2001).  
Notably, the clinical presentation of sarcopenia encompasses some of the criteria 
diagnosis for frailty (LANDI et al., 2015; CESARI; NOBILI; VITALE, 2016), such as 
weakness, slowness, and body shrinking, while exhaustion and sedentary behavior are common 
consequences of sarcopenia progression (ZIAALDINI et al., 2017). Researchers have suggested 
that sarcopenia might be envisioned as a substrate for the development of frailty (LANDI et al., 
2015; CESARI; NOBILI; VITALE, 2016). In other word, physical frailty may be the final 
pathway of sarcopenia progression (LANDI et al., 2015; CESARI; NOBILI; VITALE, 2016). 
This idea is further supported by the higher prevalence of sarcopenia in pre-frail and frail older 
adults when compared to robust people (FRISOLI et al., 2011; MIJNARENDS et al., 2015).  
 
 
Figure 9. Sarcopenia and frailty. 
In this context, insufficient dietary protein intake could be intended as a risk factor 
for the development of frailty by modulating sarcopenia-related parameters. On the other hand, 
opinion articles and consensus statements have argued that greater amounts of protein than the 
RDA (1.0–1.5 g/kg) can prevent or postpone age-related neuromuscular decline (DREYER; 
VOLPI, 2005; BAUER et al., 2013; VOLPI et al., 2013; BAUER; DIEKMANN, 2015; DEER; 
VOLPI, 2015; LANDI et al., 2016a; PHILLIPS; CHEVALIER; LEIDY, 2016), given the 
number of evidence that found higher physical function in older adults who had a protein intake 
higher than the RDA (GREGORIO et al., 2014; LAROCQUE et al., 2015; ISANEJAD et al., 
2016; RAHI et al., 2016a; COELHO-JUNIOR et al., 2018a, Article 4; TEN HAAF et al., 2018).  
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Observational studies have reported a negative relationship between protein intake 
and frailty status in older adults. Beasley et al. (2010), Rahi et al. (2016b), Sandoval-Insausti et 
al. (2016), Nanri et al. (2018) found that higher protein intake was significantly associated with 
a lower frailty prevalence in older adults. These findings were supported by a systematic review 
and metanalysis that investigated more than 18,000 community-dwelling older adults from five 
different countries (COELHO-JUNIOR et al., 2018b, Article 5).  
Although these findings indicate the need for increased protein intake in older 
adults to avoid frailty development, we clarified in the systematic review and metanalysis that 
data should be carefully interpreted due to some limitations (COELHO-JUNIOR et al., 2018b, 
Article 5). First, the use of different instruments to asses frailty (e.g., frailty phenotype, Kihon 
checklist [KCL]) may mean that studies are capturing different frailty domains (CHECA-
LÓPEZ et al., 2019). Second, some studies (BOLLWEIN et al., 2013; SHIKANY et al., 2014; 
NANRI et al., 2018) have not observed a significant relationship between protein intake and 
frailty prevalence, and authors (BOLLWEIN et al., 2013) have suggested that protein 
distribution over the day may be more crucial in muscle anabolism. Third, protein quality, an 
index of the amount of EAA that is provided by a determined quantity of protein (MILLWARD 
et al., 2008), has been suggested as another important aspect of this paradigm. 
Indeed, animal-derived proteins (e.g., meat, eggs) are thought to have a higher 
content of EAA, mainly branched-chain amino acids (BCAA; i.e., isoleucine, leucine, and 
valine) and consequently evoke greater MPS than plant-based proteins (e.g., soya, beans, nuts) 
(VAN VLIET; BURD; VAN LOON, 2015a; LANDI et al., 2016b). Indeed,  BCAA seems to 
have a key role on MPS, since it improved the phosphorylation of eIF4E-BP1 and p70S6K at rest 
(LIU et al., 2001) and further enhanced p70S6K, Thr389, and ribosomal protein s6 
phosphorylations in response to exercise (KARLSSON et al., 2004). In the work of van Vliet 
et al. (VAN VLIET; BURD; VAN LOON, 2015b), for example, whey protein stimulated 
greater aminoacidemia and MPS than soy at rest and after an acute session of exercise.  
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Figure 10. Animal- and Plant-Based Protein Sources. 
These premises lead to the investigation (Article 6) if frailty status, identified using 
4 different instruments, was associated with: a) daily protein consumption, b) daily body 
weight-adjusted protein consumption, c) BCAA consumption, d) evenness of protein 
distribution across the three main meals (i.e., breakfast, lunch, dinner), e) number of daily meals 
providing at least 0.30 g of protein per meal, and f) number of daily meals providing at least 
0.4 g of protein/kg of body weight in community-dwelling older adults. 
Some factors may limit the consumption of animal-based protein in older adults, 
such as oral health, price, and even lifestyle. Cultural and regional values and also associated 
with dietary patterns (MUKHERJEA et al., 2013; BROWN et al., 2019; RUGGIERO et al., 
2019) and may negatively influence the adherence to diet recommendations (JUÁREZ-
RAMÍREZ et al., 2019) and health-related outcomes (ZOU, 2017). In the study 7, the patterns 
of protein intake between Brazilian and Italian older adults were compared. Results indicated 
that Brazilians older adults had a higher intake of plant-based protein, while Italian older 
women consumed more animal-based protein. These differences were associated with different 
performances in physical tests among the groups. These data are supported by the study 8, in 
which higher plant-based protein intake was significantly associated with physical performance 
in community-dwelling Brazilian older women.    
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Taken together, these findings suggest that protein recommendations for 
counteracting frailty should take into consideration cultural values in an attempt to increase diet 
adherence.  
 
Frailty and physical performance   
Two main theoretical models of frailty have been proposed and tested for reliability: 
a) the frailty phenotype model, proposed by Fried et al. (2001), and b) the cumulative deficit 
model (CDM) or multidomain model (ROCKWOOD et al., 2005). The frailty phenotype model 
is the most utilized instruments for frailty characterization (CHECA-LÓPEZ et al., 2019), 
which has allowed the creation of a sketch of the mechanisms underlying its genesis and 
development (CLEGG et al., 2013; LANDI et al., 2015; CESARI; NOBILI; VITALE, 2016). 
The frailty phenotype involves five cardinal factors (i.e., weakness, slowness, 
exhaustion, sedentary behavior, shirking) (FRIED et al., 2001) highly influenced by physical 
function, which lead researchers to alternatively referred to it as physical frailty model (CLEGG 
et al., 2013; MORLEY et al., 2013b), and proposed that sarcopenia should be considered a 
substrate for frailty’s development and progression (LANDI et al., 2015; CESARI; NOBILI; 
VITALE, 2016). 
This point of view may lead health professionals to the erroneous assumption that 
frail patients shown a reduced overall physical function. Nevertheless, physical function, as a 
construct, includes different physical capacities and abilities that may not necessarily be equally 
reduced in frailty. This information is important for exercise and rehabilitation prescribers since 
comprehend which are the main impairments on physical performance (e.g., reduced mobility) 
associated with frailty may collaborate with more specific exercise programs.  
These premises are supported at least partially by evidence that found that physical 
capacities underlying mobility performance are sample-dependent (BENAVENT-CABALLER 
et al., 2016; ZARZECZNY et al., 2017; COELHO-JUNIOR et al., 2018b, Article 9). Benavent-
Caballer et al. (2016) found that functional balance, but not other physical functions, was the 
most significant factor explaining timed “Up and Go” (TUG) performance in a sample 
composed by community-dwellers and institutionalized Spanish older adults. When Coelho-
Junior et al. (2018a, Article 9) investigated only community-dwelling older women, researchers 
observed that high TUG performance was significantly associated with lower limb muscle 
strength, while low TUG performance showed an increased contribution of other physical 
capabilities, such as lower limb muscle power, balance, and aerobic capacity. Similarly, 
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Zarzeczny et al. (2017) reported a significant correlation between muscle strength/power and 
aerobic capacity in institutionalized older adults.  
Therefore, the article 10 investigated the associations between frailty status 
identified using 4 different instruments and physical performance tasks in community-dwelling 
older adults. 
 
Frailty and hypertension-related parameters 
Frailty is commonly associated with physical adverse outcomes, such as falls, 
fractures, and disability. However, expert opinions have argued that frailty may be also 
significantly associated with hypertension-related parameters (ODDEN; BEILBY; PERALTA, 
2015; BENETOS et al., 2016a), which may impose an extra risk for adverse outcomes in this 
population (RAVINDRARAJAH et al., 2017). Particularly, researchers suggest that specific 
attention may be necessary for the management of hypertension in frailty patients (ODDEN; 
BEILBY; PERALTA, 2015; BENETOS et al., 2016a).  
Nevertheless, empirical studies testing this hypothesis have shown incongruent 
findings. Ricci (2014), Aprahamian et al. (2018), and Anker et al. (2019) observed a higher 
prevalence of hypertension among pre-frail and frail individuals in comparison to robust 
counterparts. In contrast, Basile et al. (2017) found an inverse relationship between frailty status 
and office systolic (SBP) and diastolic blood pressures (DBP). Fattory et al. (2013) detected 
that for every 1 mmHg reduction in office mean arterial pressure (MAP), the likelihood of being 
frail increased by 1.4%. Bastos-Barbosa et al. (2012) reported that frail older adults had higher 
SBP and DBP obtained by ambulatory blood pressure monitoring (ABPM), but not office blood 
pressure, in comparison to robust people. These findings were expanded by Gijón-Conde et al. 
(2018), who found that one additional frailty category was significantly associated with a 
1.5442 mmHg low day time SBP and a 1.388 mmHg higher night-time SBP.  
An interesting perspective was given by Rockwood and Howlett (2011), who 
proposed a U-shaped relationship between frailty and blood pressure, regardless of 
hypertension diagnosis. In this context, high blood pressure levels would be expected in robust 
and frail older adults, while prefrail individuals would show low blood pressure levels.  
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Figure 11. U-shaped relationship between frailty and blood pressure.  
 For the moment, only two clinical trials investigated if frailty status could modify 
the impact of antihypertensive treatment. Using data from the Hypertension in the Very Elderly 
Trial (HYVET), Warwick et al. (WARWICK et al., 2015) did not find a significant interaction 
between the effect of treatment for hypertension and frailty. Similarly, older adults from the 
Systolic Blood Pressure Intervention Trial (SPRINT) had increased risk for falls and all-cause 
hospitalizations, but not cardiovascular morbidity (PAJEWSKI et al., 2016).  
The different results among the studies may be explained based on age, setting, 
hypertension diagnosis, time of hypertension, blood pressure measurement, frailty assessment, 
and comorbidities.  
Age-related changes on cardiovascular structure and functioning have been argued 
as the main mechanisms underlying the possible relationship between frailty and hypertension 
(MULLER et al., 2014; ODDEN; BEILBY; PERALTA, 2015; BENETOS et al., 2016a), 
although conceptually frailty occurs separated from normal aging. In this context, studies have 
investigated other possible pathways mediating this phenomenon, including a) abnormalities 
on cardiovascular architecture and function; b) medication; and c) renal function.  
Regarding abnormalities on cardiovascular architecture and function, a growing 
body of evidence suggests that frailty is associated with left ventricular (LV) hypertrophy 
(NEWMAN et al., 2001; NADRUZ et al., 2016), LV systolic and diastolic dysfunction 
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(NADRUZ et al., 2017), and arterial stiffness (NEWMAN et al., 2001; SINGH et al., 2012; 
AVILA-FUNES et al., 2014).  
 
 
Figure 12. Cardiovascular abnormalities in frail older adults. 
A possible scenario to associate the aforementioned cardiovascular abnormalities 
and blood pressure changes in frailty may be proposed beginning with arterial stiffness. 
Notably, arterial stiffness has not only been observed in frail older adults, but also in people 
showing one or more diagnostic criteria for frailty (e.g., weakness and slowness) (OCHI et al., 
2010; ABBATECOLA et al., 2012; SAMPAIO et al., 2014; COELHO JUNIOR et al., 2015).  
When the myocardial contracts, large elastic arteries, such as aorta and its down 
trunk, distend to store part of the stroke volume and subsequently drain this amount of blood to 
the periphery during cardiac diastolic, ensuring an adequate cardiac output and a continuous 
supply of blood to organs and tissues (SHIRWANY; ZOU, 2010; AVOLIO, 2013; SAFAR et 
al., 2018). During this phenomenon, the force of cardiomyocyte contraction generates a pulse 
wave (PW) that propagates along the vessel wall (SHIRWANY; ZOU, 2010). The velocity in 
which the forward and backward waves (PW velocity, PWV) propagate is dependent on the 
degree of impedance in conduit arteries, so that, in physiologic situations, large elastic arteries 
offer relatively low impedance and the wave returns toward the heart in late systole and early 
diastole (SHIRWANY; ZOU, 2010).  
In contrast, stiffening of the central elastic vessels leads to a significant increase on 
PWV causing an early return of reflected wave (RW) to the aorta and heart during the early 
systole, increasing afterload (Laplace’s law) (SHIRWANY; ZOU, 2010; AVOLIO, 2013; 
SAFAR et al., 2018). Observational studies have reported that arterial stiffness is a risk factor 
for increases in SBP and incident hypertension in normotensive people, even if after 
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adjustments for covariates (DERNELLIS; PANARETOU, 2005; KAESS et al., 2012; 
MITCHELL, 2014). This phenomenon can be perpetuated via positive feedback cycles, given 
that high blood pressure insults vascular structure by fragmenting elastin and increases collagen 
content (MITCHELL, 2014). 
Elevated blood pressure causes an increase in LV wall stress and, over time, LV 
wall thickens and LV mass increases, as a compensatory mechanism to normalize wall stress 
and myocardial oxygen demand (NADRUZ, 2015). At this moment, blood pressure still 
remains elevated. As LV hypertrophy progress, chronic stress will result in ventricular dilation, 
fall in contractile function and eventually progress to heart failure (HF) (DRAZNER, 2011), 
which may be associated with low blood pressure levels.  
In this context, it is conceivable to speculate that variations on blood pressure in 
studies investigating frail patients may occur in the function of the progression of 
cardiovascular abnormalities.   
A second hypothesis is based on the antihypertensive therapy of frailty patients, 
given that researchers may have investigated patients under different pharmacological 
therapies. These premises seem to be important, given that some drugs may modify frailty 
development.  
Angiotensin‐converting enzyme inhibitor (ACEI), for example, is among the most 
widely used class of antihypertensive medication (BENETOS et al., 2016b), which acts 
inhibiting the action of ACE. The renin-angiotensin system is a major blood pressure regulating 
mechanism. After being released from the juxtaglomerular cells in the kidney, renin cleaves 
angiotensinogen, forming the decapeptide angiotensin (Ang I) that in turn is converted to the 
octapeptide Ang II by ACE. There is substantial and solid literature supporting the effects of 
Ang II on the cardiovascular system (KIM; IWAO, 2000; FERRARIO, 2006) and most recently 
studies started to suggest its role on muscle metabolism (BRINK et al., 2001; SONG et al., 
2005; YOSHIDA et al., 2013), by proposing that Ang II causes protein degradation via an AT1 
receptor-dependent mechanism by stimulating ubiquitin-proteasome system (UPS) and 
reducing insulin-like growth factor-1 (IGF-1) signaling, the main anabolic pathway in skeletal 
muscle (MUSARÒ et al., 2001).  
Investigations in humans have reported positive (ONDER et al., 2002), negative 
(SPIRA et al., 2016), and null (SPIRA et al., 2016) associations between ACEI use and physical 
function (e.g., weakness and slowness). In addition, findings of a systematic review and 
metaanalysis did not identify differences in the aerobic capacity and upper limb muscle strength 
between ACEI users and non-users (ZHOU et al., 2015). Regarding muscle mass, which can be 
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associated with shrinking, most evidence has not indicated its associations with ACEI (DI BARI 
et al., 2004; SPIRA et al., 2016).  
Potential explanations for this discordance among the studies may be the use of 
other drugs and the time using ACEI. Indeed, even though di Bari et al. (2004) proposed that 
longer ACEI use could be associated with larger lower extremity muscle mass, Spira et al. 
(2016) refuted this hypothesis and proposed that ACE inhibitor therapy in skeletal muscle 
decreases over time as negative effects of angiotensin II on muscle tissue become more 
prominent.  
 
 
Figure 13. Renin-angiotensin system, ACEI, and skeletal muscle metabolism.  
Another possible mechanism is based on subclinical renal injury. Indeed, renal 
damage may increase blood pressure levels by many mechanisms (e.g., increased sodium and 
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fluid retention, renin-angiotensin hyperactivation) (HUAN; COHEN; TOWNSEND, 2014) and 
reduced glomerular filtration rate has already been observed in frail patients (NADRUZ et al., 
2016). Nevertheless, findings were based on secondary outcomes and more specific 
investigations are still necessary.    
Low-grade inflammation, increased oxidative stress, and autonomic dysfunction 
are all present in the physiopathology of hypertension (BEEVERS; LIP; O’BRIEN, 2001) and 
observed in frail patients (VARADHAN et al., 2009; ALONSO-BOUZÓN et al., 2014; 
MARZETTI et al., 2019), so that other mechanisms than those abovementioned may be 
responsible for the association between hypertension and frailty. Furthermore, most studies are 
based on a cross-sectional design, and there is still a lack of longitudinal population-based 
studies. 
To collaborate with the current knowledge, the article 11 investigated the 
relationship between frailty using 4 different instruments and office blood pressure, 
hypertension diagnosis, and antihypertensive treatment. 
 
Exercise and Frailty  
The growing knowledge regarding the adverse outcomes associated with frailty 
progression led many scientists worldwide to investigate possible therapies that could 
collaborate with frailty reversion. This topic is under intense debate and exercise training has 
been recognized as powerful tool to help clinicians in the management of frailty (DENT et al., 
2017). Nevertheless, exercise training allows many combinations and is still not clear which 
could be the best exercise training design to counteract frailty.   
In the last years, much attention has been paid to resistance training (RT), given the 
solid evidence on its effects on frailty-related parameters (LOPEZ et al., 2018). Nevertheless, 
most evidence did not investigate the effects of RT protocols on frailty status. In addition, 
studies combined RT with other types of exercise or other health interventions (SEINO et al., 
2017), limiting inferences regarding the impact of RT alone on frailty status (NUNAN, 2019). 
Low-speed (LSRT) and high-speed resistance training (HSRT) are two types of RT, which 
differ in the velocity of concentric muscle contraction. As discussed in the subtopics below, 
both LSRT and HSRT have the potential to reverse frailty. However, this issue is still poorly 
explored in the literature.  
Therefore, the present Ph.D. thesis had, as the main aim, investigate the effects of 
HSRT and LSRT on frailty status (Article 12). Secondarily, was examined the effects of both 
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RT programs on physical performance, cognitive function, and blood pressure, given its close 
association with frailty.   
 
Low-Speed Resistance Training and High-Speed Resistance Training: Physical function 
The importance of RT for the development of muscle strength has been known since 
ancient times (GRIVETTI; APPLEGATE, 1997). It is credited to Theseus the development of 
weightlifting as a sport, given the myth in which the hero had to move a heavy stone to recover 
his father’s tokens to start a journey to Athens. However, the concept of RT, as well as the 
principles of overload and progression, are attributed to Milo of Croton, who won many of the 
most important athletic festivals. According to the legend, Milo walked one-hundred twelve 
steps per day with a four-year-old bull on his shoulders. As time went on, the animal got heavier 
and Milo, stronger. One of the first recommendations of RT for health and physical performance 
were performed by Galen, who argued that Gladiators should not perform too much RT to do 
not become heavy.  
 
 
Figure 14. Theseus lifting the rock; Milo of Croton; and Cladius Galen (130-210 AD).  
Throughout history, the prescription of RT persisted restricted to athletes who 
aimed to improve physical fitness or body shape, while its applications in health, mainly in 
older adults, was limited until the 80’s and early 90’s, when evidence started to report beneficial 
effects of RT programs on muscle mass and strength of older adults (MORITANI; DEVRIES, 
1980; FRONTERA et al., 1988). Notably, such improvements were not only observed in 
community-dwelling older adults, but also in institutionalized patients with limited mobility 
(FIATARONE et al., 1990).  
Since then, many studies have investigated and described the beneficial effects of 
RT or LSRT programs in older adults. These trials explored LSRT protocols based on different 
exercise intensities (KALAPOTHARAKOS et al., 2004) and models of organization 
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(NEWTON et al., 2002; PRESTES et al., 2015; COELHO-JUNIOR et al., 2019), to quote a 
few, enabling the creation of specific guidelines for health professional responsible for exercise 
prescription in older adults (CHODZKO-ZAJKO et al., 2009). According to the American 
College of Sports and Medicine (ACSM), RT is a potent intervention to improve muscle 
strength in older adults, if programs are performed at least 2 days per week at moderate-to-high 
intensity (CHODZKO-ZAJKO et al., 2009).  
Evidence has supported investigations in robust older adults by demonstrating 
improved muscle strength in prefrail and frail older who performed LSRT programs (IKEZOE 
et al., 2005; HESS; WOOLLACOTT; SHIVITZ, 2006; LUSTOSA et al., 2011). Findings from 
a systematic review (LOPEZ et al., 2018) indicated that enhancements in muscle strength in 
frail older adults after RT ranged from 6.6 to 37.0% in the isometric knee extension, and from 
13.1 to 20.5% in leg press.   
Such enhancements in muscle strength in response to LSRT seem to occur in the 
function of improvements on neuromuscular control. According to the size principle of 
Henneman et al. (HENNEMAN; SOMJEN; CARPENTER, 1965), motoneuron and motor units 
(MU) are recruited from smallest to largest. In the light of LSRT, this means that exercise 
intensity and a reduced supply of adequate oxygenation to the muscle due to muscular 
contractions lead to recruitment of largest MU, which have a high content of type II muscle 
fibers, by increasing the number of active MUs (i.e., more type II muscle fibers working 
together) or a more rapid frequency of MU discharges (i.e., greater number of stimulus, in a 
shorter time frame) (MCKINNON et al., 2017).  
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Figure 15. Size principle in the light of Resistance Exercise. 
 Although LSRT has an important influence on muscle strength, its effects on other 
criteria diagnosis for frailty, such as mobility (CHODZKO-ZAJKO et al., 2009) seem to be 
limited. Mobility, the individual’s ability to transfer from a place to another as comfortable as 
possible with reduced risk of falls is one of the five cardinal points of frailty (FRIED et al., 
2001) and is strongly associated with falls (PIAU et al., 2019) and mortality (STUDENSKI et 
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al., 2011), as well as part of the clinical presentation of many diseases, such as stroke and 
Parkinson’s.  
Notably, many investigations in the early 2000’s began to suggest that muscle 
power, the capacity to exert force in a short time interval, declines earlier and faster and is more 
associated with mobility tasks than muscle strength (SUZUKI; BEAN; FIELDING, 2001; 
BEAN et al., 2003; LAURETANI et al., 2003). Findings from the InCHIANTI study, for 
example, indicated that women at 50-60 years of age had a 20-30% reduction on lower-limb 
muscle strength, while muscle power was reduced in ~50% (LAURETANI et al., 2003). 
Researchers also observed that lower limb muscle power showed a slightly higher 
discriminating power in the identification of poor mobility in women in comparison to upper 
limb muscle strength, lower limb muscle strength, and calf muscle area (LAURETANI et al., 
2003). Bean et al. (2003) expanded this view by indicating that older adults with low lower 
limb muscle power had two- to threefold higher odds of limited mobility in comparison with 
those with lower limb muscle strength. In the investigation performed by Suzuki et al. 
(SUZUKI; BEAN; FIELDING, 2001), dorsiflexion peak power was stronger associated with 
chair rise and stair climb performance than plantarflexion and dorsiflexion isometric strength.  
 
Figure 17. Age-related decline in muscle strength and muscle power. Adapted from Lauretani et al. 
(2003).   
These premises led researchers (MISZKO et al., 2003; HENWOOD; RIEK; 
TAAFFE, 2008; RAMÍREZ-CAMPILLO et al., 2014; LOPES et al., 2016) to suggest that RT 
programs based on concentric muscle contractions performed as fast as possible, HSRT, could 
cause greater improvements in mobility tasks than LSRT in older adults. The first studies that 
investigated the effects of HSRT on older adults did not compare HSRT and LSRT but proposed 
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RT protocols composed by many stimuli, including concentric muscle contractions performed 
as fast as possible. In these articles, Professor Häkkinen’s group (1998) found that this type of 
intervention improved many neuromuscular parameters (e.g., muscle strength, muscle power, 
neuromuscular activation).  
Professor Bean’s group was pioneer to compare the effects of HSRT and LSRT 
protocols on the physical function of older adults (BEAN et al., 2003). Researchers investigated 
independent and mobility-limited older adults who performed a traditional LSRT for important 
limb groups based on two sets of 10 repetitions or a HSRT based on task-specific movements 
performed as fast as possible during the concentric action. Similar improvements on Short 
Physical Performance Battery (SPPB) were observed after both LSRT and HSRT, while a post 
hoc analysis indicated that greater enhancements were observed in older adults with velocity 
limitations after HSRT. One major limitation of this study is that RT programs were not 
equalized according to exercise total volume, limiting extrapolations.        
Subsequent studies found greater (MISZKO et al., 2003; RAMÍREZ-CAMPILLO 
et al., 2014; LOPES et al., 2016) or similar (HENWOOD; RIEK; TAAFFE, 2008) 
improvements in mobility tasks after HSRT in comparison to LSRT. Investigations compared 
equalized RT protocols (RAMÍREZ-CAMPILLO et al., 2014; LOPES et al., 2016) or HSRT 
using less total workload per exercise sessions (HENWOOD; RIEK; TAAFFE, 2008). The 
programs occurred from 12 to 16 weeks using exercise machines and weight vests and 
intensities ranged from 40% to 75% of 1RM.  
Systematic review and metanalyses (TSCHOPP; SATTELMAYER; HILFIKER, 
2011; ORSSATTO et al., 2019) supported these findings by indicating that HSRT caused slight 
greater improvements in mobility than LSRT, but authors indicated that both RT protocols seem 
to be clinically compatible. It is worth mentioning that investigations were based on physically 
healthy older adults, short-term RT protocols, and expensive exercise machines, limiting 
extrapolations for prefrail and frail older adults. 
Indeed, evidence comparing LSRT and HSRT in frail people is still scarce, but 
studies investigated exercise programs using high-velocity muscle contractions have reported 
encouraging data (IZQUIERDO; CADORE, 2014). Nevertheless, expert opinions (CADORE; 
IZQUIERDO, 2018; FRAGALA et al., 2019) have encouraged the inclusion of HSRT on 
exercise programs for frail older adults. According to researchers, perform concentric muscle 
contractions as fast as possible would be crucial to improve mobility and restore independence. 
The plausibility behind this hypothesis is based on a neuromuscular component 
summed to the biomechanical particularities of each mobility task. High-velocity muscle 
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contractions are supposed to recruit type II muscle fibers to a similar or greater extent as LSRT 
(MCKINNON et al., 2017). Regarding the biomechanical perspective, it is suggested that 
crucial moments of some mobility tasks (e.g., plantar flexion to lift from the chair) are more 
dependent of fast than strong movements.  
However, it is still unknown if HSRT may cause greater improvements in mobility 
than LSRT in prefrail and frail older adults.   
 
Low-Speed Resistance Training and High-Speed Resistance Training: Cognition 
Cognition may be understood as the expression of brain activity by which the mind 
interacts with the world (ASSOCIATION, 2019). Although cognitive parameters are not part 
of the criteria diagnosis for physical frailty (FRIED et al., 2001), this variable has been included 
in other instruments (e.g., KCL)(SEWO SAMPAIO et al., 2016b), and observational studies 
have found that frail people are at higher risk for cognitive decline (GRANDE et al., 2019; 
MIYAMURA et al., 2019). 
The effects of RT on cognitive function are still poorly explored and the few 
available studies have reported contradictory results. A systematic review and metanalysis of 
18 studies reported that different adaptations in response to RT are observed according to 
cognitive levels, so that overall cognitive function is improved in demented older adults, while 
short-term memory was increased in cognitively intact older adults (Article 13). 
Cardalda et al. (2019) and Yoon et al. (2017) observed improved overall cognitive 
function in frail older adults. This view was expanded by Van de Rest et al. (2014), who found 
increased digit span, attention, and working memory performances in prefrail and frail older 
adults after a 24-week LSRT program. To the best of our knowledge, only Yoon et al. (2018) 
compared the effects of HSRT and LSRT, and results demonstrated similar improvements in 
overall cognitive function after both protocols of RT. 
The article 14 compared the acute effects of low-speed resistance exercise (LSRE) 
and HSRE (HSRE) on memory, inhibitory control, and attention. Findings suggested that both 
exercise protocols improved learning memory immediately after the exercise session, but 
transitory improvements were only sustained after LSRE after one hour.  
 
Low-Speed Resistance Training and High-Speed Resistance Training: Blood Pressure 
The effects of RT on the blood pressure of older adults has long been explored. 
Evidence has been accumulated that different designs of RT may reduce baseline blood pressure 
in hypertensive and normotensive older adults (FARIA TERRA et al., 2008; MORAES et al., 
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2012; MOTA et al., 2013; COELHO-JUNIOR et al., 2018c). These findings are supported by 
systematic reviews and metanalyses (CORNELISSEN; SMART, 2013; MACDONALD et al., 
2016).  
The main concern regarding the prescription of LSRT for the management of blood 
pressure in older adults is based on the fact that this kind of intervention may elicit exaggerated 
blood pressure responses (FLECK; DEAN, 1987), increasing the risk of acute events during or 
after the exercise session. In contrast, authors (COELHO-JUNIOR et al., 2018d) have argued 
that HSRT protocols may elicit significant reductions on blood pressure, while individuals are 
submitted to low cardiovascular and osteoarticular stress.  
Recent seminal observations made by our group reported significant post-exercise 
hypotension (PEH) in community-dwelling older women after an acute session of high-speed 
resistance exercise (COELHO-JUNIOR; AGING; 2017). These findings were supported by 
Machado et al. (2019), who observed lower SBP and DBP values in older adults with type II 
diabetes mellitus. On the other hand, Orsano et al. (2018) did not observe significant effects of 
HSRE on the blood pressure of community-dwelling older women. In frail people, the Article 
15 reports that a longer time reduction in SBP and an exclusive decrease in MAP are observed 
after LSRE in comparison to HSRE. 
To the best of our knowledge, only one study investigated the chronic effects of 
HSRT on the blood pressure of older adults. In this study, Coelho-Junior et al., (COELHO-
JUNIOR et al., 2018d) did not observe significant changes in blood pressure values after a 22-
week RT program composed by HSRT and LSRT sessions. However, there is no evidence in 
prefrail and frail older adults. 
50 
 
 
ARTICLES 
ARTICLE 1 
 
If my muscle could talk: Myokines as a biomarker of frailty 
Hélio J. Coelho-Juniora,b,⁎, Anna Piccaa,c, Riccardo Calvania,c, Marco C. Uchidab, Emanuele Marzettic 
a Università Cattolica del Sacro Cuore, Rome, Italy b Applied Kinesiology Laboratory–LCA, School of Physical Education, University of Campinas, 
Campinas, SP, Brazil c Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy 
 
A R T I C L E I N F O A B S T R A C T 
Keywords: 
Sarcopenia 
Mobility 
Disability 
Aging 
Exercise 
Frailty is a potentially reversible state of increased vulnerability to negative health-related outcomes that occurs as a result of 
multisystem biological impairment and environmental aspects. Given the relevance of this condition in both clinics and research, 
biomarkers of frailty have been actively sought after. Although several candidate biomarkers of frailty have been identified, none of 
them has yet been incorporated in the assessment or monitoring of the condition. Over the last years, increasing research interest 
has been focused on myokines, a set of cytokines, small proteins and proteoglycan peptides that are synthetized, expressed and 
released by skeletal myocytes in response to muscular contractions. Myokines may act in autocrine, paracrine, and endocrine 
manner and regulate several processes associated with physical frailty, including muscle wasting, dynapenia, and slowness. This 
review discusses the rationale to support the use of myokines as biomarkers of frailty in older adults. 
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1. Introduction 
Frailty is a highly prevalent condition among older adults, and is 
defined as a potentially reversible state of increased vulnerability to 
negative health-related outcomes (Collard et al., 2012). This 
condition occurs as a result of multisystem biological derangements 
that impact the organismal ability to maintain homeostasis after a 
stressor event (van Kan et al., 2010; Clegg et al., 2013; Morley and 
Malmstrom, 2013; Choi et al., 2015). Social factors may also have a 
role in frailty development, given that many environmental aspects, 
such as separation from both parents during early life (Haapanen et 
al., 2018), adult experiences with bad (e.g., social insecurity, noise 
neighborhood) and poor (e.g., lack of street lighting, recreation) 
neighborhoods (Desrichard et al., 2018), and difficult to cope with 
stressful events (Gobbens, 2019) are associated with this condition. 
As frailty progresses, the individual may experience a number 
of negative events, such as fractures, disability, hospitalization, 
nursing home placement, and death (Kojima, 2016, 2017). As such, 
frailty represents a major public health problem (Collard et al., 
2012). 
The impact of frailty on older people's wellbeing and on the 
sustainability of healthcare systems has instigated intense research on 
its biological determinants. As a corollary to this, many research 
groups have been looking for biomarkers that could be used to predict 
the risk of frailty and its progression in attempt to prevent its 
development and avoid its negative outcomes (Calvani et al., 2015, 
2017, 2018a; Wang et al., 2019). Despite the fact that several 
biomolecules have been proposed as frailty biomarkers, none of them 
has shown to capture the complexity of the condition, which indicates 
that there is still a long way to go and the need for a broad 
understanding of the possible candidates. 
Recent evidence indicates that myokines, molecules that are 
expressed, synthetized and released by skeletal myocytes in response 
to muscular contractions (Pedersen et al., 2003, 2004, 2013), regulate 
several processes associated with physical frailty, including muscle 
wasting, dynapenia, and slowness (Pedersen and Hojman, 2012; Kim 
et al., 2019). However, few studies have reported empirical findings 
regarding the association between myokines and frailty. This review 
discusses the rationale to support the use of myokines as biomarkers 
of frailty in older adults. 
2. Biomarkers of aging 
The notion of time is commonly based on a measurement that can 
be expressed in seconds, minutes, hours, etc. In the ancient Greek, 
however, time could be expressed as Chronos (Χρόνος) or Caerus 
(Καιρός). 
While Chronos is the personification of chronological time, linearity, 
quantification; Caerus represents favorable moments, moments of 
good feelings, opportunity, quality (Bulfinch, 2009; Buxton, 2004). 
Therefore, in a conversation about a train trip, Chronos would 
probably focus on the time spent sitting in the train, while Caerus 
would focus on the opportunity to talk and observe beautiful 
landscapes, even if for short periods of time. 
Similarly, the current notion of aging avoids the simplistic view 
that this process is only determined chronologically and proposes that 
aging is a highly heterogenous, nonlinear phenomenon influenced by 
many factors, including the genetic background, environment, and 
diseases (Baker and Sprott, 1988; Bürkle et al., 2015; Bai, 2018; 
Levine and Crimmins, 2018). Indeed, although aging is observed in 
many species, it is not universal, since some species show no age-
related increase in mortality or decline in fertility (Kirkwood, 2002). 
In most mammals, including humans, aging is determined by the 
capacity of the organism to cope with physical, chemical, and 
biological agents over the course of life (Franceschi et al., 2006, 
2018), which is largely influenced by the genetic background and 
exposure to damage, causing the emergence of high heterogeneity 
within individuals of the same species (Levine, 2013). 
Consequently, chronological age (CA), which is determined by 
the simple flow of time and expresses no more than for how long a 
person is alive, might not be the best indicator of body's age (Baker 
and Sprott, 1988; Bürkle et al., 2015; Mitnitski et al., 2016; Bai, 
2018), and has been indicated only as a proxy for the rate of aging 
(Levine, 2013). On the other hand, biological age (BA), the sum of 
empirical biomarkers of health (e.g., DNA methylation, physical 
function, cytokines) into a single variable by a mathematic 
regression, is strongly influenced by environmental factors and 
genetic differences taking into account the heterogeneity of people 
with the same CA (Mitnitski et al., 2016; Levine and Crimmins, 
2018). Hence, compared with CA, BA provides a more realistic 
representation of a person's biological health status. As a matter of 
fact, BA has shown to a better predictor of negative outcomes and 
death than CA independent of individual diseases and traditional risk 
factors (Levine, 2013; Soriano-Tárraga et al., 2017, 2018). 
The concept of biomarker of aging, first proposed by Baker, in 
1998, refers to a biological parameter able to predicts the functional 
status of an individual better than CA. Due to the variability of aging, 
it is unlikely that a single biomarker may provide a valid measure of 
BA (Wagner et al., 2016), which might instead be offered by the 
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combined assessment multiple genes, proteins, metabolites, and even 
other markers, such as physical performance (Bai, 2018). 
The criteria of the American Federation for Aging Research 
(AFAR) (2016) indicate that a biomarker of aging must: a) predict 
the rate of aging; b) monitor a basic process that underlies the aging 
process, not the effects of disease; c) be able to be tested repeatedly 
without harming the person (e.g., blood test); and d) be something 
that works in humans and in laboratory animals (e.g., mice). 
Nevertheless, some researchers argued that the last parameters might 
be questioned, given that preclinical models could show some 
biological differences in comparison to humans, limiting 
comparisons among the species (Bürkle et al., 2015). 
Finding a robust and specific biomarker of aging according to 
AFAR criteria might be very a difficult mission, given that age is 
associated with many syndromes and diseases. To overcome such an 
obstacle, several investigations have started searching for biomarkers 
conditions intrinsic to the aging process, such as sarcopenia and 
frailty, instead of aging per se. Recent advances in the field of frailty 
biomarkers are briefly discussed in the following sections. 
3. Challenges in frailty biomarker discovery 
Frailty is defined as a reversible state of increased vulnerability 
to health-related negative outcomes, including disability and 
mortality, which occurs separated and faster than normal aging 
process in response to a multisystem impairment of the human body 
(van Kan et al., 2010; Clegg et al., 2013; Morley and Malmstrom, 
2013; Choi et al., 2015). Although large agreement exists regarding 
the clinical relevance of frailty, its operationalization is still 
hampered by the absence of a univocal definition. Indeed, more than 
60 different instruments for the assessment of frailty are currently 
available, with limited concordance across them (Buta et al., 2016; 
Faller et al., 2019). 
Many theorical models of frailty have been proposed over the 
years (Morley et al., 2013), which are inspired by two seminal 
models: a) the phenotype model (Fried et al., 2001) and b) the 
cumulative deficit model or multidomain model (Rockwood et al., 
2005). 
Fried et al. (2001) developed and operationalized the phenotype 
model of frailty by analyzing 5317 older adults from the 
Cardiovascular Health Study (CHS). Researchers established the 
frailty phenotype based on five elements: 1) unintentional weight 
loss; 2) dynapenia; 3) fatigue; 4) poor mobility; and 5) inactive 
lifestyle. The classification is quantitative, so that people with three 
or more factors are classified as frail, while those with one or two 
factors are considered pre-frail. Alternatively, Rockwood et al. 
(2005) proposed the Clinical Frailty Scale (CFS), which is based on 
the cumulative deficit model. The scale is composed of 70 clinical 
deficits, including the presence and severity of diseases, ability to 
perform basic activities, and cognitive status, to quote a few. A score 
is assigned to each the 70 items, and then an overall score ranging 
from 1 (i.e., very fit) to 7 (i.e., severely frail) is eventually calculated. 
The diversity of the two major frailty constructs is a major 
obstacle to the comprehension of the pathophysiology of frailty. 
Nevertheless, multiple biological hypothesis have been proposed to 
explain frailty, such as anemia, abnormal hormonal levels, 
dysregulation of inflammatory process, oxidative stress, 
mitochondrial dysfunction, and cellular senescence (Fried et al., 
2009; Sieber, 2017). However, the time-course of the interaction 
between two or more biological systems over the course of life 
leading to frailty is currently unknown, and the most plausible 
explanation is that frailty occurs in response to a nonlinear and 
heterogenous process (Fried et al., 2009; Pijpers et al., 2012). Note 
that an illustration of this theory was provided by Fried et al. (2009), 
who observed that different combinations of three or more systems at 
abnormal level were significant predictors of frailty, regardless of the 
nature of individual systems. 
Recently, the notion of heterogeneity in frailty has been expanded 
by the introduction of the concept of fluctuation in frailty, that is the 
within-individual variability in the frail state over the long-term 
frailty trajectory, which can be thought as a sign of loss of 
homeostasis (Stolz et al., 2019). 
Based on these premises, frailty may be envisioned as a highly 
heterogeneous condition, with substantial variations inter- and 
withinsubjects, caused by a nonlinear decline in the function of some, 
but none in particular, inter-related biological systems. Although the 
pathophysiology of frailty is largely unclear and its clinical appraisal 
depends of the assessment tool used, a notable overlap in many 
clinical signs and frailty outcomes may be observed between frailty 
constructs, including increased risk of falls, disability, fracture, and 
death (Ensrud et al., 2008, 2009; Pilotto et al., 2012), which suggests 
that common elements work together in the development and 
progression of frailty. In this scenario, the search for biomarkers of 
frailty has been an emergent and active field of research, given that 
alterations in biological markers may precede the clinical 
manifestations of frailty, possibly allowing timely corrective 
interventions (Calvani et al., 2015, 2017, 2018a; Wang et al., 2019). 
Frailty biomarkers could also serve to comprehend the underlying 
pathophysiology, besides being relevant targets in clinical decision-
making and randomized clinical trials (Calvani et al., 2015, 2017, 
2018a; Wang et al., 2019). 
Considerable research effort has been provided by different 
laboratories and many candidate biomarkers for frailty have been 
proposed, such as proinflammatory markers (e.g., TNF-alpha, C 
reactive protein [CRP]), neuroendocrine markers (e.g., testosterone, 
vitamin D), and metabolic markers (e.g., glycated hemoglobin 
[HbA1c]), to quote a few (Saedi et al., 2019). Nevertheless, the 
perspective of a single biomarker of frailty is unlikely, and it is 
argued that there is not one biological marker that reliably tracks the 
multitude of frailty (Calvani et al., 2015). In this sense, the 
identification of the largest number of possible molecules may 
collaborate to develop a model able to predict this condition and 
clarify its physiopathology. 
4. Why could myokines be useful biomarkers of frailty? 
The skeletal muscle is the largest organ of human body and 
constitutes about 40% of the total body mass in non-obese adults. 
Once regarded simply as the biological substratum of locomotion, the 
skeletal muscle is now recognized as the largest protein reserve in the 
body, the primary site for the regulation of glucose metabolism, and 
the major energy consumer, with a pivotal role in body metabolism 
(Fougère et al., 2015). Furthermore, the skeletal muscle tissue 
communicates with many other systems (e.g., nervous, endocrine, 
immune) by the synthesis and release of molecules collectively called 
myokines. 
The existence of a muscle factor was first proposed by Goldstein 
(1961), based on the observation that a humoral factor could mediate 
exercise-induced hypoglycemia. However, this metabolic 
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perspective remained unexplored for decades, and many researchers 
in the 90's argued that the increased levels of circulating cytokines 
observed after exercise occurred due to the adherence and activation 
of neutrophils and macrophages recruited in response to exercise-
induced muscle damage and fibers disruption (Drenth et al., 1995; 
Ostrowski et al., 1998b). This view was based on the fact that 
systemic concentrations of some inflammatory factors, mainly 
interleukin (IL)-6, increased exponentially during and after exercise 
to levels similar to those observed after a trauma (Ostrowski et al., 
1998a). However, in the early 2000's, evidence began to emerge that 
contracting skeletal muscles were the major source of IL-6 produced 
during exercise (Jonsdottir et al., 2000; Steensberg et al., 2000). In 
the investigation by Jonsdottir et al. (2000), researchers observed that 
IL-6 mRNA levels were similarly increased (~20-fold) after 
concentric and eccentric contractions, but not after resting, in the calf 
muscles of rats. Similarly, Steensberg et al. (2000) found that 
contracting skeletal muscles were the major source of IL-6 
production during exercise. These findings changed the assumption 
that systemic levels of cytokines during and after exercise were 
exclusively derived from immune cells and led to the hypothesis that 
IL-6 could be functioning in a hormone-like fashion to help regulate 
glucose homeostasis (Gleeson, 2000; Steensberg et al., 2000). 
According to Gleeson (2000), the depletion on muscle glycogen 
stores during exercise could be the triggering factor to the increase of 
IL-6 levels, which would signal the liver to increase hepatic 
glycogenolysis and glucose release in the attempt to maintain glucose 
homeostasis and avoid muscle fatigue. These premises were 
confirmed by the observation that muscular glycogen content was a 
critical determinant regulating the IL-6 response to exercise (Keller 
et al., 2001; Steensberg et al., 2001), and that glucose ingestion 
during exercise attenuated the exercise-induced increase in IL-6 
levels (Henson et al., 2000; Nieman et al., 2003). 
At that time, Pedersen and coworkers first proposed the term 
myokine (Pedersen et al., 2003, 2004), to identify any molecule, 
including IL-6, expressed, produced and released by active skeletal 
muscles and exerting either paracrine or endocrine effects. 
Nowadays, myokines are conceptualized as molecules, cytokines or 
signaling peptides expressed, synthetized and released by skeletal 
muscle fibers in response to muscular contractions with pluripotent 
effects (Pedersen and Hojman, 2012; Kim et al., 2019; Lee and Jun, 
2019). Indeed, not only IL-6, but many other myokines (e.g., 
myostatin, irisin, IL-15) have been studied due to their possible 
autocrine, paracrine, and endocrine effects on numerous metabolic 
process, including energy expenditure, lipid (e.g., lipolysis, 
adipocyte browning, fat-free acids oxidation), muscular (e.g., glucose 
uptake) and liver (e.g., glycogenolysis and glycogenesis) 
metabolism, and insulin sensitivity (to review see Pedersen et al., 
2007; Pedersen and Febbraio, 2008; Pal et al., 2014; Ahima and Park, 
2015; Huh, 2018). 
According to proteomic studies, approximately 60 myokines are 
regulated in response to muscle contraction (Raschke et al., 2013), 
while ~40 different myokines have a role in muscle differentiation 
(Ojima et al., 2014). Nevertheless, some research groups have argued 
that many muscle-derived factors need further evaluation regarding 
their biological activity and function to be appropriately 
characterized as myokines (Kim et al., 2019; Lee and Jun, 2019). 
In addition, the identification of skeletal muscle as an active 
endocrine organ allows the investigation of the role of myokines in 
other important physiological process, such as muscle wasting and 
renewal, mitochondrial activity, and inflammation, to quote a few. 
Indeed, myokines have been suggested as a possible mediator for the 
positive effects of regular exercise training on human body (Pedersen 
and Hojman, 2012; Pratesi et al., 2013; Kim et al., 2019). Hence, 
myokines are possibly essential components of whole-body 
homeostasis. It follows that alterations in the synthesis, secretion and 
downstream signaling of myokines could potentially contribute to the 
development of metabolic (Carson, 2017; Garneau and Aguer, 2019), 
cardiovascular (Ouchi et al., 2016), kidney (Ebert and Kralisch, 
2016), hepatic (Yang and Luo, 2017), and bone (Guo et al., 2017) 
diseases. 
Furthermore, myokines may directly impact some variables 
associated with frailty, which allows the proposal of two theorical 
models: a) sarcopenia hypothesis and b) hypokinesia hypothesis. 
4.1. The sarcopenia hypothesis 
Sarcopenia, or, as recently suggested, muscle failure (Suetta and 
Maier, 2019), is a chronic degenerative neuromuscular disease 
(Anker et al., 2016) encompassing dynapenia, muscle atrophy, and 
low physical performance (Cruz-Jentoft et al., 2018). This condition 
has been considered a public health problem, given its possible 
adverse outcomes (e.g., disability, institutionalization, death) (Hirani 
et al., 2015; Locquet et al., 2019), high prevalence in older adults 
worldwide (Ethgen et al., 2017; Shen et al., 2019; Su et al., 2019), 
and costs for public health (Beaudart et al., 2014). 
During aging, several biological processes, including 
inflammation (Marzetti et al., 2009; Coelho Junior et al., 2016), 
oxidative stress (Marzetti et al., 2009), and mitochondrial 
dysfunction (Marzetti et al., 2010, 2013; Picca et al., 2019), 
contribute to muscle protein breakdown and muscle atrophy. In 
contrast, physical exercise (Morton et al., 2018) and increased protein 
consumption (Calvani et al., 2018b; CoelhoJunior et al., 2018a, 
2018b; Coelho-Junior et al., 2019) counteract agerelated muscle loss. 
Interestingly, myokine expression is induced under both anabolic and 
catabolic conditions, with local and systemic effects. At the time, the 
direct implication of insulin-growth factor 1 (IGF-1), myostatin, 
irisin, decorin, and myonectin on muscle mass regulation has been 
described (Fig. 1). 
The IGF-1/Akt/mammalian target of rapamycin (mTOR) 
pathway is integral to the stimulation of protein synthesis (Glass, 
2003; Zhang et al., 2007; Bonaldo and Sandri, 2013; Coelho Junior 
et al., 2016). After being secreted by contracting skeletal muscles 
(Musaro et al., 2001), IGF-1 binds to the tyrosine kinase IGF-1 
receptor in the lipid bilayer and recruit insulin receptor substrate 1 
(IRS-1) (Latres et al., 2005), which leads to the phosphorylation and 
activation of phosphatidylinositol 3-kinase (PI3K) (Glass, 2003; 
Zhang et al., 2007). Once active, PI3K triggers a number of 
downstream pathways, including the creation of the lipid binding site 
to Akt, activation of mTOR, and phosphorylation and activation of 
p70s6k (Stitt et al., 2004; Latres et al., 2005), eventually leading, to 
increased ribosomal biogenesis and protein translation (Bodine et al., 
2001; Latres et al., 2005; Csibi et al., 2010; Lamas et al., 2010). 
Alternatively, IRS-1 receptor, Akt and mTOR can be activated by 
myonectin (CTRP15), a myokine related with nutritional status and 
lipid metabolism (Seldin et al., 2012). This view is supported by the 
fact that myonectin significantly induces phosphorylation of IRS-1, 
Akt, and mTOR, as well as suppresses the transcription of autophagy 
genes (i.e., Atg7 and Atg12) in cultured hepatocytes and in the mouse 
liver (Seldin et al., 2013). Hence, myonectin can either act alone or 
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potentiate the IGF-1/PI3K/Akt/mTOR pathway. Whether these 
pathways are relevant to muscle physiology has yet to be proven. 
Myostatin is as a negative regulator of muscle mass from 
embryogenesis to adult life, impairing muscle synthesis and 
increasing muscle catabolism (Tobin and Celeste, 2005; Carnac et al., 
2006; Durieux et al., 2007). Once activated, myostatin activates 
activin type II receptor and consequently activin type I receptor, 
which phosphorylates and activates small mother against 
decapentaplegic (SMAD) proteins, mainly SMAD2 and SMAD3, 
forming a complex with SMAD4 that migrates to the nucleus and 
upregulates the transcription of target catabolic genes (Carnac et al., 
2006; Trendelenburg et al., 2009). In addition, myostatin can induce 
muscle loss by stimulating and activating the ubiquitin proteasome 
system (UPS) and by impairing the activation of Akt, satellite cells, 
and myogenic factors (e.g., MyoD) (Durieux et al., 2007; 
Trendelenburg et al., 2009). 
Decorin is a member of the small leucine-rich proteoglycan 
family and it is a component of the extracellular matrix (Guiraud et 
al., 2012). Decorin expression is significantly increased in 
contracting myotubes and skeletal muscle samples obtained from 
exercised mice (Kanzleiter et al., 2014). In humans, plasma decorin 
is increased after acute and chronic exercise (Kanzleiter et al., 2014). 
This myokine is thought to act as a counter-regulator of myostatin by 
binding and inactivating myostatin (Guiraud et al., 2012; El Shafey 
et al., 2016). This inhibits the activation of SMAD 2/3 complex 
possibly reducing muscle protein degradation (El Shafey et al., 
2016). Indeed, intramuscular injection of decorin significantly 
induced muscle hypertrophy in pre-clinical models of muscle 
dystrophy (Guiraud et al., 2012). 
Recently, Reza et al. (2017) found that irisin-treated C2C12 
myotubes showed increased expression of genes associated with 
satellite cell regulation, skeletal muscle regeneration, muscle growth, 
and myogenesis. To expand their observations, researchers injected 
recombinant irisin in mice and observed upregulation of Akt, mTOR, 
and p70s6k genes, followed by noticeable muscle hypertrophy and 
increased muscle strength. Interestingly, the regulation of muscle 
mass by irisin does not seem to be restricted to muscle protein 
synthesis, since gene expression of Atrogin-1 and muscle RING-
finger protein-1 (MuRF1), two ubiquitin ligases with important roles 
in ubiquitin-mediated protein degradation, were down-regulated in 
muscles of irisin-treated animals. 
Although muscle atrophy does not completely explain age-
related dynapenia, the progressive loss of muscle mass contributes to 
declining muscle strength/power and physical function during aging 
(Lauretani et al., 2003; Doherty, 2003; Goodpaster et al., 2006; 
Aagaard et al., 2010; Marzetti et al., 2018). Furthermore, the 
development of sarcopenia may influence the synthesis and release 
of myokines, as reflected by the fact that pre-sarcopenic and 
sarcopenic older women showed significantly lower serum irisin 
concentrations than non-sarcopenic peers (Park et al., 2019). 
In this scenario, a looping back model may be proposed, in which 
myokines signaling is altered during sarcopenia, thereby contributing 
to muscle atrophy, dynapenia, and reduced physical performance. 
Muscle failure, in turn, may lead to reduced expression and synthesis 
of myokines in response to muscle stimulation, aggravating muscle 
wasting. 
The impact of this loop on frailty appears clearer if sarcopenia is 
envisioned as the biological substratum of physical frailty and the 
pathophysiological pathway through which negative health-related 
outcomes of frailty occur (Landi et al., 2015). Indeed, weight loss, 
dynapenia, and poor mobility are convergent clinical features of the 
two conditions, while low physical activity levels are commonly 
associated with sarcopenia development (Steffl et al., 2017; Lee et al., 
2018). Although myokine signaling influences and is influenced by 
sarcopenia, no direct evidence exists about the association between 
myokines and physical frailty. On the other hand, a deeper 
understanding of myokine signaling is worth being pursued for both 
frailty biomarker discovery and the identification of intervention 
targets. 
4.2. The hypokinesia hypothesis 
Although the ability to coordinate different types of physical 
capabilities (e.g., walk, run, climb) has been instrumental to human 
evolution, the comforts of current high technological world have led 
to the acquisition of an increasingly hypokinetic behavior. 
According to the World Health Organization (WHO) (2014), 
physical inactivity increases with age, such that more than 30% of 
adults worldwide show insufficient daily physical activity levels. 
This scenario is particularly critical given that physical inactivity has 
been identified as a major risk factor for coronary heart disease, type 
2 diabetes, and breast cancer colon cancer (Lee et al., 2012a, 2012b). 
On the other hand, engagement in regular physical activity, any 
body movement that is produced by the contraction of skeletal 
muscles and that increases energy expenditure (Chodzko-Zajko et al., 
2009), and/or physical exercise, a planned, structured, and repetitive 
movement to improve or maintain physical fitness (Chodzko-Zajko 
et al., 2009), has shown to improve quality of live, prevent and treat 
several medical disorders, and avoid early death (Pedersen and Saltin, 
2006; Lee et al., 2012a, 2012b). 
Since the discovery of myokines and the regulation of their 
secretion by muscle contraction, researchers have proposed that long-
term benefits of physical activity and exercise may be, at least in part, 
mediated by myokine actions (Pedersen and Hojman, 2012; 
Pedersen, 2013). Indeed, systemic concentrations of many myokines, 
including irisin, IGF-1, brain-derived neurotrophic factor (BDNF), 
are increased in older adults following exercise training (Cassilhas et 
al., 2007; Forti et al., 2015; Tibana et al., 2017; Zhao et al., 2017). 
Based on these premises, if the endocrine function of muscle is 
not stimulated by sufficient levels of physical activity or exercise, the 
synthesis and release of myokines will be limited, which may 
contribute to malfunction of several organs (Pedersen and Febbraio, 
2008). Over time, such a biological environment may predispose to 
the development of frailty. 
5. Myokines and frailty parameters 
Currently, only a few studies have investigated the association 
between frailty and myokines in older adults. This lack of evidence 
certainly limits our discussion and the extrapolation of our models. 
Results from the Women's Health and Aging Study (WHAS) 
indicated that both prefrail and frail older women according to Fried's 
criteria tend to have lower systemic IGF-1 levels than age-matched 
nonfrail counterparts (Cappola et al., 2009; Leng et al., 2009). Using 
data from the Health in Men Study (HIMS), Yeap et al. (2013) 
observed that community-dwelling older men with low plasma IGF-
1 levels were more likely to be frail, while those without frailty but 
with low plasma IGF-1 levels were more likely to develop frailty over 
three years of follow-up. 
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It is possible to observe that investigations were restricted to the 
study of IGF-1, which was explored as a part of the growth hormone–
IGF-1 axis. However, results from observational studies 
demonstrated a significant relationship between systemic myokines 
levels and some PF parameters. These findings are presented in the 
following sections. 
5.1. Myokines and physical function 
Although a clear temporal course connecting declines in physical 
function and the development of disability is difficult to propose, it is 
possible to suggest that muscle weakness, fatigue, slowness, and low 
levels of physical activity are closely related. Therefore, findings 
regarding these parameters are presented in the same section. 
Findings from observational studies in older adults indicate a 
significant association between IGF-1 and muscle weakness (Onder 
et al., 2006; Taekema et al., 2011; Bucci et al., 2013; Vestergaard et 
al., 2014), slowness (Birnie et al., 2012; Doi et al., 2016), and 
disability (Cappola et al., 2003; Doi et al., 2016); myostatin and 
muscle weakness (Fife et al., 2018); and IL-15 and muscle weakness 
(Yalcin et al., 2018). 
Notably, the UK-based Caerphilly Prospective Study showed that 
one standard deviation (SD) increase in serum IGF-1 was associated 
with 1.5% faster mobility over 19 years of follow-up (Birnie et al., 
2012). In addition, Cappola et al. (2003) selected a random sample 
from the WHAS I and observed that low systemical IGF-1 levels 
combined with elevated pro-inflammatory markers conferred a 
higher risk for progressive functional decline, ADL disability, and 
death. 
Interestingly, some studies demonstrated a significant 
relationship between IGF binding protein (IGFBP) and muscle 
weakness (Onder et al., 2006), mobility (Onder et al., 2006; Birnie et 
al., 2012), short physical performance battery (SPPB) scores (Onder 
et al., 2006), and disability (Taekema et al., 2011), which suggests 
that the assessment of binding proteins may be related to physical 
function more than IGF-1 concentrations. 
5.2. Myokines and muscle wasting 
Numerous investigations demonstrated an association between 
myostatin and muscle wasting. However, most findings derive from 
samples composed by participants with different chronic diseases, 
instead of healthy people. Indeed, myostatin is inversely correlated 
with total-body skeletal muscle mass in patients with chronic 
obstructive pulmonary disease (CPOD) (Ju and Chen, 2012). In 
adults with heart failure (HF), myostatin was independently 
associated with muscle wasting (Furihata et al., 2016), and so was in 
patients on hemodialysis (Delanaye et al., 2019). In addition, 
Delanaye et al. (2019) observed that serum levels of myostatin and 
IGF-1 predicted 1-year mortality in patients on hemodialysis. 
Regarding older adults, in one of the few available reports on this 
matter, Yarasheski et al. (2002) found that serum myostatin 
immunoreactive protein was inversely associated with muscle mass/ 
height2 and fat free mass. More recently, Peng et al. (2018) 
investigated a random subsample from the I-Lan Longitudinal Aging 
Study (ILAS) and observed that myostatin was an independent risk 
factor for low relative appendicular muscle mass in men, but not in 
women. Differences among the results are mainly related to the 
assessment tool used to characterize frailty, suggesting that the 
association between myokines and PF parameters may be 
assessment-dependent. 
6. Challenges 
In the present review, we have discussed the prospect of using 
myokines as biomarkers of frailty. Only a limited number of 
myokines have been studied in relation to frailty or frailty-related 
parameters. 
The main concern regarding the use of myokines as biomarkers of 
frailty resides in the difficulty intrinsic to their assessment and 
interpretation. Indeed, while, basal levels of irisin, IGF-1, and 
myostatin, to quote a few, may reflect their synthesis rates in the 
skeletal muscle; systemic levels of other myokines result from their 
production by various tissues and cell types. In fact, IL6, for example, 
can be produced by almost any cell type under appropriate 
stimulation (Garneau and Aguer, 2019), and many investigations 
have studied IL6 as a pro-inflammatory cytokine with significant 
associations with lower muscle mass (Visser et al., 2002), muscle 
weakness (Visser et al., 2002; Schaap et al., 2006), and sarcopenia 
(Payette et al., 2003). Nevertheless, its role as a myokine has been 
only marginally explored. Similarly, BDNF is thought to be 
synthetized and released by both muscle and brain tissues (Lee and 
Jun, 2019), and it may be able to cross the blood-brain barrier (Pan et 
al., 1998). Finally, some researchers have argued that the list of 
myokines is much more limited than that proposed by proteomic and 
genomic studies. This implies that additional research is necessary to 
characterize these molecules as myokines, before testing their 
association with clinical outcomes (Di Raimondo et al., 2017; 
Garneau and Aguer, 2019). 
Future studies aimed at investigating myokines as biomarkers of 
frailty should include the assessment of poorly studied biomolecules 
(e.g., irisin) alone or in combination with other well-established 
parameters (e.g., muscle strength), given that this approach may 
provide further interesting findings than the use of a single parameter 
(Cappola et al., 2003; Delanaye et al., 2019). Furthermore, since 
skeletal muscle contraction is likely the primary stimulus for 
myokine synthesis and secretion, myokine baseline levels may not 
reflect the muscle biosynthetic capacity. Hence, future studies should 
also investigate if acute changes in myokine levels after an exercise 
session are related with frailty. Finally, studies should use several 
techniques to investigate if the molecular expression of such 
myokines in the active muscle may represent the systemic levels. 
7. Final considerations 
Myokines shows potential to be used as biomarkers of frailty 
based on sarcopenia and sedentary models. However, the lack of 
empirical evidence on this issue indicates that there is still a long road 
ahead to understand which, how, and when myokines should be 
assessed to better reflect their muscle synthesis rate. Such findings 
could be very important in the context of biomarkers, contributing to 
the generation of models to predict frailty based on myokines alone 
or combined with other biomarkers. Declaration of competing 
interest None. 
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Prevalence of prefrailty and frailty in South America: a systematic review 
of observational studies 
  
ABSTRACT  
Aims: The present study aimed to investigate the prevalence of prefrailty and frailty in South 
American older adults according to the setting and region. Methods: We performed a literature 
search combining the terms “frailty”, “South America” or a specific country name was 
performed at PubMed, EMBASE, Lilacs, and Scielo to retrieve articles published in English, 
Portuguese or Spanish on or before September 2019, which investigated older adults aged 60 
years or older from any setting (e.g., community, hospital, nursing home). Results: One-
hundred eighteen reports (98 performed from Brazil, seven from Chile, five from Peru, four 
from Colombia, two from Ecuador, one from Argentina, and one from Venezuela) were 
included in the present study. The mean prevalence of prefrailty in South America was 46.8% 
(50.7% in older in-patients, 47.6% in the community, and 29.8% in nursing-home residents). 
The mean prevalence of frailty in South America was 21.7% (55.8% in nursing-home residents, 
39.1% in hospitalised older adults, and 23.0% in the community). Conclusions: Prefrailty and 
frailty are highly prevalent in South American older adults, with rates higher than those 
observed in Europe and Asia. In the community, almost one-in-two are prefrail and one-in-five 
are frail, while institutionalised individuals are more frequently affected. These findings 
indicate the need for immediate attention to avoid frailty progression toward negative health 
outcomes. Our findings also highlight the need for specific guidelines for frailty in South 
America. 
 
Key words: Latin America, Low-income countries, Elderly, Sarcopenia, Mobility, Nursing 
home.  
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INTRODUCTION 
 Frailty is a potentially reversible state of increased vulnerability to stressful 
events[1] that occurs as a result of multisystem biological derangements[2–5] and 
socioeconomic inequalities[6-8]. Frailty progression increases the risk a several negative 
health-related outcomes, including disability, loss of independence, institutionalisation, and 
death[9–11]. Noticeably, frailty is associated with greater healthcare utilisation and costs[12], 
making this condition a top public health priority[1]. 
 Since the operationalisation of the frailty phenotype by Fried et al.[13], 
considerable research has been devoted to explore its incidence[14], prevalence[15–18], 
associated factors[19,20], and main outcomes[21]. These efforts have allowed the generation 
of recommendations and guidelines for the identification and management of frailty across 
healthcare settings[22–24].         
Yet, the majority of studies on which guidelines are based originated from high-
income countries, while very few publications have been produced in South America[14–16]. 
Hence, epidemiological characteristics of frailty in this region are poorly described. This is 
especially concerning since South America, in spite of the image of a young region, is ageing 
at a faster pace than Europe[25]. Furthermore, risk factors for frailty development, such as 
socioeconomic disadvantages, chronic diseases and disabilities, are highly prevalent in South 
America[6].  
 To increase the knowledge of the epidemiology of frailty in South America, the 
present systematic review explored the prevalence of prefrailty and frailty in South American 
older adults according to settings, regions, and frailty assessment tools. 
 
MATERIALS AND METHODS 
 We conducted a systematic review of observational studies to investigate the 
prevalence of prefrailty and frailty in South America. The study was fully performed by 
investigators and no librarian was part of the team. This study complies with the criteria of the 
Primary Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement 
(Appendix 1)[26]. All data are available in the Open Science Framework at DOI    
https://doi.org/10.17605/OSF.IO/XZ2S8.  
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Eligibility criteria 
 The following criteria were used for inclusion: (a) observational studies, 
including cross-sectional, cohort, case-control and longitudinal studies, which described or 
supplied data to calculate the prevalence of frailty in older adults from any setting (e.g., 
community, institutions); (b) participant age 60 years or more; (c) frailty assessment by a 
validated scale; and (d) published studies (English, Portuguese, and Spanish languages). There 
was no restriction on sample size or study population, and studies that investigated disease-
specific populations were also included and analysed accordingly. Studies that did not report 
the prevalence of robust older adults in addition to frailty prevalence or that classified 
participants as frail according to reduced physical/or cognitive function only were excluded. 
 
Search strategy and selection criteria 
 Studies published on or before August 2019 were retrieved from the following 
four electronic databases by one investigator: (1) PubMed, (2) EMBASE, (3) Lilacs, and (4) 
Scielo. Reference lists for reviews and retrieved articles for additional studies were checked 
and citation searches on key articles were performed on Google Scholar and ResearchGate for 
additional reports. A search strategy was designed using keywords, MeSH terms, and free text 
words such as frailty and South America. In addition, frailty, frail, and Frail Elderly [Mesh] 
were exhaustively combined with the name of South American countries. The complete search 
strategy used for the PubMed is shown in Appendix 2. Only eligible full-text in English, 
Portuguese or Spanish languages were considered for review.  
 
Data extraction and quality assessment  
 Titles and abstracts of retrieved articles were screened for eligibility by two 
researchers. If an abstract did not provide enough information for evaluation, the full-text was 
retrieved. Disagreements were solved by a third reviewer. Reviewers were not blinded to 
authors, institutions, or manuscript journals. Data extraction was independently performed by 
two reviews using a standardised coding form. Disagreements were solved by a third reviewer. 
Coded variables included methodological quality and the characteristics of studies. If two or 
more studies shared the same sample, the largest sample size was considered in the 
analysis[15,18]. The prevalence of prefrail and frailty were calculated according to the cut-off 
values used in the studies (Appendix 3), so that no changes were performed when frailty 
identification was made using the Fried frailty phenotype[13], Tilburg frailty indicator[27], 
FRAIL[28], Kihon checklist[29], and SOF[30] instruments. When participants were identified 
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as visible vulnerable with the Edmonton frailty scale[31] and apparently vulnerable with the 
Clinical Frailty Scale[32] they were considered prefrail, as well as they were considered frail 
when were identified as Mild, Moderate, and Severe Frailty using the Edmonton frailty 
scale[31] and mildly, moderate, and severely frail using the Clinical Frailty Scale[32].The 
quality of reporting for each study was assessed by two researchers using the Newcastle Ottawa 
Quality Assessment Scale (NOS) for non-randomised studies[33,34]. The agreement rate 
between reviewers for quality assessment was κ=0.93. 
 
RESULTS  
Literature search 
Of 20,229 registers recovered from electronic databases and hand search, 19,612 
records were excluded based on duplicate data, title or abstract. Six-hundred seventeen records 
were fully reviewed and assessed for eligibility. Finally, 118 studies met inclusion criteria 
(Figure 1). 
 
 
Figure 1. Flowchart of the study. 
 
65 
 
 
Characteristics of included studies 
 Table 1 provides a general description of included studies. Overall, a total of 
53,134 older adults (mean age ± standard deviation [SD]= 80.1 ± 3.8 years; women= 32,006 
[60.2%]) from seven countries (i.e., Argentina, Brazil, Chile, Colombia, Ecuador, Peru, and 
Venezuela) were studied between 2008 and 2019. Studies were based on cross-sectional, 
longitudinal and cohort designs. Of the 118 included studies, 98 (83.0%; n=36,786) were 
performed in Brazil [6,31,43–52,35,53–62,36,63–72,37,73–82,38,83–92,39,93–102,40,103–
112,41,113–122,42,123–130], seven (5.9%; n=6,091) in Chile[40,131–136], five (4.2%; 
n=4,052) in Peru[137–141], four (3.3%; n=3,836) in Colombia[142–145], two (1.7%; n=304) 
in Ecuador[146,147], one (0.8%; n=100) in Argentina[148], and one  (0.8%; n=1,965) in 
Venezuela[139]. 
 The frailty phenotype[13] was the most commonly used tool for frailty 
assessment (66.6%), followed by the Edmonton frailty scale (EFS) (23.6%), Tilburg frailty 
indicator (TFI) (4.9%), Fatigue, Resistance, Ambulation, Illnesses, & Loss of Weight (FRAIL) 
scale (3.3%), Kihon checklist (KCL) (2.4%), study of osteoporotic fracture (SOF) (0.8%), and 
clinical frailty scale (0.8%). Most studies (n=104; 91.5%) investigated community-dwelling 
older adults, while nursing-home residents were investigated in nine studies, hospitalised 
individuals were investigated in five studies, and three studies were performed with population 
data. Seven studies reported the prevalence of frailty using the same sample two or more times, 
while three studies used more than two tools to assess frailty. 
 Participants were recruited in different places, including urban, rural, and areas 
of social vulnerability, primary and secondary healthcare centres, and community centres, to 
quote a few. The most common comorbidities were hypertension (33 studies), diabetes (25 
studies), osteoarthritis (OA) (19 studies), cancer (17 studies), stroke (15 studies), chronic 
pulmonary obstructive disease (CPOD) (12 studies), chronic kidney disease (CKD) (10 
studies), and heart failure (HF) (10 studies). Dyslipidaemia, obesity, coronary heart disease 
(CHD), myocardial infarction (MI), atrial fibrillation, cognitive impairment, and disability were 
reported in less than five studies each. 
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Table 1. Characteristics of the included studies. 
Year Authors Study design Sample Setting 
Frailty 
criteria Sample size 
Age (mean ± SD, 
range) 
Female, n 
(%) 
Pre-frailty, n 
(%) 
Frailty population, 
n (%) Frailty by gender, n (%) Comorbidities 
Argentina 
           
2018 Costa et al. 
Prospective 
cohort Patients with HF  Hospitalized 
Clinical Frailty 
Scale 100 
77 ± 13.4 (60 or 
older) 44(44.0) — 26 (26.0) 18 (69.2) 
HTN, diabetes, dyslipidemia, obesity, CHD, CKD, stroke, 
atrial fibrillation, CPOD 
                          
Brazil                       
2012 Alencar et al. Cohort Public outpatient care Community Fried 207 78.3 (65 or older) 159 (76.8) 112 (54.1) 48 (23.0) 38 (79.1) Cognitive impariment, depression, disability 
2018 Alves et al. 
Cross-
sectional 
Public and private outpatient 
care Community Fried 148 69.7 ± 7.0 (60-86) 114 (77.0) 68 (45.9) 52 (35.0) — HTN, OA, diabetes, osteoporososis, CVD, depression 
2017
h Aprahamian et al. 
Cross-
sectional Public outpatient clinic Community Fried 124 78.6 (60 or older) 83 (66.9) 75 (60.5) 18 (15.0) — 
HTN, diabetes, cancer, CPOD, CAD, HF, asthma, stroke, OA, 
CKD 
2017
h Aprahamian et al. 
Cross-
sectional Public outpatient clinic Community FRAIL 124 78.6 (60 or older) 83 (66.9) 44 (35.5) 7 (6.0) — 
HTN, diabetes, cancer, CPOD, CAD, HF, asthma, stroke, OA, 
CKD 
2017 Aprahamian et al. 
Cross-
sectional Public outpatient clinic Community FRAIL 811 81.6 (60 or older) 591 (72.9) 394 (48.6) 305 (38.0) 231 (75.7) 
HTN, diabetes, cancer, CPOD, CAD, HF, asthma, stroke, OA, 
CKD 
2018 Aprahamian et al. 
Prospective 
cohort Public outpatient clinic Community FRAIL 701 79.5 (60 or older) 448 (63.9) 295 (42.1) 257 (37.0) — HTN, diabetes, HF, CAD, stroke, CKD, cancer 
2017 Augusti et al. 
Cross-
sectional Day care center Community Fried 306 
 72.5 ± 5.7  (65 or 
older) 185 (60.5) 71,5 (23.4) 66 (21.5) 54 (81.8) HTN, diabetes,  stroke, cancer, OA, CPOD,  CVD 
2008 Alvarado et al. 
Cross-
sectional SABE Community Fried 2143 60 or older 1262 (58.9) 917 (42.8) 762 (36.0) 491 (64.4) — 
2018 Belisário et al. 
Cross-
sectional Urban area Community Fried 705 60 or older 470 (66.7) 368 (52.2) 112 (15.9) — — 
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2019 Binotto et al. 
Cross-
sectional 
Candidates to obtain a 
driver’s license. Community Fried 421 60-70 127 (30.2) 189 (44.9) 8 (1.9) — — 
2018 Bôas et al. 
Cross-
sectional Public outpatient clinic Community EFS 150 
67.7-71.5 (60 or 
older) 84 (56.0) — 41 (27.3) — Diabetes 
2019 Bolina et al. 
Cross-
sectional Urban area Community Fried 701 60 or older 468 (66.8) 366 (52.2) 112 (16.0) — — 
2013
a Borges et al. 
Cross-
sectional Institutionalized 
Institutionali
zed EFS 54 60 or older 16 (29.6) — 40 (74.1) 16 (40.0) — 
2015
a Borges et al. 
Cross-
sectional Institutionalized 
Institutionali
zed EFS 54 60 or older 16 (29.6) — 40 (74.1) 16 (40.0) — 
2017 Brigola et al. 
Cross-
sectional 
Caregivers living in rural 
areas Community Fried 85 
69.0±6.8 (60 or 
older) 65 (76.5) 45 (52.9) 8 (9.4) 6 (75.0) — 
2016 Carneiro et al. 
Cross-
sectional Urban area Community EFS 511 74 ± 1.7 (65 or older) 327 (64.0) — 211 (41.3) 97 (45.9) Diabetes, HF, OA  
2016
b Carneiro et al. 
Cross-
sectional Urban area Community EFS 683 70 ±9 (60-98) 443 (64.9) 152 (22.3) 243 (35.6) — — 
2017
b Carneiro et al. 
Cross-
sectional Urban area Community EFS 686 70 ±9 (60-98) 445 (64.9) 63 (9.2) 46 (6.7) 33 (71.7) — 
2017
b Carneiro et al. 
Cross-
sectional Urban area Community EFS 685 75 ± 7.6 (65-79) 281 (41.0) — 360 (52.6) 137 (38.0) — 
2018 Carvalho et al. 
Cross-
sectional Hospitalized Community Fried 99 74 ± 7.3 (60 or older) 41 (41.4) 53 (53.5) 38 (38.4) — — 
2017i Cezar et al. 
Cross-
sectional Public outpatient clinic Community Fried 66 
77.0 ± 5.6 (60 or 
older) 53 (80.3) 44 (66.7) 19 (28.8) — MCI 
2017i Cezar et al. 
Cross-
sectional Public outpatient clinic Community EFS 66 
77.0 ± 5.6 (60 or 
older) 53 (80.3) 34 (51.5) 4 (6.1) — MCI 
2017 Coqueiro et al. 
Cross-
sectional Urban area Community Fried 316 74.2 ± 9.8 (60-105) 173 (54.7) — 76 (24.1) — — 
2015 Cordeiro et al. 
Cross-
sectional Institutionalized 
Institutionali
zed EFS 33 76.8 ± 9.3 (60-100) 18 (54.5) — 6 (18.2) — — 
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2014 Corona et al. 
Cross-
sectional SABE Community Fried 1256 70.0 (60 or older) 764 (60.8) — 100 (8.0) 67 (67.0) HTN, diabetes, CPOD, CVD, stroke, OA, cancer 
2018 Crosseti et al. 
Cross-
sectional Hospitalized Hospitalized EFS 395 69.7 ± 7.2 (60-94) 147 (37.2) — 177 (44.8) 80 (45.1) — 
2017 Cruz et al. 
Cross-
sectional Primary care Community EFS 339 
74.3 ± 8.2 (60 or 
older) 207 (61.1) — 117 (34.5) 79 (67.5) — 
2009 da Silva et al. 
Cross-
sectional Outpatient clinic Community Fried 30 
75.7 ± 7.6 (60 or 
older) 20 (66.7) 14 (46.7) 6 (22.0) — HTN, OA, diabetes 
2018
c da Silva et al. 
Cross-
sectional Primary care Community Fried 457 70.2 ± 8.2 (60-97) 71 (15.5) — 101 (22.1) 71 (70.3) — 
2019
c da Silva et al. 
Cross-
sectional Primary care Community Fried 457 70.2 ± 8.2 (60-97) 71 (15.5) — 101 (22.1) 27 (67.5) — 
2013 de Andrade et al. 
Cross-
sectional SABE Community Fried 1374 60 or older 818 (59.5) 561 (40.8) 116 (8.4) 11 (9.5) — 
2019 de Amorim et al. 
Cross-
sectional University workers Community Fried 258 
62.9 ± 2.47 (60 or 
older) 109 (42.2) 160 (62.0) 24 (9.3) 21 (87.5) — 
2014 de Melo et al. 
Cross-
sectional Public outpatient clinic Community Fried 150 
77.2 ± 6.7 (60 or 
older) 96 (64.0) 62 (41.3) 84 (56.0) 60 (71.4) — 
2018 de Sousa et al. 
Cross-
sectional Primary care Community Fried 243 84.4 ± 3.8 (80-98) 161 (66.3) 155 (63.8) 36 (14.8) — Cardiovascular, respirOAry, digestive and metabolic diseases 
2014 dos Santos et al. 
Cross-
sectional Urban area Community Fried 1785 60 or older 1155 (64.7) 920 (51.5) 173 (9.7) — — 
2013 Duarte et al. 
Cross-
sectional Community Community EFS 166 73.2 (60-96) 100 (60.2) 36 (21.7) 117 (70.5) — — 
2009 
Fabrício-Wehbe et 
al. 
Cross-
sectional Urban area Community EFS 137 75.3 (65-100) 102 (74.5) 28 (20.4) 43 (31.4) 36 (83.7) — 
2015 Falsarella et al. 
Cross-
sectional Community Community Fried 235 
71.76 ± 5.06 (65 or 
older) — 112 (47.7) 31 (13.2) — — 
2019 
Farías-Antúnez et 
al. 
Cross-
sectional Community Community EFS 1399 60 or older 884 (63.0) 233 (16.7) 192 (13.8) 147 (76.5) 
HTN, HF, CKD, osteoporosis, cancer, diabetes,  epilepsy, 
stroke 
2012 Fhon et al. 
Cross-
sectional Urban area Community EFS 240 73.5 ± 8.4 (60-94) 151 (62.9) 59 (24.6) 94 (39.2) 64 (68.0) — 
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2018 Fluetti et al. 
Cross-
sectional Institutionalized 
Institutionali
zed TFI 56 
77.77 ± 9.27 (60 or 
older) 32 (57.1) — 42 (75.0) — — 
2017 Filippin et al. 
Cross-
sectional Primary care Community Fried 322 60 – 79  195 (60.6) 74 (23.0) 63 (19.6) 48 (76.1) — 
2016 Freitas et al. 
Cross-
sectional Outpatient clinic Community Fried 103 
73.3 ± 6.4 (60 or 
older) 76 (73.8) 59 (57.3) 27 (26.2) — Visual disorders, HTN, insonia, OA 
2015 Frisoli Jr et al. 
Cross-
sectional Outpatient clinic CVD Fried 172 
77.13  ± 5.86 (65 or 
older) 107 (62.2) 88 (51.2) 65 (37.8) 44 (67.7) CVD 
2013 Fernandes et al. 
Cross-
sectional Primary health care Community EFS 128 68.9 ± 7.8  (60-103) 86 (67.2) — 36 (28.1) 26 (72.2) — 
2016 Gesualdo et al. 
Cross-
sectional Outpatient clinic CKD  EFS 60 
71.1 ± 6.9  (60 or 
older) 18 (30.0) — 22 (36.7) — — 
2018 Gomes et al. 
Cross-
sectional Carregivers Community Fried 312 69.5 ± 7.1 (60-74) 240 (76.9) 176 (56.4) 65 (20.8) — DS 
2018 Gross et al. 
Cross-
sectional Primary care Community Fried 555 71.1 ± 8.3 (60-102) 61 (11.0) 252 (45.4) 98 (17.7) 61 (62.2) — 
2017 Grden et al. 
Cross-
sectional Primary care Community Fried 243 80 or more 161 (66.3) 152 (62.6) 36 (14.8) 25 (69.4) — 
2012 Holanda et al. 
Cross-
sectional Institutionalized 
Institutionali
zed Fried 69 
77.5 ± 7.8 (60 or 
older) 43 (62.3) 31 (44.9) 32 (46.4) — HTN, OA, DS 
2017
d Jesus et al. 
Cross-
sectional Primary health care Community EFS 247 60 or older 197 (79.8) — 99 (40.1) 78 (78.7) — 
2018
d Jesus et al. 
Cross-
sectional Primary health care Community EFS 217 68.5 ± 7.3 (60-94) 176 (81.1) 46 (21.2) 82 (37.8) — — 
2018
d Jesus et al. 
Cross-
sectional Primary health care Community EFS 247 60 or older 197 (79.8) — 99 (40.1) 78 (78.7) — 
2015 Lealdini et al. 
Cross-
sectional Outpatient clinic Cancer EFS 52 72.5 (65-97) 23 (44.2) — 30 (57.5) — — 
2015 Lenardt et al. 
Cross-
sectional Primary health care Community Fried 203 70.8 ± 7.4 (60-93) 104 (51.2) 115 (56.7) 39 (19.2) 29 (74.3) — 
2018 Lenardt et al. 
Cross-
sectional Driving licence Community Fried 347 60 or older — 163 (47.0) 4 (1.2) — — 
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2017j Lin et al. 
Cross-
sectional Public outpatient clinic Community FRAIL 534 
79.6 ± 8.4 (60 or 
older) 336 (62.9) — 198 (37.1) — HTN, diabetes, congestive HF, CAD, strole, CKD, cancer 
2017j Lin et al. 
Cross-
sectional Public outpatient clinic Community Fried 534 
79.6 ± 8.4 (60 or 
older) 336 (62.9) — 273 (51.1) — HTN, diabetes, congestive HF, CAD, strole, CKD, cancer 
2017j Lin et al. 
Cross-
sectional Public outpatient clinic Community SOF 534 
79.6 ± 8.4 (60 or 
older) 336 (62.9) — 203 (38.0) — HTN, diabetes, congestive HF, CAD, strole, CKD, cancer 
2017 Llano et al. 
Cross-
sectional Rural area Community Fried 820 60 or older 460 (56.1) 304 (37.1) 356 (43.4) 210 (59.4) Obesity, HTN,  
2013 Lustosa et al. 
Cross-
sectional Community center Community Fried 117 
70.1 ± 7.3 (60 or 
older) 111 (94.9) 60 (51.3) 8 (6.8) — — 
2018 Mello et al. 
Cross-
sectional  Areas of social vulnerability Community Fried 137 70.2± 7.4 (61-97) 93 (67.9) 84 (61.3) 17 (12.4) 14 (82.3) — 
2016 Medeiros et al. 
Cross-
sectional Urban area Community EFS 686 70.9  ±  8.08 (60-98) 445 (64.9) — 396 (57.7) — HTN, OA, urinary incontinence 
2018 Melo et al. 
Cross-
sectional Institutionalized 
Institutionali
zed EFS 214 76.4 (60-104) 149 (69.6) 64 (29.9) 150 (70.1) — — 
2016 Morais et al. 
Cross-
sectional Carregivers Community Fried 187 68.9  (60 or older) 151  (80.7) 103 (55.1) 45 (24.1) 36 (80.0) — 
2016 Moreira et al. 
Cross-
sectional Diabetic older women Community Fried 99 65 or older 99 (100) 61 (61.6) 26 (26.3) — — 
2018 Nascimento et al. 
Cross-
sectional  Areas of social vulnerability Community Fried 347 70.1 ± 7.7  (65-older) 195 (56.2) 197 (56.8) 116 (33.4) 56 (48.2) Cogntivie impairmente, DS, obesity 
2013 Neri et al. 
Cross-
sectional FIBRA Community Fried 3478 65 or older 2354 (67.7) 1770 (50.9) 308 (8.9) 224 (72.7) — 
2018 Neves et al. 
Cross-
sectional Primary health care Community TFI 377 
68.0  ±  7.4 (60 or 
older) 227 (60.2) — 246 (65.3) 155 (63.0) DS 
2013 Nóbrega et al. 
Cross-
sectional Institutionalized 
Institutionali
zed Fried 69 77.5± 7.8  (61-95) 43 (62.3) 31( 44.9) 34 (49.3) — HTN, OA, DS, stroke, heart disease 
2014 Orlandi et al. 
Cross-
sectional Outpatient clinic CKD  EFS 60 71.1± 6.8  (60-89) 18 (30.0) 16 (26.7) 23 (38.3) — — 
2013 Oliveira et al. 
Cross-
sectional Hospitalized Hospitalized Fried 99 
74.5 ± 6.8 (65 or 
older) 50 (50.5) 49 (49.5) 46 (46.5) 23 (50.0) HTN, OA, CVD, DS, diabetes, cancer, urinary incotinence 
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2013 Parentoni et al. 
Cross-
sectional Primary health care Community Fried 106 73.9 ± 6.9 (65-91) 106 (100) 42 (39.6) 32 (30.2) — — 
2017 Pavarini et al. 
Cross-
sectional Carregivers Community Fried 343 60 or older 261 (76.1) — 72 (21.0) — — 
2013 Pegorari et al. 
Cross-
sectional Primary health care Community Fried 51 73 ± 6 (65 or older) 22 (43.1) 24 (47.1) 9 (17.6) — — 
2014 Pegorari et al. 
Cross-
sectional Urban area Community Fried 958 73 ± 7 (60 or older) 617 (64.4) 522 (54.5) 123 (12.8) 91 (73.9) — 
2015 Ramos et al. 
Cross-
sectional SABE Community Fried 639 70.6 ± 7.8 (60-98) 409 (64.0) 424 (66.4) 215 (33.6) — 
HTN,  CVD, OA, CPOD, diabetes, osteoporosis, stroke, 
asthma 
2014 Ricci et al. 
Cross-
sectional FIBRA Community Fried 761 
71.9 ± 5.9 (65 or 
older) 489 (64.3) 365 (48.0) 74 (9.7) 49 (66.2) — 
2018 Rossetti et al. 
Cross-
sectional Carregivers Community Fried 73 
70.3 ± 8.5 (60 or 
older) 59 (80.8) 40 (54.8) 27 (37.0) — — 
2013 Santiago et al. 
Cross-
sectional  Areas of social vulnerability Community TFI 219 
70.5  
±  
7.9  (60 or older)  115 (52.5) — 74 (33.8) — — 
2014 Santiago et al. 
Cross-
sectional Institutionalized 
Institutionali
zed TFI 442 
75.0  
±  
9.9  (60 or older)  158 (35.7) — 230 (52.0) 88 (38.2) — 
2018 Santiago et al. 
Cross-
sectional  Areas of social vulnerability Community TFI 640 
70.5  
±  
8.2  (60 or older)  414 (64.7) — 284 (44.4) 202 (71.1) — 
2019
k Santiago et al. 
Cross-
sectional  Areas of social vulnerability Community TFI 302 
70.4  
±  
7.6  (60 or older) 199 (65.9) — 108 (35.8) — HTN, OA, HF, dyslipidemia, stroke, asthma, cancer 
2019
k Santiago et al. 
Cross-
sectional  Areas of social vulnerability Community Fried 302 
70.4  
±  
7.6  (60 or older)  199 (65.9) — 71 (23.5) — HTN, OA, HF, dyslipidemia, stroke, asthma, cancer 
2017 Sampaio et al. 
Cross-
sectional Community Community Fried 316 
74.8  
±  
9.8  (60 or older) 173 (54.7) — 68 (21.5) — — 
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2015
e Santos et al. 
Cross-
sectional Primary health care Community Fried 139 
72.3  
±  
8.4  (60 or older)  105 (75.5) 86 (61.9) 23 (16.5) – HTN, DS, diabetes 
2016
e Santos et al. 
Cross-
sectional Primary health care Community Fried 139 
72.3  
±  
8.4  (60 or older)  105 (75.5) — 23 (16.5) – — 
2015 
Sewo Sampaio et 
al. 
Cross-
sectional Community Community KCL 72 
69.0 ± 6.41 (60 or 
older) 72 (100) — 33 (45.8) — — 
2015 
Sewo Sampaio et 
al. 
Cross-
sectional Community Community KCL 55 
70.8 ± 8.3 (60 or 
older) 55 (100) — 6 (10.9) — — 
2016 
Sewo Sampaio et 
al. 
Cross-
sectional Community Community KCL 109 
75.0 ± 5.8 (60 or 
older) 24 (100) — 24 (22.0) — — 
2017 
Santos-Orlandi et 
al. 
Cross-
sectional Community Community Fried 40 70.1 ± 8.2 (60-98) 27 (67.5) — 23 (57.5) — HTN and smoke 
2012 Sousa et al. 
Cross-
sectional FIBRA Community Fried 391 74.0 ± 6.5  (65 -96) 240 (61.4) 235 (60.1) 89 (22.8) 44 (49.4) HTN, OA, CPOD, CVD, diabetes, stoke, cancer, depression 
2013 Storti et al. 
Cross-
sectional Institutionalized 
Institutionali
zed EFS 84 73.8 ± 8.2 (60-99) 33 (39.3) 4 (4.8) 36 (42.9) — — 
2015 Silveira et al. 
Cross-
sectional Community center Community Fried 54 
72.9 ± 6.0 (65 or 
older) 32 (50.3) 25 (46.3) 6 (11.1) 5 (83.3) — 
2014 Tavares et al. 
Cross-
sectional Community Community Fried 418 60 or older 298 (71.3) 216 (51.70 116 (27.8) 84 (72.4) — 
2015 Tavares et al. 
Cross-
sectional Primary health care Community Fried 255 
68.6 ± 6.5 (60 or 
older) 33 (12.9) 136 (53.3) 67 (26.3) 33 (49.2) — 
2016 Tavares et al. 
Cross-
sectional Hospitalized Hospitalized Fried 205 60 or older 81 (39.5) 106 (51.7) 54 (26.3) 15 (27.7) HTN, obesity, dyslipedemia 
2017 Tavares et al. 
Cross-
sectional Community Community Fried 1609 60 or older 1036 (64.4) 836 (52.0) 219 (13.6) 35 (15.9) — 
2018 Tavares et al. 
Cross-
sectional Community Community Fried 255 
68.68 ± 6.56  (60 or 
older) 99 (39.8) 136 (53.3) 67 (26.3) — — 
2016 
Teixeira-Gasparini 
et al. 
Cross-
sectional Community Community EFS 114 85.5 ± 4.3 (80-103) 79 (69.3) 29 (25.4) 51 (44.7) 38 (74.5) — 
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2018 Zukeran et al. 
Cross-
sectional 
Secondary-care outpatient 
clinic Community Fried 254 60 or older 178 (70.1) 136 (53.5) 79 (31.1) — — 
2013 Viana et al. 
Cross-
sectional 
Secondary-care outpatient 
clinic Community Fried 53 
76.7 ± 5.8  (65 or 
older) 40 (75.5) 29 (54.7) 8 (15.1) — Cardiac and pulmonary diseases, and cancer 
2013 Vieira et al. 
Cross-
sectional FIBRA Community Fried 601 
74.3 ± 6.4  (65 or 
older) 398 (66.2) 278 (46.3) 52 (8.7) — — 
2017 Vieira et al. 
Cross-
sectional Community Community Fried 83 
73.9 ± 7.2  (60 or 
older) 56 (67.5) 59 (71.1) 6 (7.2) 3 (50.0) — 
2016 Zazzetta et al. 
Cross-
sectional  Areas of social vulnerability Community Fried 304 
70.1 ± 7.6  (60 or 
older) 173 (56.9) 184 (60.5) 83 (27.3) 45 (54.2) Urinary incontinence 
                          
Chile                       
2017 Albala et al. 
Prospective 
cohort ALEXANDROS Community Fried 2098 
68.3 ± 6.3 (60 or 
older) 1406 (67) 1338 (63.8) 291 (13.9) 231 (79.3) Diabetes, HTN, MCI, depression 
2018 Araya et al. 
Cross-
sectional Day care center Community TFI 35  73.31 ± 6.11 (65-86) 29 (82.9) — 28 (80.0) — — 
2008 Alvarado et al. 
Cross-
sectional SABE Community Fried 1301 60 or older 855 (65.7) 624 (48.0) 520 (40.0) 389 (74.8) — 
2019 
Bustamante-Ara et 
al. 
Cross-
sectional Rural area Community Fried 619 66.0 (60-74) 359 (58.0) 299 (48.3) 34 (5.5) 28 (82.3) HF, dieabetes, HTN, OA, CKD, diabetes 
2017 Díaz-Toro et al. 
Cross-
sectional Patients with HF  Hospitalized Fried 79 
71.02 ± 7.99 (60 or 
older) 38 (48.1) 39 (49.4) 40 (50.60) 22 (55.0) HTN, MI, CPOD, stroke, dyslipidemia, diabetes 
2018 Palomo et al. 
Cross-
sectional Primary care Community Fried 1205 73 ± 5.9 (65 or older) 816 (67.7) 469 (38.9) 296 (24.6) 221 (74.6) — 
2015 Tapia et al. 
Cross-
sectional Primary health care Community Fried 754 73.0 ± 6.0 (65-90) 463 (61.4) 520 (69.0) 34 (4.5) — HTN, OA, CPOD, dyslipidemia, diabetes, cancer 
                          
Colombia                       
2014 Curcio et al. 
Cross-
sectional Rural Community Fried 1878 
70.9 ± 7.4 (60 or 
older) 981 (52.0) 996 (53.0) 228 (12.1) — HTN, OA, HF, CPOD, diabetes, stroke 
2013 
Ocampo-Chaparro 
et al. 
Cross-
sectional Urban area Community Fried 314 60 or older 202 (64.3) 79 (25.2) 28 (8.9) 20 (41.6) CVD, HTN, OA, disabetes 
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2017 Ramírez et al. 
Cross-
sectional Community center Community Fried 101 60 or older — 46 (45.5) 8 (7.9) — — 
2017 Ramírez et al. 
Cross-
sectional Community center Community EFS 101 60 or older — 13 (12.9) 9 (8.9) — — 
2017 
Samper-Ternent et 
al. 
Cross-
sectional SABE Community Fried 1442 
70.7 ±7.7 (60 or 
older) 879 (61.0) 756 (52.4) 135 (9.4) 88 (65.1) HTN, MI, diabetes, cancer, stroke 
                          
Ecuador                       
2017f Del Brutto et al. 
Cross-
sectional Native living in rural areas Community EFS 298 70 ±8 (60 or older) 171 (57.4) 65 (21.8) 93 (31.2) 66 (70.9) HTN, stroke, obeisty 
2016f Del Brutto et al. 
Cross-
sectional 
Caregivers living in rural 
areas Community EFS 304 
70.0 ± 0.8 (60 or 
older) 174 (57.2) 74 (24.3) 92 (30.3) 65 (70.6) — 
                          
Peru                       
2015 Jotheeswaran et al. Cohort study Urban and rural areas Community Fried 1381 
75.0 ± 7.4 (65 or 
older) 805 (58.3) — 323 (23.4) — — 
2010 Pinedo et al. 
Cross-
sectional Community Community Fried 246 
69.9 ± 7.6 (60 or 
older) 147 (59.8) 159 (64.6) 19 (7.7) 16 (984.2) DS, MCI, Urinary incontinence, insomnia 
2018 Rodriguez et al. 
Cross-
sectional Urban area Populational Fried 1381 
75.0 ± 7.4 (65 or 
older) 888 (64.3) — 277 (20.1) — — 
2018 Rodriguez et al. 
Cross-
sectional Rural area Populational Fried 552 
74.2 ± 7.3 (65 or 
older) 295 (53.4) — 93 (16.8) — — 
2014 
Runzer-
Colmenares et al. 
Cross-
sectional Outpatient clinic Community Fried 311 
76.1 ± 8.3 (60 or 
older) 126 (40.5) 147 (47.3) 86 (27.7) 38 (44.1) CVD, CPOD, depression, cognitive impairment 
2017 
Runzer-
Colmenares et al. 
Cross-
sectional 
 Patients raceiveing 
radiotheraphy Cancer Fried 181 
78.1  
±  
5.2 (60 or older) — — 43 (23.8) — — 
                          
Venezuela                       
2018 Rodriguez et al. 
Cross-
sectional Populational Populational Fried 1965 
72.3 ± 6.9 (65 or 
older) 1252 (63.7) — 243 (12.4) — — 
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CHD= Coronary heart disease; CKD= Chronic kidney disease; CPOD= Chronic pulmonary obstructive disease; CVD= Cardiovascular diseases; DS= 
Depressive symptoms; EFS= Edmonton frail scale; FIBRA= Fragilidade em idosos brasileiros; FRAIL= Fatigue, resistance, ambulation, illnesses, & loss of 
weight; HF= Heart failure; HTN= Hypertension; IHG= Isometric handgrip strength; KCL= Kihon checklist; MCI= Mild-cognitive impairment; MI= Myocardial 
infarction; OA= Osteoarthritis; SABE= Saúde, bem-estar e envelhecimento; SOF= Study of osteoporotic fracture; TFI= Tilburg frailty indicator; TUG= Timed 
“Up and Go” ; WS= Walking speed. a, b, c, d, e, f= These studies used the same sample; h, i, j, k= The same study reported the prevalence with different 
assesment tools.  
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Quality assessment 
 The overall score and the point-by-point analysis of quality assessment of cross-
sectional and cohort studies are shown in Table 2. The overall score of cross-sectional studies 
ranged from 2 to 10 (maximum value: 11). All studies used a validated instrument for frailty 
assessment (item 4). Regarding selection criteria (item 1), 38.9% of the studies used a 
representative sample from a random population, 21.2% did not describe the sampling strategy, 
20.3% used a selected group of participants (e.g., institutionalised older adults), and 15.3% used 
a somewhat representative sample selected using a non-random method. The sample size (item 
2) was justified in 49.5% of the studies, while in 50.5% of studies no sample size justification 
was provided. Comparisons between respondents and non-respondents in the main 
characteristics (item 3) were only performed in 5.0% of the studies. Age was selected as the 
most important confounder factor (item 5) and it was controlled for in less than half of the 
studies (47.5%). Similarly, only 46.6% of the studies controlled for additional factors (i.e., 
gender or body mass index [BMI]) (item 5). Outcomes (item 6) were assessed using an 
independent blind method in 56.8% of the studies, self-reported scales or questionnaires in 
35.2%, record linkage in 1.7%, while 1.7% did not describe the method. Finally, appropriate 
statistical analysis (item 7) was used in 57.8% of the studies.  
 Regarding cohort studies, all of them used a structured interview to assess 
exposure (item 3), recruited the non-exposed cohort from the same setting as the exposed cohort 
(item 2), demonstrated that the outcome of interest was not present at the beginning of the study 
(item 4), and evaluated the outcome using an independent blind method (item 6). Seventy-five 
percent of the studies used a truly representative sample, and 25% a somewhat representative 
sample (item 1). One study did not control for any main (item 5) or additional factors. The 
follow-up period (item 7) was not enough in one-study, a representative sample completed the 
follow-up period in 75% of the studies.  
 
Table 2. Quality assessment of the included studies 
  Selection Comparability Outcome   
Study 1 2 3 4 5 6 7 8 TOTAL* 
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Argentina   
Costa et al.α b a a a a b d a NA 8 
                      
Brazil   
Alencar et al.β a a a a — — a b b 5 
Alves et al.α c b c a a b c a NA 6 
Aprahamian et al.α a b c a — — c a NA 5 
Aprahamian et al.α b b c a a b a a NA 8 
Aprahamian et al.α b b c a a b a a NA 8 
Augusti et al.α a a c a — — a b NA 6 
Alvarado et al.α a a c a a b c a NA 8 
Belisário et al.α a a c a a b b a NA 9 
Binotto et al.α a a c a a — a — NA 7 
Bôas et al.α c b c a — — a b NA 4 
Bolina et al.α a a c a a b a a NA 9 
Borges et al.α d b c a — — c b NA 3 
Borges et al.α d b c a — — d b NA 2 
Brigola et al.α b a c a a b a a NA 9 
Carneiro et al.α a a c a a b a a NA 9 
Carneiro et al.α c b c a a b a a NA 7 
Carneiro et al.α a a c a a b c a NA 8 
Carvalho et al.β b a a a a b a a a 8 
Cezar et al.α c b c a — b a a NA 6 
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Coqueiro et al.α a a c a — — c b NA 5 
Cordeiro et al.α c b c a — — a b NA 4 
Corona et al.α a a c a a b a a NA 9 
Crosseti et al.α c a c a — b a b NA 6 
Cruz et al.α a a c a a b a a NA 9 
da Silva et al.α d b c a — — a b NA 4 
da Silva et al.α a a c a a b a a NA 9 
da Silva et al.α a a c a a b a a NA 9 
de Andrade et al.α a a c a — — a b NA 6 
de Amorim et al.α a a c a a b c a NA 8 
de Melo et al.α b b c a — — a b NA 5 
de Sousa et al.α a b c a — b c a NA 6 
dos Santos et al.α a b c a — — c b NA 4 
Duarte et al.α a a c a — — c b NA 5 
Fabrício-Wehbe et al.α a a c a — — a a NA 7 
Falsarella et al.α a a c a — b a b NA 7 
Farías-Antúnez et al.α a a c a a b c a NA 8 
Fhon et al.α a a c a — — a b NA 6 
Fluetti et al.α c b c a — — a b NA 4 
Filippin et al.α a a c a a a a a NA 8 
Freitas et al.α c b c a — — a b NA 4 
Frisoli Jr et al.α d b c a a b a a NA 7 
Fernandes et al.       a         NA 2 
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Gesualdo et al.α d b c a a b a a NA 7 
Gomes et al.α a a a a a b a a NA 10 
Gross et al.α b a c a a b c a NA 8 
Grden et al.α a a c a a b c a NA 8 
Holanda et al.α a b c a a b a a NA 8 
Jesus et al.α c b c a — — a b NA 4 
Jesus et al.α c a c a — — a b NA 5 
Lealdini et al.α c a c a a b a a NA 8 
Lenardt et al.α c a c a a b c a NA 7 
Lenardt et al.α c b c a — — a b NA 4 
Lin et al.β b a b a a b a a NA 9 
Llano et al.α d b c a — — a b NA 4 
Lustosa et al.α a b c a — — a b NA 5 
Mello et al.α a a c a — — c b NA 5 
Medeiros et al.α a b c a a b a a NA 8 
Melo et al.α d a c a — — a b NA 5 
Morais et al.α d b c a — — c b NA 3 
Moreira et al.α d b c a a b a a NA 7 
Nascimento et al.α b a c a a b a a NA 9 
Neri et al. a a c a — — a b NA 6 
Neves et al.α b b c a — — a a NA 6 
Nóbrega et al.α d b c a a b a a NA 7 
Orlandi et al.α d b c a — — a b NA 4 
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Oliveira et al.α c b c a — — a b NA 4 
Parentoni et al.α c b c a — — a b NA 4 
Pavarini et al.α b b c a — — a b NA 5 
Pegorani et al.α a a c a — — a b NA 6 
Pegorani et al.α d a c a a b a a NA 8 
Ramos et al.α a b c a — — c b NA 4 
Ricci et al.α a a c a a b a a NA 9 
Rossetti et al.α c b c a — — c b NA 3 
Santiago et al.α d b c a — — a a NA 5 
Santiago et al.α d b c a a — c a NA 5 
Santiago et al.α c a c a a b a a NA 8 
Santiago et al.α c a c a a b c a NA 7 
Sampaio et al.α d a a a a b a a NA 9 
Santos et al.α d b c a — — c b NA 3 
Santos et al.α d b c a — — a a NA 5 
Sewo Sampaio et al.α d b c a — — c b NA 3 
Sewo Sampaio et al.α d b c a — — c b NA 3 
Sewo Sampaio et al.α d b c a a b a a NA 7 
Santos-Orlandi et al.α d b c a — — c b NA 3 
Sousa et al.α a a c a a b c a NA 8 
Storti et al.α c b c a — — b b NA 4 
Silveira et al.α b a c a — — a b NA 6 
Tavares et al.α b a c a — — c b NA 5 
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Tavares et al.α c a c a a b c a NA 7 
Tavares et al.α a a c a — — a a NA 7 
Tavares et al.α c a c a a b c a NA 7 
Tavares et al.α a b c a — — c a NA 5 
Teixeira-Gasparini et al.α a a c a — — c b NA 5 
Zukeran et al.α d b c a — — c b NA 3 
Viana et al.α c b c a — b a a NA 6 
Vieira et al.α a a c a a — c a NA 7 
Vieira et al.α c a c a — — a b NA 5 
Zazzetta et al.α c b c a — — a a NA 5 
                      
Chile                     
Albala et al.β a a a a b a a a a 9 
Araya et al.α d b c a — — a c NA 4 
Alvarado et al.α a a c a a b c a NA 8 
Bustamante-Ara et al.α b a c a a b a a NA 9 
Díaz-Toro et al.α b a c a a — c a NA 7 
Palomo et al.α a b c a a — c a NA 6 
Tapia et al.α a a c a — — c b NA 5 
                      
Colombia                     
Curcio et al.α b b c a a b c a NA 7 
Ocampo-Chaparro et al.α a b c a a b c a NA 7 
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Ramírez et al.α d b c a — — a b NA 4 
Samper-Ternent et al.α a a c a a b c a NA 8 
                      
Ecuador                     
Del Brutto et al.α b a c a a b a a NA 9 
Del Brutto et al.α b a c a a b a a NA 9 
                      
Peru                     
Jotheeswaran et al.α a a a a a b a a NA 10 
Pinedo et al.α d b c a — — a a NA 5 
Rodriguez et al.α a a a a a b c a NA 9 
Runzer-Colmenares et al.α b b c a a b c a NA 7 
Runzer-Colmenares et al.β a a a a a b a a a 9 
                      
Venezuela                     
Rodriguez et al.α a a a a a b c a NA 9 
α= Cross-sectional study; β= Cohort study; *Max= 11 points for α and 9 points for β. Cross-
sectional studies: 1) Representativeness of the sample: a) Truly representative of the average in 
the target population, b) Somewhat representative of the average in the target population, c) 
Selected group of users, d) No description of the sampling strategy; 2) Sample size: a) Justified 
and satisfactory, b) Not justified; 3) Non-respondents: a) Comparability between respondents 
and non-respondents characteristics, b) The response rate is unsatisfactory, or the comparability 
between respondents and non-respondents is unsatisfactory, c) No description of the response 
rate or the characteristics of the responders and the non-responders; 4) Ascertainment of the 
exposure: a) Validated measurement tool, b) Non-validated measurement tool, but the tool is 
available or described, c) No description of the measurement tool; 5) Comparability: a) The 
study controls for the most important factor, b) The study control for any additional factor; 6) 
Outcome: a) Independent blind assessment, b) Record linkage, c) Self report, d) No description; 
7) Statistical test: a) The statistical test used to analyze the data is clearly described and 
appropriate, and the measurement of the association is presented, including confidence intervals 
and the probability level (p value), b) The statistical test is not appropriate, not described or 
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incomplete. Cohort studies: 1) Representativeness of the exposed cohort: a) truly representative, 
b) somewhat representative, c) selected group of users, d) no description of the derivation of 
the cohort; 2) Selection of the non exposed cohort: a) drawn from the same community as the 
exposed cohort, b) drawn from a different source, c) no description of the derivation of the non 
exposed cohort; 3) Ascertainment of exposure: a) secure record (eg surgical records), b) 
structured interview, c) written self report, d) no description; 4) Demonstration that outcome of 
interest was not present at start of study: a) yes, b) no; 5) Comparability: a) study controls for 
age; b) study controls for any additional factor; 6) Assessment of outcome: a) independent blind 
assessment, b) record linkage, c) self report, d) no description; 7) Was follow-up long enough 
for outcomes to occur: a) yes (select an adequate follow up period for outcome of interest) b) 
no; 8) Adequacy of follow up of cohorts: a) complete follow up, b) subjects lost to follow up, 
c) no description of those lost, d) no statement.                                                                                                                    
 
Prevalence of prefrailty and frailty in South America 
 Overall, the mean prevalence of prefrailty was 46.8%, ranging from 23.0% in 
Ecuador to 55.9% in Peru (Figure 2). When data were analysed according to the assessment 
tool, the prevalence of prefrailty was 50.7%, 44.8%, and 18.4% for Fried, FRAIL scale, and 
EFS, respectively. The highest prevalence of prefrailty was observed in hospitalised older adults 
(50.7%), followed by community-dwelling persons (47.6%) and nursing-home residents 
(29.8%). Regarding older adults with specific conditions, CVD and CKD patients showed a 
prevalence of prefrailty of 51.2% and 26.7%, respectively. 
 
 
 
 
 
 
 
 
 
 
84 
 
 
Figure 2. Mean prevalence of prefrailty according to the country in South America. 
 
 Overall, the mean prevalence of frailty was 21.7%, ranging from 10.6% in 
Colombia to 31.3% in Chile (Figure 3). When data were analysed according to the assessment 
tool, the prevalence of frailty was 48.8%, 38.0%, 34.7%, 26.9%, 26.0%, 18.4%, 18,2% 
according to FTI, SOF, Fried, KCL, clinical frailty scale, EFS, and FRAIL, respectively. The 
highest prevalence of frailty was observed in nursing-home resident persons (55.8%), followed 
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by hospitalised (39.1%) and community-dwelling (23.0%) older adults. Regarding older people 
with specific conditions, patients with cancer showed the highest prevalence (54.9%), followed 
by those with CVD (37.8%) and CKD (37.5%). The prevalence of frailty increased 
progressively with age, so that 21.4% frailty prevalence was found in those aged 60 to 69 years, 
24.5% in those with a mean age between 70 and 79 years, and 30.3% in those aged ≥80 years. 
Most studies reported a higher prevalence of frailty in women compared with men. 
Figure 3. Mean prevalence of frailty according to the country in South America. 
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Prevalence of prefrailty and frailty according to country Argentina 
 The mean prevalence of frailty in Argentina was 26.0%. Data were exclusively 
based on older patients with heart failure. Frailty was assessed using the clinical frailty scale. 
 
Brazil 
 The mean prevalence of prefrailty in Brazil was 46.9%, ranging from 4.8% to 
71.1%. When data were analysed according to the assessment tool, the prevalence of prefrailty 
was 49.1%, 45.6%, and 19.4% for Fried, FRAIL scale, and EFS, respectively. The highest 
prevalence of prefrailty was observed in hospitalised older adults (51.0%), followed by 
community-dwelling people (47.1%) and nursing-home residents (29.8%). Regarding older 
adults with specific conditions, CVD and CKD patients showed a prevalence of prefrailty of 
51.2% and 26.7%, respectively.  
 The mean prevalence of frailty in Brazil was 26.1%, ranging from 1.9% to 
75.0%. When data were analysed according to the assessment tool, the prevalence of frailty was 
48.3%, 38.0%, 34.8%, 33.1%, 26.9%, and 19.3% for FTI, SOF, FRAIL, EFS, KCL, and Fried, 
respectively. The highest prevalence of frailty was observed in nursing-home residents (55.8%), 
followed by hospitalised (39.6%), and community-dwelling people (24.8%). Regarding older 
adults with specific conditions, patients with cancer showed the highest prevalence of frailty 
(57.7%), while those with CVD and CKD showed a prevalence of frailty of 37.8% and 37.5%, 
respectively.  
 
Chile 
 The mean prevalence of prefrailty in Chile was 54.3%, ranging from 38.9% to 
69.0%. The highest prevalence of prefrailty was observed in hospitalised older adults (51.0%), 
followed by community-dwelling people (47.1%) and nursing-home residents (29.8%).  
 The mean prevalence of frailty in Chile was 31.3%, ranging from to 4.5% to 
80.0%. When data were analysed according to the assessment tool, Fried's criteria identified a 
mean of 23.2% of older adults with frailty, while 80% were identified by FTI. The highest 
prevalence of frailty was observed in hospitalised older adults (50.0%), followed by 
community-dwellers (28.1%).  
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Colombia 
 The mean prevalence of prefrailty and frailty in Colombia was 49.3% (12.9%-
53.0%) and 10.6% (7.9%-12.1%), respectively. When data were analysed according to the 
assessment tool, Fried criteria (44.0% and 9.6%) identified a larger number of prefrail and frail 
older adults compared with EFS (12.9% and 8.9%). 
 
Ecuador 
 The mean prevalence of prefrailty and frailty in Ecuador was 57.4% and 31.2%, 
respectively. Data were exclusively based on older adults from the Atahualpa region. Frailty 
status was assessed using the TFI. 
 
Peru 
 The mean prevalence of prefrailty and frailty in Chile was of 55.9% (47.3%-
64.6%) and 19.9% (7.7%-27.7%), respectively. Older patients with cancer showed a frailty 
prevalence of 23.8%, while 22.1% of community-dwelling older adults were frail. 
 
Venezuela  
 The mean prevalence of frailty in Venezuela was 12.4%. Data were exclusively 
based on older adults from Caracas. Frailty status was assessed using Fried's criteria.  
 
DISCUSSION 
 The present study investigated the prevalence of prefrailty and frailty in older 
adults from different settings in South America. Results from our systematic review show that 
about 46.8% of older people living in Brazil, Chile, Colombia, Ecuador, and Peru are prefrail. 
The highest prevalence of prefrailty was observed in hospitalised older adults (50.7%), followed 
by community-dwelling people (47.6%) and nursing-home residents (29.8%). The cumulative 
prevalence of frailty in South America was 21.7%. The prevalence of frailty across settings 
differed from that of prefrailty, with the highest rate observed in nursing-home residents 
(55.8%), followed by hospitalised (39.1%) and community-dwelling persons (23.0%). When 
data were analysed according to the geographic area, most countries showed a mean prevalence 
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of prefrailty ~50% and a mean prevalence of frailty ~20%, with the notable exceptions of 
Colombia (10.6%) and Chile (31.3%). 
 Only one systematic review investigated the prevalence of frailty (19.6%) in 
South America, but results were based on a limited number of search terms, South America and 
Caribbean countries, and only studies with representative samples of community-dwellers[15]. 
Our findings add to these prior results by reporting the prevalence of prefrailty and frailty in 
older South Americans according to setting, country, and assessment tools.  
 Based on the present findings, the prevalence of frailty in the community in 
South America (23.0%) is almost twofold higher in comparison to Europe (12.0%)[16] and 
more than threefold higher than in Japan (7.4%)[18]. Similarly, a higher prevalence of frailty 
was observed in South American nursing-home residents (55.8%) when compared with 
European peers (45.0%)[16]. These findings are consistent with previous investigations that 
showed a higher prevalence of prefrailty and frailty in low- and middle-income countries 
compared with high-income regions[14,15,149]. A possible explanation for this phenomenon 
may reside in the fact that disadvantaged socioeconomic conditions are frequently associated 
with inequalities in healthcare access, lower dietary quality, physical inactivity, multimorbidity 
and disability[150,151], all of which contribute to the development and progression of 
frailty[6–8,20]. 
 Divergent prevalence rates of prefrailty and frailty were observed across 
settings, which may reflect different patterns of healthcare utilisation in South America 
depending on the frailty status. As people progress from robustness to prefrailty, they show 
increased prevalence of multimorbidity[152,153], disability[154], and risk of adverse health-
related events[153], leading to higher healthcare utilisation[153] and potentially 
hospitalisation[155]. In addition, muscle strength, gait speed, and balance[155,156] are reduced 
in prefrail persons compared with robust older adults, which may account for increased 
incidence of falls[152,154] and fractures[154] and related hospitalisation in these 
individuals[155]. 
 On the other hand, frail older people show worse overall health status compared 
with their prefrail counterparts[152], which make them need more time to recover from stressful 
events, increasing the need of critical care services[157] and frequent hospital 
readmission[158]. Mortality is a frequent outcome in hospitalised frail older adults[158], and 
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nursing-home allocation is a common discharge disposition for survivors[158]. Indeed, frailty 
is highly prevalent in nursing-homes[11,159], possibly reflecting the increased need of medical 
attention[157], cognitive decline[155,159], and disabilities of residents[160].   
 According to Ofori-Asenso et al.[14], the 3-year frailty incidence rate among 
prefrail individuals worldwide is 62.7 cases per 1000 person-years, which might suggest that 
more than 1 million new cases of frailty may be expected in South America each year. This 
figure has relevant public health implications and calls for immediate actions against frailty in 
South America. Indeed, early detection of prefrailty and frailty may reduce the risk for negative 
health-related outcomes and healthcare utilisation through the design and implementation of 
person-tailored interventions[161]. 
 Our study is not free of limitations. First, although our findings are based on the 
majority of the Latin American countries, limited evidence was available for most countries, 
except for Brazil. In fact, there were no studies investigating the prevalence of prefrailty and 
frailty in Bolivia, Paraguay, Uruguay, Guyana and Suriname, and only few reports were 
available for Argentina, Venezuela and Ecuador. Second, although unlikely, it is possible that 
more studies could be available in other databases than those used in the present study. 
However, selected databases have wide coverage without losing the quality of journals. Third, 
the cross-sectional design of included studies limits extrapolation and interpretation of findings.  
 
CONCLUSION 
 Prefrailty and frailty are highly prevalent in South American older adults, with 
rates higher than in Europe and Asia. Among community-dwellers, almost one in two is prefrail 
and one in five is frail, while institutionalised individuals are more often affected. These 
findings call for immediate actions to ensure sustainability of healthcare systems. In this 
scenario, our report may provide basic information for healthcare authorities and policy makers 
to devise novel models of care responsive to emerging medical needs of older South Americans.  
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Supplementary Material 2 
Cutoffs values for frailty 
instruments         
Cutoff values (points) 
Instruments   
Robu
st   Prefrail   Frail   
Fried frailty 
phenotype1   0   0   ≥3   
Tilburg frailty 
indicator2,3   0   0   ≥5   
FRAIL4   0   0   3-5   
Kihon 
checklist*5   0   —   25   
SOF6   0   0   2-3   
    
No 
frailt
y   
Visible 
Vulnerable 
Frailty   
Mild, Moderate, and 
Severe Frailty   
Edmonton 
frailty scale7,8   0-4   5-6   ≥7   
  
Ver
y fit Well 
Well, 
with 
threa
ted 
como
rbid 
disea
se 
Apparently 
vulnerable 
Mildly 
frail Moderately frail 
Severel
y frail 
Clinical Frailty 
Scale9 1 2 3 4 5 6 7 
*There is no stabilized cutoff for the Kihon checklist   
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A R T I C L E I N F O A B S T R A C T 
Section Editor: Christiaan Leeuwenburgh 
Keywords: 
Physical function 
Body composition 
Muscle atrophy 
Premature aging 
Bone mineral density 
Muscle strength 
Background: People with Down syndrome (DS) experience premature aging. Whether this accelerated aging also 
involves early declines in muscle mass, strength and physical performance is presently unclear. The present study 
investigated the prevalence of sarcopenia parameters in adults with DS. In addition, the relationship between well-
established muscle mass indexes and a set of body composition, functional, biological, and clinical parameters was 
explored. 
Methods: One hundred-five adults with DS participated in the study. Demographic, clinical, anthropometric, and 
functional parameters were assessed. Lean body mass (LBM) was estimated using bioelectrical impedance analysis. 
Bone mineral density (BMD) of the hip and the spine was measured through dual X-ray absorptiometry. For the 
analysis, participants were categorized into two subgroups (i.e., low and high) for each LBM-related measurement 
(i.e., crude LBM, LBM to body mass index ratio, and skeletal muscle index) according to their median values. 
Results: The mean age of participants was 38.4 ± 12.1 years, with 43 men (41%). Muscle mass, handgrip strength, and 
gait speed were lower than established cutoffs for sarcopenia. All muscle mass indexes were negatively correlated 
with age. However, only crude LBM and the skeletal muscle index were correlated with a set of anthropometric 
parameters and BMD. 
Conclusion: Findings from this exploratory study indicate that adults with DS show muscle mass indexes and physical 
performance levels similar to or lower than older adults with sarcopenia. The assessment of muscle mass and 
functional status should therefore be included in the routine evaluation of this population starting at young age. 
 
 
 
 
 
Abbreviations: AD, Alzheimer's disease; ADL, activities of daily living; BIA, bioimpedance analysis; BMD, bone mineral density; BMI, body mass index; CTX, carboxyterminal collagen crosslink; DHEA, 
dehydroepiandrosterone; DS, Down syndrome; DXA, dual X-ray absorptiometry; FTI, free testosterone index; HC, hip circumference; IGF-1, insulin-like growth factor 1; LBM, lean body mass; MAC, mid-
arm circumference; TUG, timed “up-and-go”; SHBG, sex hormone binding globulin; SMI, skeletal muscle index; TSH, thyroid-stimulating hormone; WC, waist circumference; WH, waist-to-hip ratio 
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Introduction 
People with Down syndrome (DS) show an accelerated aging phenotype, including 
early skin wrinkling, graying and loss of hair, visual impairments, early menopause, and high 
prevalence of Alzheimer's disease (AD) (Esbensen, 2010). Such a premature aging is thought 
to occur in response to a set of biological processes involving DNA methylation, abnormal brain 
Aβ deposition, and immunosenescence (Horvath et al., 2015; Kusters et al., 2011). 
Among the clinical features of DS, special attention has been paid to cognitive 
deficits due to their impact on quality of life and prognosis (Lott and Dierssen, 2010; Bayen et 
al., 2018). However, musculoskeletal abnormalities (e.g., hypotonia, ligament laxity) are also 
typical features of DS, that contribute to the development of physical dysfunction (Foley and 
Killeen, 2018). Whether precocious muscle atrophy also plays a role in physical function 
impairment in DS individuals is 
not established. In this context, reduced myofiber area has been described in young 
adult animals with DS, suggesting that muscle atrophy may be part of the myriad of features 
induced by the trisomy of human chromosome 21 (Cisterna et al., 2013). 
 Muscle atrophy is one defining criterion of sarcopenia, an age-related condition 
characterized by loss of muscle mass and function with a risk of adverse events (Cruz-Jentoft 
et al., 2010). The condition is highly prevalent in older adults across different settings, including 
community, hospitals, and long-term care institutions (Tarantino et al., 2016; Diz et al., 2017; 
Marzetti et al., 2018a; Xu et al., 2018). Furthermore, muscle loss often associates with other 
detrimental changes in body composition, including increased adiposity (Buch et al., 2016) and 
reduced bone mineral density (BMD) (Cheng et al., 2014; Borges Pereira et al., 2015; Edwards 
et al., 2015). Notably, obesity and osteoporosis are frequently observed in DS people (Luke et 
al., 1996; Melville et al., 2005; Bell and Bhate, 2008; Carfì et al., 2014, 2017). Nevertheless, to 
the best of our knowledge, no study has yet investigated the prevalence of sarcopenia-related 
parameters, as well as the relationship between indexes of muscle mass, physical function, and 
bone mineral density in persons with DS. 
Clinically, whole-body lean body mass (LBM) assessed trough bioelectrical 
impedance analysis (BIA) is a well-accepted parameter for the diagnosis of sarcopenia (Chen 
et al., 2014; Tosato et al., 2017; CruzJentoft et al., 2019). However, it has been proposed that 
LBM adjusted for either height or body mass index (BMI) should be used instead of crude 
LBM, since muscle mass is correlated with body size (Chen et al., 2014; Cruz-Jentoft et al., 
2019). 
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 Based on these premises, the present study aimed at investigating the prevalence of 
sarcopenia parameters in adults with DS. In addition, the relationship between well-established 
muscle mass indexes and a set of body composition, functional, biological, and clinical 
parameters was explored to obtain preliminary indications on the more meaningful muscle 
index in DS adults. 
 
Materials and methods 
This was a cross-sectional study that was approved by the Ethics Committee of the 
Università Cattolica del Sacro Cuore (Rome, Italy), under the protocol number 7437/14. The 
study was conducted in compliance with the Declaration of Helsinki and the Resolution 196/96 
of the National Health Council. 
 
Study participants 
Study participants were recruited from the outpatient clinic of the Department of 
Geriatrics, Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS at the Università 
Cattolica del Sacro Cuore (Rome). Volunteers were recruited by convenience and asked 
verbally by the researchers about their willingness to take part in the study. Prior to inclusion, 
written informed consent was obtained from each participant or surrogate legal representatives 
as needed. To minimize the risk of selection bias, no specific inclusion criterion was required. 
Candidates were considered to be eligible to participate if they had a diagnosis of DS, were ≥18 
years, and possessed sufficient physical and cognitive abilities to perform all the measurements 
required by the protocol. 
 
Clinical characteristics 
Information on comorbid conditions and pharmacological treatment was collected 
by the attending physician through a careful review of medical records. Biological parameters, 
including carboxy-terminal collagen crosslinks (CTX), dehydroepiandrosterone (DHEA), free 
testosterone index (FTI), insulin-like growth factor 1 (IGF-1), osteocalcin, sex hormone binding 
globulin (SHBG), thyroid-stimulating hormone (TSH) and 25-hydroxycholecalciferol, were 
assessed by the hospital laboratory. 
 
Assessment of anthropometry, body composition, and bone mineral density 
A medical graded weight scale with a stadiometer was used to measure body mass 
and height. BMI was calculated as the ratio between body mass (kg) and the square of height 
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(m2). An anthropometric tape (flexible and inextensible) was used to measure waist 
circumference (WC), hip circumference (HC), and mid-arm circumference (MAC). The waist-
to-hip ratio (WH) was subsequently calculated. For these measurements, participants were 
requested to wear light clothes and to stay in a standing position, head held erect, eyes forward, 
with the arms relaxed at the sides of the body, and feet kept together. WC was taken at the mid-
point between the last floating rib and the highest point of the iliac crest. HC was measured at 
the highest point of the buttocks. MAC was taken at the mid-point between the elbow and the 
deltoid muscle (Landi et al., 2010; World Health Organization, 2011). Body composition was 
estimated by BIA using a Quantum/S Bioelectrical Body Composition Analyzer (Akern Srl, 
Florence, Italy) with an operating frequency of 50 kHz at 800 μA, after an overnight fast. 
Measurements were taken under standard conditions, with the participant lying supine and 
surface electrodes placed on the right wrist and ankle (Marzetti et al., 2014). Muscle mass was 
estimated using the equation developed by Janssen et al. (2000). The skeletal muscle index 
[SMI (kg/m2)] was obtained by dividing absolute muscle mass by squared height. 
BMD was measured at the neck of the right femur and at the lumbar spine by dual 
X-ray absorptiometry (DXA) using a Hologic® Discovery A (Hologic, Inc., Bedford, MA). Hip 
BMD was based on measurements at the femoral neck, while total spine BMD was evaluated 
on measurements of three lumbar vertebrae (L2–L4) (Carfì et al., 2017). 
 
Assessment of muscle strength, physical function, and disability 
- Isometric handgrip strength 
Isometric handgrip strength was measured using a Jamar handheld hydraulic 
dynamometer (Patterson Medical Products, Inc., Cincinnati, OH). For the test, the participant 
seated on a standard chair with the shoulder abducted, the elbow near the trunk and flexed at 
90°, and the wrist in a neutral position (thumb up). The contralateral arm remained relaxed 
under the thigh. To determine handgrip strength, participants performed one familiarization trial 
and one measurement trial with the dominant hand (Landi et al., 2017b). The maximal 
contraction was measured during 4 s under encouragement. 
- Usual walking speed 
Usual walking speed was measured over 4 m. In the test, volunteers were required 
to walk 4 m at their usual pace. Before the evaluation, both feet were to remain before the 
starting line. The stopwatch was started when a foot reached the starting line and was stopped 
when a foot reached the 4-m line (Coelho-Junior et al., 2018). The faster of two trials (m/s) was 
used for the analysis. 
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- Disability status 
Functional status was further assessed using the Katz activities of daily living 
(ADL) scale (Katz et al., 1963). 
 
Statistical analysis 
Normality of data was ascertained using the Kolmogorov-Smirnov test. For the 
analysis, participants were categorized into two subgroups (i.e., low and high) for each LBM-
related measurement (i.e., crude LBM, LBM/BMI, and SMI) according to their median values. 
This approach was chosen because there is no cutoff for any muscle mass indexes that is specific 
for people with DS. Median values were 43.44 kg, 1.69, and 8.38 kg/m2 for crude LBM, 
LBM/BMI, and SMI respectively.  
Differences in continuous and categorical variables between groups (low vs. high) 
were assessed by independent t-test and chi-square (χ2) statistics, respectively. Pearson's tests 
were run to explore correlations between continuous variables and muscle mass indexes. For 
all tests, the level of significance was set at 5% (p < 0.05). All analyses were performed using 
the IBM SPSS Statistics, version 23.0, software (IBM Corp., Armonk, NY). 
 
Results 
The study sample included 105 adults diagnosed with DS. Table 1 shows the main 
characteristics of participants according to muscle mass indexes. Individuals allocated into the 
high crude LBM subgroup (≥43.44 kg) showed lower prevalence of autoimmune diseases and 
higher WC, MAC, FTI, and consumption of antipsychotic drugs in comparison with the low 
LBM category. The high LBM/BMI subgroup (≥1.69) showed higher FTI and lower BMI, WC, 
and HC values relative to low LBM/BMI participants. Finally, BMI, WC, and HC were greater 
in the high SMI subgroup (≥8.38 kg/m2) compared with the low SMI subgroup (≥8.38 kg/m2). 
In addition, higher serum CTX levels, a marker of bone resorption (Rosen et al., 2000), were 
observed in the high SMI subgroups in comparison to participants with low SMI. 
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Table 1. Main characteristics of participants according to muscle mass indexes. 
 
Total (n = 105) 
 
Total sample Low (< 43.44 kg) High (≥43.44 kg) Low 
(< 1.69 kg/(kg/m2)) 
High 
(≥1.69 kg/(kg/m2)) 
Low 
(< 8.38 kg/m2) 
High 
(≥8.38 kg/m2) 
Demographics 
Age (years), mean ± SD 38.4 ± 12.1 39.7 ± 13.2 35.8 ± 10.6 37.8 ± 12.3 37.7 ± 12.1 42.0 ± 13.1 33.7 ± 9.5 
Gender (male), % 41.0 52.2 34.8 45.7 41.3 53.2 34.0 
Comorbidities and medications (%) 
Cardiovascular disease 57.4 52.2 47.8 43.5 56.5 59.6 38.8 
Autoimmune diseases 81.9 73.9 71.7⁎⁎ 69.6 76.1 72.3 72.3 
Malnutrition 4.3 6.5 0.0 0.0 6.5 6.4 0.0 
Antipsychotics 22.3 25.0 26.7⁎ 100 100 32.4 19.4 
Benzodiazepines 4.3 10.0 0 0 11.8 8.8 2.8 
Antidepressants 14.9 20.0 13.3 22.2 11.8 11.8 22.2 
Polypharmacy (≥ 4 drugs) 9.6 7.5 13.3 8.3 11.8 11.8 8.3 
ADL impairment (%) 
1 35.1 42.9 51.7 42.4 51.6 40.6 51.5 
2 52.1 71.4 65.5 66.7 71.0 65.6 69.7 
≥3 63.8 85.7 82.8 87.9 80.6 81.3 84.8 
Anthropometric characteristics (mean ± SD) 
BMI (kg/m2) 27.9 ± 6.5 25.6 ± 5.3 29.1 ± 6.2 31.0 ± 5.9 23.7 ± 3.3⁎ 24.9 ± 4.0 30.1 ± 6.5⁎ 
WC (cm) 86.4 ± 12.8 79.9 ± 9.7 92.5 ± 12.9⁎ 91.0 ± 14.1 81.4 ± 9.8⁎ 83.0 ± 9.1 89.4 ± 15.2⁎ 
HC (cm) 102.1 ± 12.1 98.5 ± 9.6 105.0 ± 13.7 107.8 ± 9.5 95.7 ± 6.7⁎ 96.7 ± 7.8 107.3 ± 13.5⁎ 
WH 0.85 ± 0.7 0.81 ± 0.6 0.88 ± 0.6 0.84 ± 0.8 0.85 ± 0.7 0.86 ± 0.0 0.83 ± 0.0 
MAC (cm) 28.8 ± 3.5 27.4 ± 2.4 30.1 ± 4.0⁎ 30.0 ± 3.8 27.5 ± 2.8 27.5 ± 2.8 30.0 ± 3.8 
Fat mass (kg) 17.4 ± 11.4 13.7 ± 8.8 20.9 ± 12.6 23.7 ± 11.4 10.9 ± 6.8 13.9 ± 8.8 20.7 ± 12.7 
Lean body mass (kg) 44.2 ± 5.9 39.4 ± 2.8 48.9 ± 4.2⁎ 42.8 ± 5.8 45.6 ± 5.7 42.1 ± 5.0 46.2 ± 6.1 
Lean body mass/BMI 1.7 ± 0.31 1.5 ± 0.31 1.7 ± 0.32 1.4 ± 0.18 1.9 ± 0.18 1.7 ± 0.30 1.5 ± 0.33 
SMI (kg/m2) 8.4 ± 1.3 8.0 ± 1.3 8.7 ± 1.2 8.6 ± 1.4 8.1 ± 1.2 7.3 ± 0.94 9.4 ± 0.73 
Bone parameters 
Femoral BMD (g/m2) 0.68 ± 0.12 0.66 ± 11 0.72 ± 12 0.68 ± 0.11 0.69 ± 0.12 0.61 ± 0.11 0.74 ± 0.10 
Spine BMD (g/m2) 0.90 ± 0.13 −1.5 ± 1.2 −1.6 ± 1.1 0.91 ± 0.11 0.89 ± 0.14 0.87 ± 0.14 0.92 ± 0.11 
Physical function tests 
Handgrip strength (kg) 12.6 ± 6.0 10.8 ± 6.3 13.6 ± 5.7 12.3 ± 5.5 12.7 ± 6.6 14.2 ± 4.9 11.4 ± 6.5 
Usual walking speed (m/s) 0.8 ± 0.2 0.7 ± 0.3 0.9 ± 0.4 0.8 ± 0.4 0.9 ± 0.2 0.8 ± 0.5 0.8 ± 0.4 
Laboratory parameters 
25-hydroxycholecalciferol 
(nmol/L) 
19.2 ± 10.0 18.7 ± 11.2 19.7 ± 8.8 18.4 ± 10.2 19.9 ± 10.2 19.7 ± 10.8 18.4 ± 9.5 
CTX (ng/mL) 0.53 ± 0.24 0.43 ± 0.17 0.64 ± 0.25 0.49 ± 0.24 0.59 ± 0.23 0.55 ± 0.31 0.52 ± 0.14⁎ 
DHEA (mg/mL) 2300 ± 1341 1864 ± 1167 2966 ± 1312 2281 ± 1134 2602 ± 1567 2270 ± 1320 2590 ± 1346 
FTI (pmol/L) 24.7 ± 33.1 7.9 ± 14.2 43.2 ± 38.8⁎ 12.7 ± 20.1 43.6 ± 40.9⁎ 25.0 ± 33.8 27.0 ± 36.0 
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IGF-1 (nmol/L) 198.4 ± 73.4 185.1 ± 58.3 213.5 ± 83.0 176.6 ± 55.8 224.8 ± 81.4 185.2 ± 62.8 210.1 ± 80.1 
Osteocalcin (ng/mL) 29.7 ± 10.2 30.1 ± 10.4 31.8 ± 9.7 26.8 ± 9.4 35.5 ± 9.7 32.6 ± 10.5 29.2 ± 9.0 
SBGH (nmol/L) 56.6 ± 39.1 74.0 ± 41.3 34.9 ± 15.7 63.0 ± 45.8 43.7 ± 18.5 66.8 ± 44.2 40.6 ± 17.0 
TSH (U/mL) 3.2 ± 3.1 3.5 ± 4.2 2.7 ± 1.5 3.6 ± 4.1 2.6 ± 2.1 3.2 ± 4.0 2.9 ± 2.3 
Abbreviations: BMD = bone mass density; BMI = body mass index; CTX = carboxy-terminal collagen 
crosslinks; DHEA = dehydroepiandrosterone; FTI = free testosterone index; HC = hip circumference; 
IGF-1 = insulin-like growth factor 1; MAC = mid-arm circumference; SD = standard deviation; SHBG 
= sex hormone binding globulin; SMI = skeletal muscle index; TSH = thyroid-stimulating hormone; 
WC = Waist circumference; WH = waist-to-hip ratio. ⁎ p < 0.05 vs. low subgroup. 
 
Pearson's correlations were performed to investigate which variables were 
significantly associated with the different muscle mass indexes (Table 2). Low crude LBM 
(−0.35), low LBM/BMI (−0.30), and low SMI (−0.52) were negatively correlated with age. 
Furthermore, low crude LBM was correlated with HC (0.29). On the other hand, low LBM/BMI 
(−0.63) was negatively correlated with all anthropometric measures (WC: −0.40, HC: −0.63, 
MAC: −0.31, fat mass: −0.49), except for WH. MAC (−0.33) and fat mass (−0.28) were also 
negatively correlated with high LBM/BMI. Similarly, high SMI was positively correlated with 
WC (0.49), HC (0.45), MAC (0.32), and fat mass (0.41). Low and high crude LBM as well as 
low SMI were correlated with femoral BMD (0.38, 0.49, 0.38). Additional correlations were 
observed between spine BMD and low crude LBM (0.33). Finally, serum 25-
hydroxycholecalciferol levels were positively correlated with low SMI (0.51). 
 
Table 2. Pearson's correlations between muscle mass indexes and continuous variables. 
 
 Low 
(< 43.44 kg) 
High 
(≥43.44 kg) 
Low (< 1.69 kg/(kg/m2)) High (≥1.69 kg/(kg/m2)) Low 
(< 8.38 kg/m2) 
High 
(≥8.38 kg/m2) 
Age (years) −0.35⁎ −0.12 −0.30⁎ 0.25 −0.52⁎⁎ 0.09 
Anthropometric characteristics 
WC (cm) 0.22 0.22 −0.40⁎⁎ −0.21 0.20 0.49⁎⁎ 
HC (cm) 0.29⁎ 0.13 −0.63⁎⁎ −0.14 0.22 0.45⁎⁎ 
WH −0.02 0.18 0.17 −0.16 0.06 0.26 
MAC (cm) 0.21 0.23 −0.31⁎ −0.33⁎ 0.23 0.34⁎ 
Fat mass (kg) 0.19 0.12 −0.49⁎⁎ −0.58⁎⁎ 0.09 0.41⁎⁎ 
Bone parameters 
Femoral BMD (g/m2) 0.38⁎ 0.49⁎⁎ 0.03 −0.10 0.38⁎ 0.13 
Spine BMD (g/m2) 0.33⁎ 0.17 −0.18 0.08 0.28 0.13 
Physical function tests 
Handgrip strength (kg) −0.45 0.04 0.15 0.25 0.55 0.32 
Usual walking speed (m/s) 0.00 0.01 −0.48 0.09 0.12 0.08 
Hormonal profile 
25-hydroxycholecalciferol (nmol/L) 0.19 0.02 0.16 0.08 0.51⁎⁎ 0.08 
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Discussion 
The present study was undertaken to investigate (a) sarcopenia-related parameters 
and (b) functional, body composition and biological measures associated with muscle mass 
indexes in adults with DS. Our findings indicate that LBM is negatively correlated with age in 
DS, regardless of the muscle mass index considered. While the relationship between aging and 
muscle loss is well-established in the general population (Marzetti et al., 2017), our study is the 
first describing a similar phenomenon in persons with DS. 
Results of the present study lend support to the hypothesis that the trisomy of human 
chromosome 21 can impact skeletal muscle tissue development (Cisterna et al., 2013), since the 
mean muscle mass (44.1 kg) and SMI values (8.3 kg/m2) of adults with DS who participated in 
the present study was slight higher (Baumgartner et al., 1998) or even lower (Chien et al., 2008; 
Bianchi et al., 2015; Martone et al., 2017) than the proposed cutoffs for sarcopenia in older 
adults (Fig. 1). Specifically, the mean SMI of the low SMI subgroup (7.3 kg/m2) was markedly 
lower than in non-sarcopenic older adults aged ≥75 years (−15%) (Bianchi et al., 2015) and 
older patients admitted to acute care wards (−18%) (Martone et al., 2017).  
 
 
 
 
 
 
TSH (U/mL) 0.04 0.25 −0.00 0.02 0.18 0.31 
IGF-1 (nmol/L) 0.29 0.19 0.22 −0.10 0.08 −0.41 
SBGH (nmol/L) −0.38 −0.20 0.17 0.11 −0.05 0.29 
DHEA (mg/mL) 0.07 −0.11 0.01 −0.10 −0.00 −0.03 
FTI (pmol/L) 0.44 0.35 0.34 0.20 0.22 −0.34 
CTX (ng/mL) −0.06 −0.00 −0.05 −0.25 0.27 −0.27 
Osteocalcin (ng/mL) 0.31 0.07 0.13 −0.11 0.12 −0.47 
Abbreviations: BMD = bone mass density; BMI = body mass index; CTX = carboxy-terminal collagen 
crosslinks; DHEA = dehydroepiandrosterone; FTI = free testosterone index; HC = hip circumference; 
IGF-1 = insulin-like growth factor 1; MAC = mid-arm circumference; SHBG = sex hormone binding 
globulin; SMI = skeletal muscle index; TSH = thyroid-stimulating hormone; WC = waist 
circumference. ⁎ p < 0.05. ⁎⁎ p < 0.001. 
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Fig. 1. Comparison between mean values of skeletal muscle index in men (a) and (b) women with Down 
syndrome and the cutoffs for low muscle mass by the European Working Group on Sarcopenia in Older 
People (Cruz-Jentoft et al., 2010). DS = Down syndrome; EWGSOP = European Working Group on 
Sarcopenia in Older People; SMI = Skeletal muscle index. 
 
Although not linearly, muscle mass is linked to muscle strength and muscle power 
(Lauretani et al., 2003). Consequently, muscle atrophy has been associated with reduced 
physical function and other negative outcomes, such as disability, hospitalization, and mortality 
(Bianchi et al., 2015). Interestingly, low muscle mass indexes were not associated with reduced 
handgrip strength or walking speed relative to the high subgroups, probably indicating that 
muscle atrophy is not the main factor driving muscle weakness in DS individuals. This 
hypothesis is supported by findings by Bala et al. (2018), who demonstrated that Ts1Cje mice, 
a well-established animal model of DS, displayed lower muscle strength without changes in 
muscle cross sectional area. Nevertheless, similar to muscle mass indexes, mean handgrip 
strength and gait speed values in our sample of DS adults were markedly lower than the cutoff 
levels for sarcopenia (Cruz-Jentoft et al., 2019) (Fig. 2). Noticeably, the handgrip performance 
of adults with DS (12.5 kg) was lower than that observed in Italian community-dwellers aged 
80 years or older (Landi et al., 2017a). 
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Fig. 2. Comparisons between handgrip strength and walking speed in DS and proposed cutoffs for 
sarcopenia by EWGSOP (Cruz-Jentoft et al., 2019), according to gender (a and c, men; b and d, women). 
DS = Down syndrome; EWGSOP = European Working Group on Sarcopenia in Older People; IHG = 
isometric handgrip strength; WS = walking speed. 
 
A distinct pattern of correlations was observed between anthropometric 
characteristics and muscle mass indexes. Low LBM was correlated with HC, which may 
suggest an association with fat mass and muscle quality. However, other anthropometric 
parameters (i.e., MAC and WC) and fat mass did not show significant correlations. In turn, both 
low and high LBM/BMI were negatively correlated with MAC and fat mass. An interesting 
positive correlation was also observed between high SMI and all anthropometric measures, 
except for WH. These findings were unexpected as fat mass has been strongly associated with 
muscle wasting in older adults (Buch et al., 2016; Marzetti et al., 2018b). It should be stressed 
that obesity has long been recognized as a high prevalent clinical feature in DS individuals 
(Luke et al., 1996; Melville et al., 2005; Bell and Bhate, 2008), and evidence suggests that these 
individuals show reduced caloric intake in comparison with individuals with traditional 
development (Luke et al., 1996). A possible explanation for these results could be that 
participants in the high SMI subgroup might have been practicing physical exercise with or 
without nutritional supervision. However, physical activity and exercise levels as well as diet 
were not controlled in the present study. 
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In the low SMI subgroup, muscle mass and serum 25-hydroxycholecalciferol levels 
were significantly correlated. Previous studies have shown that vitamin D deficiency is 
associated with sarcopenia and may intervene in the pathogenesis of muscle atrophy (Calvani 
et al., 2013). Indeed, vitamin D modulates several pathways involved in muscle growth and 
homeostasis, including protein turnover, myogenesis, and myoblast differentiation (Gunton and 
Girgis, 2018). The possibility that low circulating vitamin D levels might contribute to muscle 
loss also in DS persons warrants further investigation. 
Regarding bone parameters, LBM and SMI were significantly correlated with spine 
and femoral BMD. These findings are supported by numerous investigations proposing that 
sarcopenia is associated with osteopenia and osteoporosis in older adults (Cheng et al., 2014; 
Borges Pereira et al., 2015; Edwards et al., 2015). Furthermore, disruption of bone-muscle 
crosstalk is proposed to play a role in the pathogenesis of both sarcopenia and osteoporosis 
(Picca et al., 2017; Tarantino and Scimeca, 2018). Nevertheless, our findings do not support a 
clear-cut pattern between muscle mass indexes and bone parameters in DS. Indeed, in the low, 
but not the high subgroup, SMI was associated with femoral BMD. These results may be, at 
least partly, explained by the cross-sectional design of the present study. 
Although this study presents novel findings, some aspects need to be discussed. The 
main limitations include the relatively low number of participants and the lack of a deeper 
analysis of body composition and physical function, as well as the analysis of the metabolic 
status and physical activity levels. Regarding the latter, muscle strength and physical function 
were assessed by handgrip strength and walking speed, respectively, since these tests are 
endorsed by the European (Cruz-Jentoft et al., 2019) and Asian (Chen et al., 2014) working 
groups on sarcopenia in older people. However, according to the recently revised European 
consensus (Cruz-Jentoft et al., 2019), other physical performance tests, such as the timed “up-
and-go” (TUG) and the 5-repetition chair-stand tests, might be included in the evaluation. In 
addition, because participants of the present study were relatively young (mean age: 38 years), 
findings may not be extrapolated to older people with DS. Future research should address the 
aforementioned limitations and expand these highly novel initial findings. 
 
Conclusion 
Taken as a whole, findings from the present study indicate that adults with DS show 
muscle mass indexes and physical performance levels similar to or lower than older adults with 
sarcopenia. Furthermore, LBM and SMI were correlated with a set of anthropometric and bone 
parameters. Since DS persons seem to suffer from premature sarcopenia, the assessment of 
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muscle mass and functional status should be included in the routine evaluation of this population 
starting at young age. Future studies are warranted to confirm these initial findings and 
investigate whether the sarcopenic status of DS people may be improved by established 
interventions, such as exercise and optimized nutrition. 
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Abstract: (1) Background: The present work aims to conduct a systematic review and meta-analysis 
of observational studies, in order to investigate the association of relative protein intake and physical 
function in older adults; (2) Methods: Observational studies, that investigated the association 
between protein intake and physical function in older adults, were retrieved from MEDLINE, SCOPUS, 
CINAHL, AgeLine, EMBASE, and Cochrane-CENTRAL. Two independent researchers conducted study 
selection and data extraction; (3) Results: Very high protein intake (≥1.2 g/kg/day) and high protein 
intake (≥1.0 g/kg/day) groups showed better lower limb physical functioning and walking speed (WS) 
performance, respectively, in comparison to individuals who present relative low protein (<0.80 
g/kg/day) intake. On the other hand, relative high protein intake does not seem to propitiate a better 
performance on isometric handgrip (IHG) and chair rise in comparison to relative low protein intake. 
In addition, there were no significant differences in the physical functioning of high and middle 
protein intake groups; (4) Conclusions: In conclusion, findings of the present study indicate that a 
very high (≥1.2 g/kg/day) and high protein intake (≥1.0 g/kg/day) are associated with better lower-
limb physical performance, when compared to low protein (<0.80 g/kg/day) intake, in community-
dwelling older adults. These findings act as additional evidence regarding the potential need to 
increase protein guidelines to above the current recommendations. However, large randomized 
clinical trials are needed to confirm the addictive effects of high-protein diets (≥1.0 g/kg/day) in 
comparison to the current recommendations on physical functioning. All data are available in the 
Open ScienceFramework. 
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Introduction 
Sarcopenia is a geriatric condition characterized by progressive muscle atrophy 
accompanied by loss of muscle strength and/or function [1]. The incidence of sarcopenia rises 
with aging and its prevalence is markedly increased in older subjects [2]. In the absence of 
targeted interventions, the clinical course of sarcopenia is marked by higher odds of mobility 
disability, loss of independence, and mortality [3–6]. In this sense, adequate protein intake and 
physical exercise have been suggested as the two main strategies to counteract sarcopenia, and 
prevent its deleterious effects [7,8].  
Although protein supplementation may be advisable in the management of 
sarcopenia, the optimal protein requirement for older adults is presently unclear. Indeed, the 
established guidelines recommended for a number of agencies, such as the Dietary Allowance 
(RDA), RDI (recommended daily intake) [9], and the RNI (reference nutrient intake) [10] have 
been questioned, and researchers have discussed if the recommended protein intake is enough 
to maintain the functional status or even prevent its decline and muscle atrophy in older adults 
[11,12]. Most critical are regarding the RDA, so that the main concern is that the amount of 
protein recommended is based on nitrogen balance studies, which may be associated with a 
methodological bias [11,13]. 
Opinion articles and consensus statements have argued that older people should be 
encouraged to consume greater quantities of protein than the RDA (1.0–1.5 g/kg) [11–14]. 
Findings from observational studies are in line with these inferences, since higher protein 
consumption is associated with lower risk of frailty, loss of lean body mass, slow walking 
speed, dynapenia, and poor balance [15–18]. Nevertheless, there is a lack of direct evidence 
testing the proposed cut-off points for protein consumption. The few available studies have 
reported incongruent results regarding the association of protein intake and physical function 
[17,19–21]. However, to the best of our knowledge, meta-analyses have not been performed to 
determine the pool of results. 
Therefore, the present work aimed at conducting a systematic review and meta-
analysis of observational studies to investigate the association of relative protein intake and 
physical function in older adults. 
 
Materials and Methods 
We conducted a systematic review and meta-analysis of observational studies to 
assess the association between relative protein intake and physical function in older adults. The 
study was fully performed by investigators and no librarians were part of the team. This study 
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complies with the criteria proposed by the Primary Reporting Items for Systematic Reviews 
and Meta-analyses (PRISMA) Statement [22], and the Meta-analysis of Observational Studies 
in Epidemiology (MOOSE) guidelines [23]. All data are available in the Open Science 
Framework at https://doi.org/10.17605/ OSF.IO/JP5SB. 
 
Eligibility Criteria 
The inclusion criteria consisted of: (a) Observational studies, including cross-
sectional and case-control studies, which investigated as primary or secondary outcome the 
association of relative protein intake and physical function in older adults. Longitudinal cohort 
studies were also included if crude baseline data were available; (b) participant age of 60 years 
or older; (c) direct assessment of at least one physical function domain (studies provided self-
reported physical function were excluded); (d) provided the comparison of at least two groups 
with different relative protein intakes; (e) mean values and a measure of dispersion (standard 
deviation or confidence interval) were provided; (f) published studies (English language). We 
excluded randomized-clinical trials (RCTs), quasi-experimental, cross-over studies and any 
kind of investigation that examined the effects of a nutritional intervention associated or not 
with other interventions (e.g., physical exercise) on physical function. Studies that enrolled 
institutionalized participants or non-institutionalized participants with cognitive impairment 
and/or disorder, gastrointestinal and/or renal diseases, anorexia, cancer or any kind of condition 
that may directly impair protein metabolism (e.g., maple syrup urine disease, tyrosinemia) were 
also excluded. Sarcopenic and frailty older people were included. 
 
Search Strategy and Selection Criteria 
Studies published on or before August 2018 were retrieved from the following three 
electronic databases by one investigator (H.J.C.J): (1) MEDLINE (PubMed interface); (2) the 
Cochrane Library (Wiley interface); (3) SCOPUS (Elsevier interface); (4) CINAHL (EBSCO 
interface); (5) AgeLine (EBSCO interface); and (6) EMBASE (EBSCO interface). Reference 
lists for reviews and retrieved articles for additional studies were checked and citation searches 
on key articles were performed in Google Scholar and ResearchGate for additional reports. 
Initially, a search strategy was designed using keywords, MeSH terms, and free text words, 
such as protein consumption, physical function, older adults. Additionally, keywords and 
subject headings were exhaustively combined using Boolean operators. The complete search 
strategy used for the PubMed is shown in List S1. Only eligible full texts in English language 
were considered for review. Authors were contacted if necessary. 
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Data Extraction and Quality Assessment 
Titles and abstracts of retrieved articles were screened for eligibility by two 
researchers (H.J.C.-J. and B.R.). If an abstract did not provide enough information for 
evaluation, the full-text was retrieved. Disagreements were solved by a third reviewer (M.U.). 
Reviewers were not blinded to authors, institutions, or manuscript journals. Studies that 
provided data for more than two groups—for example, low, middle, high, and very high relative 
protein intake were also added—since the volunteers were not shared among the groups. Data 
extraction were independently performed by two reviewers (H.J.C.-J. and L.M.-T) using a 
standardized coding form. Disagreements were solved by a third reviewer (M.U.). 
Coded variables included methodological quality and the characteristics of the 
studies, including: Year, authors, country, study design, setting, sample size (n), age, prevalence 
of female, body mass index (BMI), lean mass, appendicular muscle mass, dietary intake 
assessment method, total protein intake, relative protein intake. 
Afterwards, studies were allocated into four different groups (low (<0.8 g/kg/day), 
middle (0.8–0.99 g/kg/day), high (≥1.0 g/kg/day), and very high (≥1.2 g/kg/day) protein intake). 
These cutoffs were selected according to previous research. Indeed, longitudinal [24,25] and 
review [11–14] studies have arguing that older adults should consume at least 1.0 g/kg/day of 
protein (i.e., high) to maintain muscle mass and optimal physical functioning, so that values 
below the RDA (<0.8 g/kg/day) may be considered low, while values higher than the RDA, but 
lower than the recommended for these aforementioned studies may be considered middle. In 
addition, some evidence has proposed that a minimum of 1.2 g/kg/day of protein should be 
consumed by older adults in attempt to avoid poor health-related outcomes and maintain 
functional performance, regardless the presence of chronic diseases [26,27]. In this sense, 
investigations that showed a mean protein intake of at least 1.2 g/kg/day were allocated in the 
very high group. 
The quality of reporting for each study was performed by two researchers (H.J.C.-
J. and L.M.-T) using the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) instrument [28]. The agreement rate between reviewers was κ = 0.96 for quality 
assessment. 
 
Statistical Analysis 
Meta-analyses were conducted using Revman V.5. Effect size (ES) were measured 
using standard mean difference (SMD) and mean difference and are reported with 95% 
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confidence intervals (95% CI). SMD was used in the comparisons between High protein intake 
and Very high protein intake versus 
Low protein intake in relation to Mobility and Lower limb physical functioning, 
respectively, since the investigations assessed the same outcome, but using different tools. 
However, the mean difference was used in the remaining comparisons, since all the other 
studies used the same outcome. If the required outcome metric was not reported in the study, 
values were calculated using available data. Due to the different characteristics of the included 
studies, a random-effect model was used to calculate the pooled ES. Heterogeneity across 
studies was tested using Q-statistics and I2 index was used to assess inconsistency [29]. The I2 
index was classified as not important (0–40%), moderate (30–60%), substantial (50–90%), and 
considerable (75–100%). 
 
Results 
Characteristics and Quality of Included Studies 
Table 1 provides a general description of the included studies. Of the 4392 registers 
recovered from electronic databases and hand search, 4253 records were excluded based on 
duplicate data, title or abstract. One hundred thirty-nine studies were fully reviewed and 
assessed for eligibility. Finally, seven studies met the inclusion criteria (Figure 1). 
Included studies were published between 2014 and 2018, the majority had a 
prospective longitudinal cohort design [17,30–32], while two had a cross-sectional design 
[20,33] and one study was a case-control [21]. Overall, a total of 8754 community-dwelling 
older adults from six different countries were included. Volunteers were characterized as 
healthy in three studies [17,31,34], post-menopausal in two studies [20,31], sarcopenic in one 
study [21], and diabetic in one study [32]. Mean age of the subjects ranged from 67.8 to 83.0 
years, and the percentage of women among total subject population of various study groups 
varied from 10% to 100%. Mean BMI ranged from 23.7 kg/m2 to 29.5 kg/m2, so that one study 
investigated volunteers with normal BMI [34], while the other six studies investigated 
overweight individuals [17,20,21,31–33]. Limited information was available regarding the 
clinical characteristics of study participants. Nevertheless, osteoporosis, diabetes, hypertension, 
depression, rheumatoid arthritis, and heart diseases were diagnosed among the included 
individuals. Lean mass and appendicular skeletal muscle represented 55.8% and 24.4%, 
respectively, of the total weight. Twenty-nine percent of the volunteers reported an episode of 
fall in the 12 months before the investigations. Physical and functional evaluations included 
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isometric handgrip strength (IHG), knee extensor strength, one-leg stance, usual walking speed 
(WS), chair rise, tandem walk speed, narrow 
walk speed, short physical performance battery (SPPB), and timed 8-foot walk. 
However, only IHG, WS, knee extensor strength, SPPB, and chair rise were included in the 
final analysis, due to availability of data. According to protein intake per kg of body weight, 
volunteers could be divided into four major groups: Low (<0.8 g/kg/day), middle (0.8–0.99 
g/kg/day), high (≥1.0 g/kg/day), and very high (≥1.2 g/kg/day). Methods to evaluate dietary 
intake included 24-h dietary recall (28.5%), 3-day dietary intake record (28.5%), 4-day dietary 
intake record (14.3%), food frequency questionnaire (14.3%), and the Semi Quantitative-Food 
Frequency Questionnaire (SQFFQ) (14.3%). 
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Figure 1. Flowchart of the present study. 
 
4380  Articles  
identified from  
database search  
  4392 Records  
screened  
132 Excluded :  
  58 Lack of data regarding physical  
function;  
  26 Lack of data regarding protein  
intake;  
  11 only one group;  
  17 did not study older adults;  
17  intervention;  
2  review;  
1  Spanish;  
139  Full-text articles  
assessed for  
eligibility  
  12 Articles  
identified from  
hand search  
7  Studies included in  
meta-analysis  
  4253 excluded, due to  
duplication, title, abstract  
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Table 1. General description of the included studies. 
Year Authors Country Study 
Design Population Setting Sample Size Age 
Female 
(%) BMI 
Lean 
Mass 
Appendicular 
Muscle Mass 
Dietary 
Intake 
Assessment 
Method 
Total 
Protein 
Intake 
(g/Day) 
STROBE 
Score 
2018 
ten 
Haaf 
et al. 
Netherland Cross-sectional Healthy Community-dwelling HP: 80; LP: 60 83.0 10 26.1 — — 24-h dietary 
recall 
HP: 89.5; LP: 
64.7 19 
2016 Isanejad 
et al. Finland Longitudinal Healthy Community-dwelling 
HP = 112; MP = 269; LP 
= 171 67.8 100 26.6 
HP: 41.3, 
16.4, 6.5; 
MP:40.1, 
15.9, 6.7; 
LP: 39.1, 
15.6, 6.6 
— 
3-day 
dietary 
intake 
record 
HP: 83.4; 
MP:65.0; LP: 
51.4 
20 
2016 
Rahi 
et al. Canada Longitudinal Diabetic Community-dwelling HP: 73; LP: 99 75.0 62 29.5 — — 
24-h dietary 
recall 
HP: 91; LP: 
64.3 20 
2015 Larocque 
et al. 
United 
States Longitudinal 
Post-menopausal 
women Community-dwelling LP = 1756; HP = 2889 80.1 100 26.8 — — 
Food 
frequency 
questionnaire 
LP = 42.6; HP 
= 71.6 17 
2015 Verlaan 
et al. 
United 
Kingdom Case-control 
Sarcopenic and 
non-sarcopenic 
Sarcopenic: 66; 
Community-dwelling 
Non-sarcopenic: 66 
71.1 39 26.1 — 
Sarcopenic:19.0; 
Non-sarcopenic: 
20.4 
3-day 
dietary 
intake 
record 
Sarcopenic: 
72.5; 
Non-sarcopenic: 
75.3 
19 
2014 Chan 
et al. China Longitudinal Healthy 
LP = 617; MP =677; 
Community-dwelling 
HP = 705; HP2 = 727 
71.6 49.8 23.7 — — 
Semi 
Quantitative-Food 
Frequency — 
Questionnaire 
(SQFFQ) 
19 
2014 Gregorio 
et al. 
United 
States Cross-sectional 
Post-menopausal 
women Community-dwelling LP = 97; HP = 290 73.0 100 27.4 
LP = 40.7; 
HP = 38.2 
LP = 17.0; HP = 
15.9 
4-day 
dietary 
intake record 
LP = 49.7; HP 
= 79.7 20 
BMI = body mass index; HP = high protein; MP = middle protein; LP = low protein. 
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Table 2 provides the general characteristics of the volunteers according to their 
relative protein intake. All groups presented similar mean age (~73 years). The lowest sample 
size was observed in the middle protein intake group, followed by the very high protein intake 
group, low protein intake group and high protein intake group. The groups presented a similar 
mean lean mass and mean appendicular mass. However, it is important to observe that High 
protein intake and Very high protein intake groups showed a higher percentage of lean mass 
when compared to Low protein intake and Middle protein intake groups. In addition, a greater 
performance in knee extensor strength and SPPB was observed in High protein intake and Very 
high protein intake groups when compared to Low protein intake group. Protein, carbohydrate 
and fat intake increased according to relative protein intake. It should be stressed that these 
parameters were not reported by all the investigations. 
 
Table 2. Characteristics of the volunteers according to relative protein intake *. 
Low Protein Intake 
(0.67) 
Middle Protein 
Intake (0.88) 
High Protein 
Intake (1.3) 
Very High Protein 
Intake (1.5) 
 Variables n = 2641 n = 395 n = 5619 n = 1145 
Anthropometric characteristics   
Age (years) 73.8 74.0 74.6 73.5 
BMI (kg/m2) 29.1 26.7 27 27.1 
Lean Mass (kg) (% in relation to weight) 
41.0 (53) 40.1 (56.1) 38.7 (58.7) 38.2 (58.1) 
Appendicular Muscle Mass (kg) (% in 
relation to weight) 
— 19.0 (25.5) 20.4 (24.7) 15.9 (24.2) 
Physical functional tests    
IHG (kg) 20.4 27.5 24.3 19.1 
Knee Extensor Strength (lb) 54.5 44.5 52.1 57.5 
One-Leg Stand (s) 13.5 19.3 18.4 15.3 
Chair Rises (s) 11.4 10.6 11.8 13.5 
Tandem Walk Speed for 6 m (m/s) 0.30 0.34 0.33 — 
Usual Walking Speed (m/s) 1.1 1.2 1.2 1.07 
SPPB (points) 9.9 9.0 11.0 10.6 
Timed 8-Foot Walk (m/s) 1 — 1.1 1.1 
 Dietary factors    
Protein (g/day) 58.8 67.4 85.4 87.2 
Carbohydrate (g/day) 162.6 199.8 215.9 220.6 
Fat (g/day) 43.6 58.6 64.4 — 
BMI = body mass index; IHG = Isometric handgrip; SPPB = Short physical performance battery (i.e., 
combination of results in gait speed, chair stand e balance tests; The final score ranged from 0 (worst 
performance) to 12 (best performance). * Information was not available by all the included 
investigations. 
141 
 
 
Study quality results are shown in Table S1, while the point by point analysis is 
shown in Table S2. The overall score ranged from 17 to 20. All studies reported the items 
required by the STROBE criteria in relation to the abstract (items 1 and 2), clarity of the 
outcomes (items 7 and 15), methods of assessment (item 8), handle of quantitative variables 
(item 11), statistical methods and analysis (items 12, 16), discussion (items 18–21), and funding 
(item 22). However, 14.2% of the studies failed to clearly state specific objectives, including 
any prespecified hypotheses (item 3), the main aim of the investigation (item 4), describe the 
setting, locations and relevant dates of recruitment and data collection (item 5) [25], give the 
characteristics of study participants (item 14); and report other analyses done—e.g., analyses 
of subgroups and interactions, and sensitivity analyses (item 17). In turn, 28.5% did not 
properly report the eligibility criteria, and the sources and methods of selection of participants 
(item 6), 71.4% did not describe any efforts to address potential sources of bias (item 9), 57.1% 
explained how the study size was arrived at (item 10) and reported numbers of individuals at 
each stage of study (item 13). 
 
High Protein Intake verses Low Protein Intake 
A total of four studies provided information to investigate the association of high 
and low protein intake with physical function (Figure 2). It should be stressed, that Rahi et al. 
[32] provided their data according to gender, and the results are presented accordingly. Upper-
limb muscle strength—Upper-limb muscle strength was measured by IHG in all studies. Three 
studies were added in the meta-analysis [17,20,31]. Results did not demonstrate significant 
differences in IHG between the groups, and a small non-significant ES was observed (ES = 
−0.36; 95% CI = −1.15 to 0.44, p = 0.38). Moderate heterogeneity was found across studies (χ2 
= 4.16, df = 2, p= 0.12, I2= 52%) (Figure 2a). Lower-limb muscle strength—Lower-limb muscle 
strength was evaluated by chair-rise and knee extensor strength. A meta-analysis of three 
studies—but evaluating four subgroups—observed a small non-significant difference between 
groups (ES = −0.09; 95% CI = −0.26 to 0.08, p = 0.30). A not important heterogeneity was 
found across studies (χ2 = 3.75, df = 3, p = 0.29, I2 = 20%) (Figure 2b). 
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Figure 2. Mean difference in (a) Upper-limb muscle strength and Standardized mean difference in (b) 
Lower-limb muscle strength according to protein intake. Squares represent study-specific estimates; 
diamonds represent pooled estimates of random-effects meta-analyses. 
 
Mobility 
Mobility was evaluated by 10-m WS [17] and 6-m WS [34]. In the study of Chan 
et al. [34], three out of four groups showed a high protein intake (≥1.0 g/kg/day). In this sense, 
groups will be mentioned as Chan et al., 2014, 2014b, and 2014c, according to relative protein 
intake. In addition, the groups were evaluated alone and grouped. A small ES were observed 
when the analysis was performed with Chan et al. [34] (1.0 g/kg/day) and Isanejad et al. [17] 
(ES = 0.10; 95% CI= −0.06 to 0.27, p = 0.23, χ2 = 20.66, df = 1, p < 0.00001, I2 = 95%) (Figure 
3a), as well as with Chan et al. (2014b) (1.4 g/kg/day) and Isanejad et al. [15] (ES = 0.11; 95% 
CI = −0.05 to 0.26, p = 0.18, χ2 = 18.41, df = 1, p < 0.00001, I2 = 95%) (Figure 3b). The 
combination of the groups—Chan et al. (2014 and 2014b)—changed the results, so that a small 
and significant ES was observed (ES = 0.07; 95% CI = 0.01 to 0.12, p = 0.02, χ2 = 20.84, df = 
2, p < 0.00001, I2 = 90%) (Figure 3c). Significant results were also observed when Chan et al. 
(2014c) was evaluated alone (ES = 0.13; 95% CI = 0.01 to 0.24, p = 0.04, χ2 = 10.29, df = 1, p 
= 0.01, I2 = 90%) (Figure 3d) and with the other groups (ES = 0.06; 95% CI = 0.02 to 0.11, p = 
0.003, χ2 = 27.52, df = 3, p < 0.00001, I2 = 89%) (Figure 3e). 
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Figure 3. Mean differences in Mobility according to protein intake. (a) Chan et al., 2014, and Isanejad 
et al., 2016; (b) Chan et al., 2014b, and Isanejad et al., 2016; (c) Chan et al., 2014ab, and Isanejad et al., 
2016; (d) Chan et al., 2014c, and Isanejad et al., 2016; (e) Chan et al., 2014abc, and Isanejad et al., 2016. 
Squares represent study-specific estimates; diamonds represent pooled estimates of random-effects 
meta-analyses. 
 
Middle Protein Intake verses High Protein Intake 
A total of four studies provided information to investigate the association of high 
and middle protein intake with physical function (Figure 4). Upper-limb muscle strength—
Upper-limb muscle strength was measured by IHG in all studies. Three studies were added in 
the meta-analysis [17,21,33]. Results did not demonstrate significant differences in IHG 
between groups, and a large non-significant ES was observed (ES = 1.09; 95% CI = −3.78 to 
5.96, p = 0.66). A considerable heterogeneity was found across studies (χ2 = 25.07, df = 2, p = 
< 0.00001, I2 = 92%) (Figure 4a). Mobility—Mobility was evaluated in three studies. Pooling 
of results indicated a small and non-significant ES (ES = 0.17; 95% CI= −0.12 to 0.46, p = 
0.26). A considerable heterogeneity was found across studies (χ2 = 56.46, df = 2, p = < 0.0001, 
I2 = 96%) (Figure 4b). Lower-limb muscle strength—Lower-limb muscle strength was 
evaluated by chair-rise in all studies. A meta-analysis of two studies observe a moderate non-
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significant difference between the groups (ES = 0.49; 95% CI= −0.01 to 0.99, p = 0.05). An 
insignificant heterogeneity was found across studies (χ2 = 0.72, df = 1, p = 0.40, I2 = 0%) (Figure 
4c). 
 
Figure 4. Mean difference in (a) Upper-limb muscle strength; (b) Mobility; and (c) Lower-limb muscle 
strength according to protein intake. Squares represent study-specific estimates; diamonds represent 
pooled estimates of random-effects meta-analyses. 
 
Very High Protein Intake verses Low Protein Intake 
A total of five investigations provided information to investigate the association of 
very high protein intake and low protein intake with physical function (Figure 5). Due to the 
lack of available evidence, we did not divide the evaluation according to the type of physical 
assessment, as was performed above, and studies should assess at least one lower limb physical 
function to be included. The evaluations included knee extensor strength [32], SPPB [20], and 
walking speed [34]. Pooling of results indicated a small and significant ES (ES = 0.18; 95% CI 
= 0.01 to 0.35, p = 0.04). A considerable heterogeneity was found across studies (χ2 = 15.56, df 
= 4, p = 0.004, I2 = 74%). 
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Figure 5. Standardized mean difference in Lower-limb muscle functioning according to protein intake. 
Squares represent study-specific estimates; diamonds represent pooled estimates of random-effects 
meta-analyses. 
 
Discussion 
The present study was designed to investigate the available evidence regarding the 
association of relative protein intake and physical function in older adults. Findings of this 
investigation indicate that individuals with relatively very high (≥1.2 g/kg/day) and high (≥1.0 
g/kg/day) protein intakes show higher mobility and lower limb physical functioning, 
respectively, in comparison to those with relative low protein (<0.80 g/kg/day) intake. 
The assessment of study quality demonstrated that reports were of very good quality 
and scored between 17 and 20. The main bias associated with the studies was the lack of 
adequate description about the efforts to address potential sources of bias (item 9), the design 
of the study size (item 10), and the report regarding the number of participants in all the phases 
of the study (item 13). 
Although in recent years several study groups have strongly recommended that 
older adults consume greater levels of protein intake than the RDA, there is a lack of direct 
evidence testing this hypothesis [11,13]. Several observational studies have demonstrated 
incongruent results, so that it is possible to observe null [19,33,34] and positive [17,20,21] 
associations between protein intake and physical function in older adults. 
To the best of our knowledge, this is the first study that directly compared the 
physical function of older adults with different relative protein intakes. Our findings support at 
least partially the need to increase protein guidelines to above the current RDA in older adults, 
since the very high and high protein intake groups showed better muscular health when 
compared to the low protein intake group. The plausibility behind these findings is based on 
the anabolic resistance hypothesis, according to which the muscular anabolic response to 
appropriate stimulation would be blunted in advanced age (to review, see Calvani et al. [14]; 
Landi et al. [35]). This idea is supported by the observation that the aging muscle presents 
diminished muscle protein synthesis in response to small amount of essential amino acids 
(EAAs) [36], the key nutrient for the stimulation of protein synthesis. This would eventually 
lead to muscle catabolism, loss on lean body mass, dynapenia, and impairment on muscle 
function [35]. Higher availability of EAAs, mainly leucine, seems to be necessary to reverse 
overcome the anabolic resistance of muscle [37]. Therefore, the greater physical performance 
observed in the groups with higher protein intake levels (i.e., very high and high) might be 
ascribed to a larger EAAs availability. 
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Although our findings demonstrated that very high and high protein intakes were 
associated with greater physical functioning in comparison to low protein intake, there were no 
differences between high and middle protein intake groups. These results are interesting and 
deserve concern because the middle group represented the level of protein intake recommended 
by the RDA. 
The main motivation for considering changes from a minimum of 0.8 g/kg/day to 
1.0 g/kg/day has been the findings of longitudinal studies that demonstrated preserved muscle 
mass [24] and lower risk of frailty [25] in older adults who had a protein intake ≥1.0 g/kg/day, 
as well as the evidence that showed a significant reduction on muscle mass of older adults who 
consumed the current RDA of protein for a long period [38]. However, no previous studies had 
directly comparing these proposed protein cutoffs, and the lack of significant differences 
between high and middle groups may occur, because the values of protein intake are similar, 
according to ten Haaf et al. [33]. 
Nonetheless, some researchers may argue that very high protein intake could be 
sufficient to elicit significant differences, since the studies of Vellas et al. [26] and Mustafa et 
al. [27] demonstrated that a very high protein intake was associated with a lower risk to poor 
health-related outcomes and physical disability. However, there was no available evidence to 
compare very high and middle protein intake groups. Taken together, these data suggest that a 
protein intake higher than 1.0 g/kg/day causes beneficial effects when compared to protein 
intake levels lower than 0.8 g/kg/day, but more studies are still necessary to precisely define 
the different effects of very high and high protein intakes in comparison to middle protein 
intake. 
Conversely, from a practical point of view, the consumption of high protein intake 
by older adults has been the subject of intense scientific debate and a frequent concern of health 
professionals. Nowadays, has been accepted that older adults without a previous history of 
kidney disease show a lower risk of poor-health outcomes in response to high-protein diets 
[13,39]. However, although higher glomerular filtration rate seems to be a normal mechanism 
in response to the elevated amount of protein in the physiological system of patients with 
normal kidney function, an increased protein intake may collaborate to decline in the renal 
function of patients with a pre-existing renal disease [39]. Therefore, findings of the present 
study should be carefully extrapolated for other populations than healthy older adults. 
On the other hand, data of the present study demonstrated that high protein intake 
was not associated with better performance on the IHG and chair rise when compared to low 
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protein intake group. These findings support the inferences that a higher protein intake may be 
associated with better scores on some, but not all physical tests [19]. 
One possible explanation for these results is that a greater intake of protein might 
promote better functioning of systems other than the neuromuscular system. It should be 
stressed that the performance on the IHG and chair-rise seems to be mainly dictated by the 
neuromuscular system. On the other hand, walking ability needs a larger integration among the 
body systems in comparison with sit and stand up or tightening an object. Indeed, walking is a 
complex activity involving a variety of neural process (e.g., sensory, cortical cognitive, 
temporal) [40,41], cerebral and peripheral vascular beds [42,43], as well as lung [44], cardiac 
and muscular functions [45], to list a few. Consequently, walking ability represents the 
functioning of multiple organ systems instead of just one system [46], and marked disturbances 
in gait pattern may occur in response to cardiovascular, neurological and neuromuscular 
pathologies [40,41]. 
Regarding the relationship between protein intake and neural functioning, for 
example, evidence has demonstrated that an insufficient protein intake may impair spatial 
learning and memory and cause brain atrophy [47], while high protein intake decreases markers 
of oxidative stress (lipid peroxidation) in the brain of rats [48], and is associated with low levels 
of insoluble amyloid-β protein (Aβ) in older adults [49]. In addition, a systematic review 
showed that protein intake was positively associated with cognitive function in older adults 
[50]. Furthermore, increased protein intake may cause changes in the vessel wall structure and 
in cardiovascular control exerted by the central nervous system, consequently mediating the 
negative association between protein intake and blood pressure [51,52]. 
Physical activity levels [33], vitamin intake [31], inflammation [15], mood 
disorders [53], and the prevalence of chronic conditions (e.g., sarcopenia) [17] may also affect 
the relationship between protein intake and physical function. In the study by Isanejad et al. 
[17], for example, higher protein intake and physical function were significantly associated in 
non-sarcopenic, but not in sarcopenic older women. These inferences are in keeping with the 
hypothesis that individuals suffering from illness, physical stress, sarcopenia and/or frailty may 
require higher protein levels (1.2–1.5 g/kg) than healthy older adults [11,12,14]. In the present 
investigation, a considerable heterogeneity (I2) 
was observed in most of the studies. Although we tried to explore heterogeneity 
among the studies performing the analysis with random effects, the investigations did not offer 
sufficient details about the samples, as indicated in the quality assessment and food intake 
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limiting the analysis of subgroups and meta-regression (see Table 2). Therefore, our results 
should be taken with caution and should be confirmed with further studies. 
In this context, future studies aimed at investigating the association of protein intake 
and physical function should collect a number of data allowing better inferences and an 
inclusion in future systematic reviews and meta-analysis, including total and appendicular 
muscle mass, the prevalence of morbidities, frailty and sarcopenia assessment, physical activity 
levels, and an extensive report on food consumption (e.g., amino acid content, protein source) 
and not just the consumption of macronutrients. Other limitations of the present study include 
the lack of comparison between low and middle protein intake, as well as very high and middle 
protein intake (due to the lack of available data), and the use of the mean protein intake to 
identify the groups. 
In relation to the latter, we allocated the groups mentioned in the studies into low, 
middle, high, and very high according to the mean protein intake reported. Nevertheless, it is 
possible that some individuals showed higher or lower protein intake levels. One possible way 
to solve this problem 
would be that future studies designed the groups based on proposed cut-offs for 
older adults [11,12,14], instead of separatrix measures (e.g., quartiles), since a low quartile does 
not necessarily represent a low protein intake. 
 
Conclusions 
In conclusion, findings of the present study indicate that a very high (≥1.2 g/kg/day) 
and high protein intake (≥1.0 g/kg/day) are associated with better lower-limb physical 
performance when compared to low protein (<0.80 g/kg/day) intake in community-dwelling 
older adults. These findings add evidence regarding the potential need to increase protein 
guidelines to above the current recommendations. However, large randomized clinical trials are 
needed to confirm the addictive effects of high-protein diets (≥1.0 g/kg/day) in comparison to 
the current recommendations on physical functioning. 
 
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-
6643/10/9/1330/ s1, List S1: The complete search strategy used for the PubMed. Table S1: 
Quality assessment analysis, Table S2: Individual quality assessment analysis of each included 
study. 
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Abstract: (1) Background: Several factors have been suggested to be associated with the 
physiopathology of frailty in older adults, and nutrition (especially protein intake) has been 
attributed fundamental importance in this context. The objective of this study was to conduct 
a systematic review and meta-analysis to investigate the relationship between protein intake 
and frailty status in older adults. (2) Methods: A search of scientific studies was conducted in 
the main databases (Medline, Scopus, Cochrane library), and in the reference lists of selected 
articles. The search terms included synonyms and Medical Subject Headings and involved the 
use of Boolean operators which allowed the combination of words and search terms. 
Observational studies—cross-sectional and longitudinal—that met the eligibility criteria were 
included in the review. Article selection and data extraction were performed by two 
independent reviewers. Meta-analyses with random effects were performed. Publication bias 
was measured using the Strengthening the Reporting of Observational Studies in 
Epidemiology instrument. (3) Results: In the final sample, 10 articles, seven cross-sectional 
and three longitudinal, were included in the present study. Overall, studies investigated a total 
of 50,284 older adults from three different continents between 2006 and 2018. Four cross-
sectional studies were included in the meta-analyses. The results demonstrated that a high 
protein intake was negatively associated with frailty status in older adults (odds ratio: 0.67, 
confidence interval = 0.56 to 0.82, p = 0.0001). (4) Conclusions: Our findings suggest that a 
high consumption of dietary protein is inversely associated with frailty in older adults. 
 
Keywords: frailty; protein intake; older adults 
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Introduction 
The aging process is a continuous phenomenon characterized by alterations in 
major physiological systems, accompanied by the development of chronic diseases and geriatric 
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syndromes, such as frailty. Frailty may be conceptualized as a multidimensional geriatric 
clinical state that involves multiple signs and symptoms leading to extreme vulnerability to 
stressors and resulting in increased risk of negative health-related outcomes (e.g., functional 
decline, disability, falls, hospitalization, institutionalization, death) [1,2]. 
Nutrition is acknowledged as a major factor in the context of frailty. In fact, 
malnutrition is considered one of the pillars for the development of this condition [3], since it 
can influence all diagnostic criteria for frailty (i.e., unintentional weight loss, low muscle 
strength, exhaustion, reduced physical activity levels, and slow walking speed) [4]. Three 
previous systematic reviews have been 
conducted on the association between nutrition and frailty. Authors observed that 
several factors might be responsible for this close relationship between frail and nutrition, 
including oral health, nutritional status, dietary patterns, diet quality, the antioxidant capacity 
of the diet, micronutrients and macronutrients intake [3,5]. Nevertheless, protein intake might 
be the main factor behind this relationship, through its actions on muscle mass and strength. 
Indeed, human skeletal muscle protein turnover comprises the process of muscle 
protein synthesis and muscle protein breakdown [6–8]. On one hand, muscle hypertrophy 
occurs when the rates of protein synthesis exceed protein breakdown, which may be elicited by 
hyper amino acidemia induced by dietary protein intake; on the other hand, an inadequate 
protein intake leads to lower protein synthesis rate, resulting in net protein breakdown and 
muscle catabolism [6–8]. During aging, numerous process collaborate to a reduced protein 
intake, such as lack of hunger, impaired oral health, and loss of acuity in taste, smell and sight, 
to quote a few [9]; consequently, collaborating to muscle catabolism [9]. In addition, evidence 
has demonstrated that the anabolic response to hyper aminoacidemia may be blunted in older 
adults [10,11], which indicate that this population should consume larger amounts of protein in 
comparison to young adults in an attempt to maintain muscle protein synthesis. Nevertheless, 
over time, the lack of adequate protein intake leads to a state called as sarcopenia [9,12,13], 
which is characterized by marked muscle atrophy, dynapenia, and reduced physical function, 
all variables encompassed on frailty definition [14]. If there is no immediate intervention to 
reduce sarcopenia and frailty progression, as well as improve protein intake, the patients will 
develop a severe physical disability and consequently exhaustion and sedentary behavior [1,15]. 
It should be stressed that other pathways besides sarcopenia may be also responsible 
for the association between protein intake and frailty, since evidence has demonstrated that 
protein intake is associated with dementia, global cognitive scores, visuospatial skill, nonverbal 
memory, and logical memory in older adults [16–18]; all aspects linked with frailty [1]. 
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However, investigations on the association between protein intake and frailty have 
shown positive, negative and even null results. In addition, to the best of our knowledge, there 
is a lack of systematic reviews and meta-analysis dedicated to investigating the relationship 
between protein intake and frailty in older adults. 
Therefore, the present study was conducted to perform a systematic review to 
identify and compare studies reporting the relationship between frailty status and protein intake 
in older adults. Additionally, data were combined to calculate the pooled overall relationship 
between frailty status and protein intake. 
 
Materials and Methods 
We conducted a systematic review and meta-analysis of observational studies to 
investigate and quantify the association between protein intake and frailty in older adults. The 
study was fully performed by investigators and no librarian was part of the team. This study 
complies with the criteria of the Primary Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) Statement [19] and the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) guidelines [20]. 
 
Eligibility Criteria 
The inclusion criteria of the present study consisted of: (a) observational studies, 
including cross-sectional, case-control and longitudinal studies, which investigated as primary 
or secondary outcome the association of protein intake and frailty in older adults; (b) study 
sample 60 years or older; (c) frailty defined by a validated scale; (d) reported information on 
the proportion of frailty among those with high and low levels of protein intake; (e) published 
studies (English language). To be included in the meta-analysis, in addition to the 
aforementioned inclusion criteria, the investigations had to provide: (f) at least two groups 
divided according to protein intake (e.g., high and low), (g) the prevalence of frailty in each 
group, (h) and the total sample size in each group. We excluded randomized-clinical trials 
(RCTs), quasi-experimental, cross-over studies and any kind of investigation which examined 
the effects of a nutritional intervention associated or not with other interventions (e.g., physical 
exercise) on frailty. Studies that classified the volunteers as frail according to reduced 
physical/or cognitive function were also excluded. 
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Search Strategy and Selection Criteria 
Studies published on or before July 2018 were retrieved from the following three 
electronic databases by one investigator: (1) PubMed, (2) the Cochrane Library, and (3) 
SCOPUS. Reference lists for reviews and retrieved articles for additional studies were checked 
and citation searches on key articles were performed on Google Scholar and ResearchGate for 
additional reports. Initially, a search strategy was designed using keywords, MeSH terms, and 
free text words such as protein intake, frailty, older adults. Additionally, keywords and subject 
headings were exhaustively combined using Boolean operators. The complete search strategy 
used for the PubMed can be shown in List S1. Only eligible full texts in English language were 
considered for review. Authors were contacted if necessary. 
 
Data Extraction and Quality Assessment 
Titles and abstracts of retrieved articles were screened for eligibility by two 
researchers. If an abstract did not provide enough information for evaluation, the full-text was 
retrieved. Disagreements were solved by a third reviewer. Reviewers were not blinded to 
authors, institutions, or manuscript journals. Data extraction was independently performed by 
two reviews using a standardized coding form. Disagreements were solved by a third reviewer. 
Coded variables included methodological quality and the characteristics of the studies. The 
quality of reporting for each study was performed by two researchers using the Strengthening 
the Reporting of Observational Studies in Epidemiology (STROBE) instrument [21]. The 
agreement rate between reviewers was κ = 0.98 for quality assessment. 
 
Statistical Analysis 
The meta-analysis was conducted using Revman V.5. Effect sizes (ESs) were 
measured using odds ratio (OR) and 95% confidence intervals (CIs). The OR indicates the risk 
for frailty according to protein intake, high in relation to low. A significant OR is required to 
have a 95% confidence interval (CI 95%) that did not include the value of 1 and a p value for 
the test of significance of the total overall effect (Z) lower than 0.05. An inverse variance 
random-effect model was used to calculate the pooled ES since the studies demonstrated 
different characteristics regarding the main aspects associated with frailty (e.g., modified frailty 
criteria), protein intake (e.g., different cut-offs for high and low protein intake definition), and 
covariates (e.g., energy intake). Funnel plots and Egger’s regression analysis were used to 
evaluate the publication bias. Heterogeneity across studies was tested using the Q-statistics and 
I2 index was used to assess inconsistency [22]. Additionally, I2 index was classified as might 
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not be important (0–40%), may represent moderate heterogeneity (30–60%), may represent 
substantial heterogeneity (50–90%), and considerable heterogeneity (75–100%) [22]. Forest 
plots were used to illustrate summary statistics and the variation (heterogeneity) across studies. 
 
Results 
Literature Search 
Of the 2555 registers recovered from electronic databases and hand search, 2523 
records were excluded based on duplicate data, title or abstract. Thirty-two studies were fully 
reviewed and assessed for eligibility. Finally, 10 studies met the inclusion criteria (Figure 1). 
 
Figure 1. Flow chart of the present study. 
 
Characteristics of the Included Studies 
Table 1 provides a general description of the included studies. Overall, a total of 
18,120 community-dwelling older adults from five different countries (France, Germany, Italy, 
Japan, and the United States of America) were investigated between 2006 and 2018 in the cross-
sectional studies. Frailty assessment was performed with two tools. The frailty phenotype 
proposed by Fried et al. (2001) was used in six of the seven studies [23–28], while one study 
used the Kihon checklist (KCL) [29]. However, it is important to mention that the frailty 
phenotype [14] was modified in 5 of the 6 studies. Indeed, weight loss criterion was modified 
in the studies of Rahi et al. [28] and Shikany et al. [27], while Bartali et al. [23] removed this 
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variable. In turn, in the investigations performed by Kobayashi et al. [24,25], slowness and 
weakness were indirectly measured based on a questionnaire. Slowness assessment was also 
modified in the study of Rahi et al. [28]. Dietary intake was primarily assessed by population-
specific food-frequency questionnaires (FFQ) (57.1%) [23,26,27], followed by self-
administered diet history questionnaires (28.6%) [24,25], and the 24 h dietary recall (14.3%) 
[28]. High and low protein intake was differently defined in the investigations. Measures of 
centrality (e.g., tertiles, quartiles, quintiles) were used in 6 of the 7 studies [23–27], while Rahi 
et al. [28] performed the analysis based on a pre-established cut-off (i.e., protein intake levels 
≥ 1 g/kg of body weight). Regarding longitudinal studies, 32,164 community-dwelling older 
adults were investigated between 2010 and 2016. The studies were conducted in North America 
(United States of America) and Europe (Spain). The mean duration of follow-up was 3.7 years 
(3.0–4.6 years). The frailty phenotype was used in all studies for frailty assessment. However, 
as was observed in cross-sectional studies, the frailty phenotype was modified in 2 of the 3 
longitudinal studies. Shikany et al. [27] considered the loss of appendicular lean mass as a 
measurement of weight loss. In turn, Beasley et al. [30] used a modified version of frailty 
phenotype as they measured muscle weakness and slowness using the Rand-36 Physical 
function scale. FFQ (66.6%) and computerized face-to-face diet history (33.3%) were used for 
a dietary intake assessment. In longitudinal studies, all investigations used measures of 
centrality (i.e., quartile and quintile) to determine the levels of protein intake. 
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Table 1. General description of the included studies. 
Year Authors Country Study Design Setting n 
Mean Age 
(age range; 
min–max) 
Sex Ratio of 
Participants 
(female/male) by 
frail vs. non-
frail 
Frailty 
Assessment 
Method 
Dietary Intake 
Assessment 
Method 
Protein 
Intake 
(g/day) 
Protein Intake 
Level Definition 
Outcomes Covariates Included in Models 
Quality 
Analysis 
Score 
Cross-sectional              
2006 
Bartali et 
al. [23] 
Italy Crosssectional Communitydwelling 802 74.1 1.2 
CHS frailty index 
(a) 
Food-frequency 
questionnaire 
- Dichotomous 
Low protein 
intake is 
associated with 
frailty 
Results were adjusted for age, 
sex, education, economic status, 
household composition, 
smoking status, number of 
diseases, cognitive function, 
body mass index, and 
“happiness.” 
22 
2013 
Kobayashi et 
al. [24] 
Japan Crosssectional Communitydwelling 2108 74.7 - 
CHS frailty index 
(b) 
Self-administered 
diet history 
questionnaire 
74.0 
Quintile 
(≤62.9 g/day, 
6369.8 g/day, 
69.8–76.1 g/day, 
76.1–84.3 g/day, 
≥84.3 g/day) 
Protein intake 
was inversely 
associated with 
frailty 
Results were energy-adjusted and 
for age, BMI, residential 
block, size of residential area, 
living alone, current smoking, 
alcohol drinking, dietary 
supplement use, history of 
chronic disease, depression 
symptoms, and energy intake. 
20 
2013 
Bollwein et 
al. [26] 
Germany Crosssectional Communitydwelling 194 83.0 (75–96) 6.5 vs. 1.3 CHS frailty index 
Food-frequency 
questionnaire 
76.6 
Quartiles 
(≤0.90, 
0.91–1.07, 1.08, 
≥1.27) 
Protein intake 
was not 
associated with 
frailty 
Results were adjusted for age and 
sex, instrumental activities 
of the daily living score, number of 
medications, 
and chewing difficulties 
19 
2014 
Shikany et 
al. [27] 
United States of 
America 
Crosssectional Commnitydwelling 5925 75.0 - 
CHS frailty index 
(c) 
Food-frequency 
questionnaire 
- 
Quintile 
(≤6.0–13.7%, 
13.8–15.2%, 
15.3–16.5%, 
16.6%–18.3%, 
18.4–29.3%) 
Protein intake 
was not 
associated with 
frailty 
Results were adjusted for age, 
race, center, education, marital 
status, smoking, health status, 
medical conditions, body mass 
index, and energy intake 
20 
2016 
Rahi et 
al. [28] 
France Crosssectional Communitydwelling 1345 75.6 4.0 vs. 1.46 
CHS frailty index 
(d) 
24 h dietary 
recall 
70.4 
Dicothomous 
<1g/kg body 
weight/day 
and ≥1g/kg body 
weight 
Protein intake 
was associated 
with frailty 
The model 1 was adjusted for age, 
sex, and educational level; and the 
model 2 was 
additionally adjusted for BMI, 
diabetes, cardiovascular history, 
depression, cognitive 
performance, number of drugs, 
and total energy intake. 
20 
2017 
Kobayashi et 
al. [25] 
Japan Crosssectional Communitydwelling 2108 74.0 - 
CHS frailty index 
(b) 
Self-administered 
diet history 
questionnaire 
73.1 
Tertile 
(≤67.6 g/day, 
67.6–78.3 g/day, 
≥78.3 g/day) 
Protein intake 
was inversely 
associated with 
frailty 
Dietary total antioxidant 
capacity 
20 
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2018 
Nanri et 
al. [29] 
Japan Crosssectional Communitydwelling 5638 73.2 0.88 vs. 1.05 * KCL 
Food-frequency 
questionnaire 
- 
Men = quartiles 
(≤48.8 g/day, 
48.8–56.1 g/day, 
56.1–65.4 g/day, 
>65.4 g/day); 
Women = 
quartiles 
(<43.8 g/day, 
43.8–51.1 g/day, 
51.1–59.5 g/day, 
>59.5 g/day) 
Protein intake 
was inversely 
associated with 
frailty 
For men, the model 1 was 
adjusted forage, body mass 
index, total energy intake, 
alcohol status, smoking status and 
history of disease and the 
model 2 was adjusted for family 
structure, educational 
attainment, population density, 
and self-related health. 
20 
 
Table 1. Cont. 
Year Authors Country 
Study 
Design 
Setting n 
Mean Age 
(age range; 
min–max) 
Sex Ratio of 
Participants 
(female/male) by 
frail vs. non-
frail 
Frailty 
Assessment 
Method 
Dietary Intake 
Assessment 
Method 
Protein 
Intake 
(g/day) 
Protein Intake 
Level Definition 
Outcomes Covariates Included in Models 
Quality 
Analysis 
Score 
Longitudinal              
2010 
Beasley et 
al. [30] 
United States of 
America 
Longitudinal 
(3.0 years 
follow-up) 
Communitydwelling 24,417 65–79 - 
CHS frailty index 
(e) 
Food-frequency 
questionnaire 
72.8 
Quintiles of 
protein intake 
(% kilocalories) 
Protein intake 
was 
significantly 
associated with 
the odds of 
becoming frail 
Results were adjusted for age, 
ethnicity, BMI, income, 
education, having a current 
health care provider, smoking, 
alcohol, general health status, 
history of comorbid conditions, 
history of hormone therapy use, 
number of falls, whether 
participant lives alone, disabled 
defined by at least 1 activity of 
daily living affected, depressive 
symptoms, log-transformed 
calibrated energy intake 
20 
2014 
Shikany et 
al. [27] 
United States of 
America 
Longitudinal 
(4.6 years 
follow-up) 
Communitydwelling 5925 75.0 - 
CHS frailty index 
(c) 
Food-frequency 
questionnaire 
- 
Quintile 
(≤6.0–13.7%, 
13.8–15.2%, 
15.3–16.5%, 
16.6%–18.3%, 
18.4–29.3%) 
Protein intake 
was not 
associated with 
the odds of 
becoming frail 
Results were adjusted for age, 
race, center, education, marital 
status, smoking, health status, 
medical conditions, body mass 
index, and energy intake 
20 
Sandoval-Insausti 
2016 Spain 
et al. [31] 
Longitudinal 
(3.5 years 
follow-up) 
Communitydwelling 1822 68.7 0.9 vs. 2.4 CHS frailty index 
Computerized 
face-to-face diet 
history 
76.6 
Quartiles of 
protein intake 
Protein intake 
was associated 
with the odds of 
becoming frail 
Results were adjusted for age, 
energy intake, ethanol, lipids, 
animal or vegetal protein, level of 
education, marital status, 
tobacco consumption, BMI, 
abdominal obesity, 
and dietary fiber, diseases. 
20 
CHS = Cardiovascular Health Study; KCL = Kihon checklist; bw/d = body weight/day; BMI= Body mass index; (a) Bartali et al. used a modified version of the CHS frailty 
index, since weight loss was removed; (b) Kobayashi et al. used the CHS frailty index version modified by Woods et al as they did not have direct measures of gait speed and 
strength; (c) Shikany et al., used a modified version of the CHS frailty index as they measured weight loss criterion based on loss of appendicular lean mass; (d) Rahi et al., 
used a modified version of the CHS frailty index as a loss of 3 kg and a reduced BMI (<21 kg/m2) were both accepted as measures of weight loss criterion, slowness was 
determined based on the Rosow-Breslau test, and weakness was identified using the chair standing method (e) Beasley et al., used a modified version of the CHS frailty index 
as they measured muscle weakness and slow walking speed using the Rand-36 Physical function scale; * frail vs non-frail. 
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Quality Assessment 
The overall score of the quality assessment of cross-sectional and longitudinal 
studies is shown in Table 1 and the analysis of each variable is detailed in Tables S1 and S2, 
respectively. The point by point analysis is shown in Table S3. The overall score of cross-
sectional studies ranged from 19 to 22. All studies reported the items required by the STROBE 
criteria in relation to the abstract (items 1 and 2), objectives and hypothesis (items 3 and 4), 
described the settings, locations, relevant dates, eligibility criteria and the source and methods 
of selection of participants (items 5 and 6), clarity of the outcomes (items 7), methods of 
assessment (item 8), handle of the quantitative variables (item 11), give the characteristics of 
study participants (item 14), reported the number of outcome events (item 15), statistical 
methods and analysis (items 12, 16, 17), and discussion (items 18–21). However, 57.1% of the 
studies failed to clearly report the efforts performed to address potential sources of bias (item 
9) [24,26–28], 42.9% did not properly explain how the study size arrived at (item 10) [26–28], 
and 14.3% did not show the number of individuals at each stage of study (item 13) [26]. 
Similar results were seen in longitudinal studies, in which all investigations 
received a STROBE score of 20. None of the studies adequately presented a description of how 
the study was arrived at (item 10), while 66.6% failed to describe any efforts to address potential 
sources of bias (item 9) [27,31], and 33.3% did not show the number of individuals at each 
stage of study (item 13) [30]. 
 
Association between Protein Intake and Frailty 
-Protein Intake and Frailty Prevalence (i.e., Cross-Sectional Studies) 
A total of four studies provided information regarding different intakes of protein 
in at least two groups, the prevalence of frailty in each group, and the total sample size in each 
group; therefore, they were added in the meta-analysis (Figure 2). Two aspects should be 
mentioned before the presentation of data. First of all, Nanri et al. [29] provided the data 
according to gender, and the results are presented accordingly. In turn, the investigations 
performed by Kobayashi et al. [24, 25] used the same database (i.e., Three-generation Study of 
Women on Diets and Health), so that the studies were not analyzed in combination. The overall 
meta-analysis results showed a 0.67 OR (Figure 2a) and a 0.66 OR (Figure 2b) for frailty (95% 
CI = 0.56 to 0.82, p = 0.0001; 95% CI = 0.54 to 0.80, p = 0.0001) in older adults with high 
protein intake compared with low protein intake according to the inclusion of Kobayashi et al. 
[24] or Kobayashi et al. [25], respectively. When the study of Kobayashi et al. [25] was not in 
the analysis, it was possible to observe an I2 lower than 40% accompanied by a p = 0.18, 
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indicating that this heterogeneity might not be important [22]. However, when the study of 
Kobayashi et al. [24] was removed, the I2 increased to 49% and p value was of 0.12, which can 
indicate a moderate heterogeneity [22]. 
  
Figure 2. Odds ratio (OR) of the prevalence of frailty in older adults with high and low protein intake. 
Squares represent study-specific estimates; diamonds represent pooled estimates of random-effects 
meta-analyses. (a) The analysis was performed included Kobayashi et al. 2013; (b) The analysis was 
performed included Kobayashi et al. 2017. 
 
Figure 3 shows the funnel plots (a) and (b) based on the primary outcome according 
to the inclusion of Kobayashi et al. [24] or Kobayashi et al. [25], respectively. The figures are 
asymmetrical indicating that potential publication bias might influence the results of this 
review. Egger’s linear regression test indicated possible publication bias for the association 
when the study of Kobayashi et al. [24] was included (p = 0.02), but not Kobayashi et al. [25] 
(p = 0.09). 
Figure 3. Funnel plots including (a) Kobayashi et al. 2013 and (b) Kobayashi et al. 2017 OR. 
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-Protein Intake and Frailty Risk (i.e., Longitudinal Studies) 
We found three studies that evaluated the longitudinal relationship between protein 
intake and frailty risk. The findings demonstrate that two of the three studies observed that 
higher protein intake was negatively associated with frailty risk. 
 
Discussion 
Frailty is a multifactorial condition associated with poor prognosis. Low protein 
intake has been proposed among the factors possibly involved in the pathogenesis of frailty. 
We, therefore, performed a systematic review and meta-analysis to investigate the relationship 
between protein intake and frailty in older adults. The main findings of the present study 
indicate that low protein intake is associated with frailty prevalence in older adults. 
Study quality assessment demonstrated that reports were of very good quality, such 
that cross-sectional studies scored between 19 and 22 and all longitudinal studies scored 20. 
Interestingly, cross-sectional and longitudinal studies did not provide the same items, including 
efforts to address potential sources of bias (item 9), the design of the study size (item 10), and 
the report regarding the number of participants in all the phases of the study (item 13). 
Some recent systematic and descriptive reviews have investigated the relationship 
between nutrition and frailty [3,4,32,33]. However, none of these studies was specifically 
designed to investigate the role of protein intake in this phenomenon and the findings were not 
quantitatively assessed. Thus, to the best of our knowledge, this is the first systematic review 
and meta-analysis designed to investigate the relationship between protein intake and frailty in 
older adults. 
The results of the present study may be at least partially explained by the theoretical 
overlap between sarcopenia and physical frailty [34,35]. Indeed, physical frailty, as measured 
by the Fried’s criteria [14,36], encompasses features as slowness, weakness, exhaustion, and 
sedentary behavior, which are strongly associated with the sarcopenia condition [34,35]. 
Slowness (i.e., slow walking speed) and weakness (i.e., low upper-limb muscle strength), for 
example, are proposed as diagnostic criteria for sarcopenia by the European Working Group on 
Sarcopenia in Older Persons (EWGSOP) [15], while exhaustion and sedentary behavior are 
common consequences of sarcopenia progression [37]. Indeed, Landi et al. [35] suggested that 
sarcopenia may be envisioned as a central mechanism for the development of physical frailty. 
In another word, physical frailty may be the final pathway of sarcopenia progression [35]. This 
idea is further supported by the higher prevalence of sarcopenia in pre-frail and frail older adults 
when compared to non-frail peers [38,39]. 
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Sufficient protein consumption may cause a shifting on net balance in favor of 
muscle protein synthesis [7,40]. Protein supplementation per se has been shown to prevent the 
progression of physical decline in frail older adults [30,41]. In addition, protein intake has a 
key role in the physiological adaptations elicited by the resistance training on the neuromuscular 
apparatus since a greater muscle protein synthesis is expected when both non-pharmacological 
therapies are offered in combination [6,7]. Taken together, these findings suggest that sufficient 
protein intake may reverse or at least prevent functional decline in frail older adults. 
However, this kind of inference deserves caution since not all evidence has 
demonstrated the positive effects of protein supplementation on the sarcopenia aspects 
associated with frailty, such as muscle mass, muscle strength and physical function [42,43]. 
Finally, it should be noted that the changes observed after protein supplementation may be 
different from those observed in response to dietary protein intake. 
It is worth mentioning, that our main findings are based on cross-sectional studies 
and causal extrapolations should be performed carefully. Unfortunately, there were no available 
data from longitudinal studies to perform a meta-analysis. Overall, findings are still 
controversial. Shikany et al. [27] observed that protein intake was inversely associated with the 
risk of transitioning from robust to pre-frail status in a range of 4.6 years, while there were no 
significant associations between protein and frailty status. However, Sandoval-Insausti et al. 
[31] reported that total protein and animal protein intake were inversely associated with frailty 
and its components (i.e., slowness) over a mean follow-up of 3.5 years. Similarly, Beasley et 
al. [30] concluded that higher protein intake 
was associated with reduced risk of frailty in community-dwelling older women. 
Interestingly, the main variables investigated in the present study were differently 
defined across the investigations. Regarding frailty, although this variable was assessed using 
the frailty phenotype in most investigations, adaptations of some of the criteria were observed 
in 5 of the 6 cross-sectional studies, as well as in 2 of the 3 longitudinal studies. In fact, weight 
loss criterion was modified in the trial of Rahi et al. [28], in which researchers included 
volunteers with self-reported unintentional loss > 3 kg or as a body mass index < 21 kg/m2, 
while Shikany et al. [27] included subjects who lost appendicular muscle mass. In turn, Bartali 
et al. [23] removed the weight loss criterion of their investigation. Slowness and weakness were 
also modified. In this case, Kobayashi et al. [24,25], Beasley et al. [30], and Rahi et al. [28] 
(only slowness) used self-reported questionnaires instead of direct evaluations. It is also 
possible to observe that different cutoffs to define high a low protein intake (i.e., tertiles, 
quartiles, quintiles and pre-established values) were used in the investigations. 
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These modifications have direct implications in the findings of the present study. 
Although scales and questionnaires may offer more information in a shorter period when 
compared to performance-based measurements, evidence has demonstrated the limited capacity 
of these tools to reflect different measures of physical status [44,45]. This probably occurs 
because the results of patient-reported questionnaires may be biased due to mood, motivation, 
fatigue, health status, fluctuations in memory, and the specific knowledge and familiarity with 
the questionnaires and scales [44,45]. In this sense, different results than those observed in the 
present study could occur if the investigations were performance based on direct measures, as 
proposed by Fried et al. [14]. Furthermore, the use of different cut-offs to define protein intake 
levels leads to disagreements and restrict the proposal of public health recommendations to 
older adults due to the range of approaches used by the studies. 
Taken together, these differences may also explain the heterogeneity of results 
observed among the longitudinal studies. Nevertheless, different settings, eligibility criteria, 
gender, sarcopenia status, dietary assessment methods, and follow-up periods of the various 
studies may also explain this variability. In this sense, more well-controlled cross-sectional and 
longitudinal studies are still necessary to improve the actual knowledge about frailty and protein 
intake in older adults, as well as to confirm our findings. 
We should state the absence of subgroup analyses as the major limitation of the 
present study. Indeed, the use of crude OR limits interpretation of our meta-analysis, since the 
influence of important covariates (e.g., age, type of protein [animal, vegetal], sarcopenia) were 
not taken into consideration in the results, and we recommend that readers interpret our results 
carefully. The main aspect that prevented us to perform the analysis was the lack of available 
data in the included studies. Regarding dietary assessment, it is worth mentioning that total 
protein intake, which was used in all studies for comparisons, is probably not the best parameter 
to represent adequate protein consumption, since investigations in the context of physical 
function and sarcopenia have used relative protein intake (g/kg/day) [46–48]. In addition, recent 
evidence has demonstrated that a spread distribution of protein intake during the main meals is 
better associated with gait speed than relative protein intake [49]. Providing support to the 
importance of the distribution of protein intake, Loenneke et al. [50] observed that a frequent 
consumption of meals containing at least 30 g of protein was associated with greater lean mass 
and lower-limb muscle strength in middle-aged and older adults. The role of animal and plant-
based protein sources on variables associated with frailty has also been the object of discussion 
among researchers [51,52]. Therefore, although future investigations are still necessary to 
confirm our findings, the present study may serve as a guide for future studies in this field; so 
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that investigation should include more information regarding the factors that may interfere in 
the relationship between protein intake and frailty, taking into account the variables that have 
been investigated by other studies. 
In addition, funnel plots and Egger’s linear regression test indicated that biases from 
publications and other factors may have had a significant influence on the results of our meta-
analysis mainly 
when the study of Kobayashi et al. [24] was included. Possible explanations for this 
publication bias included the small number of studies investigated, multiple publication bias, 
and heterogeneity [22]. 
Finally, another aspect of the present study that deserves concerns is the use of 
STROBE instrument as a tool to quality assessment. As discussed by da Costa et al. [53], 
STROBE was primarily developed to improve the reporting of observational studies. Thus, 
some may argue that another tool should have been used in the present study. However, it 
should be stressed that there is no gold standard tool to assess the risk of bias in non-randomized 
studies, as well as some of the STROBE questions may represent an evaluation of risk of bias; 
consequently, making it a tool commonly used in systematic reviews and meta-analysis [53]. 
In conclusion, our findings support the need for increased protein intake in older 
adults in an attempt to avoid frailty development. 
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 ARTICLE 6 
 
Protein-related dietary parameters and frailty status in older adults: A 
comparison among 4 frailty instruments 
 
Abstract 
Aims: The present study investigated the associations of frailty status using 4 different frailty 
instruments and a) daily protein consumption, b) daily body weight-adjusted protein 
consumption, c) branched chain amino acids (BCAA) consumption, d) evenness of protein 
distribution across the three main meals, e) number of daily meals providing at least 0.30 g of 
protein per meal, and f) number of daily meals providing at least 0.4 g of protein/kg of body 
weight in community-dwelling older adults. Methods: Two-hundred older women (mean age: 
68.7 years) were recruited to take part of the present study. Frailty were identified using Fried 
frailty phenotype, FRAIL, SOF, and Gérontopôle Frailty Screening Tool (GFST). Dietary 
assessment was assessed using a 24-h recall diary. Results: We observed that the relationship 
between protein-related dietary parameters and frailty status is tool-dependent, given that 
protein consumption was only associated with frailty status when participants were identified 
using Fried frailty phenotype and GFST. In addition, a higher consumption of protein and 
BCAA was observed in robust and prefrail individuals, while both were poor consumed in frail 
participants. Conclusions: Our findings suggest that the relationship between diet 
characteristics and frailty status is tool-dependent. In addition, a lower consumption of protein 
and BCAA is observed in frail older adults.  
 
Keywords: Elderly; Diet; Physical function; Disability; Sarcopenia 
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Introduction 
Frailty is a highly prevalent condition among older adults, and is defined as a state 
of increased vulnerability to negative health-related outcomes [1], which occurs as a result of 
multisystem physiological derangements and poor social support that impact the individual’s 
ability to maintain homeostasis after a stressor event [2–4]. Frailty progress increase the risk 
for many negative events, such as fractures, disability, hospitalization, nursing home placement, 
and death [5,6]. As such, frailty represents a major public health problem [1] and researchers 
have been looking for therapies to counteracting this condition. 
Good diet habits are suggested as a key factor for the preservation of independence 
during aging [7,8]. In this context, prior investigations found that high protein intake is 
associated with better physical performance [9,10] and low prevalence of frailty [11–15], 
leading to the recommendation that adequate protein consumption might avoid the genesis and 
progression of frailty  in older adults [15,16].  
Nevertheless, positive effects of protein intake on frailty seems to occur in the light 
of the metabolism of branched chain amino acids (BCAA) in skeletal muscle [17]. In fact, 
adequate amounts of BCAA, and mainly leucine are essential to stimulate muscle protein 
synthesis by being a building block for protein synthesis [17], and also stimulates intracellular 
anabolic signaling involved in the initiation of protein synthesis [17,18]. 
Although much importance has been given to the role of protein quantity on frailty-
related parameters, evidence has supporting the hypothesis that the distribution of protein intake 
across meals might be more important than simply the total amount of macro and micronutrients 
consumed [19–21]. Recent evidence observed that older adults who showed a spread-feeding 
pattern in which considerable amounts of protein are distributed over the main meals had higher 
gait speed than those who had a pulse-feeding pattern (i.e., high protein intake in a unique meal) 
[21].  
It is worth mentioning, that Loenekke et al. [19] found that adults who consumed ≥ 
30 g of protein in at least one meal had greater lower-limb muscle strength and leg lean mass 
in comparison with those who consumed <30 g, leading to the assumption that a minimum of 
30g of protein per meal seem to be necessary to avoid negative health related outcomes. 
However, contrarious to the hypothesis of absolute doses of protein per meal, Moore et al. [22] 
found a plateau in muscle protein synthesis stimulation at 0.4 g of protein/kg of body weight in 
older men.  
Based on these premises, the present study investigated the associations of frailty 
status using 4 different frailty instruments and a) daily protein consumption, b) daily body 
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weight-adjusted protein consumption, c) BCAA consumption, d) evenness of protein 
distribution across the three main meals (i.e., breakfast, lunch, dinner), e) number of daily meals 
providing at least 0.30 g of protein per meal, and f) number of daily meals providing at least 
0.4 g of protein/kg of body weight in community-dwelling older adults.  
 
Materials and Methods 
The study approved by the Research Ethics Committee of the University of 
Campinas. All study procedures were conducted in compliance with the Declaration of Helsinki 
and the Resolution 196/96 of the National Health Council. All participants were thoroughly 
informed about the study procedures before providing written consent. 
 
Participants 
Participants were recruited by convenience in a community senior center located in 
Poá, Brazil. Poá is a city located in the southern area of São Paulo with a population of 
approximately 100 thousand people, being ~3460 older (60 year or over) [23]. The community 
senior center offers daily sessions of flexibility, aquatic and multicomponent physical exercises, 
dance classes, adapted sports, nursing and medical care, and cognitive stimulation therapy. 
Candidate participants were considered eligible if they were 60 or older, were community-
dwellers, and possessed sufficient physical and cognitive abilities to perform all of the 
measurements required by the protocol.  
 
Anthropometric measurements 
A weight scale with a stadiometer was used to measure body mass and height. The 
body mass index (BMI) was subsequently calculated as following: 
a) body mass (kg)/ height (m²).  
 
Frailty assessment  
-Frailty phenotype 
The frailty phenotype was first described by Fried et al. [24]. The instrument 
incorporates measures of multiple physical domains, including weight loss, exhaustion, 
weakness, slowness, and sedentary behavior [25,26]. People are respectively identified as 
robust, prefrail and frail according to the presence of none, 1-2, and ≥3 of the following criteria: 
(1) unintentional weight loss of ≥5 kg in the prior year; (2) self-reported fatigue; (3) weakness, 
grip strength lower than 0.8 kg; (4) slowness, defined by Timed “Up-and-Go” (TUG) 
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performance [27] equal or higher than 4.4 s; and (5) low physical activity levels according to 
the short form of the International Physical Activity Questionnaire (IPAQ) [28]. Gender- and 
BMI-specific cutoff points were used for grip strength and height-specific cutoff points were 
used for TUG based in the median values of our sample. Gender-specific cutoffs were used for 
physic activity levels [26]. 
 
-FRAIL index  
FRAIL scale consists of 5 simple questions require a yes or no answer, with 1 point 
given to any affirmative response [29]. Instrument scores range from 0 to 5 points, and people 
are identified as robust (0 points), prefrail (1-2 points), and frail (≥3 points) according to the 
following criteria: (1) self-reported fatigue; (2) poor resistance, based on the inability to climb 
a flight of stairs; (3) limited ambulation, based on the inability to walk 1 block; (4) illnesses, 
presence of ≥ 5 illnesses; and (5) unintentional weight loss of ≥5% in the past 6 months. 
 
-SOF index 
SOF is derived from the Study of Osteoporotic Fractures [30]. The instrument is 
based on 3 criteria: (1) unintentional weight loss of ≥4.5 kg in the prior year; (2) self-reported 
exhaustion; (3) inability to rise from a chair 5 times without using arms. SOF scores range from 
0 to 3, and people are identified as robust, prefrail, and frail according to the presence of 0, 1, 
and 2-3 criteria.  
 
Gérontopôle Frailty Screening Tool 
The Gérontopôle Frailty Screening Tool (GFST) is an 8-item questionnaire 
assessing individual’s social, physical, functional and cognitive situation. In the present study, 
only the first six self-reported questions were used to analysis given that the last two questions 
are dependent of general practitioner’s personal view. The GFST is based on the following 
criteria: (1) living alone; (2) unintentional weight loss in the prior 3 months; (3) self-reported 
fatigue in the last 3 months; (4) self-reported mobility difficulties in the last 3 months; (5) 
complains of memory problems; and (6) slowness, defined by a Timed “Up-and-Go” (TUG) 
performance equal or higher than 4.4 s. Once there is no clear cut-off point to classify the patient 
as frail or not [31], we proposed the following cutoffs for robust, prefrail and frail individuals, 
respectively, 0, 1-2, ≥3 components.   
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Dietary assessment 
Food intake was assessed using a 24-h recall diary. This method uses an open-ended 
questionnaire to provides a quantitative and subjective estimation of actual food consumption. 
In the present protocol, trained researchers asked the participants to detailly recall all foods they 
consumed on a meal-by-meal basis, including snacks, during the previous 24-h period. 
Interviews occurred on Tuesdays, Wednesdays, Thursdays, and Fridays to avoid bias associated 
with the weekend. Participants were requested to detailly describe cooking methods (e.g., fried, 
grilled, roasted), amounts in portions, product brands, sauces, spices, and condiments 
consumed, and the use of dietary supplements. The amounts of beverages consumed were also 
recorded, and participants should describe if and how beverages were sweetened. Two-
dimensional aids (e.g., photographs), household utensils (e.g., standard measuring cups and 
spoons), and food models were used as memory aids to assess portion sizes. Diet composition 
was estimated using the NutWin software, version 1.5 (Federal University of São Paulo, 
Brazil)[9]. 
 
Statistical Analysis  
Continuous and categorical variables were compared among the three groups (i.e., 
robust, prefrail, and frail) via one-way analysis of variance (ANOVA) and chi-square (χ²) 
statistics, respectively. Bonferroni posthoc analyses were performed to determine whether there 
were significant differences between groups. χ² and Z-score were further used to explore the 
association between diet characteristics and frailty status across frailty instruments. Median 
values were chosen as the cutoff values for isoleucine (4.4 g), leucine (7.1 g), and valine (4.7g). 
Cutoff values for body weight-adjusted protein consumption [15,32], body weight-adjusted 
protein consumption per meal [22], and protein consumption per meal [19] were chosen based 
on prior reports. Protein intake distribution across the main meals (i.e., breakfast, lunch, and 
dinner) was calculated for each participant as a coefficient of variance (CV)[20], as following: 
b) CV= Standard deviation of grams of protein intake per main meals/ mean average total 
amount of proteins (grams) of the main meals.  
Participants were further divided into tertiles according to CV values (<0.8 g/kg, 
0.8-1,2 g/kg, and >1.2 g/kg). A low CV represents less difference in protein intake between the 
meals and therefore a more spread distribution, whereas a high CV represents a pulse-feeding 
distribution of protein intake [21]. For all tests, alpha was set at 5% (p <0.05) and Z-score was 
set at 1.96. All analyses were conducted using the IBM SPSS Statistics, version 20.0, software 
(IBM Corp., Armonk, NY, USA).  
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Results 
 
Clinical Characteristics 
Two-hundred fifty-four people accepted to be evaluated for inclusion. Of these, 
forty-six were middle-aged adults, 6 had missing data for frailty status, and 2 had missing data 
for diet characteristics, leaving a total of 200 participants. Table 1 shows clinical, 
sociodemographic, and diet characteristics of study participants according to frailty status and 
instruments. Frailty frequency was 26.0% using FRAIL index, 23.0% using SOF, 15.5% using 
Fried frailty phenotype, and 12.5% using GFST. There were no differences on clinical, 
sociodemographic and diet characteristics among frailty status when participants were 
identified using FRAIL and SOF indexes. On the other hand, significant differences in clinical 
parameters and diet characteristics were observed using Fried and GFST. When participants 
were identified according to Fried criteria, prefrail individuals had higher body weight (P=0.34) 
in comparison to robust counterparts. Frail individuals showed a lower intake of total protein 
(P=0.005), valine (P=0.005), leucine (P=0.004), and isoleucine (P=0.004) when compared to 
prefrail and robust individuals, while body weight-adjusted protein (P=0.020) consumption was 
only lower when compared to non-frail participants. Frail individuals according to GFST index 
were older (P<0.001) and had higher body weight (P=0.036) than both prefrail and robust. Frail 
individuals had lower consumption of body weight-adjusted protein (P=0.008), valine 
(P=0.004), leucine (P=0.001), isoleucine (P=0.003), and total protein lunch (P=0.010) when 
compared to prefrail participants, while total protein consumption (P=0.001) was only 
significantly lower in comparison to robust participants. A lower consumption of body weight-
adjusted protein dinner (P= 0.004) was observed in frail when compared to prefrail and robust. 
Finally, prefrail individuals had higher intake of body weight-adjusted protein dinner (P= 
0.036) in comparison to robust individuals.  
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Table 1. Characteristics of the participants according to frailty status. 
  FRAIL   Fried   GFST   SOF 
Variables 
Robust 
(n=22) 
Prefrail  
(n=126) 
Frail  
(n=52) 
  
Robust 
(n=15) 
Prefrail 
(n=154) 
Frail 
(n=31) 
  
Robust 
(n=38) 
Prefrail 
(n=137) 
Frail 
(n=25) 
  
Robust 
(n=27) 
Prefrail 
(n=127) 
Frail 
(n=46) 
Characteristics                               
Age, years 
66.0 ± 4.5 68.8 ± 7.3 
67.6 ± 
6.4   65.1 ± 7.5 67.8 ± 6.1 71.2 ± 9.1   65.2 ± 3.8 67.8 ± 6.3 
75.1 ± 
9.0ab   68.6 ± 8.0 68.2 ± 6.9 
68.0 ± 
6.1 
Body weight, 
kg 
66.5 ± 
11.7 69.6 ± 12.7 
68.2 ± 
10.4   63.5 ± 9.2 
69.9 ± 
12.1ª 
66.4 ± 
12.4   
71.3 ± 
11.1 68.9 ± 11.7 
65.3 ± 
14.5ab   
68.8 ± 
12.2 69.7 ± 12.0 
66.7 ± 
12.0 
BMI, kg/m² 
28.1 ± 4.4 28.9 ± 5.3 
28.5 ± 
4.3   27.7 ± 3.6 28.9 ± 5.0 28.4 ± 5.5   28.6 ± 4.6 29.0 ± 4.9 27.5 ± 4.8   29.4 ± 5.2 29.0 ± 4.8 
27.5 ± 
5.1 
Sex, f (%) 18 (81.8) 103 (81.7) 45 (86.5)   13 (92.9) 125 (81.2) 27 (87.1)   31 (81.6) 115 (83.9) 20 (80.0)   22 (81.5) 106 (83.5) 38 (82.6) 
Tabagism, n 
(%) 0 (0.0) 3 (2.4) 3 (5.8)   1 (7.1) 4 (2.6) 1 (3.2)   1 (2.6) 3 (2.2) 2 (8.0)   0 (0.0) 3 (2.4) 3 (6.5) 
Diseases, n (≥ 
5) 0 (0.0) 7 (5.6) 7 (13.5)   2 (14.3) 6 (3.9) 6 (19.4)   1 (2.6) 6 (4.4) 7 (28.0)   4 (14.8) 9 (7.1) 1 (2.2) 
                                
Race, n (%)                               
Asian 0 (0.0) 8 (6.3) 3 (5.8)   0 (0.0) 9 (5.8) 2 (6.5)   1 (2.6) 7 (5.1) 3 (12.0)   0 (0.0) 7 (5.5) 4 (8.7) 
Black 3 (13.6) 22 (17.5) 12 (23.1)   2 (14.3) 28 (18.2) 7 (22.6)   9 (23.7) 23 (16.8) 5 (20.0)   6 (22.2) 22 (17.3) 9 (19.6) 
Caucasian 19 (86.4) 96 (76.2) 37 (71.2)   12 (85.7) 117 (76.0) 22 (71.0)   28 (73.7) 107 (78.1) 17 (68.0)   21 (77.8) 98 (77.2) 33 (71.7) 
                                
Diet                               
Protein, g 
112.6 ± 
47.3 
105.4 ± 
40.8 
104.9 ± 
38.7   
122.2 ± 
37.3 
108.2 ± 
41.4 
89.7 ± 
36.4ab   
101.1 ± 
42.1 
111.7 ± 
41.6 
81.9 ± 
23.0a   
106.4 ± 
43.8 
107.4 ± 
41.4 
102.4 ± 
38.3 
Protein, g/kg 1.7 ± 0.8 1.5 ± 0.6 1.5 ± 0.5   1.9 ± 0.6 1.5 ± 0.6 1.3 ± 0.4ª   1.4 ± 0.6 1.6 ± 0.6 
1.3 ± 
0.5b   1.6 ± 0.7 1.5 ± 0.6 1.5 ± 0.5 
Valine, g 5.5 ± 2.3 5.2 ± 2.1 5.3 ± 2.1   6.1 ± 1.9 5.4 ± 2.1 
4.4 ± 
1.9ab   5.1 ± 2.1 5.5 ± 2.1 
4.0 ± 
1.1b   5.2 ± 2.1 5.3 ± 2.1 5.0 ± 2.0 
Isoleucine, g 4.6 ± 2.9 4.7 ± 2.3 4.7 ± 2.0   5.3 ± 2.2 4.8 ± 2.3 
3.9 ± 
1.9ab   4.2 ± 2.7 5.0 ± 2.2 
3.6 ± 
1.1b   4.4 ± 2.7 4.8 ± 2.3 4.6 ± 1.9 
Leucine, g 8.4 ± 3.5 7.9 ± 3.2 7.9 ± 3.0   9.3 ± 2.9 8.2 ± 3.2 
6.7 ± 
2.9ab   7.7 ± 3.2 8.4 ± 3.2 
6.1 ± 
1.7b   7.9 ± 3.2 8.1 ± 3.2 7.7 ± 3.0 
Protein 
breakfast, g 11.4 ± 5.2 13.3 ± 7.1 
12.9 ± 
7.4   12.8 ± 5.2 12.9 ± 7.7 12.6 ± 7.1   13.6 ± 8.3 12.9 ± 7.4 11.4 ± 5.9   11.7 ± 4.7 13.1 ± 7.1 
12.8 ± 
9.4 
Protein lunch, g 
59.5 ± 
33.6 54.8 ± 26.4 
58.5 ± 
28.4   
70.2 ± 
28.4 56.2 ± 28.5 
50.8 ± 
22.0   
49.2 ± 
32.2 59.8 ± 27.5 
47.7 ± 
16.6b   
56.4 ± 
30.8 56.3 ± 28.1 
56.3 ± 
27.7 
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Protein dinner, 
g 
31.0 ± 
29.7 23.9 ± 27.2 
21.7 ± 
25.7   
28.3 ± 
30.9 25.8 ± 27.7 
14.9 ± 
21.0   
26.5 ± 
25.0  26.2 ± 28.6 9.8 ± 16.4   
25.4 ± 
29.3 24.8 ± 27.6 
21.6 ± 
24.8 
Protein 
breakfast, g/kg 
0.17 ± 
0.09 0.19 ± 0.10 
0.17 ± 
0.12   
0.20 ± 
0.09 0.18 ± 0.11 
0.18 ± 
0.10   
0.19 ± 
0.12 0.18 ± 0.10 
0.19 ± 
0.12   
0.17 ± 
0.81 0.19 ± 0.11 
0.18 ± 
0.11 
Protein lunch, 
g/kg 
0.90 ± 
0.55 0.81 ± 0.41 
0.86 ± 
0.41   1.1 ± 0.46 0.82 ± 0.44 
0.76 ± 
0.30   
0.71 ± 
0.51 
0.88 ± 
0.41ª 
0.75 ± 
0.34   
0.82 ± 
0.50 0.83 ± 0.43 
0.85 ± 
0.3. 
Protein dinner, 
g/kg 
0.49 ± 
0.49 0.35 ± 0.40 
0.30 ± 
0.37   
0.46 ± 
0.51 0.38 ± 0.41 
0.20 ± 
0.29   
0.38 ± 
0.37 0.39 ± 0.43 
0.13 ± 
0.25ab   
0.40 ± 
0.48 0.36 ± 0.41 
0.30 ± 
0.37 
BMI = body mass index; GFST= Gérontopôle Frailty Screening Tool; SOF= Study of Osteoporotic Fractures; aP<0.05 vs Robust; bP<0.05 vs Prefrail.  
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The association between diet characteristics and frailty status across the different 
frailty indexes are shown in Table 2. No significant associations were observed when 
individuals were identified using FRAIL and SOF instruments. On the other hand, a significant 
association between the consumption of isoleucine, leucine, and valine (P< 0.001 for all) and 
frailty status were observed in Fried and GFST indexes. Z-score indicated that a higher 
frequency of prefrail individuals identified by both frailty indexes consumed more than the 
median values for all BCAA, while an inverse phenomenon was observed in frailty participants, 
so that a lower frequency of frail individuals consumed more than the median values for leucine 
(Z-score= 4.2 and 3.7), isoleucine (Z-score= 4.2 and 3.7), and valine (Z-score= 4.1 and 3.6). In 
addition, a higher prevalence of robust and prefrail individuals identified by the GFST index 
showed a body weight-adjusted protein consumption ≥1.2 g/kg (P= 0.008, Z-score= 2.2 and 
3.1).  
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Table 2. Frequency (%) of the distribution of older adults according to diet characteristics and frailty status. 
  FRAIL   Frailty phenotype   GFST   SOF 
Variables 
Robust 
(n=22) 
Prefrail  
(n=126) 
Frail  
(n=52) 
  
Robust 
(n=15) 
Prefrail 
(n=154) 
Frail 
(n=31) 
  
Robust 
(n=38) 
Prefrail 
(n=137) 
Frail 
(n=25) 
  
Robust 
(n=27) 
Prefrail 
(n=127) 
Frail 
(n=46) 
Protein, g/kg                               
<0.8 0 (0.0) 8 (4.0) 3 (1.5)   0 (0.0) 10 (5.0) 1 (5.0)   4 (2.0) 5 (2.5) 2 (1.0)   0 (0.0) 7 (3.5) 4 (2.0) 
≥0.8 22 (11.0) 118 (59.0) 49 (24.5)   
14 (7.0) 144 (72.4) 
30 
(15.1)   34 (19.0) 137 (68.5) 
25 
(12.5)   27 (13.5) 120 (60.0) 
42 
(21.0) 
                                
Protein, g/kg                               
<1.0 2 (1.0) 27 (13.5) 10 (5.0)   0 (0.0) 30 (15.1) 9 (4.5)   10 (5.0) 21 (10.5) 8 (4.0)   4 (2.0) 26 (13.0) 9 (4.5) 
≥1.0 20 (10.0) 99 (49.5) 42 (21.0)   
14 (7.0) 124 (62.3) 
22 
(11.1)   28 (14.0) 116 (8.5) 17 (8.5)   23 (11.5) 101 (50.5) 
37 
(18.5) 
                                
Protein, g/kg                               
<1.2 10 (5.0) 39 (19.5) 16 (8.0)   2 (1.0) 50 (25.1) 12 (6.0)   18 (9.0) 35 (17.5) 12 (6.0)   12 (6.0) 38 (19.0) 15 (7.5) 
≥1.2 12 (6.0) 87 (43.5) 36 (18.0)   
12 (6.0) 104 (52.3) 19 (9.5)   20 (10.0)* 102 (51.0)* 13 (6.5)   15 (7.5) 89 (44.5) 
31 
(15.5) 
                                
Protein, g/kg                               
<1.5 12 (6.0) 66 (33.0) 25 (12.5)   
4 (2.0) 78 (39.2) 
20 
(10.1)   22 (11.0) 64 (32.0) 17 (8.5)   17 (8.5) 65 (32.5) 
21 
(10.5) 
≥1.5 10 (5.0) 60 (30.0) 27 (13.5)   
10 (5.0) 76 (38.2) 11 (5.5)   16 (8.0) 73 (36.5) 8 (4.0)   10 (5.0) 62 (31.0) 
25 
(12.5) 
                                
Isoleucine, g                               
<4.4 12 (6.0) 62 (31.0) 25 (12.5)   
5 (2.5) 67 (33.7) 
26 
(13.1)   22 (11.0) 56 (28.0) 
21 
(10.5)   17 (8.5) 56 (28.0) 
26 
(13.0) 
≥4.4 10 (5.0) 64 (32.0) 27 (13.5)   
9 (4.5) 87 (43.7)* 5 (2.5)*   16 (8.0) 81 (40.5)* 4 (2.0)*   10 (5.0) 71 (35.5) 
20 
(10.0) 
                                
Leucine, g                               
<7.1 11 (5.5) 62 (31.0) 26 (13.0)   
5 (2.5) 67 (33.7) 
26 
(13.1)   22 (11.0) 56 (28.0) 
21 
(10.5)   16 (8.0) 56 (28.0) 
27 
(13.5) 
≥7.1 11 (5.5) 64 (32.0) 26 (13.0)   9 (4.5) 87 (43.7)* 5 (2.5)*   16 (8.0) 81 (40.5)* 4 (2.0)*   11 (5.5) 71 (35.5) 19 (9.5) 
                                
Valine, g                               
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<4.7 12 (6.0) 62 (31.0) 26 (13.0)   
5 (2.5) 68 (34.2) 
26 
(13.1)   22 (11.0) 57 (28.5) 
21 
(10.5)   17 (8.5) 57 (28.5) 
26 
(13.0) 
≥4.7 10 (5.0) 64 (32.0) 26 (13.0)   
9 (4.5) 86 (43.2)* 5 (2.5)*   16 (8.0) 80 (40.0)* 4 (2.0)*   10 (5.0) 70 (35.0) 
20 
(10.0) 
                                
CV, g/kg                               
<0.8 6 (3.0) 52 (26.0) 18 (9.0)   6 (3.0) 57 (28.6) 13 (6.5)   14 (7.0) 55 (27.5) 7 (3.5)   6 (3.0) 53 (26.5) 17 (8.5) 
0.8-1,2 16 (8.0) 71 (35.5) 32 (16.0)   8 (4.0) 94 (47.2) 16 (8.0) 
  
23 (11.5) 79 (39.5) 17 (8.5) 
  21 (10.5) 71 (35.5) 
27 
(13.5) 
>1.2 0 (0.0) 3 (1.5) 2 (1.0)   0 (0.0) 3 (1.5) 2 (1.0)   1 (5.0) 3 (1.5) 1 (5.0)   0 (0.0) 3 (1.5) 2 (1.0) 
                                
≥0.4g 
protein/kg/meal 
        
                      
0 1 (5.0) 15 (7.5) 8 (4.0)   1 (5.0) 19 (9.5) 4 (2.0)   6 (3.0) 13 (6.5) 5 (2.5)   1 (5.0) 16 (8.0) 7 (3.5) 
1 14 (7.0) 74 (37.0) 28 (14.0)   9 (4.5) 84 (42.2) 
22 
(11.1)   21 (10.5) 78 (39.0) 17 (8.5)   19 (9.5) 72 (36.0 
25 
(12.5) 
≥2 7 (3.5) 37 (18.5) 16 (8.0)   4 (2.0) 51 (25.6) 5 (2.5)   11 (5.5) 46 (23.0) 3 (1.5)   7 (3.5) 39 (19.5) 14 (7.0) 
                                
≥0.30g 
protein/meal 
        
                      
0 1 (5.0) 15 (7.5) 8 (4.0)   1 (5.0) 19 (9.5) 4 (2.0)   6 (3.0) 13 (6.5) 5 (2.5)   1 (5.0) 16 (8.0) 7 (3.5) 
1 14 (7.0) 74 (37.0) 28 (14.0)   9 (4.5) 84 (42.2) 
22 
(11.1)   21 (10.5) 78 (39.0) 17 (8.5)   19 (9.5) 72 (36.0 
25 
(12.5) 
≥2 7 (3.5) 37 (18.5) 16 (8.0)   4 (2.0) 51 (25.6) 5 (2.5)   11 (5.5) 46 (23.0) 3 (1.5)   7 (3.5) 39 (19.5) 14 (7.0) 
 
CV= coefficient of variation; GFST= Gérontopôle Frailty Screening Tool; SOF= Study of Osteoporotic Fractures; *P<0.05                 
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Discussion 
The main findings of the present study indicate that the relationship between diet 
characteristics and frailty status are tool-dependent. Indeed, a significant association between 
frailty status and protein consumption were only observed when participants were identified 
using Fried frailty phenotype and GFST, while no significant associations were observed with 
FRAIL and SOF. In addition, a poor consumption of protein and BCAA was observed in frail 
participants.  
Prior studies have compared the association between different frailty instruments 
and cognitive function, falls, disability, fractures, hospitalization, and all-cause mortality [33–
35]. Most studies have found significant associations among the frailty indexes, even when 
participants were identified using different frailty concepts (e.g., Fried frailty phenotype and 
frailty index) [34]. However, Mori et al. [26] observed differences to predict disability and 
hospitalization among frailty indexes in prefrail older adults, suggesting that the pathogenic 
bases associated with frailty progress might be tool-dependent.  
In the present study, protein intake-related parameters were significantly associated 
with frailty status using Fried frailty phenotype and GFST, but not FRAIL and SOF. One 
potential explanation for these differences may be the type of physical assessment used in each 
instrument, given that protein intake has a key role in muscle protein synthesis and consequently 
in the preservation of muscle mass and physical function with aging [18,36]. Indeed, if on one 
hand, objective measures of physical function and self-reported exhaustion are part of the frailty 
criteria proposed by both Fried frailty phenotype [24] and GFST [31]; on the other hand, the 
analysis of the physical component of FRAIL [29] and SOF [30] instruments are exclusively 
dependent of the patient’s perception, which does not necessarily reflect current physical 
performance status [37,38].   
We observed an inverse relationship between body-adjusted protein (only for 
GFST) and BCAA consumptions and frailty status, so that most robust and prefrail older adults 
consumed more leucine, isoleucine, and valine than the median, while only a lower frequency 
of frail participants showed this diet pattern. Findings of the present study are supported by 
prior investigations which observed a negative association between frailty and essential AA 
[12,39].  
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Beasley et al. [12] found that higher intake of essential AA was significantly 
associated with a lower risk to develop frailty over three years in a subset of older women of 
the Women’s Health Initiative Observational Study (WHI-OS). Similarly, Kobayashi et al. [40] 
observed that higher consumption of selected AA, including BCAA, were associated with lower 
prevalence of frailty in 2108 Japanese older women.  
Our findings add to the current knowledge on the relationship between AA intake 
and frailty and suggest that this phenomenon may be highly influenced by BCAA intake. 
According to the anabolic resistance hypothesis [41,42], muscular anabolic response to 
appropriate stimulation is blunted in advanced age, collaborating to muscle catabolism, loss of 
lean body mass, dynapenia, and impairment on physical function [42,43].  
In this context, a higher availability of AA, mainly leucine, would be necessary to 
reverse this state and stimulates muscle protein synthesis [18]. These premises have been 
confirmed by observational studies which observed that reduced systemic concentration of 
BCAA were significantly associated with sarcopenia markers in older adults [44,45]. 
Notably, an exclusive association between body weight-adjusted protein 
consumption ≥ 1.2 g/kg/day and frailty status were observed when participants were identified 
using GFST. These differences may be explained by the fact that only GFST contains a 
cognitive component based on memory complains [31], and an increasing number of evidences 
suggested that protein consumption may collaborated with cognitive function in older adults 
[46].  However, future studies are still necessary to investigate if protein consumption is 
differently associated across different frailty definitions (e.g., physical frailty, cognitive frailty, 
accumulative deficit frailty).    
The present study has some limitations that should be acknowledged. The study 
population was relatively small and composed exclusively by community-dwellers, limiting 
inferences to older adults from other settings (i.e., nursing homes) and deeper statistical 
analysis. Second, both Fried frailty phenotype and GFST were adapted given that walking speed 
test was replaced by TUG. In addition, the cross-sectional design of the study does not allow 
inference to be drawn on the time course of changes of the variables considered and on cause-
effect relationships.  
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Conclusions  
Our findings suggest that the relationship between diet characteristics and frailty 
status is tool-dependent, so that a significant association between frailty status and protein 
consumption were only observed when participants were identified using Fried frailty 
phenotype and GFST. In addition, a poor consumption of protein and BCAA was observed in 
frail participants.  
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 ARTICLE 7 
Association Between Diet Habits and Physical Function in Brazilian and Italian Older 
Women: A cross-sectional study 
 
ABSTRACT  
Aims: The present study was undertaken to determine the differences in protein consumption 
and physical function between Brazilian and Italian older women. In addition, we investigated 
if physical function could be differently associated with different diet patterns among the 
samples. Methods: Seventy-five Brazilian older women (mean age: 75.2 years) were recruited 
in a community senior center located in the southern area of São Paulo. Fifty-three Italian older 
women (mean age: 77.6 years) matched on age and body mass index (BMI) were randomly 
selected from the Italian survey ("Longevity Check-up"), conducted during Milan EXPO 2015. 
In both studies, physical performance was evaluated by isometric handgrip strength (IHG) and 
sit-to-stand tests. Dietary assessment was assessed using a 24-h recall diary. Results: A 
different intake of specific protein sources was observed among the groups, given that Italian 
older women consumed more animal-based protein, while a higher intake of plant-based protein 
was found in Brazilian older women. The binary logistic regression analysis indicated that body 
weight-adjusted protein consumption was positively associated with IHG/BMI and negatively 
associated with sit-to-stand in Brazilian. In the Italian sample, valine, isoleucine, and leucine 
were significantly associated with sit-to-stand performance. Conclusions: Our findings indicate 
that Brazilian and Italian community-dwellers older women show different patterns of protein 
consumption, given that a higher consumption of plant-based protein was observed in the 
Brazilian sample, while Italians consumed more animal-based protein. These diet pattern likely 
influenced the relationship between physical function and protein intake found in these samples. 
 
INTRODUCTION 
Physical function refers to the ability to integrate and convert many physiological 
stimuli, but mainly those arising from the neuromuscular system, into an action (e.g., walk, 
jump) that allow the interaction between the subject and the world. Notably, substantial changes 
occur in physical function over the course of life, so that infancy is characterized by a dramatic 
increase of motor abilities[1], while an age-related decline in physical performance has been 
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widely described among people from different countries after ~30 years of age[2,3]. Regarding 
gender, such reductions seem to be more pronounced in women due to the effects of 
menopause[4]. 
The biggest concern regarding the deterioration of physical function with aging is 
its close association with a wide range of poor outcomes, such as cognitive impairment, falls, 
disability, institutionalization, and mortality[5–9], as well as its impact on the development of 
geriatric syndromes (e.g., frailty)[10,11] and neuromuscular diseases (e.g., sarcopenia)[12,13]. 
These premises lead the World Health Organization (WHO) to indicate the maintaining of 
physical function as a central component for the preservation of functionality, autonomy and 
independence in older adults[14].  
In this context, diet habits have been identified as a strategy to counteract age-
related decline in physical performance[15,16]. Protein intake, for example, has a key role in 
muscle protein synthesis and consequently in the preservation of muscle mass and physical 
function[17,18]. In the last years, many studies have investigated the association between 
protein-related diet parameters (e.g., sources) and physical function in older adults[19–23], 
which allowed the creation of perspectives regarding the adequate protein consumption for this 
population[24–26]. However, few data are available investigating the relationship between diet 
habits and physical function in populations from different countries.  
These information seems to be important since dietary patterns hold significant 
cultural and regional values[27–29] which might negatively influence the adherence to diet 
recommendations[30] and health related outcomes[31], whereas understanding the food 
behavior of some populations may allow the creation of more adequate and specific  dietary 
recommendations to address disparities in diet quality and quantity in older adults.  
 Therefore, the present study was undertaken to determine the differences in protein 
consumption and physical function between Brazilian and Italian older women. In addition, we 
investigated if physical function could be differently associated with different diet patterns 
among the samples.  
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MATERIALS AND METHODS 
The study approved by the Research Ethics Committee of the University of Mogi 
das Cruzes (UMC) under the protocol number 621-614. All study procedures were conducted 
in compliance with the Declaration of Helsinki and the Resolution 196/96 of the National 
Health Council. All participants were thoroughly informed about the study procedures before 
providing written consent. 
 
Brazilian study sample 
Brazilian older women were recruited by convenience in a community senior center 
located in Poá, Brazil. Poá is a city located in the southern area of São Paulo with a population 
of approximately 100 thousand people, being ~3460 older (60 year or over)[32]. The 
community senior center offers daily sessions of flexibility, aquatic and multicomponent 
physical exercise, dance classes, adapted sports, nursing and medical care, and cognitive 
stimulation therapy. Candidate participants were considered eligible if they were 60 or older, 
lived independently, and possessed sufficient physical and cognitive abilities to perform all of 
the measurements required by the protocol.  
 
Italian study sample 
The “Longevity Check-up” project was an initiative developed by the Department 
of Geriatric Medicine of the Catholic University of the Sacred Heart in Rome, with the intent 
to promote a healthy lifestyle in the general population. Milan EXPO 2015 exhibition was 
chosen as the setting for the initiative because of the chance to meet an unselected population 
of individuals, not generally referred to traditional healthcare services [33]. In the period 
between June 1, 2015 and June 15, 2015 (pavilion of Marche Region), and between September 
1, 2015 and October 31, 2015 (Casa Ferrarini pavilion), a sample of 3206 persons from different 
Italian regions underwent individual assessments that consisted of a brief questionnaire, the 
objective measurement of the seven cardiovascular health metrics, the evaluation of specific 
anthropometric parameters, and handgrip strength testing. Candidate participants were 
considered to be eligible for enrolment if they were at least 18 years of age and provided written 
informed consent. Self-reported pregnancy, inability to perform functional tests, and 
unwillingness to give written informed consent were considered exclusionary. For the present 
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study, age- and body mass index (BMI)-matched Italian older women aged 60 or older were 
randomly selected [34].  
 
Anthropometric measurements 
A weight scale with a stadiometer was used to measure body mass and height. The 
BMI was subsequently calculated as following: 
a) body mass (kg)/ height (m²).  
 
Dietary assessment 
Food intake was assessed using a 24-h recall diary. This method uses an open-ended 
questionnaire to provides a quantitative and subjective estimation of actual food consumption. 
In the present protocol, trained researchers asked the participants to detailly recall all foods they 
consumed on a meal-by-meal basis, including snacks, during the previous 24-h period. 
Interviews occurred on Tuesdays, Wednesdays, Thursdays, and Fridays to avoid bias associated 
with the weekend. Participants were requested to detailly describe cooking methods (e.g., fried, 
grilled, roasted), amounts in portions, product brands, sauces, spices, and condiments 
consumed, and the use of dietary supplements. The amounts of beverages consumed were also 
recorded, and participants should describe if and how beverages were sweetened. Two-
dimensional aids (e.g., photographs), household utensils (e.g., standard measuring cups and 
spoons), and food models were used as memory aids to assess portion sizes. Diet composition 
was estimated using the NutWin software, version 1.5 (Federal University of São Paulo, Brazil) 
for the Brazilian population[35] and MètaDieta (ME.TE.DA, LLC, San Benedetto del Tronto, 
Italy) for the Italian population [36]. 
 
Functional assessments  
- Isometric handgrip strength test (IHG) 
IHG was measured using a Jamar® handheld hydraulic dynamometer (Sammons 
Preston, Bolingcobrook, IL, USA)[37]. The measure was obtained from the dominant hand with 
the participant seated on a chair with the shoulders abducted, the elbow of the dominant side 
near the trunk and flexed at 90°, and the wrist in a neutral position (thumb up). The contralateral 
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arm remained relaxed under the thigh. To determine the dominant hand, volunteers were asked 
which of the hands was the strongest. IHG was measured during 4 s under encouragement.  
 
Sit-to-stand test 
Participants rose from a chair five times as quick as possible with their arms folded 
across their chest. Timing began when the participant raised their buttocks off the chair and was 
stopped when the participant was seated at the end of the fifth stand[38]. 
 
Statistical analysis  
To determine the differences in the continuous data between the groups (i.e., 
Brazilian and Italian), the Student’s t-test for independent samples was performed. Chi-square 
(χ²) test was performed to investigate the association between the dependent categorical 
variables (i.e., IHG, IHG/BMI, and sit-to-stand) and the independent categorical variables. The 
median values were chosen as the cutoff values, as following: IHG (Brazilian: 22 kg; Italian: 
14 kg), IHG/BMI (Brazilian: 0.8 kg; Italian: 0.5 kg), sit-to-stand (Brazilian: 11.3 s; Italian: 14.7 
s), age (Brazilian: 66 years; Italian: 77 years), BMI (Brazilian: 28.7 kg/m²; Italian: 29.7 kg/m²), 
relative protein consumption (Brazilian: 23.6%; Italian: 17.7%), relative animal-based protein 
(Brazilian: 41.4%; Italian: 67.3%), relative plant-based protein (Brazilian: 53.7%; Italian: 
29.0%), body-weight adjusted protein consumption (Brazilian: 1.0 g/kg/day; Italian: 1.0 
g/kg/day), total protein (Brazilian: 68.8g; Italian: 64.6g), animal protein (Brazilian: 29.0g; 
Italian: 41.8g), plant-based protein (Brazilian: 34.8g  Italian: 18.3g), valine (Brazilian: 2573.7 
mg; Italian: 2943.2 mg), isoleucine (Brazilian: 2232.9 mg; Italian: 2480.8 mg), leucine 
(Brazilian: 4184.6 mg; Italian: 4646.2 mg).  Independent variables with a P<0.05 in the ᵪ² test 
were included in a univariate logistic binary analysis. To be considered as an independent 
variable associated with physical function, the results were required to have a P< 0.05 and a 
95% confidence interval (CI 95%) that did not include the value of 1. All analyses were 
conducted using the IBM SPSS Statistics, version 20.0, software (IBM Corp., Armonk, NY, 
USA).  
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RESULTS 
The characteristics of the study participants are shown in Table 1. One-hundred 
twenty-eight (75 Brazilian and 53 Italian) older women were recruited to take part in the study.  
Brazilian older women had better physical performance in IHG (P<0.001), IHG/BMI 
(P=0.081), and sit-to-stand (P<0.001) tests, as well as a higher total (P=0.043) and relative 
(P<0.001) protein consumption. A different intake of specific protein sources was observed 
among the groups, given that Italian older women consumed more animal-based protein, both 
relative (P<0.001) and total (P<0.001), while a higher intake of plant-based protein (P<0.001 
for both) was found in Brazilian older women.        
 
Table 1. Characteristics of the participants. 
Variables     
Characteristics Brazilian (n= 75) Italian (n=53) 
Age, years 75.2 ± 7.5 77.6 ± 5.5 
Body weight, kg 71.4 ± 12.5 70.7 ± 13.1 
BMI, kg/m² 28.2 ± 7.0 30.1 ± 5.5 
      
Physical functional tests     
IHG, kg 20.0 ± 10.9 13.1 ± 6.8* 
IHG/BMI, kg 1.2 ± 3.1 0.4 ± 0.2* 
Sit-to-stand, s 11.9 ± 3.3 16.7 ± 6.0* 
      
Diet     
Protein, % 22.9 ± 5.3 17.6 ± 4.7* 
Animal-based protein, % 39.7 ± 18.5 63.9 ± 16.2* 
Plant-based protein, % 52.7 ± 16.4 30.5 ± 13.7* 
Protein, g/kg/day 1.04 ± 0.41 1.09 ± 0.44 
Protein, g/day 72.7 ± 26.8 63.9 ± 19.2* 
Animal-based protein, g/day 29.7 ± 17.2 41.5 ± 17.7* 
Plant-based protein, g/day 37.9 ± 17.2 19.0 ± 8.4* 
Valine, mg 2744 ± 1314 2935 ± 1047 
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Isoleucine, mg 2409 ± 1155 2512 ± 921 
Leucine, mg 4437 ± 2142 4516 ± 1607 
BMI = body mass index; IHG= Isometric handgrip strength*P<0.05 vs Brazilian 
The association between physical function and dietary characteristics according to 
the country are shown in Table 2. IHG (P=0.04) and sit-to-stand (P=0.01) were significantly 
associated with BMI in Brazilian older women. In addition, body weight-adjusted protein 
consumption was associated with IHG/BMI (P=0.002) and sit-to-stand (P=0.04) performances. 
In Italian older women, leucine (P=0.03), isoleucine (P=0.03), and valine (P=0.02) were 
significantly associated with sit-to-stand.  
 
Table 2. Frequency (%) of the distribution of older women according to physical function. 
  Brazilian Italian 
  IHG IHG/BMI Sit-to-stand IHG IHG/BMI Sit-to-stand 
Variable Low High Low High Low High Low High Low High Low High 
Age, years                         
Low 
13 
(37.1
%) 
22 
(55.0
%) 
17 
(39.5
%) 
18 
(56.3
%) 
17 
(45.9
%) 
18 
(47.4
%) 
12 
(22.6
%) 
15 
(28.3
%) 
15 
(28.3
%) 
12 
(22.6
%) 
13 
(24.5
%) 
14 
(26.4
%) 
High 
22 
(62.9
%) 
18 
(45.0
%) 
26 
(60.5
%) 
14 
(43.8
%) 
20 
(54.1
%) 
20 
(52.6
%) 
10 
(18.9
%) 
16 
(30.2
%) 
14 
(26.4
%) 
12 
(22.6
%) 
13 
(24.5
%) 
13 
(24.5
%)  
                          
BMI (kg/m²)                         
Low 
22 
(62.9
%) 
16 
(40.0
%) 
20  
(46.5
%) 
18 
(56.3
%) 
24 
(64.9
%) 
14 
(36.8
%) 
12 
(22.6
%) 
14 
(26.4
%) 
12 
(22.6
%) 
14 
(26.4
%) 
13 
(24.5
%) 
13 
(24.5
%) 
High 
13 
(37.1
%) 
24 
(60.0
%)* 
23 
(53.5
%) 
14 
(43.8
%) 
13 
(35.1
%) 
24 
(63.2
%)* 
10 
(18.9
%) 
17 
(32.1
%) 
17 
(32.1
%) 
10 
(18.9
%) 
13 
(24.5
%) 
14 
(26.4
%) 
                          
Protein, %                         
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Low 
17 
(48.6
%) 
21 
(52.5
%) 
24 
(55.8
%) 
14 
(43.8
%) 
20 
(54.1
%) 
18 
(47.4
%) 
13 
(24.5
%) 
13 
(24.5
%) 
17 
(32.1
%) 
9 
(17.0
%) 
13 
(24.5
%) 
13 
(24.5
%) 
High 
18 
(51.4
%) 
19 
(47.5
%) 
19 
(44.2
%) 
18 
(56.3
%) 
17 
(45.9
%) 
20 
(52.6
%) 
9 
(17.0
%) 
18 
(34.0
%) 
12 
(22.6
%) 
15 
(28.3
%) 
13 
(24.5
%) 
14 
(26.4
%) 
                          
Animal-based 
protein, % 
    
                    
Low 
16 
(45.7
%) 
22 
(55.0
%) 
19 
(44.2
%) 
19 
(59.4
%) 
17 
(45.9
%) 
21 
(55.3
%) 
12 
(22.6
%) 
15 
(28.3
%) 
15 
(28.3
%) 
12 
(22.6
%) 
14 
(26.4
%) 
13 
(24.5
%) 
High 
19 
(54.3
%) 
18 
(45.0
%) 
24 
(55.8
%) 
13 
(40.6
%) 
20 
(54.1
%) 
17 
(44.7
%) 
10 
(18.9
%) 
16 
(30.2
%) 
14 
(26.4
%) 
12 
(22.6
%) 
12 
(22.6
%) 
14 
(26.4
%) 
                          
Plant-based 
protein, % 
    
                    
Low 
20 
(57.1
%) 
18 
(45.0
%) 
25 
(58.1
%) 
13 
(40.6
%) 
18 
(48.6
%) 
20 
(52.6
%) 
9 
(17.0
%) 
17 
(32.1
%) 
13 
(24.5
%) 
13 
(24.5
%) 
13 
(24.5
%) 
13 
(24.5
%) 
High 
15 
(42.9
%) 
22 
(55.0
%) 
18 
(41.9
%) 
19 
(59.4
%) 
19 
(51.4
%) 
18 
(47.4
%) 
13 
(24.5
%) 
14 
(26.4
%) 
16 
(30.2
%) 
11 
(20.8
%) 
13 
(24.5
%) 
14 
(26.4
%) 
                          
Protein, 
g/kg/day 
    
                    
Low 
14 
(40.0
%) 
15  
(37.5
%) 
23 
(53.%
%) 
6 
(18.8
%) 
10 
(27.0
%) 
19 
(50.0
%) 
8 
(15.1
%) 
18 
(34.0
%) 
11 
(20.8
%) 
15 
(28.3
%) 
15 
(28.3
%) 
11 
(20.8
%) 
High 
21 
(60.0
%) 
25 
(62.5
%) 
20 
(46.5
%) 
26 
(81.3
%)* 
27 
(73.0
%) 
19 
(50.0
%)* 
14 
(26.4
%) 
13 
(24.5
%) 
18 
(34.0
%) 
9 
(17.0
%) 
11 
(20.8
%) 
16 
(30.2
%) 
                          
Protein, g/day                         
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Low 
16 
(45.7
%) 
22 
(55.0
%) 
24 
(55.8
%) 
14 
(43.8
%) 
18 
(48.6
%) 
20 
(52.6
%) 
14 
(26.4
%) 
12 
(22.6
%) 
17 
(32.1
%) 
9 
(17.0
%) 
10 
(18.9
%) 
16 
(30.2
%) 
High 
19 
(54.3
%) 
18 
(45.0
%) 
19 
(44.2
%) 
18 
(56.3
%) 
19 
(51.4
%) 
18 
(47.4
%) 
8 
(15.1
%) 
19 
(35.8
%) 
12 
(22.6
%) 
15 
(28.3
%) 
16 
(30.2
%) 
11 
(20.8
%) 
                          
Animal-based 
protein, g/day 
    
                    
Low 
18 
(51.4) 
21 
(52.5
%) 
22 
(51.2
%) 
17 
(53.1
%) 
20 
(54.1
%) 
19 
(50.0
%) 
12 
(22.6
%) 
14 
(26.4
%) 
16 
(30.2
%) 
10 
(18.9
%) 
10 
(18.9
%) 
16 
(30.2
%) 
High 
17 
(48.6
%) 
19 
(47.5
%) 
21 
(48.8
%) 
15 
(46.9
%) 
17 
(45.9
%) 
19 
(50.0
%) 
10 
(18.9
%) 
17 
(32.1
%) 
13 
(24.5
%) 
14 
(26.4
%) 
16 
(30.2
%) 
11 
(20.8
%) 
                          
Plant-based 
protein, g/day 
    
                    
Low 
15 
(42.9
%) 
21 
(52.5
%) 
23 
(53.5
%) 
13 
(40.6
%) 
15 
(40.5
%) 
21 
(55.3
%) 
14 
(26.4
%) 
14 
(26.4
%) 
18 
(34.0
%) 
10 
(18.9
%) 
12 
(22.6
%) 
16 
(30.2
%) 
High 
20 
(57.1
%) 
19 
(47.5
%) 
20 
(46.5
%) 
19 
(59.4
%) 
22 
(59.5
%) 
17 
(44.7
%) 
8 
(15.1
%) 
17 
(32.1
%) 
11 
(20.8
%) 
14 
(26.4
%) 
14 
(26.4
%) 
11 
(20.8
%) 
                          
Valine, mg                         
Low 
16 
(45.7
%) 
19 
(47.5
%) 
22 
(51.2
%) 
13 
(40.6
%) 
15 
(40.5
%) 
20 
(52.6
%) 
13 
(24.5
%) 
14 
(26.4
%) 
17 
(32.1
%) 
10 
(18.9
%) 
9 
(17.0
%) 
18 
(34.0
%) 
High 
19 
(54.3
%) 
21 
(52.5
%) 
21 
(48.8
%) 
19 
(59.4
%) 
22 
(59.5
%) 
18 
(47.4
%) 
9 
(17.0
%) 
17 
(32.1
%) 
12 
(22.6
%) 
14 
(26.4
%) 
17 
(32.1
%) 
9 
(17.0
%)* 
                          
Isoleucine, mg                         
Low 
16 
(45.7
%) 
21 
(52.5
%) 
22 
(51.2
%) 
15 
(46.9
%) 
17 
(45.9
%) 
20 
(52.6
%) 
13 
(24.5
%) 
13 
(24.5
%) 
17 
(32.1
%) 
9 
(17.0
%) 
9 
(17.0
%) 
17 
(32.1
%) 
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High 
19(54
.3%) 
19 
(47.5
%) 
21 
(48.8
%) 
17 
(53.1
%) 
20 
(54.1
%) 
18 
(47.4
%) 
9  
(17.0
%) 
18 
(34.0
%) 
12 
(22.6
%) 
15 
(28.3
%) 
17 
(32.1
%) 
10 
(18.9
%)* 
                          
Leucine, mg                         
Low 
16 
(45.7
%) 
21 
(52.5
%) 
23 
(53.5
%) 
14 
(43.8
%) 
16 
(43.2
%) 
21 
(55.3
%) 
11 
(20.8
%) 
15 
(28.3
%) 
16 
(30.2
%) 
10 
(18.9
%) 
9 
(17.0
%) 
17 
(32.1
%) 
High 
19 
(54.3
%) 
19 
(47.5
%) 
20 
(46.5
%) 
18 
(56.3
%) 
21 
(56.8
%) 
17 
(44.7
%) 
11 
(20.8
%) 
16 
(30.2
%) 
13 
(24.5
%) 
14 
(26.4
%) 
17 
(32.1
%) 
10 
(18.9
%)* 
BMI = body mass index; IHG= Isometric handgrip strength*P<0.05 
 
Table 3 presents the unadjusted OR and 95% CI results for physical function. The 
binary logistic regression analysis indicated that body weight-adjusted protein consumption 
was positively associated with IHG/BMI (unadjusted OR = 1.6; CI 95% = 1.708–14.543; P-
value = 0.003) and negatively associated with sit-to-stand  (unadjusted OR = -0.993; CI 95% = 
0.141-0.972; P-value = 0.04) in Brazilian. In the Italian sample, valine (unadjusted OR = -1.329; 
CI 95% = 0.085-0.825; P-value = 0.02), isoleucine (unadjusted OR = -1.167; CI 95% = 0.101-
0.958; P-value = 0.04), and leucine (unadjusted OR = -1.167; CI 95% = 0.101-0.958; P-value 
= 0.04) were significantly associated with sit-to-stand performance.  
 
Table 3. Unadjusted Or and 95% confidence intervals (CI) for physical function Brazilian. 
  IHG/BMI Sit-to-stand 
Variable Unadjusted OR  CI 95% Unadjusted OR  CI 95% 
Protein, g/kg/day         
High 1.6 1.708-14.543 -0.993 0.141-0.972* 
Low Ref.   Ref.   
          
Italian 
  Sit-to-stand 
Variable Unadjusted OR  CI 95% 
Valine, mg         
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High -1.329 0.085-0.825* 
Low Ref.     
          
Isoleucine, mg         
High -1.167 0.101-0.958* 
Low Ref.     
          
Leucine, mg         
High -1.167 0.101-0.958* 
Low Ref.     
BMI = body mass index; IHG= Isometric handgrip strength*P<0.05; Ref = reference; OR = odds ratio;  
CI = confidence interval. 
 
DISCUSSION 
The present study investigated the main differences in physical function and diet 
characteristics between Brazilian and Italian community-dwellers older women. Our results 
revealed that Brazilian older women had a better physical function and a higher intake of plant-
based protein, while higher animal-based protein intake was observed in Italian older women. 
Furthermore, we tested the hypothesis that physical function could be differently associated 
with different patterns of protein intake among the samples. We observed that body weight-
adjusted protein consumption was significantly associated with IHG/BMI and sit-to-stand tests 
in the Brazilian sample. On the other hand, branched-chain amino acids (BCAA) were 
negatively associated with sit-to-stand performance in Italian participants.  
These results provide an interesting perspective about the influence of sociocultural 
factors on dietary consumption and physical function. In Brazilian, the higher intake of plant-
based protein may be explained by a rich diet of legumes, vegetables and animal derived foods 
(e.g., dairy products), given that this diet pattern is commonly observed in Brazilian older 
women[39,40]. Beans, for example, are a widely known source of plant protein[41], one of the 
most consumed foods in Brazil[40], and were present in at least one of the main meals (i.e., 
lunch or dinner) of the Brazilian participants.  
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An additional explanation may be that meat consumption had for a long time a high 
symbolic value due to its high cost and status of great cultural importance, which could have 
collaborated with changes in the diet patterns of the Brazilian population[42]. 
One may argue that the diet pattern observed in the Brazilian population was more 
likely to be found in the Italian population because legumes and vegetables are the basis of 
Mediterranean diet[43]. However, our sample recruitment occurred prevalently in the Northern 
part of Italy and a populational study found higher adherence to the Mediterranean diet in the 
Southern Italy, but not in the Northern part[27].    
These different patterns of protein consumption likely impact on the relationship 
between protein intake and physical performance. In the present study, a body weight-adjusted 
protein consumption ≥1 g/kg/day were significantly associated with IHG/BMI and sit-to-stand 
tests in the Brazilian sample.  
A possible explanation for these findings may reside in the fact that plant-based 
protein generally contains smaller amounts of essential amino acids and stimulates protein 
synthesis as well as inhibits protein breakdown in a less extent than animal-based protein[44], 
which leads to the recommendation that greater amounts of plant-based protein may be 
necessary to elicit the same protein anabolism evoked by smaller quantities of animal-based 
protein[41]. In fact, we recently observed that plant-based protein intake was significantly 
associated with walking speed in Brazilian older adults who consumed twofold more plant-
based protein than the Framingham cohort[45,46]. 
On the other hand, physical function was significantly associated with valine, 
leucine, and isoleucine intake in Italian older women. Notably, animal-based protein is the main 
source of BCAA[47] and it represented more than 60% of the protein source consumed by 
Italians. Once in the body, BCAA, and specially leucine, stimulates muscle protein 
synthesis[48] via the activation of the downstream cascade of the mammalian target of 
rapamycin (mTOR)[49]. Researchers have argued that BCAA have a key role in muscle mass 
and physical function regulation during aging[41] and an increasing number of evidence have 
demonstrated lower systemic concentrations of BCAA in older adults with sarcopenia[48].  
Based on these premises, it is possible to suggest that the association between 
BCAA and physical function observed in Italian older adults occurred due to a high intake of 
animal-based protein.  
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It is worth mentioning that the median values of body weight-adjusted protein 
consumption of Brazilian older women were higher than the recommended dietary allowance 
(RDA, 0.8 g kg−1 day−1). These findings are in line with a recent systematic review and meta-
analysis that found better physical performance in older adults who had higher protein intake 
than the RDA[20].  
Many researchers have questioned if the current RDA is enough to maintain the 
functional status or even prevent its decline in older adults[24,41], given that the amount of 
recommended protein is based on nitrogen balance studies, which may be associated with a 
methodological bias[24,25]. A further consideration regarding the RDA is that it has no specific 
recommendations for older adults[24,25], although the aging muscle shows a state of anabolic 
resistance characterized by blunted protein synthesis in response to protein ingestion or amino 
acid infusion[50].  
Taken together, these findings support increasing the protein RDA for older adults 
and suggest that country-based recommendations should take into consideration the cultural 
factors and the regional diet patterns to ensure the optimal protein intake to avoid impairments 
on physical function. 
We recognize some limitations to this study. Different sample recruitments were 
used in the present study, so that Brazilian participants were limited to a unique city, while 
Italian participants included people from different regions. The possibility cannot be ruled out 
that results could be different with a randomly multicentric Brazilian sample. In addition, our 
study is based in a relatively small number of participants, and no power calculation was 
performed. Body composition[51], physical activity levels[52], and oral health status[53]are 
associated with protein consumption in older adults and were not controlled in the present study. 
Finally, the diet evaluation through the 24-h recall diary should also be acknowledged as a 
limitation of the study.  
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CONCLUSION  
Our findings indicate that Brazilian and Italian community-dwellers older women 
show different patterns of protein consumption, given that a higher consumption of plant-based 
protein was observed in the Brazilian sample, while Italians consumed more animal-based 
protein. These diet pattern likely influenced the relationship between physical function and 
protein intake found in these samples. Indeed, body weight-adjusted protein consumption was 
significantly associated with IHG/BMI and sit-to-stand tests in the Brazilian sample. On the 
other hand, BCAA were negatively associated with sit-to-stand performance in Italian 
participants.  
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Abstract 
Background Adequate nutrition and, especially, optimal protein intake are necessary to 
preserve physical function during aging. Increased consumption of animal-derived protein is 
often advocated as a strategy to support physical performance in old age. However, there is a 
lack of empirical evidence to support this claim. Aims To assess the relationship of protein 
consumption and specific protein sources with physical function in older adults. Methods 
Participants were community dwellers aged 60 years and older recruited in São Paulo, Brazil. 
Enrollees had their medical books reviewed and were evaluated for anthropometry, physical 
performance, and diet. Physical performance was evaluated by isometric handgrip strength and 
walking speed (WS) tests. Diet was assessed using a 24-h recall diary. Results Ninety older 
adults were recruited (mean age: 68.0 ± 6.7 years; 87.0% women). Body weight-adjusted 
protein consumption was significantly associated with upper-limb muscle strength (r = 0.21; p 
< 0.05), but not with usual (r = 0.09; p > 0.05) or fast WS (r = 0.08; p > 0.05). Conversely, 
relative protein consumption was correlated with usual WS (r = 0.13; p < 0.05), while fast WS 
was negatively associated with relative animal protein intake (r = − 0.18; p < 0.05) and 
positively associated with relative plant-based protein ingestion (r = 0.15; p < 0.05). Discussion 
Findings of the present study indicate that different measures of protein intake are associated 
with distinct components of physical function. In addition, high relative ingestion of vegetable 
protein is associated with faster WS. Conclusions A comprehensive dietary evaluation is 
necessary to appreciate the impact of specific nutrients on physical performance in older people. 
Future interventional studies are needed to establish the optimal blend of protein sources to 
support physical performance in old age. 
 
Keywords Diet · Physical performance · Muscle strength · Gait speed · Animal protein · 
Nutrition 
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Introduction 
The aging process is a continuous phenomenon resulting from derangements in 
multiple body systems and marked by increased risk of developing chronic diseases and death 
[1]. Among the changes that accompany aging, declining physical performance has received 
considerable attention because of its association with a vast array of negative health-related 
outcomes, including disability, falls, dementia, institutionalization, and mortality [2–7]. Indeed, 
preservation of physical function is acknowledged as a key determinant of successful aging [8]. 
Adequate nutrition and, especially, optimal protein intake are core elements for 
preserving physical function and promoting healthy aging [9, 10]. Yet, the prevalence of 
protein–energy malnutrition is concernedly high among older people [11, 12]. What is more, 
the aging muscle shows a state of anabolic resistance characterized by blunted myofibrillar 
protein synthesis (MPS) in response to protein ingestion or amino acid infusion [13]. Hence, 
protein intake above the recommended dietary allowance (RDA, 0.8 g kg−1 day−1) is advisable 
to maintain muscle mass and function into old age [14, 15]. Indeed, a recent systematic review 
and metaanalysis showed that very high (≥ 1.2 g kg−1 day−1) and high protein intake (≥ 1.0 g 
kg−1 day−1) were associated with better physical performance compared with low protein intake 
(< 0.8 g kg−1 day−1) in community-dwelling older adults [16]. Notwithstanding, the possible 
differential effect of specific protein sources on physical function is not clearly established. 
Animal-derived foods are thought to provide higher quality protein than plant-based aliments 
[17]. Though, low protein intake, especially of animal origin, has been associated with reduced 
all-cause mortality [9, 18]. Such an association was not observed in people older than 65 years 
[9]. The mechanisms underlying the switch from the detrimental to the protective effect of high 
protein ingestion in old age are presently unclear. However, the lower responsiveness of the 
aged muscle to dietary protein and amino acids may explain the higher protein requirements of 
older adults [19]. Notably, animal-derived protein was reported to stimulate MPS to a greater 
extent than soy protein in older men under both at rest and post-exercise [20]. Furthermore, 
greater protein consumption, particularly of animal origin, has been associated with higher 
levels of function in communitydwelling older people [21]. 
In the attempt to increase the understanding of protein requirements in old age, the 
present study was undertaken to assess the impact of total protein consumption and protein from 
different sources on physical function in communitydwelling older adults. 
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Methods 
Informed consent 
The study was approved by the Research Ethics Committee of the University of 
Mogi das Cruzes (UMC) under the protocol number 621-614. All study procedures were 
conducted in compliance with the Declaration of Helsinki and the Resolution 196/96 of the 
National Health Council. All participants were thoroughly informed about the study procedures 
before providing written consent.  
 
Study participants 
This study was designed as a cross-sectional investigation. Participants were 
recruited based on convenience in the metropolitan area of São Paulo, Brazil. The study was 
advertised through posters placed in public sites (e.g., parks, city hall, public offices, bus stops, 
train stations) as well as local radio and newspapers. People were also invited to participate by 
direct contact. Candidate participants were considered to be eligible if they were ≥ 60 years of 
age and possessed sufficient physical and cognitive abilities to perform all the measurements 
required by the protocol. 
 
Dietary assessment 
Food intake was assessed using a 24-h recall diary. The method is based on an open-
ended questionnaire to provide a quantitative and subjective estimation of food consumption. 
Trained researchers asked participants to recall all foods they consumed on a meal-by-meal 
basis, including snacks, during the previous 24 h. Interviews occurred on Tuesdays, 
Wednesdays, Thursdays, and Fridays to avoid possible bias associated with the weekend. 
Participants were requested to report cooking methods (e.g., fried, grilled, roasted), amounts in 
portions, product brands, sauces, spices, and condiments consumed, and the eventual use of 
supplements. The amount of beverages consumed was also recorded, and participants were 
asked to report if and how beverages were sweetened. Two-dimensional aids (e.g., 
photographs), household utensils (e.g., standard measuring cups and spoons), and food models 
were used as memory aids to assess portion sizes. Diet composition was estimated using the 
NutWin software, version 1.5 (Federal University of São Paulo, Brazil) [22]. 
218 
 
 
Functional assessments 
All functional tests were administered by two experienced researchers (H.J.C.-J. 
and I.O.G.). While one was responsible for detailing the operational procedures, demonstrating 
the test before the assessment, quantifying the performance, and evaluating the motor pattern, 
the other ensured participant safety. After the end of the explanation and before each test, 
volunteers performed a familiarization trial to ensure they had fully understood the test. Then, 
volunteers performed all tests twice, and the best result obtained was considered for the 
analysis. The tests were administered in a dedicated room and were performed in a sequential 
order with 1-min interval between trials, as follows: isometric handgrip strength (IHG) [23], 
walking speed (WS) at usual pace, and WS fast pace [24]. 
 
Isometric handgrip strength test 
IHG was measured using a Jamar® handheld hydraulic dynamometer (Sammons 
Preston, Bolingcobrook, IL, USA) [23]. The measure was obtained from the dominant hand 
with the participant seated on a chair with the shoulders abducted, the elbow of the dominant 
side near the trunk and flexed at 90°, and the wrist in a neutral position (thumb up). The 
contralateral arm remained relaxed under the thigh. To determine the dominant hand, volunteers 
were asked which of the hands was the strongest. IHG was measured during 4 s under 
encouragement. 
 
Walking speed tests 
WS was measured over 3 m [24]. This distance was chosen because of the space 
limitations. However, high concordance has been observed between the results recorded on 3- 
and 6-m courses [25]. For the test, volunteers were required to walk 5 m (including 1-m 
acceleration and 1-m deceleration) at their usual and fastest possible pace (without running). 
Before the evaluation, both feet were to remain on the starting line. The measurement was 
started when a foot reached the 1-m line and was stopped when a foot reached the 4-m line. 
The 1-m intervals at the beginning and at the end of the course were used to avoid early 
acceleration and/ or deceleration. 
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Anthropometric measurements 
A weight scale with a Filizola® (Brazil) stadiometer was used to measure body 
mass and height. The body mass index (BMI) was subsequently calculated as the ratio between 
body mass (kg) and the square of height  (m2). A flexible and inextensible anthropometric tape 
(Sanny®, São Paulo, Brazil) was used to measure waist (WC) and hip (HC) circumferences. 
WC was assessed at the mid-point between the last floating rib and the highest point of the iliac 
crest. HC was taken at the highest point of the buttocks [26]. 
 
Comorbid conditions 
Information pertaining to comorbidities was collected through self-report and 
careful review of medical charts including medication use. 
 
Statistical analysis 
Normality of data was ascertained using the KolmogorovSmirnov test. For the 
analysis, participants were categorized into two subgroups (i.e., low and high) for each physical 
function test (i.e., IHG, IHG/BMI, and WS at usual and fast pace). Data are presented as mean 
± standard deviation (SD) or absolute numbers and percentages for continuous and categorical 
variables, respectively. Differences in continuous variables between groups were assessed via 
independent t test statistics. Comparisons of categorical variables were performed by Chi-
square (χ2) statistics. Pearson’s correlations were used to explore relationships between results 
of the physical function tests and diet characteristics. For all tests, the level of significance was 
set at 5% (p < 0.05). All analyses were conducted using the IBM SPSS Statistics software, 
version 20.0 (IBM Corp., Armonk, NY, USA). 
 
Results 
Participant characteristics 
Ninety people were recruited. The main characteristics of enrollees are shown in 
Table 1. The mean age was 68.0 ± 6.7 years (range 60–85 years), and 78 (87.0%) participants 
were women. The mean BMI was 29.3 ± 5.4 kg/ m2. The average IHG (23.5 ± 8.4 kg) and WS 
at both usual (1.2 ± 0.4 m/s) and fast pace (1.5 ± 0.5 m/s) were higher than the proposed cutoffs 
for sarcopenia [27]. Participant diet was hierarchically composed of carbohydrates (56.6%), 
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protein (23.3%), and fat (20.5%). The average body weight-adjusted protein consumption was 
1.1 ± 0.4 g kg−1 day−1, which is higher than the RDA, with a predominance of plant-derived 
proteins over those of animal origin (53.4% vs. 40.3%). 
 
Table 1. Main characteristics of study participants 
 
Demographics and anthropometry 
Age, years (mean ± SD) 68.0 ± 6.7 
Women, n (%) 78 (87.0) 
Body weight, kg (mean ± SD) 72.0 ± 13.0 
Height, m (mean ± SD) 1.60 ± 0.10 
BMI, kg/m2 (mean ± SD) 29.3 ± 5.4 
WC, cm (mean ± SD) 97.6 ± 11.9 
HC, cm (mean ± SD) Physical function tests 104.5 ± 10.8 
Handgrip strength, kg (mean ± SD) 23.5 ± 8.4 
Handgrip strength/BMI (mean ± SD) 0.8 ± 0.4 
Usual walking speed, m/s (mean ± SD) 1.2 ± 0.4 
Fast walking speed, m/s (mean ± SD) Diet 1.5 ± 0.5 
Energy intake, kcal (mean ± SD) 1146 ± 146 
Fat, % kcal 20.5 
Carbohydrates, % kcal 56.6 
Protein, % kcal 23.3 
Animal protein, % total protein 40.3 
Plant protein, % total protein 53.4 
Protein, g d ay−1 (mean ± SD) 74.5 ± 26.0 
Protein, g k g−1 day−1 (mean ± SD) 1.1 ± 0.4 
Animal protein, g d ay−1 (mean ± SD) 31.3 ± 16.6 
Plant protein, g d ay−1 (mean ± SD) 39.4 ± 16.6 
Leucine, mg  day−1 (mean ± SD) 4627 ± 2127 
Isoleucine, mg  day−1 (mean ± SD) 2511 ± 1142 
Valine, mg day−1 (mean ± SD) 2860 ± 1298 
 
BMI body mass index, HC hip circumference, WC waist circumference 
 
Participant characteristics and diet parameters according to physical function 
Table 2 shows participant characteristics according to categories of physical 
performance. Overall, participants with high physical performance were younger than those 
with low performance. The high IHG subgroup showed greater BMI and HC than the low IHG 
subgroup. Similarly, body circumferences were significantly greater in the high fast WS 
subgroup than in the low WS subgroup. 
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As for diet characteristics, specific patterns were observed between groups. 
Participants with high IHG/BMI showed lower relative carbohydrate consumption than those 
with low IHG/BMI. In contrast, higher relative protein consumption was observed in the high 
usual WS subgroup compared with the low usual WS counterpart. There were no differences 
in relative protein consumption between high and low fast WS subgroups. However, 
participants with high fast WS showed lower consumption of animal protein and higher 
consumption of plant protein. 
 
Table 2.  Characteristics of study participants according to physical function categories. 
IHG 
 
 Low (< 25 kg) High  
(≥ 25 kg) 
IHG/BMI 
 
Low  
(< 0.82 kg) 
High  
( ≥ 
0.82 
kg) 
Usual WS 
 
Low  
(< 1.3 m/s) 
High  
(≥ 1.3 
m/s) 
Fast 
WS 
 
Low  
(< 1.6 
m/s) 
High  
(≥ 1.6 
m/s) 
Demographics and anthropometry 
Age, years  69.7 ± 7.5 
(mean ± SD) 
66.4 ± 
5.5* 70.0 ± 7.6 
66.1 ± 
5.2* 70.9 ± 7.4 
65.3 ± 
4.6* 
71.5 ± 
7.6 
65.5 ± 
4.6* 
Women, n (%) 36 (85.8) 41 
(87.3) 
38 (86.1) 39 
(86.7) 
41 (82.5) 37 
(89.6) 
44 
(80.0) 
32 
(90.6) 
Body 70.3 ± 13.5 weight, kg (mean ± SD) 73.5 ± 
12.5 
72.6 ± 14.0 71.6 ± 
12.1 
69.9 ± 14.3 73.2 ± 
11.4 
69.4 ± 
13.3 
73.2 ± 
12.5 
BMI, kg/m2 28.3 ± 5.3 (mean ± SD) 30.1 ± 
5.4* 
29.4 ± 6.8 29.2 ± 
4.4 
28.8 ± 5.9 29.4 ± 
4.8 
28.3 ± 
5.9 
29.6 ± 
4.9 
WC, cm  96.3 ± 14.5 
(mean ± SD) 
98.8 ± 
9.0 
98.9 ± 13.7 96.7 ± 
9.9 
96.7 ± 14.1 98.3 ± 
9.9 
93.1 ± 
10.8 
100.5 
± 
11.8* 
HC, cm  101.6 ± 12.1 
(mean ± SD) 
107.1 
± 8.7* 
104.9 ± 12.0 104.2 
± 9.6 
102.0 ± 11.2 106.1 
± 9.9 
101.3 
± 10.7 
106.2 
± 
10.2* 
Physical functional tests 
Handgrip 9.7 ± 8.4 strength, kg (mean 
± SD) 
28.6 ± 
4.8* 
10.6 ± 9.5 28.4 ± 
5.2* 
17.9 ± 10.6 20.6 ± 
12.4 
18.7 ± 
11.3 
19.9 ± 
11.9 
Handgrip  0.4 ± 0.3 strength/ 
BMI, kg  
(mean ± SD) 
1.0 ± 
0.2* 
0.3 ± 0.3 1.0 ± 
0.2* 
0.62 ± 0.36 0.70 ± 
0.43 
0.6 ± 
3.9 
0.6 ± 
4.1 
Usual walking 1.0 ± 0.5 speed, m/s 
(mean ± SD) 
1.1 ± 
0.6 
1.0 ± 0.5 1.1 ± 
0.6 
0.56 ± 0.43 1.46 ± 
0.23* 
0.5 ± 
0.5 
1.3 ± 
0.2* 
Fast walking 
speed, m/s 
(mean ± SD) 
1.3 ± 0.6 1.3 ± 
0.8 
1.3 ± 0.6 1.3 ± 
0.7 
0.77 ± 0.64 1.77 ± 
0.27* 
0.6 ± 
0.5 
1.7 ± 
0.2* 
Diet 
Energy intake, 
kcal (mean ± 
SD) 
1294 ± 417 1136 
± 161 
1152 ± 164 1136 
± 161 
1238 ± 279 1316 
± 439 
1241 
± 249 
1307 
± 439 
Fat, % kcal 19.4 21.4 20.9 20.1 19.4 20.9 19.5 20.7 
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Carbohydrates, 
% kcal 
58.2 55.1* 57.3 55.9 58.1 55.7 56.9 56.7 
Protein, %  
kcal 
23.0 23.5 22.5 23.9 22.3 23.9* 23.4 23.0 
Animal protein, 
% protein 
41.7 39.0 41.2 39.1 41.6 38.4 45.6 36.2* 
Plant protein, % 
protein 
55.0 52.0 53.3 53.6 53.4 54.1 49.7 56.4* 
Protein, g 
day−1  
(mean ± SD) 
73.5 ± 23.0 75.4 ± 
28.7 
68.9 ± 21.0 79.2 ± 
29.2 
70.6 ± 25.5 77.7 ± 
26.4 
73.5 ± 
23.2 
75.2 ± 
28.0 
Protein, g kg−1 
day−1 (mean 
± SD) 
1.1 ± 0.4 1.0 ± 
0.4 
0.9 ± 0.3 1.1 ± 
0.4 
1.0 ± 0.4 1.0 ± 
0.3 
1.1 ± 
0.4 
1.0 ± 
0.3 
Animal 
protein, g 
day−1 (mean 
± SD) 
31.5 ± 16.1 30.4 ± 
17.7 
28.9 ± 14.6 32.2 ± 
18.5 
30.8 ± 16.0 30.5 ± 
17.6 
34.3 ± 
14.9 
28.3 ± 
17.7 
Plant protein, g 
day−1  
(mean ± SD) 
39.4 ± 12.7 39.3 ± 
19.6 
36.2 ± 13.6 42.1 ± 
18.8 
37.3 ± 16.2 41.5 ± 
16.4 
36.6 ± 
15.4 
41.6 ± 
16.8 
Table 2  (continued) 
       
 IHG 
 
Low (< 25 kg) High  
(≥ 25 
kg) 
IHG/BMI 
 
Low  
(< 0.82 kg) 
High  
( ≥ 
0.82 
kg) 
Usual WS 
 
Low  
(< 1.3 m/s) 
High  
(≥ 1.3 
m/s) 
Fast 
WS 
 
Low  
(< 1.6 
m/s) 
High  
(≥ 1.6 
m/s) 
Leucine, mg 
day−1 (mean 
± SD) 
4817 ± 1749 4453 
± 
2427 
4400 ± 1722 4773 
± 
2432 
4653 ± 2162 4614 
± 
2141 
4785 
± 
2051 
4533 
± 
2206 
Isoleucine, mg 
day−1 (mean 
± SD) 
2620 ± 250 2411 
± 
1295 
2388 ± 932 2593 
± 
1310 
2527 ± 1159 2501 
± 
1151 
2609 
± 
1106 
2450 
± 
1181 
Valine, mg 
day−1 (mean 
± SD) 
2981 ± 1088 2748 
± 
1467 
2717 ± 1046 2956 
± 
1492 
2875 ± 1312 2847 
± 
1313 
2965 
± 
1249 
2791 
± 
1347 
BMI body mass index, HC hip circumference, IHG isometric handgrip strength, WC waist 
circumference, WS walking speed test. *p < 0.05 vs. low 
 
Relationship between physical function and diet characteristics 
Pearson’s correlations were performed to explore the relationship between age, diet 
composition, and performance tests (Table 3). Age was negatively associated with both usual 
and fast WS. IHG/BMI was negatively correlated with relative carbohydrate consumption and 
positively correlated with body weight-adjusted protein consumption. A positive correlation 
was also observed between relative protein consumption and usual WS. Finally, fast WS was 
negatively correlated with relative animal protein intake and positively correlated with 
consumption of plant-based protein. 
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Table 3.  Relationship between dietary factors and results of physical tests as assessed by Pearson’s 
correlation. 
 IHG IHG/BMI Usual WS Fast WS 
Age, years − 0.18 − 0.14 − 0.35** − 0.38** 
Energy intake, kcal − 0.001 0.04 0.11     0.03 
Fat, % kcal 0.10 0.04 0.06 0.02 
Carbohydrates, % kcal − 0.30 − 0.27* − 0.13 − 0.05 
Protein, % kcal 0.17 0.20 0.13* 0.06 
Animal protein, %  
protein 
0.06 0.04 − 0.16 − 0.18* 
Plant protein, % protein − 0.20 − 0.16 0.10 0.15* 
Protein, g day−1 0.12 0.17 0.16 0.04 
Protein, g kg−1 day−1 0.07 0.21* 0.09 − 0.08 
Animal protein, g day−1 0.12 0.13 − 0.02 − 0.10 
Plant protein, g day−1 − 0.02 0.05 0.20 0.12 
Leucine, mg day−1 0.04 0.07 0.03 − 0.04 
Isoleucine, mg day−1 0.03 0.07 0.03 − 0.04 
Valine, mg day−1 0.04 0.07 0.03 − 0.04 
BMI body mass index, HC hip circumference, WC waist circumference, WS walking speed *p < 0.05, 
**p < 0.01 
 
Discussion 
The present study investigated the association between dietary factors and physical 
performance in a sample of well-functioning older community dwellers. Our analyses revealed 
that upper-limb muscle strength was positively associated with body weight-adjusted protein 
consumption and negatively associated with relative carbohydrate consumption. In addition, 
high relative protein consumption was associated with faster usual WS. Finally, fast WS was 
negatively correlated with relative animal protein ingestion and positively correlated with 
relative plant protein intake. 
In keeping with the present study, Gregório et al. [28] found that postmenopausal 
women who consumed dietary protein above the RDA performed better in the one-leg stand 
and the short physical performance battery than those reporting a protein intake below the RDA. 
Similarly, Isanejad et al. [29] found that older women who consumed ≥ 1.2 g kg−1 day−1 of 
protein had better performance in IHG, knee extension, one-leg stand, and chair rise tests. While 
WS was found to be positively associated with relative protein intake, no significant 
correlations were determined between body weight-adjusted protein consumption and gait 
speed at either usual or fast pace (Table 3). Noticeably, prospective studies showed that older 
adults with higher protein intake at baseline experienced milder decline in muscle strength over 
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the follow-up, with no impact on mobility [29, 30]. Taken together, these findings suggest that 
protein consumption might be associated with muscle strength, but not mobility. It may be 
hypothesized that the loss of muscle mass might have a greater impact on muscle strength [31, 
32] than on muscle function [32], which instead relies on multiple organ systems (e.g., central 
and peripheral nervous system, cardiovascular system, respiratory system) [4]. Hence, a greater 
protein consumption may increase the availability of essential amino acids (EAAs), thereby 
stimulating MPS and overcoming anabolic resistance [14, 15]. Other cross-sectional studies 
and meta-analyses observed that mobility (e.g., WS), but not muscle strength was associated 
with protein consumption [16, 28]. These discrepancies may derive from differences in physical 
activity levels [33] and methods used to assess muscle mass [34]. 
Our analyses showed that relative protein consumption was associated with usual 
WS, while fast WS was negatively correlated with relative animal protein intake and positively 
related to plant-based protein ingestion. These findings suggest that different measures of 
protein intake are associated with specific components of physical function. Future studies are 
warranted to conclusively establish the relationship between various measures of protein 
consumption and domains of physical performance to refine dietary recommendations for older 
adults. 
Animal-derived foods are regarded as a source of highquality protein enriched with 
EAAs readily available for MPS [35, 36]. Several studies have demonstrated that a high animal 
protein consumption is associated with lean body mass [15, 35–37] and upper-limb muscle 
strength in older adults [15, 38]. In contrast, higher ingestion of plant-derived protein has been 
related with lower skeletal muscle index [36] and IHG in older people [38]. No association 
between protein sources and muscle strength was observed in our sample. Indeed, physical 
performance in fast WS was better in participants with higher vegetable protein consumption. 
A possible explanation for these findings may reside in the fact that our sample of 
Brazilian older adults showed higher absolute (0.39 g day−1) and relative (53.4%) plant protein 
consumption than that reported in other studies [36, 38]. Specifically, a twofold greater intake 
was observed relative to the Framingham study [38]. It should also be considered that a 
saturable dose–response relationship between the amount of protein ingested per meal and MPS 
rate has been determined in healthy older adults, such that MPS becomes maximally stimulated 
by 0.4 g of protein per kg of body weight per meal [39]. Although the main concern regarding 
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plant-based protein is associated with its low quality [36, 37], it is suggested that the co-
ingestion of protein from foods such as soy, bean and nuts, could provide the quantity of EAAs 
requested for muscle homeostasis [36]. 
Albeit dealing with a highly relevant subject, our study presents some limitations 
that need to be discussed. First, the results shown in this work derive from cross-sectional 
observations. The possibility cannot be ruled out that differences in birth cohort might have 
influenced some of the assessed parameters. For the same reason, reverse causality between 
dietary patterns and physical performance cannot be excluded. Indeed, it is possible that dietary 
choices were somewhat influenced by the level of physical function rather than vice versa. In 
addition, since enrollees were recruited on a voluntary basis, it is possible that those who 
accepted to participate were more engaged in their health management than those who declined. 
Therefore, future studies adopting probabilistic random sampling are needed to rule out such a 
potential source of bias. The relatively small number of participants, the lack of power 
calculation, diet evaluation through the 24-h recall diary, and the lack of direct measures of 
body composition should also be acknowledged as limitations of the study. Furthermore, neither 
objectively measured nor self-reported physical activity throughout the life course was 
collected. Hence, the impact of physical activity on functional tests and dietary choices could 
not be established. Finally, in older adults, protein intake distribution has shown to impact 
physical performance more than the amount of protein ingested throughout the day [33]. 
Because of the small sample size, the pattern of protein ingestion according to food sources 
could not be analyzed. Future investigations should clarify whether the distribution of protein 
intake from different sources has an impact on physical performance in old age. 
 
Conclusions 
Findings from the present study indicate that physical performance is associated 
with dietary factors in well-functioning older community dwellers. Based on our analyses, 
different measures of protein intake are associated with specific components of physical 
function. Specifically, body weight adjusted protein consumption was correlated with upper 
limb muscle strength and relative protein consumption was positively associated with usual 
WS. In addition, our findings add new evidence to the relationship between protein sources and 
physical function, since fast WS was negatively correlated with relative animal protein 
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consumption and positively correlated with relative plant protein intake. Future interventional 
studies are needed to establish the optimal blend of protein sources to support physical 
performance in old age. 
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Timed ‘Up and Go’ (TUG) has been widely used in research and clinical practice to evaluate physical function and 
mobility in older adults. However, the physical capabilities underlying TUG performance are not well elucidated. 
Therefore, the present study aimed at investigating a selection of physical capacities underlying TUG performance in 
community-dwelling older women. Four hundred and sixty-eight apparently healthy older women independent to 
perform the activities of daily living (mean age: 65.8 ± 6.0 years) were recruited from two specialized healthcare 
centers for older adults to participate in the study. Volunteers had their medical books reviewed and underwent 
evaluations of anthropometric data as well as physical and functional capacities. Pearson's correlation results 
indicate that TUG performance was significantly associated with upper (i.e., handgrip strength) and lower (i.e., sit-
to-stand) limb muscle strength, balance (i.e., one-leg stand), lower limb muscle power (i.e., countermovement jump), 
aerobic capacity (i.e., 6-minute walk test), and mobility (i.e., usual and maximal walking speeds). When the analyses 
were performed based on TUG quartiles, a larger number of physical capabilities were associated with TUG > 75% in 
comparison with TUG < 25%. Multiple linear regression results indicate that the variability in TUG (~20%) was 
explained by lower limb muscle strength (13%) and power (1%), balance (4%), mobility (2%), and aerobic capacity (< 
1%), even after adjusted by age and age plus body mass index (BMI). However, when TUG results were added as 
quartiles, a decrease in the impact of physical capacities on TUG performance was determined. As a whole, our 
findings indicate that the contribution of physical capabilities to TUG performance is altered according to the time 
taken to perform the test, so that older women in the lower quartiles — indicating a higher performance — have an 
important contribution of lower limb muscle strength, while volunteers in the highest quartile demonstrate a 
decreased dependence on lower limb muscle strength and an increased contribution of other physical capabilities, 
such as lower limb muscle power and balance. 
 
 
Abbreviations: ADLs, activities of daily living; BMI, body mass index; DP, double product; GUG, get up and go; HC, hip circumference; iTUG, instrumented TUG; MAP, mean 
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Introduction 
The aging process is accompanied by several alterations in the neuromuscular 
apparatus (Deschenes, 2004), causing among others a significant decrease in strength and power 
generation (Lauretani et al., 2003). The ultimate consequence of such a deterioration is the 
progressive decrease of the ability to perform activities of daily living (ADLs) and loss of 
independence (Millan-Calenti et al., 2010; Vermeulen et al., 2011). 
In this sense, a number of tools have been developed to objectively measure physical 
function and mobility in older adults with the aim of identifying people at risk of negative health 
events and assessing the 
effectiveness of therapeutic interventions. Among the available tools, the timed ‘Up 
and Go’ (TUG) test has shown to be reliable, inexpensive, and easy and quick to perform tool, 
repeatedly validated in several populations (Barry et al., 2014; Benavent-Caballer et al., 2016; 
Bischoff et al., 2003; Bohannon, 2006; Kamide et al., 2011; Lorefice et al., 2017; Podsiadlo and 
Richardson, 1991; Pondal and del Ser, 2008; Zarzeczny et al., 2017). 
TUG was developed by Podsiadlo and Richardson (Podsiadlo and Richardson, 
1991) as a modified version of the “Get-up and go” (GUG) test. The main concern of the 
researchers regarding the GUG test was the absence of a direct evaluation of the test scores, 
once the results were based on the observer's perception of the patient's risk of falling. In their 
updated version, Podsiadlo and Richardson maintained the test protocol, which consists of, on 
the word “go”, get up from a chair, walk 3 m at a comfortable and safe pace, turn, return to the 
chair, and sit down again. However, the score given was based in the time taken to complete 
the test. When the authors tested the validity of TUG (Podsiadlo and Richardson, 1991), results 
demonstrated that TUG scores were significantly correlated with balance, gait speed, and 
functional capacity in frail older adults, indicating that this test may be a useful clinical tool to 
evaluate basic mobility skills. 
In the last years, several evidence have expanded the initial knowledge about TUG, 
demonstrating that TUG scores are associated with risk of falls (Alexandre et al., 2012; Rydwik 
et al., 2011; ShumwayCook et al., 2000; Viccaro et al., 2011), hospitalization (Viccaro et al., 
2011), nursing home placement (Nikolaus et al., 1996), health status (Viccaro et al., 2011), 
capacity to perform the ADLs (Rydwik et al., 2011; Viccaro et al., 2011), physical function (van 
Iersel et al., 2008; Rydwik et al., 2011; Viccaro et al., 2011), and some cognitive domains (e.g., 
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executive function) (Donoghue et al., 2012). In addition, modified versions (i.e., rising from the 
chair without using hands, walk at maximum pace) have been proposed to contemplate its 
usefulness in different groups (Barry et al., 2014; Kamide et al., 2011; Rydwik et al., 2011), as 
well as reference values have been suggested to different populations (Alexandre et al., 2012; 
Bischoff et al., 2003; Bohannon, 2006; Kamide et al., 2011; Kojima et al., 2015; Rydwik et al., 
2011). Lastly, is important to mention that changes on TUG scores are used to verify the 
effectiveness of physical exercise programs (Coelho Junior et al., 2017a). 
Regarding physical function, — pragmatically — authors have proposed that TUG 
performance basically reflects the balance and gait skills, which is a product of the seminal 
study published by Podsiadlo and Richardson (1991). However, recent evidence have suggested 
that the physical capacities underlying TUG performance are sample-dependent (Benavent-
Caballer et al., 2016; Zarzeczny et al., 2017). 
Studying a sample composed of a mixture of community-dwelling and 
institutionalized older adults, for example, Benavent-Caballer et al. (Benavent-Caballer et al., 
2016) confirmed the importance of functional balance (i.e., evaluated by Berg Balance Scale) 
in TUG performance. On the other hand, findings from Zarzeczny et al., (2017) indicate that 
the results of 30-s chair stand test and 6-minute walk test were significantly correlated with 
TUG performance in very old volunteers (> 80 years). This view is supported by Nur et al., 
(2017) who showed that muscle strength was central to TUG performance in patients with knee 
osteoarthritis. 
The aforementioned mentioned studies indicate that several physical capabilities 
may be associated with TUG performance, and, therefore, indicate that this test is only 
dependent on balance and gait seems to be a very simplistic view. Despite the interesting results 
from these studies, experiments were performed in small sample sizes, composed of a mixture 
of different populations, and using a limited number of evaluations. To overcome such a 
limitation, the current study was designed to investigate the contribution of a selection of 
different physical capabilities to the variability of TUG in a large sample of apparently healthy 
community-dwelling older women. 
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Materials and methods 
This study had a cross-sectional design and was approved by the Research Ethics 
Committee of the University of Mogi das Cruzes (UMC) under the protocol number 621–614 
and was conducted in accordance with the Declaration of Helsinki and with Resolution 196/96 
of the National Health Council. Experiments were developed in the city of Poá, state of São 
Paulo, Brazil, starting in January 2015 and ending in November 2015. 
 
Study participants 
The study participants were recruited from two specialized healthcare centers for 
older adults in a town located in the metropolitan area of São Paulo, Brazil. Volunteers were 
recruited by convenience and asked verbally by the medical team and researchers about their 
willingness to take part in the study. All participants were apparently healthy and provided 
informed consent before enrolment. 
The participants were identified as apparently healthy according to the capacity to 
perform the ADL, walking without the aid of assistive devices, and the absence of disease likely 
to impact physical function. 
Participants were eligible to participate in the present study if they had age ≥ 60 
years, were community-dwelling older women, showed independence to perform the ADL 
according to Katz Index (6 points) (Shelkey and Wallace, 1999), and did not present clinical 
signs of cognitive impairment, since they scored higher than the cutoff points adjusted for 
schooling on the Mini-Mental State Examination (MMSE) (Herrera Jr et al., 2002). 
Exclusion criteria were as follows: nursing home residence, missing values, taking 
hormone replacement and/or psychotropic drugs, cerebrovascular disease, pulmonary diseases 
with respiratory insufficiency (e.g., chronic obstructive pulmonary disease), neurological or 
psychiatric diseases, musculoskeletal disorders, complaints of any kind of dizziness, blurred 
vision or lightheadedness when rising or standing for long time, indicative of orthostatic 
hypotension and/or vestibular disorders. The presence of hypertension (HTN), type II diabetes 
mellitus (T2DM), arthritis, cardiovascular diseases (CVD) and osteoporosis was not considered 
an exclusion criterion provided that the clinical symptoms were pharmacologically controlled. 
The evaluations regarding the exclusion criteria, and the clinical and pharmacological control 
of the abovementioned diseases was performed by a physician and a certified nurse. 
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After the application of the exclusion and inclusion criteria, 468 older women were 
included in the analyses (Fig. 1). 
 
Fig. 1. Flow diagram of the sample selection process. 
 
Functional assessments 
Two experienced researchers applied each test. While one was responsible for 
detailing the operational procedures, demonstrate the test before the evaluation, quantify the 
evaluation time and evaluate the motor gesture; the other, ensured the safety of the participant. 
After the end of the explanation and before the start of the tests, volunteers performed a 
familiarization trial to ensure the understanding of the test. Then, the volunteers performed all 
tests twice (except for the six-minute walk test), and the best result obtained in each test was 
used in the analysis. The tests were distributed in a room as stations, and were performed in a 
circuited fashion one after the other. A one-minute interval between trials was provided. During 
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all tests, verbal encouragement was provided to ensure that volunteers achieved the best possible 
performance without compromising safety. During TUG, walking speed test at maximal pace, 
and sit-to-stand tests researchers provided stimulus such as: Come on, faster!; A little more!; 
and; Lets go! During OLS, verbal encouragement was provided to keep the participant focused 
on the test. Therefore, the volunteers were stimulated with the sentences: Focus! Keep your 
posture!; Very good!. During handgrip test, the researchers repeatedly used the sentences: as 
much force as possible!; Lest go!; and more strength! For the countermovement jump test, 
verbal encouragement was only provided before the test, with the sentence: Jump as high as you 
can using all your strength! Regarding Six-minute walk test, researchers told the volunteers that 
they were close to finalizing the test (i.e., Come on! Force! There is little left!). The protocol 
used in this study has been used by our group elsewhere (Coelho Junior et al., 2015, 2016; 
Coelho Junior et al., 2017b). 
 
TUG test 
The TUG test involves getting up from a chair (total height: 87 cm; seat height: 45 
cm; width: 33 cm;), walking three meters around a marker placed on the floor, coming back to 
the same position, and sitting back on the chair. The subjects started the test wore their regular 
footwear, with their back against the chair, arms resting on the chair's arms, and with the feet in 
contact with the ground. A researcher instructed the volunteers to, on the word ‘go’, get up and 
walk as fast as possible without compromising safety in the demarcation of three meters on the 
ground, turn, returns to the chair, and sit down again. Timing was started when the volunteer 
got up from the chair and was stopped when the participant's back touches the backrest of the 
chair (Podsiadlo and Richardson, 1991). A stopwatch (1/100 s accuracy) was used for time 
evaluation, and a longer time taken to perform the test indicates a lower performance. 
Participants were divided into quartiles based on TUG performance: 
TUG quartiles: < 25% ≤6.07 s; 25%–50% = 6.07 s–6.81 s; 50%–75% = 6.82 s–7.65 s; > 75%≥ 
7.65 s. The main reason to choose this approach is because there is no standard cutoff for 
apparently health Brazilian older adults, so that the use of any suggested cutoff to divide our 
sample could be associated with a great risk of bias. Therefore, quartiles seem to be the best 
approach since volunteers are allocated in the subgroups according to results of the whole 
sample. 
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Handgrip strength 
The handgrip strength was measured using a Jamar® (USA) dynamometer while 
the participants remained seated in a chair with the shoulders abducted, elbows near the trunk 
and flexed at 90°, and wrists in a neutral position (thumbs up). The contralateral arm remained 
relaxed under the thigh. To determine handgrip strength, the volunteers performed a maximal 
contraction during 4 s with the dominant hand (Mathiowetz et al., 1984). To determine the 
dominant hand, the volunteers were asked which of the hands was the strongest. Results were 
recorded in kgf. 
 
One-leg stand test 
The one-leg stand test was performed with the volunteers standing in a unipodal 
stance with the dominant lower limb, the contralateral knee remaining flexed at 90°, the arms 
folded across the chest, and the head straight. A stopwatch was activated when the volunteer 
raised their foot off the floor and was stopped when the foot touched the floor again. The 
maximum performance time was up to 30 s, considered the best test result (Vellas et al., 1997). 
 
Sit-to-stand test 
Volunteers were requested to rise from a chair five times as quick as possible with. 
arms folded across the chest. The stopwatch was activated when the volunteer raised 
their buttocks off the chair and was stopped when the volunteer seated back at the end of the 
fifth stand (Guralnik et al., 1994). 
 
Walking speed test 
Walking speed was measured over three meters. This distance was chosen due to 
space limitations (Middleton et al., 2016). It is worth to mentioning, that a high concordance 
has been observed between the results recorded after 3-meter and 6-meter courses (Lyons et al., 
2015). In the test, volunteers were required to walk five meters at their usual and fastest possible 
cadences (without running). Before the evaluation, both feet of each volunteer were to remain 
on the starting line. The measurement was started when a foot reached the one-meter line and 
was stopped when a foot reached the four-meter line. The one-meter intervals at the beginning 
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and at the end of the course were used to avoid early acceleration and/or deceleration (Lyons et 
al., 2015). 
 
Countermovement jump 
The countermovement jump was performed to evaluate lower limb muscle power. 
In the initial position, the volunteers stood on a jump platform (Jump System Pro, Cefise, 
Brazil), their feet remained approximately parallel at shoulder width, and their hands rested on 
their hips. When instructed, the volunteers flexed their knees at approximately 90° and jumped 
the maximum height possible. The maximum height was adopted and expressed in centimeters 
(cm) (RamírezCampillo et al., 2014). 
 
6-minute walk test (6MWT) 
The 6-minute walk test was performed according to the American Thoracic Society 
guidelines (2002) (Enright, 2003). The test was performed indoors on a 30-meter track. Briefly, 
after remaining seated for 15 min, the volunteers were asked to walk on the track as fast as 
possible for 6 min. In the case the volunteers experienced chest pain, substantial dyspnea, leg 
cramps, stagger, diaphoresis, pale or ashen appearance, or any other complaint, the test was 
interrupted. The distance walked by the volunteers in meters was used in the analysis. 
 
Anthropometric measurements 
A weight scale with a Filizola® (Brazil) stadiometer was used to measure body 
mass (kg) and height (cm). The body mass index (BMI) was determined by using the formula 
body mass (kg)/height (m2). An anthropometric tape (flexible and inextensible) (Sanny®, 
Brazil) was used to obtain all measurements (i.e., waist circumference [WC], hip circumference 
[HC], and neck circumference [NC]). Participants remained in a standing position, head held 
erect, eyes forward, with the arms relaxed at the side of the body, feet kept together, wearing 
light clothes. The WC was assessed at the mid-point between the last floating rib and the highest 
point of the iliac crest. HC was evaluated at the highest point of the buttocks. NC was measured 
right above the cricoid cartilage and perpendicular to the long axis of the neck (Coelho Junior 
et al., 2016). 
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Evaluation of hemodynamic parameters at rest 
The procedures for measurement of blood pressure were adapted from the VII Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC7) (Chobanian et al., 2003). All procedures occurred in the morning 
(08:30 am–10:30 am). In summary, volunteers remained in a sitting position on a 
comfortable chair for 15 min in a quiet room. Afterwards, an appropriate cuff was placed at 
approximately the midpoint of the upper left arm (heart level). An automatic, noninvasive and 
validated arterial blood pressure monitor (Microlife-BP 3BT0A, Microlife, Widnau, 
Switzerland) was used to measure systolic blood pressure (SBP), diastolic blood pressure 
(DBP), and heart rate (HR) (Cuckson et al., 2002). During blood pressure recording, volunteers 
remained relaxed in the sitting position, with parallel feet at shoulder width, both forearm and 
hands on the table, supinated hands, back against the chair, without move or talk. The volunteer 
did not have access to blood pressure values during measurement. The evaluation lasted 
approximately 80 s and was performed three times with one-minute interval between the 
measurements. The mean value was used in the analysis. Mean arterial pressure (MAP) and 
double product (DP) were calculated according to the following equations: 
MAP = [SBP + (2∗DBP)]/3 (1) 
DP = SBP HR∗ . (2) 
 
Statistical analysis 
Normality of data was tested using the Kolmogorov-Smirnov test. To determine the 
differences in continuous and categorical data among groups (i.e., TUG quartiles: < 25% ≤6.07 
s; 25%–50% = 6.07 s–6.81 s; 50%–75% = 6.82 s–7.65 s; > 75%≥ 7.65 s), one-way analysis of 
variance (ANOVA) followed by Dunnett's posthoc test and the chi-square (Lauretani et al., 
2003) test were performed, respectively. Pearson's correlation was used to explore correlations 
between continuous variables and TUG performance. Multiple linear regression was applied to 
examine how the variability in TUG performance could be explained by physical capacities 
(i.e., muscle strength [sit-to-stand and handgrip strength] and power [countermovement jump], 
ambulation [usual and maximal walking speeds], balance [one-leg stand], aerobic capacity 
[6MWT]). The level of significance was 5% (p < 0.05) and all analyses were conducted using 
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the IBM SPSS Statistics, version 20.0, software (IBM Corp., Armonk, NY, USA). Data are 
presented as mean ± standard deviation (SD). 
 
Results 
The final study sample included 468 older women. Table 1 shows the general 
characteristics of the study population. Volunteers showed a normal to overweight BMI 
classification (28 kg/m2) according to cutoff values for older adults (Corona et al., 2014), while 
an elevated cardiovascular risk was indicated based on circumferences evaluation (WC, HC, 
and NC). HTN was the most prevalent morbidity (59.0%), followed by osteoarthritis (31.2%), 
osteoporosis (26.3%), T2DM (18.2%), and CVD (4.7%). 
BMI = body mass index; WC = waist circumference; HC = hip circumference; NC 
= neck circumference; TUG = timed up and go; 6MWT = 6-minute walk test; SBP = systolic 
blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; HR = Heart 
rate; HTN = hypertension; T2DM = type 2 diabetes mellitus; CVD = cardiovascular disease. 
 
Table 1. Characteristics of older women. 
Variables Total (n = 468) Minimum-Maximum 
Anthropometric characteristics 
Age (years) 65.8 ± 6.0 60–89 
Weight (kg) 69.7 ± 13.2 35.5–122.0 
Height (m) 1.57 ± 0.02 1.00–1.93 
BMI (kg/m2) 28.0 ± 5.0 16.2–45.7 
WC (cm) 97.0 ± 12.8 50–136 
HC (cm) 104.7 ± 11.1 56–144 
NC (cm) 36.3 ± 3.3 30–58 
Physical functional tests 
TUG (s) 7.0 ± 1.3 4.6–14.3 
Handgrip strength (kgf) 23.6 ± 5.0 6.7–42.0 
One-leg stand (s) 15.2 ± 12.7 0–30 
Sit-to-stand (s) 10.8 ± 2.3 5.2–25.1 
Usual walking speed (m/s) 1.2 ± 0.2 0.47–2.94 
Maximal walking speed (m/s) 1.7 ± 0.4 0.45–3.09 
Countermovement jump (cm) 11.2 ± 7.9 0–108 
6MWT (m) 580.9 ± 141.6 72–2.560 
Hemodynamic parameters 
SBP (mm Hg) 135.1 ± 61.7 89–194 
DBP (mm Hg) 77.1 ± 10.6 53–144 
MAP (mm Hg) 96.5 ± 11.6 68.3–160.7 
HR (bpm) 77.0 ± 11.3 51–119 
Disease prevalence 
HTN(%) 59.0 – 
Osteoarthritis (%) 31.2 – 
Osteoporosis (%) 26.3 – 
T2DM(%) 18.2 – 
CVD (%) 4.7 – 
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 The main characteristics of study participants according to TUG quartiles are 
shown in Table 2. Age increased across TUG quartiles, with participants in the last quartile 
were older than volunteers of all other subgroups. With regard to anthropometry, TUG > 75% 
showed an obesity classification according to BMI, as well as an elevated cardiovascular risk 
as defined by WC, HC and NC. A similar pattern was observed in TUG 25–50% and TUG 50–
75%, but not in TUG < 25%. Hypothesis test indicated that BMI and WC were higher in TUG 
> 75% and TUG 50–75% comparing to TUG < 25%. A reduced performance on all physical 
functional tests was observed in TUG > 75% compared with TUG < 25%, TUG 25–50%, and 
TUG 50–75%. As expected, physical performance was reduced according to TUG quartiles. 
Indeed, TUG 50–75% showed a lower performance in one-leg stand, sit-tostand, usual and 
maximal walking speeds, and 6MWT tests in comparison to TUG < 25% and TUG 25–50% 
(only for one-leg stand test). 
 
Table 2. Characteristics of older women according to TUG. 
 
Total (n = 468) 
 
Variables < 25% Minimum- 25%–50% Minimum- 50%–75% Minimum- > 75% Minimum- 
 Maximum Maximum Maximum Maximum 
 
(n = 117)  (n = 117)  (n = 117)  (n = 117)  
Anthropometric characteristics 
Age (years) 63.3 ± 4.4 
60–81 64.4 ± 4.5 60–76 66.0 ± 5.7a 60–88 69.4 ± 7.1a,b,c 60–89 
Weight (kg) 67.3 ± 12.7 38.8–108.3 69.8 ± 11.4 44.7–113.8 70.3 ± 14.0 35.5–109.4 71.0 ± 14.4 44.1–122.0 
Height (m) 1.58 ± 0.08 1.0–1.93 1.57 ± 0.06 1.37–1.75 1.57 ± 0.07 1.41–1.82 1.56 ± 0.06 1.43–1.74 
BMI (kg/m2) 26.7 ± 4.8 16.2–43.3 28.3 ± 4.5 20.4–45.7 28.6 ± 4.8a 17.3–42.1 29.1 ± 5.3a 19.0–44.1 
WC (cm) 92.5 ± 12.0 63–128 96.7 ± 11.6 68–129 98.2 ± 13.3a 50–133 100.6 ± 13.1a 69–136 
HC (cm) 103.4 ± 10.4 81–144 104.9 ± 10.1 69–133 104.9 ± 12.3 56–135 105.4 ± 11.3 67–141 
NC (cm) 36.0 ± 2.9 30–46 36.6 ± 3.8 30–58 36.4 ± 3.2 30–47 36.4 ± 3.1 30–46 
Physical functional tests 
TUG (s) 5.6 ± 0.34 4.6–6.0 6.4 ± 0.19 6.1–6.8 7.1 ± 0.23 6.8–7.6 8.9 ± 1.1 7.6–14.3 
Handgrip strength (kgf) 24.9 ± 4.7 9.4–42 24.1 ± 4.7 6.7–34.1 23.7 ± 5.2 12.5–41.5 21.6 ± 5.1a,b,c 8.9–40.4 
One-leg stand (s) 20.7 ± 12.9 0–30 21.2 ± 11.3 0–30 12.9 ± 11.3a,b 0–30 6.6 ± 9.4a,b,c 0–30 
Sit-to-stand (s) 9.5 ± 1.4 5.2–16.0 10.2 ± 1.6a 7.4–15.3 10.8 ± 1.9a 7.1–19.9 12.7 ± 2.8a,b,c 7.8–25.1 
Usual walking speed (m/ 
s) 
1.36 ± 0.31 0.50–2.94 1.31 ± 0.29 0.60–2.66 1.24 ± 0.22a 0.58–2.11 1.10 ± 0.25a,b,c 0.47–1.94 
Maximal walking speed 
(m/s) 
1.97 ± 0.52 0.45–3.00 1.88 ± 0.41 0.77–3.09 1.75 ± 0.39a 0.77–3.00 1.46 ± 0.38a,b,c 0.56–3.00 
Countermovement jump 
(cm) 
13.9 ± 5.5 2.0–85.0 11.1 ± 3.8a 0–25.5 12.1 ± 12.1 3.4–108 7.6–3.8a,b,c 0–17.2 
6MWT (m) 637.9 ± 130.7 211–1248 592.7 ± 203.8 384–2.560 573 ± 82.4a 352–960 499.5 ± 114.1a,b,c 72–704 
Hemodynamic parameters 
SBP (mm Hg) 129.1 ± 18.0 90–182 132.5 ± 18.7 90–185 132.5 ± 18.1 96–192 136.5 ± 19.4a 89–194 
DBP (mm Hg) 76.8 ± 11.1 52–112 77.2 ± 9.6 56–104 77.0 ± 10.0 57–103 77.0 ± 11.8 56–144 
MAP (mm Hg) 94.1 ± 11.8 68.3–121.7 95.6 ± 11.2 70–131 95.5 ± 11.0 74.6–126.7 96.8 ± 12.4 69–160.7 
HR (bpm) 76.9 ± 10.7 52–113 74.8 ± 10.3 55.0–102 77.6 ± 11.3 54–117 78.7 ± 12.7 51–119 
Disease prevalence 
HTN (%) 47.9 – 53.8 – 59.8 – 74.4⁎ – 
T2DM (%) 10.3 – 18.8 – 21.4 – 22.2 – 
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Arthritis (%) 27.4 – 28.2 – 30.8 – 38.5 – 
CVD (%) 2.6 – 6.0 – 4.3 – 6.0 – 
Osteoporosis (%) 21.4 – 26.5 – 29.1 – 28.2 – 
BMI = body mass index; WC = waist circumference; HC = hip circumference; NC = neck 
circumference; TUG = timed up and go; 6MWT = 6-minute walk test; SBP = systolic blood pressure; 
DBP = diastolic blood pressure; MAP = mean arterial pressure; HR = Heart rate; HTN = hypertension; 
T2DM = type 2 diabetes mellitus; CVD = cardiovascular disease.  a P < 0.05 vs < 25%. b P < 0.05 vs 
25%–50%. c  P < 0.05 vs 50%–75%. ⁎ P < 0.05 vs 25% (chi-square test). 
 
Similar to TUG 50–75%, TUG 25–50% demonstrated worse results in the sit-to-stand and 
countermovement jump tests relative to TUG < 25%. Hemodynamic parameters indicated 
higher blood pressure levels in TUG > 75% compared with TUG < 25%. Lastly, TUG > 75% 
had a higher prevalence of HTN compared to TUG < 25%. 
Table 3 depicts the Pearson's correlation between TUG and physical functional 
tests. In the total sample (n = 468), TUG was significantly correlated with handgrip strength (r 
= −0.24), sit-to-stand (r = 0.53), countermovement jump (r = −0.27), 6MWT (r = −0.36), and 
usual (r = −0.27) and maximal (r = −0.19) walking speeds. When the analyses were performed 
based on TUG quartiles, TUG < 25% was correlated with sit-to-stand (r = 0.46) and usual 
walking speed (r = −0.26), while TUG 25%–50% and TUG 50%–75% were only significantly 
correlated with sit-to-stand (r = 0.21 and 0.19, respectively). A greater number of correlations 
was found in the TUG > 75%. In fact, significant correlations were observed between TUG and 
sit-to-stand (r = 0.34), countermovement jump (r = −0.30), 6MWT (r = −0.23), and usual 
walking speed (r = −0.20). 
Table 3. Pearson's correlation between TUG and physical capabilities. 
 
Total (n = 468) 
 
      
Variables TUG_Total TUG_ < 
25% 
TUG_25%–50%  TUG_50%–75% TUG_ > 75% 
Handgrip strength (kgf) −0.242⁎ −0.045 0.150 
  
−0.092 −0.039 
One-leg stand (s) −0.391⁎ 0.170 −0.030   −0.023 −0.087 
Sit-to-stand (s) 0.533⁎ 0.464⁎ 0.218⁎   0.196⁎ 0.347⁎ 
Usual walking speed (m/s) −0.271⁎ 0.262⁎ 0.031   −0.032 −0.201⁎ 
Maximal walking speed (m/s) −0.195⁎ −0.035 −0.136   −0.136 −0.118 
Countermovement jump (cm) −0.270⁎ 0.031 −0.218⁎   −0.031 −0.307⁎ 
6MWT (m) −0.366⁎ 0.139 −0.099   −0.039 −0.239⁎ 
TUG = timed up and go; 6MWT = 6-minute walk test. ⁎ P < 0.05. 
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Table 4 shows the results from multiple linear regression to predict TUG. Results 
indicate that the variability in TUG was explained by lower limb muscle strength (i.e., sit-to-
stand; 13%), balance (i.e., oneleg stand; 4%), mobility (i.e., usual walking speed; 2%), lower 
limb muscle power (i.e., countermovement jump; 1%), and aerobic capacity (i.e., 6MWT; < 
1%). When age (Model 2) and age plus BMI (Model 3) were added as independent variables, 
results became less remarkable but remained statically significant. However, when TUG results 
were added as quartiles (Model 4), a decrease in the impact of physical capacities on TUG 
performance was determined, as it may be observed for lower limb muscle strength (3%), lower 
limb muscle power (< 1%), usual walking speed (< 1%), and balance (< 1%).x′ The 
collaboration of aerobic capacity remained near 0%. The addition of age (Model 5) and age plus 
BMI (Model 6) as independent variables did not cause marked changes in the model. 
 
Table 4. Results from multiple linear regression to predict TUG performance. 
Dependent variable Predictor variable Unstandardized Beta Standardized Beta P R⁎ R2⁎ Adjustated R2⁎ 
sr2 
Model 1 
TUG Sit-to-stand 0.235 0.398 0.001 
   
0.13 
 Countermovement jump −0.019 −0.122 0.040    0.01 
 One-leg stand −0.026 −0.232 0.001    0.04 
 6MWT −0.001 −0.093 0.038    0.00 
 Usual walking speed −0.840 −0.165 0.001 0.654 0.428 0.416 0.02 
Model 2 
TUG Sit-to-stand 0.226 0.382 0.001 
   
0.12 
 Countermovement jump −0.015 −0.097 0.017    0.00 
 One-leg stand −0.021 −0.187 0.001    0.03 
 6MWT −0.001 −0.088 0.039    0.00 
 Usual walking speed −0.550 −0.108 0.015    0.00 
 Age 0.064 0.269 0.001 0.700 0.490 0.478 0.06 
Model 3 
TUG Sit-to-stand 0.226 0.383 0.001 
   
0.12 
 Countermovement jump −0.014 −0.088 0.028    0.00 
 One-leg stand −0.020 −0.178 0.001    0.02 
 Usual walking speed −0.531 −0.104 0.018    0.00 
 6MWT −0.001 −0.084 0.045    0.00 
 Age 0.068 0.287 0.001    0.06 
 BMI 0.029 0.115 0.004 0.709 0.502 0.489 0.01 
Model 4 
TUG Sit-to-stand 0.130 0.220 0.001 
   
0.03 
 Countermovement jump −0.007 −0.043 0.189    0.00 
 One-leg stand −0.007 −0.065 0.063    0.00 
 Usual walking speed −0.299 −0.059 0.102    0.00 
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 6MWT −0.054 −0.020 0.593    0.00 
 TUG Quartiles 2.023 0.623 0.001 0.815 0.664 0.656 0.23 
Model 5 
TUG Sit-to-stand 0.130 0.221 0.001 
   
0.03 
 Countermovement jump −0.005 −0.032 0.313    0.00 
 One-leg stand −0.005 −0.046 0.173    0.00 
 Usual walking speed −0.146 −0.029 0.414    0.00 
 6MWT 0.000 −0.018 0.598    0.00 
 TUG Quartiles 1.894 0.584 0.001    0.19 
 Age 0.041 0.174 0.001 0.830 0.689 0.681 0.02 
Model 6 
TUG Sit-to-stand 0.132 0.224 0.001 
   
0.03 
 Countermovement jump −0.005 −0.029 0.355    0.00 
 One-leg stand −0.005 −0.045 0.185    0.00 
 Usual walking speed −0.144 −0.028 0.419    0.00 
 6MWT 0.000 −0.017 0.605    0.00 
 TUG Quartiles 1.864 0.574 0.001    0.18 
 Age 0.044 0.184 0.001    0.02 
 BMI 0.013 0.051 0.104 0.832 0.692 0.682 0.00 
TUG = Timed up and go; 6MWT = 6 min walking test; BMI = body mass index; sr2 = square of 
semipartial correlation. ⁎ Values for the model. 
 
Discussion 
Findings from the present study indicate that the contribution of physical 
capabilities to TUG performance is altered according to the time necessary to complete the test, 
so that older women in the lower quartiles — indicating higher performance — have an 
important contribution of muscle strength, while those in the highest quartile — indicating 
reduced performance — demonstrate a decreased dependence on muscle strength and an 
increased contribution of other physical capabilities, such as lower limb muscle power, balance, 
and aerobic capacity. 
It is worth mentioning that our sample was composed of non-institutionalized older 
women, with total ADL independence, and able to walk without the use of assistive devices. A 
number of available normative values for TUG in clinical and nonclinical settings have been 
proposed in the last years, but they were typically developed in nonLatin American countries 
and the TUG was performed at a normal pace which limits the characterization of our sample 
in relation to these studies (Bohannon, 2006; Kamide et al., 2011; Pondal and del Ser, 2008). 
Nevertheless, when the TUG values of the highest quartile group (8.9 ± 1.1 s) were 
compared with other studies it was possible observed that, although these values were 
characterized as weak in the current study, they were lower than those reported in patients with 
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hip fracture (35.9 s) (Kristensen et al., 2009), multiple sclerosis (14.02 s) (Lorefice et al., 2017), 
and Parkinson's disease (10.0 s) (Son et al., 2017): Similarly, values were lower than the 
proposed cut-offs (i.e., 10–19 s, 12 s, 12.6 s, 13.5 s) for impaired mobility, dependency to 
perform basic and extended ADL (e.g., chair transfers, climb stairs), and risk of falls (Barry et 
al., 2014; Bischoff et al., 2003; Kojima et al., 2015; Podsiadlo and Richardson, 1991), indicating 
that our volunteers showed a “healthy” status and may not represent the reality of many older 
adults. 
In the current study, the association between lower limb muscle strength (i.e., sit-
to-stand; 13%), balance (one-leg stand; 4%), and mobility (usual walking speed; 2%), explained 
a great variability in the TUG results (~19%). These data are supported by several evidence in 
the scientific literature which demonstrated that TUG performance is strongly determined by 
these variables (Benavent-Caballer et al., 2016; Jung and Yamasaki, 2016; Nur et al., 2017; 
Shimada et al., 2010; Zarzeczny et al., 2017). 
Indeed — in an experiment similar to the present study — BenaventCaballer et al. 
(Benavent-Caballer et al., 2016) asked older adults to complete a battery of functional 
performance-based tests (e.g., handgrip strength, one-leg stand) to investigate the physical 
factors underlying TUG. These researchers observed that balance and lower limb muscle 
strength explained together 45.1% of the variation in TUG. However, the balance was the most 
significant factor explaining TUG performance. 
It should be stressed that Benavent-Caballer et al. (BenaventCaballer et al., 2016) 
investigated a sample composed of a mix of apparently healthy community-dwelling and 
institutionalized older adults (TUG performance = 11.1; 77.8% female). This may be one of the 
key determinants for the difference between the results because, as demonstrated in the current 
study, volunteers with an impaired performance demonstrated a greater need for other physical 
capacities than lower limb muscle strength. Interestingly, this hypothesis is in line with evidence 
from Zarzeczny et al., (Zarzeczny et al., 2017) who demonstrated that TUG performance in very 
old women (> 80 years) living in nursing home is strongly associated with 6MTW, which may 
represent an evaluation of aerobic capacity (Coelho Junior et al., 2017b; Ohtake, 2005; Ross et 
al., 2010; Rostagno and Gensini, 2008). Results of the present study support these data since 
the pattern shown in Pearson's correlation analyses (Table 2 and Table 3) differed according to 
TUG quartiles. 
In fact, when the analysis was conducted in the entire sample, lower limb muscle 
strength (sit-to-stand) demonstrated the strongest correlation between the variables and TUG 
(0.53); whereas its influence decreased according to TUG quartiles in the subgroup analysis 
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(from 0.46 to 0.19). In addition, other physical capabilities, such as lower limb muscle power 
and aerobic capacity (i.e., 6MWT), were significantly associated with TUG performance in the 
> 75% quartile, but not in the other quartiles. Lastly, the impact on TUG performance is shown 
by the multiple linear regression, where the addition of TUG quartiles as an independent 
variable decreased the unstandardized and standardized beta of the models, as well as the square 
of semipartial correlation (Table 4). 
Taken together, these data indicate that TUG performance is not circumscribed to 
balance and walk, as widely stated in the literature, and that the physical capabilities underlying 
this phenomenon are dependent on TUG levels. 
Unfortunately, our sample size (n = 117) did not allow further inferences regarding 
the physical capabilities associated with TUG performance in the > 75% quartile. Nevertheless, 
it is noteworthy that, when the multivariable linear regression was performed using these 
volunteers, lower limb muscle strength (i.e., sit-to-stand; 5%), lower limb muscle power (i.e., 
countermovement jump; 4%), and mobility (i.e., usual walking speed; 4%) explained the 
variations in TUG performance (Supplementary material Table SM 1), suggesting that the 
variables underlying TUG performance may be dependent of the time taken to perform the test. 
In fact, when compared to the analysis performed in the whole sample (Table 4), it 
is possible to observe a marked decrease in the collaboration of lower limb muscle strength 
(−12%), followed by an increase in the collaboration of lower limb muscle power (+3%) and 
mobility (+2%), in TUG performance. However, more data investigating and comparing 
populations with different levels of performance are still necessary for a better understanding. 
TUG scores have been widely used in the clinical setting as predictors of poor 
outcomes, screening tools to identify older adults at risk of reduced functionality, and, even, as 
sensitivity analysis to identify the effectiveness of therapeutic interventions (Benavent-Caballer 
et al., 2016). Our results have a great practical application because propitiate an additional 
understanding about the physical capabilities that explaining TUG performance, collaborating 
with the development of interventions focused on the variables. In this sense, is possible to 
suggest that older women with a TUG value ≤7.65 s may benefit from therapies composed 
exclusively — or with a high component — of resistance training (Häkkinen et al., 1998, 2001; 
Henwood et al., 2008; Kalapotharakos et al., 2004), leading to a significant increase in muscle 
strength. On the other hand, a larger number of physical stimuli should be offered to people 
with TUG values > 7.65 s, such as approached in multicomponent exercise programs (MCEP), 
propitiating improvements in more than one physical capability (Cadore and Izquierdo, 2015; 
Cadore et al., 2013; Coelho Junior et al., 2017a; Marzetti et al., 2017a). 
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Our study had several limitations. First, aging is strongly associated with the 
sarcopenic process, which, in turn, is a major determinant of functional impairment (Cruz-
Jentoft et al., 2010; Marzetti et al., 2017b). Although previous findings did not indicate an 
association between the cross-sectional area of rectus femoris and TUG performance 
(Benavent-Caballer et al., 2016), volunteers of the current study were not classified into 
sarcopenic and non-sarcopenic due to the lack of muscle mass evaluations. Second, in the 
experiment of Zarzeczny et al., (Zarzeczny et al., 2017) authors not only indicated that 6MWT 
and lower limb muscle strength were associated with the TUG performance, but — after 
fragmented TUG performance using the instrumented TUG (iTUG) analysis — they suggested 
that this phenomenon occurred due the association of these factors with the moment when the 
volunteer speeds up vertically to get up from the chair. Therefore, future studies must approach 
these limitations to a better understanding of the relation among TUG and physical capabilities 
in older women. 
Conclusions 
In conclusion, data of the current study indicate that the determinist thought 
regarding the physical capabilities associated with TUG performance is not totally correct since 
the contribution of physical capabilities to TUG performance is altered according to the time 
taken to perform the test. Indeed, older women who perform TUG at velocities ≤7.65 s use a 
high component of muscle strength, while other variables, such as aerobic capacity have only a 
small participation. On the other hand, when TUG is performed at velocities > 7.65 s the 
participation of muscle strength decreases, and a number of other physical capacities seem to 
be required. 
 
Supplementary data to this article can be found online at https:// 
doi.org/10.1016/j.exger.2018.01.025. 
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ARTICLE 10 
Cross-sectional Associations Between Physical Function and Frailty Status 
Across 4 Frailty Different Instruments 
 
Abstract 
Aims: The present study investigated the associations of frailty status using 4 different frailty 
instruments and physical performance tasks in community-dwelling older adults. Methods: 
One-hundred ninety-nine people participated of the present study. Frailty were identified using 
Fried frailty phenotype, FRAIL, SOF, and Gérontopôle Frailty Screening Tool (GFST). 
Physical performance tests included isometric handgrip strength (IHG), sit-to-stand test, timed 
“Up-and-Go” test, and one-leg stand. Results: No significant associations were observed when 
individuals were identified using FRAIL and SOF instruments. On the other hand, IHG 
(P<0.001 and P=0.004), TUG (P<0.0001), and one-leg stand (P=0.003 and P=0.004) 
performances were significantly associated with frailty status when participants were identified 
by Fried frailty phenotype and GFST indexes. Z scores identified that most frail participants 
identified by Fried frailty phenotype showed low IHG (Z score= 5.6) and one-leg stand 
performance (Z score= 3.3), while most frail participants identified by GFST showed low IHG 
(Z score= 2.2) and TUG (Z score= 7.0) scores. Conclusions: Our findings suggest that the 
relationship between physical function and frailty status in community-dwelling older adults is 
tool-dependent. A possible explanation for these findings is based on the fact that Fried frailty 
phenotype and GFST involve performance-based physical function tests, while FRAIL and 
SOF include self-reported assessments. Additionally, low IHG and one-leg stand performances 
were observed in most frail participants identified by Fried frailty phenotype, while most frail 
participants identified by GFST showed low IHG and TUG scores. 
 
Keywords: Elderly; Diet; Physical function; Disability; Sarcopenia 
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Introduction 
Frailty is a highly prevalent condition among older adults, and is defined as a state 
of increased vulnerability to negative health-related outcomes [1], which occurs as a result of 
multisystem physiological derangements and poor social support that impact the individual’s 
ability to maintain homeostasis after a stressor event [2–4]. Frailty progress increase the risk 
for many negative events, such as fractures, disability, hospitalization, nursing home placement, 
and death [5,6]. As such, frailty represents a major public health problem [1] and researchers 
have been looking for therapies to counteracting this condition. 
Nowadays, two main theorical models of frailty have been proposed: a) the 
phenotype model [7] and b) the cumulative deficit model or multidomain model [8]. The frailty 
phenotype [7] is the most utilized model for frailty diagnosis and many instruments [3,9] have 
been created in the last years in attempt to propitiate a deeper and faster analysis.  
Although most studies have found a similar association between different frailty 
indexes and many negative health-related outcomes, such as disability, hospitalization, and 
death [6,10,11], Lin et al.[12] observed differences among frailty indexes to predict disability 
and hospitalization in prefrail older adults, suggesting that frailty instruments may reflect 
different pathogenic bases. 
Physical function has a key role in frailty [13] and many researchers [13,14] have 
stressed that dynapenia, loss of muscle power and poor mobility may be considered substrate 
for frailty development and progression. Indeed, the phenotype model is alternatively called as 
physical frailty model, given that its characterization is based on changes on physical function 
[3]. 
Nevertheless, physical function is a construct that includes different physical 
capacities and abilities, so that it is possible to suggest that be frail does not mean have poor 
physical function in all domains. However, evidence regarding this topic are still scarce.   
Based on these premises, the present study investigated the association between 
frailty status and physical function in community-dwelling older adults using 4 different frailty 
instruments.  
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Materials and Methods 
The study approved by the Research Ethics Committee of the University of 
Campinas. All study procedures were conducted in compliance with the Declaration of Helsinki 
and the Resolution 196/96 of the National Health Council. All participants were thoroughly 
informed about the study procedures before providing written consent. 
 
Participants 
Participants were recruited by convenience in a community senior center located in 
Poá, Brazil. Poá is a city located in the southern area of São Paulo with a population of 
approximately 100 thousand people, being ~3460 older (60 year or over) [15]. The community 
senior center offers daily sessions of flexibility, aquatic and multicomponent physical exercises, 
dance classes, adapted sports, nursing and medical care, and cognitive stimulation therapy. 
Candidate participants were considered eligible if they were 60 or older, were community-
dwellers, and possessed sufficient physical and cognitive abilities to perform all of the 
measurements required by the protocol.  
 
Anthropometric measurements 
A weight scale with a stadiometer was used to measure body mass and height. The 
body mass index (BMI) was subsequently calculated as following: 
a) body mass (kg)/ height (m²).  
 
Frailty assessment  
-  Frailty phenotype 
The frailty phenotype was first described by Fried et al. [7]. The instrument 
incorporates measures of multiple physical domains, including weight loss, exhaustion, 
weakness, slowness, and sedentary behavior [16,17]. People are respectively identified as 
robust, prefrail and frail according to the presence of none, 1-2, and ≥3 of the following criteria: 
(1) unintentional weight loss of ≥5 kg in the prior year; (2) self-reported fatigue; (3) weakness, 
grip strength lower than 0.8 kg; (4) slowness, defined by Timed “Up-and-Go” (TUG) 
performance [18] equal or higher than 4.4 s; and (5) low physical activity levels according to 
the short form of the International Physical Activity Questionnaire (IPAQ) [19]. Gender- and 
BMI-specific cutoff points were used for grip strength and height-specific cutoff points were 
used for TUG based in the median values of our sample. Gender-specific cutoffs were used for 
physic activity levels [17]. 
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- FRAIL index  
FRAIL scale consists of 5 simple questions require a yes or no answer, with 1 point 
given to any affirmative response [20]. Instrument scores range from 0 to 5 points, and people 
are identified as robust (0 points), prefrail (1-2 points), and frail (≥3 points) according to the 
following criteria: (1) self-reported fatigue; (2) poor resistance, based on the inability to climb 
a flight of stairs; (3) limited ambulation, based on the inability to walk 1 block; (4) illnesses, 
presence of ≥ 5 illnesses; and (5) unintentional weight loss of ≥5% in the past 6 months. 
 
- SOF index 
SOF is derived from the Study of Osteoporotic Fractures [21]. The instrument is 
based on 3 criteria: (1) unintentional weight loss of ≥4.5 kg in the prior year; (2) self-reported 
exhaustion; (3) inability to rise from a chair 5 times without using arms. SOF scores range from 
0 to 3, and people are identified as robust, prefrail, and frail according to the presence of 0, 1, 
and 2-3 criteria.  
 
- Gérontopôle Frailty Screening Tool 
The Gérontopôle Frailty Screening Tool (GFST) is an 8-item questionnaire 
assessing individual’s social, physical, functional and cognitive situation. In the present study, 
only the first six self-reported questions were used to analysis given that the last two questions 
are dependent of general practitioner’s personal view. The GFST is based on the following 
criteria: (1) living alone; (2) unintentional weight loss in the prior 3 months; (3) self-reported 
fatigue in the last 3 months; (4) self-reported mobility difficulties in the last 3 months; (5) 
complains of memory problems; and (6) slowness, defined by a Timed “Up-and-Go” (TUG) 
performance equal or higher than 4.4 s. Once there is no clear cut-off point to classify the patient 
as frail or not [22], we proposed the following cutoffs for robust, prefrail and frail individuals, 
respectively, 0, 1-2, ≥3 components.   
 
- Functional Assessments 
All physical function tests were administered by two experienced exercise 
physiologists. One examiner was responsible for detailing the operational procedures, 
demonstrating the test before the assessment, quantifying performance and evaluating motor 
patterns. The other examiner ensured participant safety by providing occasional verbal and/or 
tactile cueing, if needed, without interfering with the physical function tests. After the 
explanation and before each test, participants performed a familiarization trial to ensure they 
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had fully understood each test. Except for the one-leg stance test, participants performed all 
tests twice with the best result used for analysis.  
 
- Isometric Handgrip Strength (IHG) 
IHG strength of the dominant hand was measured using a Jamar® handheld 
hydraulic dynamometer (Sammons Preston, Bolingbrook, IL, USA)[23]. To determine the 
dominant hand, participants were asked which of their hands was the strongest. The measure 
was obtained while the participant was seated on a chair with the shoulder abducted, the elbow 
near the trunk and flexed at 90°, and the wrist in a neutral position (thumbs up). The 
contralateral arm remained relaxed under the thigh. To measure handgrip strength, participants 
performed a maximal contraction during 4 s. The test reliability in the present study was ≥0.8 
(κ= 0.96). Results were recorded in kg. 
 
- Five Times Sit to Stand Test 
Participants rose from a chair five times as quick as possible with their arms folded 
across their chest. Timing began when the participant raised their buttocks off the chair and was 
stopped when the participant was seated at the end of the fifth stand [24]. The test reliability in 
the present study was ≥0.8 (κ= 0.97). 
 
- Timed-Up-and-Go Test (TUG) 
The TUG test involved getting up from a chair (total height: 87 cm; seat height: 45 
cm; width: 33 cm), walking three meters around a cone placed on the floor, coming back to the 
same position, and sitting back on the chair [25].  Participants wore regular footwear, placed 
their back against the chair, rested their arms on the chair's arms, and put their feet on the 
ground. A researcher instructed the participant to, on the word “go”, get up, walk three meters 
as fast as possible without compromising safety, turn, walk three meters back to the chair, and 
sit down. Timing began when the participant got up from the chair and was stopped when the 
participant’s back touched the backrest of the chair. The test reliability in the present study was 
of ≥0.8 (κ= 0.94). 
 
- One-Leg Stance Test 
The one-leg stance test was performed with the participant standing in a unipodal 
stance on the dominant lower limb, with the contralateral knee flexed at 90°, arms folded across 
the chest, and head held straight [26].  Timing began when the participant raised the non-
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dominant foot off the floor and was stopped when the foot touched the floor again. The 
maximum performance time was set at 30 s. 
 
- Statistical Analysis  
Continuous and categorical variables were compared among the three groups (i.e., 
robust, prefrail, and frail) via one-way analysis of variance (ANOVA) and chi-square (χ²) 
statistics, respectively. Bonferroni posthoc analyses were performed to determine whether there 
were significant differences between groups. χ² and Z-score were further used to explore the 
association between diet characteristics and frailty status across frailty instruments. Median 
values were chosen as the cutoff values for IHG (23 kg), sit-to-stand (13 s), TUG (6.7 s), and 
one leg stance (16 s) tests. For all tests, alpha was set at 5% (p <0.05) and Z-score was set at 
1.96. All analyses were conducted using the IBM SPSS Statistics, version 20.0, software (IBM 
Corp., Armonk, NY, USA). 
 
Results 
Clinical Characteristics 
One-hundred ninety-nine people participated of the present study. Table 1 shows 
clinical, sociodemographic, and physical function of study participants according to frailty 
status and frailty instruments. Frailty frequency was 26.1% using FRAIL index, 22.6% using 
SOF, 15.5% using Fried frailty phenotype, and 12.0% using GFST. There were no differences 
on clinical, sociodemographic and physical function among frailty status when participants 
were identified using FRAIL and SOF indexes. On the other hand, significant differences in 
age and physical function were observed using Fried and GFST. Frail participants identified by 
both Fried frailty phenotype and GFST were older and had poor physical function in all tests 
when compared to prefrail and robust individuals. In addition, prefrail older adults identified 
by Fried frailty phenotype had poorer performance on IHG/BMI and sit-to-stand tests in 
comparison to robust counterparts.  
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Table 1. Characteristics of the participants according to frailty status.
  FRAIL   Fried Frailty Phenotype   GFST   SOF 
Variables 
Robust 
(n=22) 
Prefrail  
(n=125) 
Frail  
(n=52) 
  
Robust 
(n=14) 
Prefrail 
(n=154) 
Frail 
(n=31) 
  
Robust 
(n=38) 
Prefrail 
(n=137) 
Frail 
(n=24) 
  
Robust 
(n=27) 
Prefrail 
(n=127) 
Frail 
(n=45) 
Characterist
ics                               
Age, years 
66.0 ± 4.5 68.8 ± 7.3 
67.6 ± 
6.4   65.1 ± 7.5 67.8 ± 6.1 
71.2 ± 
9.1ab   65.2 ± 3.8 67.8 ± 6.3 
75.1 ± 
9.0ab   68.6 ± 8.0 68.2 ± 6.9 
68.0 ± 
6.1 
Body weight, 
kg 
66.5 ± 
11.7 69.6 ± 12.7 
68.2 ± 
10.4   63.5 ± 9.2 69.9 ± 12.1 
66.4 ± 
12.4   
71.3 ± 
11.1 68.9 ± 11.7 
65.3 ± 
14.5   
68.8 ± 
12.2 69.7 ± 12.0 
66.7 ± 
12.0 
BMI, kg/m² 
28.1 ± 4.4 28.9 ± 5.3 
28.5 ± 
4.3   27.7 ± 3.6 28.9 ± 5.0 28.4 ± 5.5   28.6 ± 4.6 29.0 ± 4.9 27.5 ± 5.8   29.4 ± 5.2 29.0 ± 4.8 
27.5 ± 
5.1 
Sex, f (%) 
18 (9.0) 103 (81.7) 45 (86.5)   13 (6.5) 125 (62.8) 27 (13.6)   31 (81.6) 115 (83.9) 20 (80.0)   22 (81.5) 106 (83.5) 
38 
(82.6) 
Tabagism, n 
(%) 0 (0.0) 3 (2.4) 3 (5.8)   1 (7.1) 4 (2.6) 1 (3.2)   1 (2.6) 3 (2.2) 2 (8.0)   0 (0.0) 3 (2.4) 3 (6.5) 
                                
Race, n (%)                               
Asian 0 (0.0) 8 (4.0) 3 (1.5)   0 (0.0) 9 (4.5) 2 (1.0)   1 (5.0) 7 (3.5) 3 (1.5)   0 (0.0) 7 (3.5) 4 (2.0) 
Black 3 (1.5) 22 (11.0) 12 (6.0)   2 (1.0) 28 (14.1) 7 (3.5)   9 (4.5) 23 (11.5) 5 (2.5)   6 (3.0) 22 (11.0) 9 (4.5) 
Caucasian 
19 (9.5) 96 (48.0) 37 (18.5)   12 (6.0) 117 (58.8) 22 (11.1)   28 (14.0) 107 (53.5) 17 (8.5)   21 (10.5) 98 (49.0) 
33 
(16.5) 
                                
Physical 
function                               
IHG, kg 
25.6 ± 
14.2 24.1 ± 11.6 
21.9 ± 
8.8   
35.5 ± 
18.2 25.0 ± 9.2 
11.9 ± 
7.4ab   
28.8 ± 
12.1 24.2 ± 9.9 
12.7 ± 
10.7ab   22.6 ± 8.1 24.5 ± 12.8 
22.0 ± 
7.7 
Sit-to-stand, 
s 12.5 ± 2.4 14.8 ± 7.9 
13.6 ± 
3.5   11.5 ± 3.7 13.6 ± 5.4a 
19.4 ± 
10.9ab   13.4 ± 2.5 13.5 ± 5.7 
21.2 ± 
12.3ab   14.1 ± 5.8 14.4 ± 6.7 
13.9 ± 
7.0 
TUG, s 6.9 ± 2.3 16.2 ± 43.2 7.2 ± 2.0   8.1 ± 2.2 9.0 ± 19.7 
34.0 ± 
7.3ab   5.7 ± 0.6 8.6 ± 15.0 
46.9 ± 
85.0ab   
15.0 ± 
33.4 10.3 ± 22.6 
18.7 ± 
56.0 
One-leg 
stand, s 
18.5 ± 
10.4 16.5 ± 11.4 
15.3 ± 
10.2   
21.0 ± 
11.5 17.6 ± 10.4 
8.1 ± 
9.8ab   19.6 ± 9.6 17.3 ± 10.3 
7.2 ± 
10.4ab   15.0 ± 2.2 17.3 ± 10.7 
15.0 ± 
11.0 
BMI= Body mass index; GFST= Gérontopôle Frailty Screening Tool; IHG= Isometric handgrip strength; SOF= Study of Osteoporosis Fractures; TUG= 
Timed "Up-and-Go"; aP<0.05 vs Robust; bP<0.05 vs Prefrail. 
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The association between physical function and frailty status across the different 
frailty indexes are shown in Table 2. No significant associations were observed when 
individuals were identified using FRAIL and SOF instruments. On the other hand, IHG 
(P<0.001 and P=0.004), TUG (P<0.0001), and one-leg stand (P=0.003 and P=0.004) 
performances were significantly associated with frailty status when participants were identified 
by Fried frailty phenotype and GFST indexes. Z scores identified that most frail participants 
identified by Fried frailty phenotype showed low IHG (Z score= 5.6) and one-leg stand 
performance (Z score= 3.3), while most frail participants identified by GFST showed low IHG 
(Z score= 2.2) and TUG (Z score= 7.0) scores.  
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Table 2. Frequency (%) of the distribution of older adults according to frailty status. 
  FRAIL   Fried Frailty Phenotype   GFST   SOF 
Variables 
Robust 
(n=22) 
Prefrail  
(n=125) 
Frail  
(n=52) 
  
Robust 
(n=14) 
Prefrail 
(n=154) 
Frail 
(n=31) 
  
Robust 
(n=38) 
Prefrail 
(n=137) 
Frail 
(n=24) 
  
Robust 
(n=27) 
Prefrail 
(n=127) 
Frail 
(n=45) 
IHG, kg                               
<23 12 (6.0) 60 (30.2) 27 (13.6)   1 (5.0) 69 (34.7) 29 (14.6)   12 (6.0) 69 (34.7) 18 (9.0)   14 (7.0) 60 (30.2) 25 (12.6) 
≥23 10 (5.0) 65 (32.7) 25 (12.6)   13 (6.5) 85 (42.7) 2 (1.0)*   26 (13.1) 68 (34.2) 6 (3.0)*   13 (6.5) 67 (33.7) 20 (10.1) 
                                
Sit-to-stand, 
s 
        
                      
<13 11 (5.8) 39 (20.6) 20 (10.6)   8 (4.2) 53 (28.0) 9 (4.8)   14 (7.4) 51 (27.0) 5 (2.6)   11 (5.8) 40 (21.2) 19 (10.1) 
≥13 11 (5.8) 79 (41.8) 29 (15.3)   6 (3.2) 96 (50.8) 17 (9.0)   24 (12.7) 80 (42.3) 15 (7.9)   15 (7.9) 84 (44.4) 20 (10.6) 
                                
TUG, s                               
<6.7 20 (10.0) 106 (53.0) 49 (24.5)   12 (6.0) 145 (72.9) 17 (8.5)   38 (19.0) 126 (63.0) 11 (5.5)   20 (10.0) 115 (57.5) 40 (20.0) 
≥6.7 2 (1.0) 20 (10.0) 3 (1.5)   2 (1.0) 9 (4.5) 14 (7.0)*   0 (0.0) 11 (5.5) 14 (7.0)*   7 (3.5) 12 (6.0) 6 (3.0) 
                                
One-leg 
stand, s 
        
                      
<16 9 (4.5) 64 (32.0) 27 (13.5)   5 (2.5) 71 (35.7) 24 (12.1)   15 (7.5) 65 (32.5) 20 (10.0)   15 (7.5) 60 (30.0) 25 (12.5) 
≥16 13 (6.5) 62 (31.0) 25 (12.5)   
9 (4.5) 83 (41.7) 7 (3.5)*   23 (11.5) 137 (68.5) 
25 
(12.5)*   12 (6.0) 67 (33.5) 21 (10.5) 
BMI= Body mass index; GFST= Gérontopôle Frailty Screening Tool; IHG= Isometric handgrip strength; SOF= Study of Osteoporosis Fractures; TUG= 
Timed "Up-and-Go"; *P<0.05  
 
 
262 
 
 
Discussion 
The main findings of the present study indicate that the relationship between 
physical function and frailty status in community-dwelling older adults is tool-dependent. A 
possible explanation for these findings is based on the fact that Fried frailty phenotype [7] and 
GFST [22] involve performance-based physical function tests, while FRAIL [20] and SOF [21] 
include self-reported assessments.  
In fact, self-reported physical function may be more influenced by gender, cognitive 
function, pain, culture, language and education than performance based-assessments [27–29], 
leading to the suggestion that different physical constructs are captured by these tools [30]. 
These premises are supporting by empirical evidence that observed a weak to moderate 
correlation between self-reported and performance-based physical function assessments [27–
30].  
In this context, our results suggest that Fried frailty phenotype and GFST should be 
prioritize by health professionals responsible for older adults care that are looking for frailty 
instruments that may reflect current patient’s physical function, given that both tools offer a 
better comprehension of performance-based physical function in comparison to FRAIL and 
SOF.   
Additionally, we observed a significant correlation between physical function tests 
and frailty status. Particularly, low IHG and one-leg stand performances were observed in most 
frail participants identified by Fried frailty phenotype, while most frail participants identified 
by GFST showed low IHG and TUG scores. Although these results are at last partially expected, 
given that IHG is part of the criteria for frailty diagnosis [7] our findings expand this view to 
indicate that frail individuals identified by Fried frailty phenotype are also at increased risk for 
poor balance.  
This phenomenon likely occurs because these physical functions are controlled by 
similar neuromuscular mechanisms since age-related changes in sensory receptors and 
peripheral nerves, as well as decreased visual acuity and vestibular function affect both postural 
control and strength production [31].  
Regarding GFST, our findings are supported by prior studies that observed a 
significant association between TUG performance and balance, lower-limb muscle power, and 
lower- and upper-limb muscle strength in older adults [18,32,33]. According to Benavent-
Caballer et al. [32], TUG incorporates many functional tasks, such as sit-to-stand, walking, and 
turning. In this context, even if upper-limb muscle strength is not strictly necessary for TUG 
performance, Lauretanni et al. [34] found a significant correlation between IHG and mobility, 
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which might indicate that the existing relationship between TUG and IHG may reflect that frail 
older adults identified by GFST show limited physical function.  
These discoveries have high clinical applicability and collaborate to the creation of 
more specific therapies to counteract frailty in older adults. The practice of exericse training 
[35,36] and adequate protein consumption [37], for example, have been associated with low 
prevalence of frailty and high physical performance scores, and could be interesting alternatives 
to reverse frailty in the present sample.  
One may argue that frail participants identified by Fried frailty phenotype should 
also have low mobility, given that it is part of the criteria for frailty diagnosis [7]. However, 
mobility limitations in only one of the five criteria for frailty and it is possible that participants 
with low mobility did not meet other criteria.  
The present study has some limitations that should be acknowledged. Frist, the 
study population was relatively small and composed exclusively by community-dwellers, 
limiting inferences to older adults from other settings (i.e., nursing homes) and deeper statistical 
analysis. Second, both Fried frailty phenotype and GFST were adapted given that walking speed 
test was replaced by TUG. Third, the relationship between TUG and mobility seems to be age-
dependent and we cannot rule out the possibility that different associations could be observed 
in an older sample. Finally, the cross-sectional design of the study does not allow inference to 
be drawn on the time course of changes of the variables considered and on cause-effect 
relationships.  
 
Conclusions  
Our findings suggest that the relationship between physical function and frailty 
status in community-dwelling older adults is tool-dependent. A possible explanation for these 
findings is based on the fact that Fried frailty phenotype and GFST involve performance-based 
physical function tests, while FRAIL and SOF include self-reported assessments. Additionally, 
low IHG and one-leg stand performances were observed in most frail participants identified by 
Fried frailty phenotype, while most frail participants identified by GFST showed low IHG and 
TUG scores.  
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ARTICLE 11 
 
Frailty is not associated with hypertension, blood pressure or antihypertensive medication 
in community-dwelling older adults: A comparison using 4 frailty instruments 
 
Abstract 
Aims: The present study investigated the associations of frailty status using 4 different frailty 
instruments and a) office blood pressure, b) hypertension prevalence, c) antihypertensive 
treatment in community-dwelling older adults. Methods: One-hundred eighty older adults were 
recruited to take part of the present study. Frailty were identified using Fried frailty phenotype, 
FRAIL, SOF, and Gérontopôle Frailty Screening Tool (GFST). Office blood pressure was 
measured using an oscilometric blood pressure monitor. Information concerning hypertension 
diagnosis and antihypertensive therapy were obtained through self-report and careful review of 
medical charts. Results: No significant associations were observed between any hypertension-
associated parameter and frailty status. Conclusions: Findings of the present study indicate that 
hypertension, office blood pressure levels and antihypertensive medication were not associated 
with frailty status in community-dwelling older adults, regardless of the frailty index used to 
frailty identification. 
 
Keywords: Elderly; Cardiovascular disease; Physical function; Disability; Sarcopenia 
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Introduction 
Frailty is a highly prevalent condition among older adults, and is defined as a state 
of increased vulnerability to negative health-related outcomes1, which occurs as a result of 
multisystem physiological derangements and poor social support that impact the individual’s 
ability to maintain homeostasis after a stressor event2–4. Frailty progress increase the risk for 
many negative events, such as fractures, disability, hospitalization, nursing home placement, 
and death5,6. As such, frailty represents a major public health problem1.  
Hypertension is another great health concern for older adults. As frailty, 
hypertension is highly prevalent in older adults7 and represents a major risk factor for 
cardiovascular and cerebrovascular diseases7. Notably, many researchers have proposed a 
theorical model supporting that hypertension progression may predispose the development of 
frailty due to many different mechanisms8–12.  
Investigations in animal models of hypertension 13–15 and hypertensive patients 16,17 
have found that chronic elevations on blood pressure levels may affect cerebral blood flow. 
Although changes on cerebral integrity have been observed on areas responsible for autonomic 
control 14, researchers 16,18,19 have proposed that this phenomenon could also be observed in 
cerebral areas responsible for motor control and explain the relationship between hypertension 
and impaired physical performance observed in some studies 16,19,20.  
On the other hand, continuous use of angiotensin-converting enzyme (ACE) 
inhibitors seems to reduce muscle loss and physical function decline in older adults with and 
without disability21,22, suggesting that the antihypertensive therapy may delay frailty 
development and progression.  
Nevertheless, although a theorical bases supporting the relationship between 
hypertension and antihypertensive medication with frailty exists, results of empirical evidence 
are still uncertain, so that positive 8–12 and null8,9,23 associations have been observed. Notably, 
a recent systematic review and meta-analysis of observational studies did not find longitudinal 
or cross-sectional associations between hypertension and frailty status in adults24. 
Based on these premises, the present study investigated if hypertension, blood 
pressure, and antihypertensive therapy were significantly associated with frailty status in 
community-dwelling older adults. In addition, we tested the hypothesis that a similar 
association could be observed using different frailty instruments.  
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Materials and Methods 
The study approved by the Research Ethics Committee of the University of 
Campinas. All study procedures were conducted in compliance with the Declaration of Helsinki 
and the Resolution 196/96 of the National Health Council. All participants were thoroughly 
informed about the study procedures before providing written consent. 
 
Participants 
Participants were recruited by convenience in a community senior center located in 
Poá, Brazil. Poá is a city located in the southern area of São Paulo with a population of 
approximately 100 thousand people, being ~3460 older (60 year or over)25. The community 
senior center offers daily sessions of flexibility, aquatic and multicomponent physical exercises, 
dance classes, adapted sports, nursing and medical care, and cognitive stimulation therapy. 
Candidate participants were considered eligible if they were 60 or older, were community-
dwellers, and possessed sufficient physical and cognitive abilities to perform all of the 
measurements required by the protocol.  
 
Anthropometric measurements 
A weight scale with a stadiometer was used to measure body mass and height. The 
body mass index (BMI) was subsequently calculated as following: 
a) body mass (kg)/ height (m²).  
 
Frailty assessment  
- Frailty phenotype 
The frailty phenotype was first described by Fried et al.26. The instrument 
incorporates measures of multiple physical domains, including weight loss, exhaustion, 
weakness, slowness, and sedentary behavior27,28. People are respectively identified as robust, 
prefrail and frail according to the presence of none, 1-2, and ≥3 of the following criteria: (1) 
unintentional weight loss of ≥5 kg in the prior year; (2) self-reported fatigue; (3) weakness, grip 
strength lower than 0.8 kg; (4) slowness, defined by Timed “Up-and-Go” (TUG) performance29 
equal or higher than 4.4 s; and (5) low physical activity levels according to the short form of 
the International Physical Activity Questionnaire (IPAQ)30. Gender- and BMI-specific cutoff 
points were used for grip strength and height-specific cutoff points were used for TUG based 
in the median values of our sample. Gender-specific cutoffs were used for physic activity levels 
28. 
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- FRAIL index  
FRAIL scale consists of 5 simple questions require a yes or no answer, with 1 point 
given to any affirmative response 31. Instrument scores range from 0 to 5 points, and people are 
identified as robust (0 points), prefrail (1-2 points), and frail (≥3 points) according to the 
following criteria: (1) self-reported fatigue; (2) poor resistance, based on the inability to climb 
a flight of stairs; (3) limited ambulation, based on the inability to walk 1 block; (4) illnesses, 
presence of ≥ 5 illnesses; and (5) unintentional weight loss of ≥5% in the past 6 months. 
 
- SOF index 
SOF is derived from the Study of Osteoporotic Fractures 32. The instrument is based 
on 3 criteria: (1) unintentional weight loss of ≥4.5 kg in the prior year; (2) self-reported 
exhaustion; (3) inability to rise from a chair 5 times without using arms. SOF scores range from 
0 to 3, and people are identified as robust, prefrail, and frail according to the presence of 0, 1, 
and 2-3 criteria.  
 
- Gérontopôle Frailty Screening Tool 
The Gérontopôle Frailty Screening Tool (GFST) is an 8-item questionnaire 
assessing individual’s social, physical, functional and cognitive situation. In the present study, 
only the first six self-reported questions were used to analysis given that the last two questions 
are dependent of general practitioner’s personal view. The GFST is based on the following 
criteria: (1) living alone; (2) unintentional weight loss in the prior 3 months; (3) self-reported 
fatigue in the last 3 months; (4) self-reported mobility difficulties in the last 3 months; (5) 
complains of memory problems; and (6) slowness, defined by a Timed “Up-and-Go” (TUG) 
performance equal or higher than 4.4 s. Once there is no clear cut-off point to classify the patient 
as frail or not 33, we proposed the following cutoffs for robust, prefrail and frail individuals, 
respectively, 0, 1-2, ≥3 components.   
 
Hemodynamic parameters  
The procedures for measurement of blood pressure were adapted from the VII Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC7)34. For the evaluation, participants remained sitting on a comfortable chair for 
15 minutes in a quiet room. An appropriate cuff was selected after measuring the arm 
circumference of each participant (Sanny, São Paulo, Brazil) and was placed at approximately 
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the midpoint of the upper left arm (heart level). An automatic, noninvasive, and validated35 
arterial blood pressure monitor (Microlife-BP 3BT0A, Microlife, Widnau, Switzerland) was 
used to measure systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate 
(HR). During blood pressure recording, participants remained relaxed in the sitting position, 
with parallel feet at one shoulder width, both forearm and hands on the table, supinated hands, 
back against the chair, without move or talk. The evaluation lasted approximately 80 seconds 
and was performed three times with 1-min rest among the measurements. Mean values were 
used in the final analysis. The size of the arm cuff was selected after measuring the arm 
circumference of each participant (Sanny, São Paulo, Brazil). 
 
Disease conditions and pharmacological treatment 
Information pertaining to disease conditions was collected by two researchers 
through self-report and careful review of medical charts of the community senior center. 
Medical charts, which are updated every six months by a local physician, were reviewed to 
determine the prevalence of disease conditions.  
 
Statistical Analysis  
Continuous and categorical variables were compared among the three groups (i.e., 
robust, prefrail, and frail) via one-way analysis of variance (ANOVA) and chi-square (χ²) 
statistics, respectively. Bonferroni posthoc analyses were performed to determine whether there 
were significant differences between groups. χ² was used to explore the association between 
hemodynamic parameters and frailty status across the different frailty instruments. For all tests, 
alpha was set at 5% (p <0.05). All analyses were conducted using the IBM SPSS Statistics, 
version 20.0, software (IBM Corp., Armonk, NY, USA). 
 
Results 
Clinical Characteristics 
One-hundred eighty older adults were recruited to take part of the present study. 
Table 1 shows clinical and sociodemographic characteristics of study participants according to 
frailty status. Frailty frequency was 26.6% using FRAIL index, 20.5% using SOF, 10.0% using 
Fried frailty phenotype, and 7.2% using GFST. There were no differences on clinical, 
sociodemographic, and diseases prevalence among frailty status when participants were 
identified using FRAIL and SOF indexes. On the other hand, significant differences in the 
prevalence of diseases were observed using Fried frailty phenotype and GFST instruments, so 
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that prefrail older adults according to Fried frail phenotype and GFST showed a higher 
frequency of dyslipidemia and osteoporosis, and a higher frequency of diabetes mellitus and 
CVD using the GFST.  
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 Table 1. Characteristics of the participants according to frailty status. 
 
 
             
  FRAIL  Fried Frailty Phenotype  GFST  SOF 
Variables 
Robust 
(n=22) 
Prefrail  
(n=110) 
Frail  
(n=48) 
  
Robust 
(n=14) 
Prefrail 
(n=148) 
Frail 
(n=18) 
  
Robust 
(n=38) 
Prefrail 
(n=129) 
Frail 
(n=13) 
  
Robust 
(n=26) 
Prefrail 
(n=117) 
Frail 
(n=37) 
Characteristics                               
Age, years 
66.0 ± 4.5 68.8 ± 7.3 
67.6 ± 
6.4   65.1 ± 7.5 67.8 ± 7.1 
71.2 ± 
9.1   65.2 ± 3.8 67.8 ± 6.3 
75.1 ± 
9.0   68.6 ± 8.0 68.2 ± 6.9 
68.2 ± 
6.9 
Body weight, kg 
66.5 ± 
11.7 69.6 ± 12.7 
68.2 ± 
10.4   63.5 ± 9.2 69.9 ± 12.1 
66.4 ± 
12.4   
71.3 ± 
11.1 68.9 ± 11.7 
65.3 ± 
14.5   
68.8 ± 
12.2 69.7 ± 12.0 
66.7 ± 
12.0 
BMI, kg/m² 
28.1 ± 4.4 28.9 ± 5.3 
28.5 ± 
4.3   27.7 ± 3.6 28.9 ± 5.0 
28.4 ± 
5.5   28.6 ± 4.6 29.0 ± 4.9 
27.5 ± 
5.8   29.4 ± 5.2 29.0 ± 4.8 
27.5 ± 
5.1 
Sex, f (%) 18 (9.0) 103 (51.5) 45 (22.5)   13 (6.5) 125 (62.8) 27 (13.6)   31 (15.5) 115 (57.5) 20 (10.0)   22 (11.0) 106 (53.0) 38 (19.0) 
Tabagism, n (%) 0 (0.0) 3 (1.5) 3 (1.5)   1 (5.0) 4 (2.0) 1 (5.0)   1 (5.0) 3 (1.5) 2 (1.0)   0 (0.0) 3 (1.5) 3 (1.5) 
                                
Race, n (%)                               
Asian 0 (0.0) 8 (4.0) 3 (1.5)   0 (0.0) 9 (4.5) 2 (1.0)   1 (5.0) 7 (3.5) 3 (1.5)   0 (0.0) 7 (3.5) 4 (2.0) 
Black 3 (1.5) 22 (11.0) 12 (6.0)   2 (1.0) 28 (14.1) 7 (3.5)   9 (4.5) 23 (11.5) 5 (2.5)   6 (3.0) 22 (11.0) 9 (4.5) 
Caucasian 19 (9.5) 96 (48.0) 37 (18.5)   12 (6.0) 117 (58.8) 22 (11.1)   28 (14.0) 107 (53.5) 17 (8.5)   21 (10.5) 98 (49.0) 33 (16.5) 
                                
Comorbidities, n 
(%)                               
Dyslipidemia 4 (2.0) 17 (8.5) 11 (5.5)   4 (2.0) 17 (8.5) 10 (5.0)   7 (3.5) 16 (8.0) 9 (4.5)   7 (3.5) 20 (10.0) 5 (2.5) 
Osteoporosis 4 (2.0) 30 (15.0) 15 (7.5)   3 (1.5) 27 (13.6) 19 (9.5)   2 (1.0) 33 (16.5) 14 (7.0)   8 (4.0) 28 (14.0) 13 (6.5) 
Diabetes 
mellitus 2 (1.0) 34 (17.0) 18 (9.0)   5 (2.5) 39 (19.6) 10 (5.0)   9 (4.5) 33 (16.5) 12 (6.0)   6 (3.0) 35 (17.5) 13 (6.5) 
Cardiovascular 
disease 2 (1.0) 15 (7.5) 10 (5.0)   2 (1.0) 18 (9.0) 17 (3.5)   3 (1.5) 15 (7.5) 9 (4.5)   6 (3.0) 15 (7.5) 6 (3.0) 
BMI= Body mass index; GFST= Gérontopôle Frailty Screening Tool; SOF= Study of Osteoporosis Fractures; *P<0.05  
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Figure 1 shows SBP, DBP, and HR distribution according to frailty status across 
the different frailty indexes. No significant differences in hemodynamic parameters were 
observed among frailty status, regardless of the frailty index. 
 
Figure 1. Hemodynamic parameters according to frailty status across the different frailty indexes. SBP= 
Systolic blood pressure; DBP= Diastolic blood pressure; GFST= Gérontopôle Frailty Screening Tool; 
HR= Heart rate; SOF= Study of Osteoporosis Fractures.  
 
The association between hypertension, pharmacological therapy and frailty status 
across the different frailty indexes is shown in Table 2. No significant associations were 
observed between any hypertension-associated parameter and frailty status. 
 
276 
 
 
Table 2. Frequency (%) of the distribution of older adults according to frailty status. 
  FRAIL   Fried Frailty Phenotype   GFST   SOF 
Variables 
Robust 
(n=22) 
Prefrail  
(n=110) 
Frail  
(n=48) 
  
Robust 
(n=14) 
Prefrail 
(n=148) 
Frail 
(n=18) 
  
Robust 
(n=38) 
Prefrail 
(n=129) 
Frail 
(n=13) 
  
Robust 
(n=26) 
Prefrail 
(n=117) 
Frail 
(n=37) 
Hypertension                               
Yes 13 (6.5) 73 (36.5) 
31 
(15.5) 
  9 (4.5) 
90 (45.2) 17 (8.5)   25 (12.5) 74 (37.0) 18 (9.0)   
19 (9.5) 
71 (35.5) 
27 
(13.5) 
No 9 (4.5) 53 (26.5) 
21 
(10.5) 
  
5 (2.5) 64 (32.2) 14 (7.0)   13 (6.5) 63 (13.5) 7 (3.5)   8 (4.0) 56 (28.0) 19 (9.5) 
                                
β‐Blocker                               
Yes 3 (1.5) 26 (13.0) 9 (4.5)   3 (1.5) 29 (14.6) 6 (3.0)   8 (4.0) 22 (11.0) 8 (4.0)   6 (3.0) 23 (11.5) 9 (4.5) 
No 19 (9.5) 100 (50.0) 
43 
(21.5) 
  11 (5.5) 125 (62.8) 
25 
(12.6)   30 (15.0) 115 (57.5) 17 (8.5)   21 (10.5) 104 (52.0) 
37 
(18.5) 
                                
Diuretics                               
Yes 4 (2.0) 23 (11.5) 5 (2.5)   3 (1.5) 25 (12.6) 4 (2.0)   6 (3.0) 18 (9.0) 8 (4.0)   7 (3.5) 17 (8.5) 8 (4.0) 
No 18 (9.0) 103 (51.5) 
47 
(23.5) 
  
11 (5.5) 129 (64.8) 
27 
(13.6)   32 (16.0) 119 (59.5) 17 (8.5)   20 (10.0) 110 (55.0) 
38 
(19.0) 
                                
ACE inhibitors                               
Yes 3 (1.5) 8 (4.0) 4 (2.0)   1 (5.0) 13 (6.5) 1 (5.0)   3 (1.5) 9 (4.5) 3 (1.5)   3 (1.5) 11 (5.5) 1 (5.0) 
No 19 (9.5) 118 (59.0) 
48 
(24.0) 
  
13 (6.5) 141 (70.9) 
30 
(15.1)   35 (17.5) 128 (64.0) 
22 
(11.0)   24 (12.0) 116 (58.0) 
45 
(22.5) 
                                
Angiotensin II receptor 
antagonists 
        
                      
Yes 4 (2.0) 37 (18.5) 12 (6.0)   2 (1.0) 43 (21.6) 8 (4.0)   14 (7.0) 31 (15.5) 8 (4.0)   10 (5.0) 35 (17.5) 8 (4.0) 
No 18 (9.0) 89 (44.5) 
40 
(20.0) 
  
12 (6.0) 111 (55.8) 
23 
(11.6)   24 (12.0) 106 (53.0) 17 (8.5)   17 (8.5) 92 (46.0) 
38 
(19.0) 
                                
Calcium channel blocker                               
Yes 2 (1.0) 2 (1.0) 3 (1.5)   0 (0.0) 5 (2.5) 2 (1.0)   2 (1.0) 4 (2.0) 1 (5.0)   2 (1.0) 3 (1.5) 2 (1.0) 
No 20 (10.0) 124 (62.0) 
49 
(24.5) 
  14 (7.0) 149 (74.9) 
29 
(14.6)   36 (18.0) 133 (66.5) 
24 
(12.0)   25 (12.5) 124 (62.0) 
44 
(22.0) 
ACE= Angiotensin converting enzyme; BMI= Body mass index; GFST= Gérontopôle Frailty Screening Tool; SOF= Study of Osteoporosis Fractures; *P<0.05  
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Discussion 
An increasing number of studies have investigated the association between frailty 
and hypertension in the last years, but results are still uncertain. In the present study, we add 
knowledge to the current literature to suggest that hypertension, blood pressure levels and 
antihypertensive medication were not associated with frailty status in community-dwelling 
older adults, regardless of the frailty index used to frailty identification. 
Although some evidence suggests a significant association between hypertension 
and blood pressure levels with frailty8–12, a recent systematic review and meta-analysis of 
observational studies support our findings, given that no significant association was found 
between frailty and hypertension in adults24. 
Discrepancy in results among the studies may be explained by differences in age, 
time of diagnosis, controlled blood pressure levels, setting, lesions in physiological systems, 
type of blood pressure measurement, and sample size.  
Regarding age, frail participants of the present study had a mean age of 70.2 years, 
while a mean age ≥ 72.6 years was observed in most investigations in which frailty was 
significantly associated with hypertension and blood pressure8,9,12,36. 
As time goes by, hypertension progresses and blood pressure levels remain 
increasing continuously7. This phenomenon affects cerebral microcirculation by provokes 
cerebral microbleeds, white-matter damage, and vessel rarefaction, to quote a few, potentially 
reducing cerebral blood flow in areas responsible for mobility (e.g. motor cortex) 17,18, causing 
substantial impairments on physical performance37. Indeed, a prospective study using data from 
the Cardiovascular Health Study (CHS), observed that older adults (~72 years) with previous 
diagnosis of hypertension and uncontrolled blood pressure levels had faster progression on 
vascular brain abnormalities over the follow-up than those with controlled hypertension37.  
Besides that, results from preclinical models found that hypertension progression is 
accompanied by increase in inflammatory and oxidative markers in the brain 13,15 and blood-
brain barrier leakage14,15, which allows the interaction between many potentially harmful 
molecules with the brain parenchyma14,15.   
As a whole, this data might suggest that the association between frailty and 
hypertension can be dependent of the time of diagnosis and age, so that very old adults with a 
greater time since diagnosis may show structural and functional changes on brain areas and 
vessels responsible for body movement, consequently collaborating with frailty progression.    
Nevertheless, prior investigations observed that the relationship between frailty and 
cardiovascular abnormalities occurred in hypertensive outpatients11 in the light of impaired 
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function of organ systems (e.g., reduced glomerular filtration rate)10,38, while participants of the 
present study were community-dwelling older adults whose showed controlled blood pressure 
levels and lower prevalence of diseases in comparison with other studies11.  
Another potential explanation for our findings might be the time and type of blood 
pressure measurement used in the present study, since some authors proposed that frailty was 
significant associated with ambulatory blood pressure, but not office blood pressure8.  
However, any of the abovementioned confounding factors were controlled in the 
present study limiting the extrapolation of our findings and future studies targeting these 
limitations would be welcome.  
Finally, we tested the hypothesis that hypertension would be differently associated 
with frailty status across the frailty instruments. Even though most studies have found a similar 
association between different frailty indexes and cognitive function, falls, disability, fractures, 
hospitalization, and all-cause mortality [33–35], Lin et al.28 observed differences to predict 
disability and hospitalization among frailty indexes in prefrail older adults, suggesting that the 
pathogenic bases associated with frailty progress might be tool-dependent. In this context, 
understanding the association of hypertension and frailty according to each instrument may 
collaborate to a better patient’s view and management.   
It is worth mentioning that frailty instruments used in the present study are based 
on physical frailty and future studies should investigate other frailty concepts (e.g., cumulative 
deficit model)39, given that hypertension may be associated with cognitive decline40,41 
The present study has some limitations that should be acknowledged in addition to 
the lack of control of many confounding factors, such as a) our relatively small sample 
composed exclusively by community-dwellers, limiting inferences to older adults from other 
settings (e.g., nursing homes) and deeper statistical analysis, b) the adaptations performed in 
Fried frailty phenotype and GFST regarding walking speed test, c) and the cross-sectional 
design of the study, which does not allow inference to be drawn on the time course of changes 
of the variables considered and on cause-effect relationships.  
 
Conclusion 
Findings of the present study indicate that hypertension, office blood pressure levels 
and antihypertensive medication were not associated with frailty status in community-dwelling 
older adults, regardless of the frailty index used to frailty identification. 
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ARTICLE 12 
Effects of Low-Speed and High-Speed Resistance Training Programs on Frailty Status, 
Physical Performance, Cognitive Function, and Blood Pressure in Prefrail and Frail older 
adults 
 
INTRODUCTION 
Frailty is defined as a reversible state of increased vulnerability to adverse 
outcomes, including disability and mortality, which occurs separated and faster than a normal 
aging process in response to a multisystem impairment of the human body and social factors 
(1–4). Frailty is highly prevalent in older adults (2,4) with an incidence estimated as 43.4 new  
cases per 1000 person-years (5). In South America, a recent systematic review and metanalysis 
indicates an average frailty prevalence of 21.7% (Coelho-Junior et al., 2019; Article 2). As 
frailty progress, patients may present many negative health-related parameters, such as 
cardiovascular abnormalities, cognitive dysfunction, fractures, disability, hospitalization, 
nursing home placement, and death (6–10). As such, frailty represents a major public health 
problem (11).  
The pathophysiological bases of frailty are still not totally elucidated, and many 
possibilities have been proposed, including endocrine dysregulation (3,12), low-grade 
inflammation (13), myokines activity (14), to quote a few. Sarcopenia, a neuromuscular disease 
characterized by significant dynapenia, reduced muscle function, and muscle loss, has been 
proposed as a substrate for frailty development and the physiopathologic pathway through 
which the negative consequences of frailty succeed (15,16). These statements are based on the 
fact that the clinical presentation of sarcopenia and frailty present substantial overlap, mainly 
when frailty presentation is based on the physical domain (15,16).  
In this context, low-speed resistance training (LSRT), a type of exercise performed 
against a resistance with concentric muscle contractions performed at low-to-moderate velocity 
(17), has been recommended (18,19) as a first-line therapy to counteract sarcopenia-related 
parameters, given the numerous studies (20–23) that found improved muscle strength in 
response to LSRT protocols. However, there is still no consensus regarding the effects of LSRE 
on other frailty diagnosis criteria, as mobility (24).  
Mobility is one of the five cardinal points of frailty (25) and represents the 
individual’s ability to transfer from a place to another as comfortable as possible with a reduced 
risk of falls. Mobility impairments are a well-established risk factor for falls (26) and mortality 
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(27), as well as part of the clinical presentation of many diseases, such as stroke and 
Parkinson’s.  
Notably, many investigations in the early 2000’s began to suggest that muscle 
power, the capacity to exert force in a short time interval, was more associated with mobility 
tasks than muscle strength (28–30). These findings led researchers (31–35) to examine if high-
speed resistance training (HSRT) could cause greater improvements in mobility tasks than 
LSRT, and most studies have found superior effects of the former in robust community-
dwelling older adults (31,32,35,36) and mobility-limited older adults (33), but no studies were 
performed in frail patients. Systematic reviews and metanalyses (37,38) supported these results 
but indicated that data must be carefully extrapolated to the clinical, given that meaningless 
differences were found among RT protocols.  
Expert opinions (39–42) have encouraged the inclusion of HSRT on exercise 
programs for frail older adults. According to researchers, perform concentric muscle 
contractions as fast as possible would be crucial to improve mobility and restore independence.  
Nevertheless, empirical evidence investigating the impact of HSRT programs on 
frail people are scarce. In one of the few investigations, Cadore et al. (43) found increased 
physical function and reduced incidence of falls in institutionalized frail older adults who 
performed exercise programs with a muscle power component.  
Based on these premises, the current study investigated the effects of HSRT and 
LSRT on frailty status. Secondarily, we examined the effects of both RT programs on physical 
performance, cognitive function, and blood pressure, given its close association with frailty.   
 
MATERIALS AND METHODS 
Study design 
This is a three-arm randomized controlled trial that investigated the effects of two 
types of RT on frailty status, physical performance, cognitive function, and blood pressure of 
prefrail and frail older adults. Ethics approval was granted by the University of Campinas 
Human Research Ethics Committee (Protocol No. 835.733). All participants provided written 
informed consent prior to participating. All study procedures were conducted following the 
principles of the Declaration of Helsinki. Figure 1 shows the experimental design of the present 
study.  
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Figure 1. Experimental design of the present study. 
 
Participants  
Candidate participants were recruited from two different places. Prefrail volunteers 
(60-76 years) were recruited from the Center for Older Adults of the city of Poá, SP, Brazil. 
The study was advertised through posters placed in public sites (e.g., parks, city hall, public 
offices, bus stops, train stations) as well as via local radio and newspapers. People were also 
invited to participate by direct contact. Volunteers were on the waiting list to take part in one 
of the exercise groups offered by the Center for Older Adults and attended the center for primary 
health care (e.g., blood pressure measurement) and dancing classes.  
Frail volunteers (66-99 years) were recruited from the Lar Mãe Mariana Nursing 
Home, SP, Brazil. The nursing home is a philanthropic institution structured with male and 
female accommodations, kitchen, dining room, TV room, nursing unit, rehabilitation unit, and 
psychological stimulation room. Most residents arrive at the nursing home due to abandonment, 
maltreatment, and/or financial, cognitive and physical disabilities. Patients are accommodated 
in the rooms according to gender and health status. On an ordinary day, residents commonly 
wake up around 0700 am, are monitored by nurses, and attend to the rehabilitation unit 
according to their self-will, where physiotherapists offer analgesia, massages, and physical 
movements without load up to 45 minutes. In the evenings, older patients watch movies, 
perform artworks, are visited by people, and/or remain in the garden. Visits to theaters, cinemas, 
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parks, and other places occur at least once a month. Meals are offered 5 times per day and no 
specific nutritional recommendations (e.g., protein consumption) for older adults are followed.     
All candidate participants met the following inclusion criteria: a) aged 60 years or 
over; b) were prefrail or frail according to Fried’s criteria (25); c) performed the sit-to-stand 
test alone, with a mobility aid, or researcher's help; d) possessed sufficient physical and 
cognitive abilities to perform exercise sessions; and e) had a physician authorization to 
participate. Exclusion criteria included having participated in a structured physical exercise 
training program in the past six months, prescription of hormone replacement therapy and/or 
psychotropic drugs, and any unstable cardiovascular event (e.g., myocardial infarction) or 
complication in the past 6 months. 
The power of the sample size was determined using G*Power version 3.1.9.2 on 
the basis of the magnitude of the mean differences among the groups (i.e., for prefrail and after 
frail). Considering an effect size of 0.75 based on changes in muscle strength (44), a power of 
80%, a level of significance set at 5%, and a dropout of 16.9% (45), the sample size necessary 
was estimated to be of 66 volunteers.  
A computer-generated list of random numbers was used by an independent 
researcher to allocate participants into one of three experimental groups according to age, body 
mass index (BMI), and sit-to-stand performance: Low-speed resistance training (LSRT), High-
speed resistance training (HSRT), and control group (CG), before baseline evaluations. 
 
Clinical characteristics 
Clinical characteristics were measured at baseline for sample characterization. 
Body mass and height were measured using an analog weight scale with a Filizola® (Brazil) 
stadiometer. BMI was calculated according to the following formula:  
a) BMI= body mass (kg)/ height (m²);  
Information pertaining to disease conditions, medication, schooling, and time of 
institutionalization was collected through self-report and careful review of medical charts.  
 
Primary outcome  
- Frailty status (appendix 3) 
The frailty phenotype was first described by Fried et al. (25). The instrument 
incorporates measures of multiple physical domains, including weight loss, exhaustion, 
weakness, slowness, and sedentary behavior (46,47). People are respectively identified as 
robust, prefrail and frail according to the presence of none, 1-2, and ≥3 of the following criteria: 
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(1) unintentional weight loss of ≥5 kg in the prior year; (2) self-reported fatigue; (3) weakness, 
based on isometric handgrip strength (IHG); (4) slowness, based on walking speed (WS) 
performance; and (5) low physical activity levels according to the short form of the International 
Physical Activity Questionnaire (IPAQ) (47). Gender-specific and gender- and height-specific 
cutoff points based on the median values of older adults from Poá, São Paulo, Brazil (Coelho-
Junior et al., Article 16) were used for IHG and WS, respectively. Gender-specific cutoffs were 
used for physic activity levels (47). 
 
Secondary outcomes 
- Physical function 
Physical function tests were administered by experienced exercise physiologists 
and physiotherapists. One examiner was responsible for detailing the operational procedures, 
demonstrating the test before the assessment, quantifying performance and evaluating motor 
patterns. The other examiner ensured the participant’s safety by providing occasional verbal 
and/or tactile cueing if needed. Notably, most frail participants needed physical support for 
performing mobility tests, which was provided by the research team without interfering in the 
performance. After the explanation and before each test, prefrail participants performed a 
familiarization trial to ensure they had fully understood each test, while frail participants were 
requested to verbally explain the tests, to avoid fatigue. Except for the 6-min walking test 
(6MWT), participants performed all tests twice with the mean result used for analysis. Tests 
were administered in a sequential order with a 2-10-minute rest interval, as follows: 1) IHG, 2) 
muscle strength of knee extensors, hip flexors, and ankle extensors; 3) one-leg stand; 4) balance 
tests of the Short Physical Performance Battery (SPPB); 5) sit-to-stand; 6) Timed “Up and Go” 
(TUG); 7) WS at usual and fast paces; 8) 6MWT. 
  
- Isometric Handgrip Strength 
IHG of the dominant and nondominant hands was measured using a Jamar® 
handheld hydraulic dynamometer (Sammons Preston, Bolingbrook, IL, USA) (Figure 2) (49). 
The measure was obtained while the participant was seated on a chair with the shoulder 
abducted, the elbow near the trunk and flexed at 90°, and the wrist in a neutral position (thumbs 
up). The contralateral arm remained relaxed under the thigh. To measure IHG, participants 
performed a maximal contraction during 4 s. The test reliability in prefrail and frail participants 
was 0.97 and 0.98, respectively.  
289 
 
 
 
Figure 2. Frail participant performing IHG test. 
 
- Isometric muscle strength of knee extensors, hip flexors, and ankle extensors 
The isometric strength of knee extensors, hip flexors, and ankle extensors was 
measured using a handheld dynamometer (mTasF-1; ANIMA, Tokyo, Japão) (50). Before 
testing, participants remained seated with both hands on their thighs, and their knee and hip 
flexed at 90°. Muscle strength was assessed with the handheld placed: a) near the midpoint of 
the tibia, for knee extensors; b) near the midpoint of the femur, for hip flexors; and c) between 
the patella and the femur, for ankle extensors. Participants were requested to perform as much 
strength was possible to move their joints for 4 seconds. The test reliability in prefrail and frail 
participants was 1.0.  
 
Figure 3. Muscle strength of knee extensors (Figure 3a and 3b), hip flexors and ankle extensors (Figure 
3c).  
 
One-Leg Stand Test 
The one-leg stand test was performed with participants standing in a unipodal 
stance on the dominant and nondominant lower limbs, with the contralateral knee flexed at 90°, 
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arms folded across the chest or stretched over the body, and head held straight (51) (Figure 4). 
Timing began when participants raised one foot off the floor and was stopped when the foot 
touched the floor again. The maximum performance time was set at 30 s. The test reliability in 
prefrail and frail participants was 0.8.   
 
Figure 4. Frail participants performing the one-leg stand test. 
 
Balance tests of the SPPB 
Participants performed the hierarchical test of standing balance of the SPPB (52). 
Participants were asked to stand with their feet side by side, followed by the semitandem (heel 
of one foot alongside the big toe of the other foot) and tandem (heel of one foot directly in front 
of and touching the other foot) positions for 10 s each. The test reliability in prefrail and frail 
participants was 0.8. 
  
Sit-to-Stand Test 
Participants rose from a chair five times as quick as possible with at least one arm 
positioned on the waist, while the other arm remained folded across the chest or holding a 
researchers’ hand. Timing began when the participant raised their buttocks off the chair and 
was stopped when the participant was seated at the end of the fifth stand (Figure 5) (52). A 50-
Hz linear encoder (Peak Power, CEFISE, Brazil) was attached to the wrist of the arm that was 
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at the waist to obtain muscle power (w) and the velocity (m/s²) of concentric and eccentric 
contractions. The test reliability in prefrail and frail participants was 1.0 and 7.8, respectively.   
 
Figure 5. Frail participants performing the sit-to-stand test. 
 
Timed-Up-and-Go Test 
The TUG test involved getting up from a chair (total height: 87 cm; seat height: 
45cm; width: 33 cm), walking three meters around a cone placed on the floor, coming back to 
the same position, and sitting back on the chair (53). Participants wore regular footwear, placed 
their back against the chair, rested their arms on the chair's arms, and put their feet on the 
ground. A researcher instructed the participant to, on the word “go”, get up, walk three meters 
as fast as possible without compromising the safety, turn, walk three meters back to the chair, 
and sit down. Timing began when the participant got up from the chair and was stopped when 
the participant’s back touched the backrest of the chair. TUG was performed at usual and fast 
paces in the present study. The test reliability in prefrail and frail participants was 0.9. 
 
Timed-Up-and-Go Test with secondary tasks 
After performing the traditional TUG task, participants performed b) TUG 
combined with a verbal fluency task, naming as many animals as they could remember, (c) 
TUG with a motor task, carrying a full cup of water), and (d) TUG test with both cognitive and 
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motor tasks; i.e., performing the verbal fluency test while carrying a full cup of water (Figure 
6)(54). The test reliability in prefrail and frail participants was 0.98 and 0.94, respectively.  
 
Figure 6. Frail participants performing TUG with motor task. 
 
Walking Speed Tests 
WS was measured over four meters (Figure 7)(52). For the test, participants were 
required to walk six meters (including one-meter acceleration and one-meter deceleration) at 
their usual and fastest possible pace (without running). Before the evaluation, both feet of each 
participant were to remain on the starting line. Timing began when a foot reached the 1-meter 
line and was stopped when a foot reached the 4-meter line. The 1-meter intervals at the 
beginning and at the end of the course were used to avoid early acceleration and/or deceleration. 
The test reliability in prefrail and frail participants was 1.0. 
 
Figure 7. Prefrail participants performing WS test. 
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6-min walking test 
The 6MWT was performed according to the American Thoracic Society guidelines 
(55). The test was performed indoors on a 30-m track. In summary, after remaining seated for 
15 min, the volunteers were asked to walk on the track as fast as possible for six minutes. In the 
case that the volunteers experienced chest pain, intolerable dyspnea, leg cramps, stagger, 
diaphoresis, pale or ashen appearance, or any other complaint, the test was interrupted. The 
distance walked by the volunteers in meters was used in the analysis. 
 
Cognitive function 
- Mini-Mental State Examination (MMSE) (appendix 4) 
The participants’ cognitive function was assessed using the MMSE, which is a 
standard test in cognitive aging research to assess mental status with a possible score of 0–30. 
MMSE evaluates orientation, registration, and short-term recall, attention and concentration, 
language (naming, sentence writing, and comprehension), and visuospatial abilities. Individual 
items are summed to generate the total score. If individuals decline or are unable to attempt a 
task, the value of that particular item would be missing (56,57). 
 
- Clock Drawing Test (CDT) 
CDT involves draw the face of a large clock, place all the numbers inside the clock 
and place the pointers indicating 11:10 (eleven hours and ten minutes). No time limit was given 
to participants and they were allowed to draw as many watches as they wanted as long as only 
one of them was indicated for analysis. CDT was analyzed according to the method proposed 
by Shulman et al. (58). 
 
- Rey's Auditory Verbal Learning Test (RAVLT) (appendix 5) 
RAVLT is a neuropsychological tool used for testing episodic memory (59–62) and 
its scores have been strongly associated with the atrophy of medial temporal lobe structures 
(e.g., hippocampus) responsible for memory formation and maintenance after learning (61). In 
addition, RAVLT is useful to distinguish patients with and without dementia (59) and normative 
data according to gender and age have been provided to young, middle-aged and older adults 
(62,63) and patients with stroke, epilepsy, and neoplasm (60). The test consists of read-aloud 
two lists (A and B) of 15 substantives each (with a 1-s interval between each word). At the 
beginning of the test, list A was read five consecutive times by a researcher. Then, participants 
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were requested to recall as many words were possible after each trial (A1-A5). The list B, 
interference list, with new 15 substantives was read after A5 and words were retrieved (B1). 
Finally, participants were asked to recall the words from list A immediately after the 
interference list (A6, immediate recall) and after a delay of 20 minutes (A7, delayed recall), 
without listening to the list A again (63). Four summary scores were used to assess episodic 
memory, delayed memory, and susceptibility to interference (63):    
a)Verbal learning (VL) score= ƩA1-A5 – (5 * A1); 
b)Proactive interference (PI)= B1/A1; 
c)Retroactive interference (RI)= A6/A5; 
d)Forgetting speed (FS)= A7-A6; 
 
- Stroop test 
A computerized version of the Stroop test (TESTINPACSTM) was used to provide 
reaction time (ms) and the number of correct words in each stimulus (control, congruent, 
incongruent) (Figure 8)(64,65). To the test, participants remained seated in front of a 17-inch 
color monitor. The distance between the participant and the monitor was chosen according to 
the participants’ vision needs. Stroop was divided into three phases. In the first phase, control 
stimulus, the monitor exhibited a rectangle painted in green, yellow, blue, or red. Two possible 
responses, corresponding or not to the color of the rectangle, were exhibited at the lower corners 
of the monitor, and participants were requested to tell the color corresponding to the rectangle. 
The second phase was called congruent stimulus and consisted in stimulus (i.e., name of a color) 
and responses (i.e., name of two colors, one corresponding to the first color and the other not) 
exhibited as words in white. The correct answer was telling which colors match. The third 
phase, incongruent stimulus, is called Stroop effect and consisted of four colors exhibited is an 
incompatible color. The participants were requested to tell the color corresponding to the letters 
and inhibit the response for the identity of the disclosed word. A total of 36 stimuli (12 attempts 
each phase) were randomly provided and the time was registered in milliseconds. After the 
participants’ response, a researcher was responsible to immediately press the corresponding key 
(←  or →). This protocol was established after a pilot study in which we observed that 
participants of the present study took too long or were not able to return the hand to the initial 
position, if they had to take it off, even if the keyboard was composed only by two keys. 
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Figure 8. STROOP test: control, congruent and incongruent stimulus. 
 
Blood pressure and heart rate 
Blood pressure was measured accordingly to the VII Joint National Committee of 
High Blood Pressure (JNC7)(66). Pre- and post-intervention blood pressure values were based 
on the mean values measured in three consecutive visits in three different days. For blood 
pressure evaluation, participants remained seated in a comfortable chair in a room with artificial 
light. Blood pressure and heart rate were blindly measured in the left arm using automated 
oscillometric equipment (BP 3BT0A, Microlife AG, Widnau, Switzerland) (67). At the end of 
each measurement, the equipment provided systolic blood pressure (SBP), diastolic blood 
pressure (DBP), and heart rate (HR). 
 
Exercise interventions 
Exercise interventions were carried out over a total of 16 weeks in the mornings 
(08:00 am–12:00 am) under the supervision of at least two fitness instructors. The first four 
weeks were dedicated to participants' familiarization. In this period, participants performed four 
exercises for lower limbs (Figure 9): 1st) squat on the chair, 2nd) seated unilateral hip flexion, 
3rd) seated unilateral knee extension, and 4th) bilateral calf raise with 12–15 submaximal 
repetitions avoiding fatigue (i.e., inability to complete a repetition in a full range of motion). 
The number of sets was increased linearly during the first month, such that one set was 
performed in the 1st week, two sets in the 2nd week, 3 sets in the 3rd week, and 4 sets in the 4th 
week. Subsequently, participants performed the main exercise period. After a brief warm-up, 
participants performed the same exercises that were performed during the familiarization period 
using an adjustable weight vest and ankle weights (DOMYOS®, Shangai, China). The total 
volume (sets x repetitions x load) was equalized among the exercise sessions. However, LSRT 
and HSRT were designed according to the peculiarities of each type of resistance exercise 
(17,68). During LSRT, participants performed 4 sets of 8-10 repetitions at 70%-75% of 1-
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repetition maximum (1RM). The concentric and eccentric phases should be carried out for ~2.5-
s. For HSRT, exercises were performed 8 times (sets) with 3-5 repetitions at 70%-75% of 1RM. 
The concentric phase was performed as fast as possible and the eccentric phase was carried out 
for ~2.5-s. Bilateral calf raise was performed with the load of unilateral knee extension. A 
researcher was responsible for monitoring and ensuring that the velocity of muscle contraction 
was according to the protocol. Particularly, verbal encouragement was provided in the HSRT. 
 
Figure 9. Resistance exercises used in the present study. 1st) squat on the chair, 2nd) seated 
unilateral hip flexion, 3rd) seated unilateral knee extension, 4th) bilateral calf raise. 
 
Ten-repetition maximum test (10RM)  
10RM tests were performed prior, monthly, and at the end of the exercise programs 
in the following three exercises: squat on the chair (until 90° knee flexion), seated unilateral 
hip flexion, and seated unilateral knee extension. Before the tests, individuals performed a brief 
specific warm-up using light loads. Afterward, the 10RM load was determined up to 5 attempts, 
with a 3-minute interval between the attempts. The resistance was increased according to the 
capacity of the volunteer to perform more than one successful repetition maximum with the 
proper technique. The test was completed when participants were unable to perform more than 
10 repetitions using a proper technique (69). All trials were performed with participants using 
the full range of motion. Subsequently, the 1RM was calculated based on the following formula: 
b) 1RM= (10RM/ (1.0278 - [0.0278 × 10])) (70). 
 
Statistical Analysis 
Normality of data was ascertained using the Kolmogorov-Smirnov test. Data are 
presented as mean ± standard deviation (SD) or absolute numbers (percentages) for continuous 
and categorical variables, respectively. A group × time repeated-measures ANOVA followed 
by Bonferroni posthoc analyses were performed to determine whether there were significant 
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differences between groups. For all tests, the level of significance was set at 5% (p <0.05). All 
analyses were conducted using GraphPad Prism 6.0. (San Diego, CA). The intention-to-treat 
principle was applied to the analysis of the outcomes for all participants based on their assigned 
treatment, after excluding volunteers who had missed four or more exercise sessions in a 
recurrent and sequential manner according to the records. 
 
RESULTS 
The flowchart of the present study is shown in Fig. 10. One-hundred twenty-two 
older adults were recruited and evaluated for eligibility criteria. Of these, 37 were identified as 
robust and 7 could not attend exercise training in the mornings, leaving a total of 78 older adults, 
39 prefrail and 39 frails, who were randomized into the three groups (i.e., LSRT, HSRT, and 
CG). Adherence to exercise sessions was above 95% in both prefrail and frail groups. Five 
prefrail and eleven frail participants withdrew from the trial. In prefrail, 3 participants from the 
CG withdrew to start a programmed exercise program, while two, one from the HSRT and one 
from the LSRT, withdrew after two weeks because they were not randomized to the same 
exercise group. In frail, four participants withdrew due to personal reasons, two participants 
due to the 10RM test, one start to take psychotropic drugs, one could not attend for exercise 
sessions for two months due to substantial weight loss and complains of muscle fatigue, one 
had a stroke, one had urinary tract infection, and one died. 
Most participants complained of extraneous muscle fatigue during the 
familiarization period, but not in the main period. Two participants reported pain and one 
participant from the HSRT group reported epigastric discomfort and nausea during the 
performance of the squat on the chair exercise.   
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Figure 10. Flowchart of the present study. LSRT= Low-speed resistance training; HSRT= High-speed 
resistance training; CG= Control group. 
 
Clinical characteristics 
Table 1 shows the clinical characteristics of prefrail and frail participants according 
to group allocation. There were no significant differences between experimental and CG groups 
regarding the clinical characteristics of study participants. Frail participants were older and had 
a lower time of formal education in comparison to prefrail. The average BMI was within normal 
limits for both groups. Hypertension and type II diabetes were highly prevalent in prefrail and 
frail, while osteoarthritis, stroke, and Parkinson’s disease were most notorious in frail. There 
were significant differences in physical performance between exercise and CG in prefrail and 
frail. In prefrail, LSRT showed higher right and left muscle strength of knee extensors, right 
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hip flexor, and balance on one-leg stand test. In addition, CG showed higher TUG performance 
when compared to LSRT. In frail, LSRT showed higher right and left muscle strength of knee 
extensors in comparison with HSRT and CG, and lower TUG performance in comparison to 
HSRT. No differences in cognitive function or blood pressure were observed in any group.  
 
Table 1. Main characteristics of study participants. 
  Prefrail (n= 32) Frail (n= 28) 
  
LSRT (n= 
11) 
HSRT (n= 
11) 
CG (n= 
10) 
LSRT (n= 
8) 
HSRT (n= 
11) CG (n= 9) 
Variables             
Clinical Characteristics             
Age, years 65 ± 3.5   65 ± 3.5 75 ± 4.6 73 ± 7.5 75.0 ± 9.2 
Gender, female/male 9/2 11/0 11/0 6/2 6/5 6/3 
BMI, kg/m² 26.8 ± 5.7 24.5 ± 2.4 25.5 ± 3.3 25.3 ± 3.1 24.6 ± 3.5 25.7 ± 2.4 
Schooling, years 7 ± 2.9 4 ± 2.1 8 ± 2.1 2 ± 4.5 0 ± 3.5 0 ± 4.9 
Time of institutionalization, 
years — — — 2 ± 0.9 2.0 ± 3.1 2.0 ± 1.5 
              
Comorbidities, %             
Hypertension 72.7 36.6 100 87.5 63.6 44.4 
Osteoarthritis 27.2 27.2 36.3 25.0 36.3 66.6 
Stroke 0 0 0 12.5 9.0 11.1 
Diabetes 9.0 27.2 9.0 37.5 9.0 11.1 
Parkinson's disease 0 0 0 0 9.0 0 
              
Frailty phenotype, %             
Weakness 45.4 72.7 0 87.5 72.7 77.7 
Slow walking speed 18.1 45.4 20.0 87.5 81.8 66.6 
Unintentional weight loss 0 9.0 40.0 50 63.6 77.7 
Exhaustion 45.4 72.7 81.8 100 100 100 
Low activity level 0 9.0 20.0 100 100 100 
              
Physical performance             
Right IHG, kg 25.0 ± 4.0 21.9 ± 5.7 25.9 ± 3.2 6.2 ± 5.5 4.8 ± 6.4 
13.8 ± 
13.7ab 
Left IHG, kg 25.5 ± 6.1 21.3 ± 6.0 25.7 ± 3.6 8.5 ± 9.5 9.6 ± 9.3 
12.7 ± 
12.4ab 
Right knee extensor, kgf 17.3 ± 4.2 11.7 ± 2.3a 
10.1 
±1.9a 7.0 ± 1.9 7.1 ± 2.8 7.0 ± 5.7 
300 
 
 
Left knee extensor, kgf 14.8 ± 3.1 12.3 ± 3.4a 
10.3 ± 
2.3a 6.6 ± 2.0 6.1 ± 3.7 6.6 ± 5.0 
Right hip flexor, kgf 11.1 ± 3.2 8.2 ± 3.3a 8.6 ± 3.6a 6.0 ± 1.7 5.4 ± 2.2 4.7 ± 2.8 
Left hip flexor, kgf 10.1 ± 2.7 8.1 ± 2.8 8.3 ± 2.5 5.4 ± 1.1 5.1 ± 2.5 4.3 ± 2.5 
Right ankle extensor, kgf 6.8 ± 2.1 6.4 ± 1.8 5.8 ± 1.1 5.6 ± 1.5 4.3 ± 2.6 3.8 ± 2.3 
Left ankle extensor, kgf 7.1 ± 1.7 6.4 ± 1.8 6.4 ± 1.1 3.8 ± 2.8 4.4 ± 2.4 3.7 ± 2.6 
Right one-leg stand, s (30 s max) 19.4 ± 9.7 
10.9 ± 
11.6a 
12.5 ± 
12.0a 0.1 ± 0.3 0.1 ± 0.4 2.2 ± 3.1 
Left one-leg stand, s (30 s max) 16.4 ± 11.0 13.0 ± 12.2 
7.3 ± 
10.4a 0.0 ± 0.2 0.2 ± 0.4 2.3 ± 4.4 
Normal balance, s (10 s max) 10.0 ± 0.0 9.8 ± 0.6 10.0 ± 0.0 1.2 ± 3.5 1.8 ± 4.0 4.4 ± 5.2 
Semi tandem balance, s (10 s 
max) 10.0 ± 0.0 9.8 ± 0.6 10.0 ± 0.0 0.0 ± 0.0 1.0 ± 3.0 4.4 ± 5.2 
Tandem balance, s (10 s max) 10.0 ± 0.0 6.9 ± 0.6 10.0 ± 0.0 0.0 ± 0.0 0.8 ± 2.7 5.5 ± 5.2 
Sit-to-stand, s 8.4 ± 1.1 10.0 ± 2.3 8.0 ± 0.6 26.7 ± 11.6 26.2 ± 13.3 28.6 ± 10.9 
TUG at usual pace, s 8.0 ± 0.8 10.2 ± 2.7 6.2 ± 1.4a 
119.8 ± 
180.2 
20.8 ± 
27.3a 46.4 ± 36.3 
TUG at fast pace, s 6.5 ± 1.1 8.4 ± 2.5 5.6 ± 0.9 38.0 ± 46.3 
17.4 ± 
22.8a 28.5 ± 25.4 
TUG with verbal task, s 8.3 ± 1.0 10.7 ± 3.9 7.1 ± 1.2 
69.0 ± 
109.8 18.4 ± 24.1 37.5 ± 43.2 
TUG with motor task, s 8.7 ± 1.7 10.1 ± 2.1 8.0 ± 0.8 14.2 ± 13.0 7.1 ± 12.9 16.1 ± 20.7 
TUG with both verbal and motor 
tasks, s 8.3 ± 1.1 11.6 ± 3.2 10.9 ± 1.4 17.6 ± 19.7 8.3 ± 18.7 17.7 ± 23.2 
WS at usual pace, m/s 1.3 ± 0.3 1.2 ± 0.2 1.3 ± 0.3 0.41 ± 0.37 0.81 ± 0.99 0.51 ± 0.41 
WS at fast pace, m/s 1.8 ± 0.3 1.5 ± 0.3 1.9 ± 0.3 0.46 ± 0.41 0.66 ± 0.91 0.62 ± 0.50 
6MWT, m 480 ± 137 460 ± 151 589 ± 179 150 ± 174 100 ± 136 91.4 ± 107 
              
Cognitive function             
MMSE, points 24.3 ± 1.9 23.2 ± 1.8 23.4 ± 1.5 15.6 ± 4.5 13.8 ± 3.7 16.0 ± 2.0 
CDT, points 1.6 ± 0.8 1.6 ± 0.7 2.0 ± 0.7 5.5 ± 1.4 5.5 ± 1.3 4.4 ± 1.4 
              
Hemodynamic parameters             
SBP, mmHg 
130.4 ± 
14.9 
131.6 
±19.5 
137.8 ± 
13.5 
124.0 ± 
21.6 
114.3 ± 
17.0 
140.1 ± 
15.4 
DBP, mmHg 68.0 ± 23.0 72.0 ± 10.0 
79.8 ± 
11.8 81.9 ± 15.5 67.8 ± 9.4 79.2 ± 11.7 
HR, bpm 73.7 ± 11.6 73.7 ± 9.6 73.1 ± 4.2 65.9 ± 5.6 70.5 ± 12.2 86.7 ± 12.3 
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BMI= Body mass index; IHG= isometric handgrip strength; TUG= Timed "Up-and-Go"; 6MWT= 6-
min walking test; MMSE= Mini mental state examination; CDT= Clock Drawing Test; SPB= Systolic 
Blood Pressure; DBP= Diastolic Blood Pressure; HR= Heart Rate; LSRT= Low-Speed Resistance 
Training; HSRT= High-Speed Resistance Training; CG= Control Group; aP<0.05 vs LSRT; bP<0.05 
vs HSRT. 
 
Frailty Status 
The effects of RT on frailty status are shown in Figures 11 and 12. Both LSRT and 
HSRT reduced the prevalence of frailty criteria in prefrail and frail older adults. Six (54.5%) 
prefrail participants returned to robust condition after LSRT, while only two (18.1%) 
participants became robust after HSRT. RT improved weakness, slowness, and exhaustion in 
prefrail.  
 
 
Figure 11. The effects of RT on frailty criteria (a) and status (b) in prefrail older adults. LSRT= Low-
speed resistance training; HSRT= High-speed resistance training; CG= Control group. 
 
Regarding frail, ten participants, five in each intervention group (62.5%, 45.4%), 
returned to prefrail condition, and two participants (12.5%, 9.0%), one in each intervention 
group, returned to robust condition after LSRT and HSRT. RT improved weight loss, sedentary 
behavior, and exhaustion. 
 
Figure 12. The effects of RT on frailty criteria (a) and status (b) in frail older adults. LSRT= Low-speed 
resistance training; HSRT= High-speed resistance training; CG= Control group. 
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Physical function 
The effects of RT on physical function are shown in Figures 13 and 14. LSRT and 
HSRT caused different patterns of improvements in physical function in prefrail. LSRT 
improved muscle strength of the right knee extensors (P=0.01), right (P=0.01) and left 
(P=0.001) hip flexors, and right (P=0.001) and left (P=0.01) ankle extensors, while the right 
(P<0.001) and left (P=0.01) one-leg stand performances were significantly reduced. In contrast, 
TUG at fast pace (P=0.01), TUG associated with a verbal task (P=0.001), TUG associated with 
motor and verbal tasks (P<0.001), and tandem balance (P=0.01) were only improved after 
HSRT. Performance time (P<0.001), power (P=0.05, P<0.001), and the velocity of muscle 
contraction (P<0.001) in the sit-to-stand test, TUG at usual pace (P=0.01, P<0.001), and TUG 
associated with a motor task (P=0.01, P<0.001) were significantly improved in response to 
LSRT and HSRT. CG showed a significant increase in the time on the sit-to-stand (P<0.001) 
test. At the end of the protocol, higher TUG performance (P<0.001) and muscle strength of the 
right (P<0.001) and left knee extensors (P<0.001) were observed in exercise groups in 
comparison to CG, while only LSRT showed lower right and left one-leg stand performances 
(P<0.001) and higher muscle strength of the right (P=0.01) and left (P<0.01) hip flexors, and 
right (P<0.01) and left (P<0.01) ankle extensors in comparison to CG. Significant differences 
in TUG associated with motor task (P=0.01), TUG associated with motor and verbal tasks 
(P=0.01), and power (P=0.01) in the sit-to-stand test were found between LSRT and HSRT.   
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Figure 13. Effects of RT on physical performance in prefrail older adults. LSRT= Low-speed resistance 
training; HSRT= High-speed resistance training; CG= Control group. 6MWT= 6-minute walking test; 
IHG= Isometric handgrip strength; TUG= Timed “Up and Go”; WS= Walking speed; aP<0.05 vs Pre-
intervention; bP<0.05 vs LSRT; cP<0.05 vs HSRT. 
 
 
RT caused fewer improvements in frail in comparison to prefrail. Power (P<0.01) 
in the sit-to-stand test, muscle strength of the left knee extensors (P=0.01) and right (P=0.001) 
left (P=0.001) hip flexors were both improved after LSRT and HSRT. Particularly, exclusive 
improvements in TUG associated with a motor task (P=0.01), TUG associated with motor and 
verbal tasks (P=0.01), and time in the sit-to-stand test (P=0.01) were found in LSRT, while only 
HSRT improved muscle strength of the left ankle extensors (P=0.001) and the velocity of the 
muscle concentric contraction in the sit-to-stand test (P=0.01). Exercise groups showed higher 
performance (P=0.001) and power (P=0.001) in the sit-to-stand tests in comparison to CG. 
There were no significant differences among exercise groups.  
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Figure 14. Effects of RT on physical performance in frail older adults. LSRT= Low-speed resistance 
training; HSRT= High-speed resistance training; CG= Control group. 6MWT= 6-minute walking test; 
IHG= Isometric handgrip strength; TUG= Timed “Up and Go”; WS= Walking speed; aP<0.05 vs Pre-
intervention; bP<0.05 vs LSRT; cP<0.05 vs HSRT. 
 
Fourteen participants, six in the HSRT, four in the LSRT, and four in the CG, 
performed the sit-to-stand test with mobility aids or researchers’ help at baseline. On the other 
hand, four participants in the LSRT and three in the HSRT no longer needed help after exercise 
protocols.  
 
Cognitive parameters 
The effects of RT on cognitive parameters are shown in Figures 15-22. There were 
no within- and between-group differences on MEEM, CDT, and STROOP. On the other hand, 
higher verbal learning was observed after both LSRT and HSRT when compared to CG. 
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Figure 15. Effects of RT on cognitive parameters in prefrail older adults. LSRT= Low-speed resistance 
training; HSRT= High-speed resistance training; CG= Control group; MMSE= Mini-mental state 
examination; bP<0.05 vs LSRT; cP<0.05 vs HSRT.  
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Figure 16. Effects of RT on RAVLT performance in prefrail older adults. LSRT= Low-speed resistance 
training; HSRT= High-speed resistance training; CG= Control group. 
 
 
Figure 17. Effects of RT on Clock Drawing Tests (CDT) performance in prefrail older adults. LSRT= 
Low-speed resistance training; HSRT= High-speed resistance training; CG= Control group.  
P
re
-A
1
P
re
-A
2
P
re
-A
3
P
re
-A
4
P
re
-A
5
P
os
t-A
1
P
os
t-A
2
P
os
t-A
3
P
os
t-A
4
P
os
t-A
5
0
5
10
15
LSRT
HSRT
CG
L
e
a
rn
in
g
Pre-intervention Post-intervention
0.0
0.5
1.0
1.5
2.0
2.5
LSRT
HSRT
CG
C
D
T
 (
p
o
in
ts
)
313 
 
 
 
Figure 18. Examples of CDT tests in prefrail participants. In frail, no significant within- and between-
group differences were observed on MEEM and STROOP performances. However, RAVLT 
performance (P=0.01) was significantly improved after HSRT.  
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Figure 19. Effects of RT on cognitive parameters in frail older adults. LSRT= Low-speed resistance 
training; HSRT= High-speed resistance training; CG= Control group; MMSE= Mini-mental state 
examination.  
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Figure 20. Effects of RT on RAVLT performance in frail older adults. LSRT= Low-speed resistance 
training; HSRT= High-speed resistance training; CG= Control group. 
 
 
Figure 21. Effects of RT on Clock Drawing Tests (CDT) performance in frail older adults. LSRT= Low-
speed resistance training; HSRT= High-speed resistance training; CG= Control group.  
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Figure 22. Examples of CDT tests in frail participants. 
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Blood pressure and heart rate 
The effects of RT on blood pressure and heart rate are shown in Figure 23. There 
were no within- and between-group differences on blood pressure and heart rate in response to 
any intervention in prefrail and frail.  
 
Figure 23. Effects of RT on blood pressure in prefrail (a, b, c) and frail (d, e, f) older adults. LSRT= 
Low-speed resistance training; HSRT= High-speed resistance training; CG= Control group; SBP= 
Systolic blood pressure; DBP= Diastolic blood pressure; HR= Heart rate.  
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DISCUSSION 
The main findings of the present study (Table 2) indicate that RT reversed frailty 
status and improved physical function in prefrail and frail older adults. Nevertheless, different 
improvements were observed among the groups in response to LSRT and HSRT. In addition, 
prefrail older adults showed higher RAVLT performance after both RT protocols in comparison 
to CG. Finally, no changes in blood pressure and heart rate were observed in any group.  
 
Table X. Effects of RT on frailty status, physical performance, cognitive function, and blood pressure and 
heart rate of prefrail and frail people.  
  Prefrail Frail 
Variable LSRT HSRT CG LSRT HSRT CG 
Frailty status             
Weakness ↑ ↔ ↔ ↑ ↔ ↔ 
Slow walking speed ↑ ↑ ↔ ↔ ↔ ↔ 
Unintentional weight loss ↔ ↔ ↔ ↑ ↑ ↔ 
Exhaustion ↑ ↑ ↔ ↑ ↑ ↔ 
Low activity level ↔ ↔ ↔ ↑ ↑ ↔ 
              
Physical performance             
Upper-limb muscle strength ↔ ↔ ↔ ↔ ↔ ↔ 
Lower-limb muscle strength  ↑↑ ↑ ↔ ↑↑ ↑ ↔ 
Lower-limb muscle power ↑↑ ↑ ↔ ↑ ↑ ↔ 
Mobility ↑ ↑↑ ↔ ↔ ↔ ↔ 
Dual-task ↑ ↑↑ ↔ ↑ ↑ ↔ 
Balance ↓ ↑ ↔ ↔ ↔ ↔ 
              
Cognitive function             
Overaal ↔ ↔ ↔ ↔ ↔ ↔ 
RAVLT ↑ ↑ ↔ ↔ ↔ ↔ 
STROOP ↔ ↔ ↔ ↔ ↔ ↔ 
              
Hemodynamic parameters             
SBP ↔ ↔ ↔ ↔ ↔ ↔ 
DBP ↔ ↔ ↔ ↔ ↔ ↔ 
HR ↔ ↔ ↔ ↔ ↔ ↔ 
LSRT= Low-speed resistance training; HSRT= High-speed resistance training; CG= Control group; SBP= Systolic 
blood pressure; DBP= Diastolic blood pressure; HR= Heart rate; ↑= Improved vs Pre-intervention; ↑↑= Improved vs 
Pre-intervention and CG and/or experimental group; ↓= Reduced;  ↔= Unchanged. 
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Effects of RT on frailty status 
RT reversed frailty status in both prefrail and frail older adults. In prefrail, 54.5% 
of prefrail participants returned to robust condition after LSRT, while 18.1% became robust 
after HSRT. Changes in frailty status occurred in response to improvements in weakness, 
slowness, and self-reported exhaustion. Similar findings were observed in frail, given that 
LSRT reversed frail to prefrail in 62.5% of the cases and to robust in 12.5%, while 45.4% 
became prefrail and 9.0% robust after HSRT. However, frailty reversion occurred based on 
changes in weight loss, sedentary behavior and exhaustion complaints. 
Our findings are supporting by prior investigations that observed that exercise 
training could reverse frail status in prefrail and frail older adults (71–77). However, most 
studies combined RT with other types of exercise or other health interventions (75), limiting 
inferences regarding the impact of RT alone on frailty status (78). 
This information seems to be important since some studies have reported low 
adherence to multicomponent exercise training programs, mainly in institutionalized frail older 
adults (74,76), which might occur due to the fact the frail patients cannot support very-long 
exercise sessions (79). In addition, aerobic and gait exercises are not feasible and probably hard 
to prescribe in frail nursing home residents due to the high prevalence of mobility limitations 
and the need for help to transfer from a place to another found in this population (80).   
On the other hand, RT programs may be fully performed with individuals sitting in 
bed or in a chair without the need for transferring or walking, prioritizing some muscle groups, 
using body weight, free weights or elastic bands (17,24).  
Most studies investigating RT have focused on frailty components and only a small 
number of evidence reported its effects on frailty status (71,81). In one of the few studies 
addressing this topic, Giné-Garriga et al. (71) found that a 12-week RT program composed by 
exercises that mimic activities of daily living (ADL) performed at moderate-to-high intensity 
reversed frailty in community-dwelling older adults. However, although these findings brought 
promising perspectives for the management of frailty by RT, the lack of important information 
about the RT protocol (e.g., familiarization, cadence) and the inclusion of balance training 
restrict its clinical reproducibility.       
Our findings have high clinical applicability by demonstrating that 16-week lower-
limb LSRT and HSRT programs considerably reversed frailty status in prefrail and frail older 
adults, possibly reducing the risk of negative health outcomes in these people (6–10). 
Notably, improvements in frailty criteria in response to RT occurred according to 
frailty status, so that weakness, slowness, and exhaustion were increased in prefrail, and weight 
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loss, sedentary behavior, and exhaustion were improved in frail. Although surprising, similar 
results were found in the LIFE-P study (72), in which frailty reversion in frail people by exercise 
training was not associated with improvements on slowness and weakness, but physical activity 
levels.  
A possible explanation for these findings is based on the direct and indirect effects 
of RT on frailty components. As prefrail individuals show more preserved physical function in 
comparison to frail counterparts, improvements on weakness (IHG) and slowness (WS) are 
easier to reach the threshold for detecting frailty. In contrast, some frail participants of the 
present study showed IHG scores next to zero and the time taken to perform WS higher than 
sixty seconds.  
In this context, improvements in physical function may have reduced perceived 
fatigue (82), motivating frail patients to increase physical activity levels. Regarding weight loss, 
muscle hypertrophy is a well-established product of RT (83,84) and it is possible to suggest that 
our exercise programs reduced weight loss by modulating muscle mass.  
 
Effects of RT on the physical function of prefrail and frail older adults 
- Effects of RT on muscle strength and power of prefrail and frail older adults 
In the present study, we observed that LSRT and HSRT improved lower-limb 
muscle strength (i.e., knee extensors, hip flexors, ankle extensors) and power (i.e., time and 
power in the sit-to-stand) in prefrail and frail older adults. Nevertheless, greater improvements 
were observed in LSRT when compared to HSRT and CG.  
These findings are in concordance with previous original articles (22,73,85–87) and 
systematic reviews (81) that found improved physical function in prefrail and frail older adults 
after LSRT (73,85,86) and HSRT (85,87,88) programs. However, just a few studies compared 
the effects of LSRT and HSRT in prefrail and, for the best of our knowledge, there are no 
investigations in frail people.  
In contrast to the present study, Zech et al. (86) and Drey et al. (85) observed that 
12 weeks of LSRT and HSRT similarly improved SPPB performance and had no effect on 
lower-limb muscle power in prefrail community-dwelling older adults. It is likely that these 
results are based on the fact that exercise intensity was controlled based on the rating of 
perceived exertion (RPE) method and physical exercises were performed in a Bodyspider 
machine, in which individuals had to perform single-leg exercises, likely leading to inadequate 
perceptions of exertion due to instability. This view was reinforced by Lopez et al. (89), who 
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proposed that frail people may show a reduced capacity to exercising based on effort perception, 
affecting exercise prescription, resulting in limited gains.  
Several mechanisms may potentially explain why LSRT elicited greater 
improvements in lower limb muscle strength and power in comparison to HSRT, including the 
time under tension (TUT), range of motion (ROM), the prevalence of comorbidities, and 
cognitive status.  
TUT refers to the time spent performing muscular contractions (90). Results from 
a systematic review and meta-analysis suggested that TUT has a strong effect on strength gains 
by healthy older adults in response to RT (83), with large effects being observed for muscular 
contractions that lasted on average 6 s (83). These premises are supported by original 
investigations that found larger hypertrophy (91–93) and greater isometric muscle strength (91) 
after RT performed with slow movements (~7 s) in comparison to very-speed RT (~2 s) (92,93). 
According to the size principle of Henneman et al. (94), motoneuron and motor 
units (MU) are recruited from smallest to largest. In the light of RT, this means that type II 
muscle fibers, those more associated with force generation and muscle hypertrophy (95), are 
primarily recruited in response to the exercise intensity and the velocity of muscle contractions 
(96). However, some designs of RT performed at low-to-moderate intensity may reduce the 
supply of oxygen and metabolic substrates to the muscle (91), leading to the accumulation of 
products of cellular metabolism, including lactate, H+, inorganic phosphate (Pi), and ADP 
(92,93), reducing force development, and stimulating progressive recruitment of additional MU 
(97).  
In this context, the long total contraction time performed by LSRT (~5 s vs ~3 s in 
HSRT) may have caused greater improvements on muscle strength by creating a more 
challenging environment, inducing the recruitment of large MU and type II muscle fibers, 
resulting in superior neuromuscular adaptations.  
Alternatively, TUT has been associated with increased myofibrillar protein 
synthesis and phosphorylation of anabolic signaling proteins (i.e., p70S6K, 4EBP1, and 
p90RSK) (98), likely inducing muscle hypertrophy (99). However, skeletal muscle mass was 
not measured in the present study.  
In relation to the higher muscle power observed in LSRT, force plays a key role in 
power production (96,100), so that improvements on muscle strength serve as the main driver 
for the ability to express high power outputs (100).  
Another possible explanation for the inferior improvements in muscle strength and 
power found after HSRT is based on the range of motion (ROM), given many frail participants 
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used wheelchairs and showed a clinical diagnosis of lower limb osteoarthritis. Indeed, the 
length-tension curve relationship states that exercises performed at optimal muscle length 
evokes greater myosin and actin interaction, and so strength (101). On the other hand, exercises 
performed at partial ROM commonly produce less neuromuscular adaptations, which are 
restricted to the specific ROM in which the trained occurred (102). 
Considering that sit-to-stand performance involves the total extension of the knee 
and hip joints, older adults with joint limitations may not have exercised in the full ROM and 
completely improved their muscle strength and power. Sit-to-stand performance may also has 
been influenced by the prevalence and severity of comorbidities such as femoral fracture and 
stroke, given that participants’ performance in these conditions is practically based on one leg. 
According to Cadore and Izquierdo (39), the prescription of HSRT in older adults 
with disabilities should take into consideration other factors than the variables of RT, such as 
emotional aspects of the patient, physical and emotional environment, and the structure of the 
instructions. Regarding the latter, further attention from HSRT participants is needed to keep 
high the velocity of concentric muscle contractions and researchers have recommended 
avoiding complex oral instructions (39). 
Although participants of the present study were cognitively able to understand 
exercise and testing instructions, HSRT sessions were closely monitored, and our HSRT 
protocol was composed by a few repetitions in an attempt to maintain participants’ 
concentration, the possibility that HSRT was not performed with the maximal power output 
cannot be ruled out.  
 
- Effects of RT on mobility, dual-task performance, and balance in prefrail and frail older adults 
The main motivation for the prescription of HSRT to older adults is based on the 
fact that this type of RT could elicit greater improvements in mobility when compared to LSRT 
(24,39,40,42,103). These assumptions are supported by the observation that lower limb muscle 
power was significantly associated with physical and mobility tests, such as SPPB (30,104), 
gait speed (30,104), chair rise time (29), stair climb time (29,30,104), and various domains of 
disability (28,105) in health and mobility-limited older adults; and that, when compared to 
muscle strength, muscle power may be a better predictor of general mobility (28–30).  
Researchers have also considered the coupling body of evidence that directly 
compared the effects of HSRT and LSRT on functional capacity. Bean et al. (33) reported 
similar improvements in SPPB in older adults after non-equalized 16-week LSRT and HSRT 
programs. Nevertheless, the superior effects of HSRT were observed when participants were 
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categorized according to baseline mobility limitations (33). Miszko et al. (31), Botataro et al. 
(106), and Ramírez-Campillo et al. (34) found that HSRT program caused greater 
improvements in physical performance tests comparison with LSRT, while Lopes et al. (35) 
observed exclusive improvements in sit-to-stand and TUG performances after HSRT.  
Although systematic review and metanalyses (37,38) support the abovementioned 
data, authors found a wide confidence interval among studies, which indicate that the effects of 
both LSRT and HSRT are still compatible with a clinically non-relevant difference. In addition, 
most studies were based on physically healthy older adults, short-term RT protocols, and 
expensive exercise machines, limiting extrapolations for prefrail and frail older adults.  
In this context, findings of the present study are unique and add to the current 
knowledge by indicating that HSRT is more effective to improve TUG performance in 
comparison to LSRT in prefrail older adults. A question that remains from these findings, then, 
is “how HSRT produced greater improvements in TUG performance than LSRT in the absence 
of superior improvements in muscle strength and power?”  
A likely explanation is that muscle power was improved in other muscle actions 
than those assessed in the present study. TUG involves the interaction among several body 
movements, including sit-to-stand transition, walking, turn and stand-to-sit transition (107). 
Besides muscle power and strength of the knee and hip extensors to sit-to-stand (108), TUG 
performance might require muscle power of the ankle flexors and extensors to stride velocity 
(29) and fast response to perturbations to turn (109).  
Despite the significant similar improvements in muscle power, mobility remained 
unchanged in frail participants after LSRT and HSRT. These results should be interpreted 
cautiously, given that most participants of the current study needed researchers’ help or were 
not able to perform mobility tests at baseline, causing a wide variability in the results. Indeed, 
although no significant within-group differences were observed in WS and TUG, seven 
participants became independent in the performance of mobility tests after RT protocols. This 
phenomenon might also have influenced frailty status and indicates that long-term RT protocols 
seem to be necessary to reverse physical dysfunction in institutionalized frail older adults.     
Notably, improvements in muscle power may also account for the observed 
differences in balance in prefrail (30). However, it is worth mentioning that all participants in 
the LSRT and CG achieved the highest performance in normal and tandem tests in both pre- 
and post-intervention periods, while one participant in the HSRT could not perform the test for 
10 s at baseline and showed improvements in response to RT. In fact, one-leg stand performance 
supports the hypothesis that any exercise protocol was effective to improve balance.       
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Another important finding is that prefrail HSRT participants showed better 
performance on TUG with verbal, motor, and both tasks in comparison to those in the LSRT, 
while LSRT was most effective to increase dual-task performance in frail. These results suggest 
that the effects of RT on dual-task performance are dependent on frail status.   
 
Effects of RT on cognitive function, blood pressure and heart rate of prefrail and frail older 
adults 
Although a number of studies have been published in the last years, there is still no 
consensus on the effects of RT on the cognitive function of older adults (Coelho-Junior et al., 
2019, article 13) and only a few studies have examined prefrail and frail people. Cardalda et al. 
(87) and Yoon et al. (110) observed improved overall cognitive function in frail older adults. 
This view was expanded by Van de Rest et al. (45), who found increased digit span, attention, 
and working memory performances in prefrail and frail older adults after a 24-week LSRT 
program. To the best of our knowledge, only Yoon et al. (111) compared the effects of HSRT 
and LSRT, and results demonstrated similar improvements in overall cognitive function after 
both protocols of RT. 
The current study contributes to the growing literature by indicating that RT might 
improve verbal memory in community-dwelling prefrail older adults, regardless of the velocity 
of muscle contraction. However, our findings differed from prior investigations since we did 
not observe significant changes in overall cognition, middle-term memory, inhibitory capacity, 
and attention in prefrail and frail older adults. 
Different results might be partially attributed to differences in sample 
characteristics, given that some studies (45,112,113) combined prefrail and frail participants, 
cognitive status (e.g., MCI) (87,112–114), mobility (mobility-limited vs able to walk) 
(87,112,113), methods used for cognitive outcome measures (45,87,113,115), and designs of 
the RT programs (45,87,113,115). 
Healthy and older adults with mild cognitive impairment (MCI), for example, 
showed different patterns of electrical brain activation after RT (114), which may have 
impacted cognitive adaptations (Coelho-Junior et al., 2019, article 13). Furthermore, the limited 
mobility of our sample likely influenced physical activity levels and may have a role in our 
results (116). Still, findings from Cardada et al. (87) should be carefully interpreted since 
exercise intensity was not controlled.  
Notably, the present findings also differed from prior investigations on the acute 
effects of RT on cognitive function (Coelho-Junior et al., 2019, article 14), in which low-speed 
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and high-speed resistance exercise acutely improved RAVLT, but not STROOP performance 
in frail older adults.    
Taken as a whole, the present study indicates that LSRT and HSRT may similarly 
improve verbal memory in community-dwelling prefrail older adults. On the other hand, these 
RT protocols were not able to increase many cognitive domains in frail older adults, suggesting 
that more studies testing different designs of exercise are still necessary. 
Regarding blood pressure, researchers (117–122) have argued that frail patients 
may need further attention in the management of cardiovascular risk factors, although 
observational studies (Coelho-Junior et al., 2019; article 11), systematic reviews and meta-
analysis (123) and large randomized clinical trials have not supported this hypothesis (124). 
Our findings refute the hypothesis that RT may reduce blood pressure levels and 
heart rate in prefrail and frail older adults. A possible explanation for these results may be the 
fact frail patients show multiple cardiac and vascular abnormalities (e.g., left ventricular 
hypertrophy, worse systolic function, increased arterial stiffness) (6,125), cardiac autonomic 
(126) and endothelial (127) dysfunctions, while RT is not enough to reverse these abnormalities 
and consequently improve blood pressure and heart rate.  
Indeed, most evidence on the effects of RT on blood pressure has investigated 
robust community-dwelling older adults (128–132) and no prior studies included prefrail or 
frail participants.  
 
Practical Applications 
Current RT protocols were first thought to improve lower-limb muscle strength, 
power and mobility, and possibly frailty status, of prefrail and frail older adults that have no 
access to exercise machines or gyms. The main muscles responsible for get up and walk were 
selected and worked during the exercise sessions, and findings certainly support the importance 
of incorporating functional exercises when designing an intervention aiming to improve 
physical function in older adults (71). Although one may argue that exercise for gluteus and 
abdomen could offer additional improvements, frail participants complained of exhaustion 
during a pilot study using more than four exercises.   
Two main features of the current RT protocols should be highlighted. First, its low 
cost, given that the price of all the equipment was around R$ 700,00 and seems feasible to 
public health programs aim to improve health in older adults. Second, the short duration of 
exercise sessions, which lasted approximately 25 minutes. Nevertheless, it is important to 
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mention that RT sessions were performed individually in frail and in groups of 3-4 participants 
in prefrail to ensure the effectiveness of exercise programs.  
There is limited research indicating the minimal clinically important difference 
(MCID) for the physical performance tests used in the present study. However, when data are 
interpreted in the light of sarcopenia cutoffs (133), it is possible to observe the prefrail 
participants already had good physical performance before the intervention, while 
improvements in the physical function of frail participants did not reach non-sarcopenia status, 
although values have increased substantially.     
In this context, (ex) prefrail participants would take part in more structured exercise 
training programs (e.g., multicomponent exercise programs [MCEP]) in an attempt to improve 
other physical functions than muscle strength and power, such as cardiorespiratory capacity and 
balance. Such an approach could collaborate to an overall enhancement of health status 
concomitant with a reduction in the risk for many health-related negative outcomes.  
On the other hand, (ex) frail are still improving essential physical capacities and the 
inclusion of other types of exercise at this moment does not seem to be a good strategy, so that 
they could perform HSRT and LSRT for some more time until reestablishing enough mobility 
to perform aerobic exercises, for example. Nevertheless, since ROM limitations could have 
restricted the effects of exercise interventions, participants could benefit from flexibility 
training programs.     
Another practical aspect of the current study is that the reversion of frailty was also 
influenced by the nursing home environment. Indeed, when frail participants showed minimal 
ability and resistance to walking few steps, the board of the institution and the chief 
physiotherapist were contacted, and I explained the importance to improve patients’ physical 
activity levels. A non-structured walking program was created in which frail participants 
walked for some time with the assistance of nursing students.  
It is worth mentioning that an affinity loop was created between researcher and 
participants. Long conversations about many subjects before or after exercise sessions were 
common and undoubtedly influenced dropout rates and the successes of the protocol.  
Finally, the question that remains is “What is the best RT protocol to improve the 
frail status and health-related parameters associated with frailty in prefrail and frail older 
adults?” Taking into consideration all limitations of the present study (please, see below), both 
exercise programs seem to be important in these populations improving different domains and 
reversing frailty status. As was abovementioned, the next step would be combining LSRT and 
HSRT with other exercise interventions. However, future studies investigating RT protocols 
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based on LSRT and HSRT, as classically proposed by professor’s Häkkinen group (134), would 
be welcome to expand the current findings.  
 
Limitations 
The present study is not free of limitations. First, participants' randomization was 
stratified by age, BMI, and sit-to-stand performance and non-significant differences among the 
groups at baseline may have impacted significant differences post-intervention. Second, 
participants were not screened for dementia since they were only required to understanding 
exercise commands. Third, the current findings are prevalently based on prefrail and frail older 
women and extrapolations should be carefully performed. Forth, although LSRT and HSRT 
had no effects on blood pressure, researchers observed that frailty was associated with higher 
systolic and diastolic pressures measured by ambulatory blood pressure monitoring, but not 
office blood pressure (117). Fifth, the lack of changes in cognitive function may have occurred 
in function of the short period, since periods of intervention shorter than 12 months may not be 
enough to detect changes on cognitive parameters, as proposed by Vellas et al. (135). Sixth, our 
sample size and inclusion criteria limited further analysis (e.g., respondents and 
nonrespondents) (136,137). Seventh, the possible mechanisms underlying the effects of RT on 
physical function were not investigated. Eight, prefrail and frail older adults were recruited 
from different settings.  Finally, additional covariables (e.g., high inflammatory status (138)) 
that could influence the current results were not controlled.  
 
CONCLUSION 
Findings of the present study indicate that both LSRT and HSRT reversed frailty 
status and improved physical performance in prefrail and frail older adults. However, different 
patterns of improvement were observed among RT protocols. Regarding frailty status, LSRT 
seemed to be more effective in reverse prefrailty and frailty when compared to HSRT. Greater 
improvements in muscle strength and power were also observed after LSRT, while HSRT 
caused greater improvements in mobility and dual-task performance. Finally, RT programs 
similarly improved verbal memory in prefrail.  
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ARTICLE 13 
Can resistance training improve cognitive function in older adults? A systematic review 
and meta-analysis 
 
Abstract  
Objective: To investigate the impact of resistance training (RT) on cognitive function in older 
adults with and without dementia by conducting a systematic review of experimental studies. 
Design: We followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines. Data sources: We performed a literature search with no 
restriction on publication year in MEDLINE, Embase, CINAHL, SPORTDiscus, and AgeLine 
from inception up to August 2019. Eligibility criteria: Experimental studies investigating the 
impact of RT on cognitive function in people aged 60 years or older with or without dementia. 
Results: We included 18 studies, of which 11 investigated non-demented community-dwelling 
older adults, four investigated older adults with mild-cognitive impairment, and three 
investigated prefrail and frail older adults. RT significantly improved overall cognitive function 
in demented older adults (SMD= 1.02; 95% CI= 0.22 to 1.82, P=0.01; χ2= 11.47, df= 3, P= 
0.009, I²= 74%) and short-term memory in cognitively intact older adults (MD= -0.15; 95% 
CI= -0.23 to -0.08, P<0.0001; I² = 0%, χ2= 3.97, df = 6, P = 0.68). Conclusion: Cognition is 
significantly improved by RT in older adults. However, different adaptations are observed 
according to cognitive levels. In fact, overall cognitive function is only improved in cognitively 
healthy individuals, while amelioration of short-term memory was exclusively found in 
demented older adults. These findings encourage the use of RT as a tool to preserve mental 
health in the older population. 
 
Keywords: Physical exercise; Strength training; Dementia; Frailty.  
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Introduction 
Cognition may be understood as the expression of brain activity by which mind 
interacts with the world [1]. Over the life course, the human brain undergoes extensive 
structural and functional changes. To simplify, cognitive function expands from the gestational 
period until adulthood, and prevalently declines past the age of 60  [2]. Age-related diseases 
accelerate the rate of neuronal dysfunction and cognitive decline, which in a growing share of 
the older population becomes severe enough to compromise social engagement. This 
phenomenon has gained widespread attention owing to the profound clinical and 
socioeconomic impact of cognitive impairment. Indeed, recent reports of the World Health 
Organization (WHO) [3] alert that the maintenance of mental health should be prioritize in older 
adults in the attempt to preserve the individual’s autonomy and avoid the genesis of chronic 
degenerative diseases. 
In this context, accumulating evidence indicates that physical activity (PA), any 
bodily movement that results in energy expenditure above resting levels [4], may positively 
affect cognitive function in older adults and individuals with mild cognitive impairment (MCI) 
[5], thereby reducing the risk of dementia [6]. Based on these premises, researchers have argued 
that exercise training, a structured form of physical activity that has as objective the 
improvement or maintenance of physical fitness [4], could elicit greater benefits in comparison 
to PA and consequently be used as a tool for the preservation of mental health in older adults 
[7].  
Resistance training (RT) is a type of exercise training that involves performing 
muscle contractions against an applied force and has been suggested as a first line therapy to 
counteract the effects of aging on the neuromuscular system [8,9]. Regarding cognition, 
systematic reviews and meta-analyses of randomized clinical trials have found improved 
cognitive performance in RT-trained older adults [10,11]. However, investigations are old [12], 
included individuals aged <60 years [10,11], did not involve pooled analyses [10], and 
restricted the sample to demented older adults [12], thereby limiting conclusions. 
To fill this gap in knowledge, the present systematic review and meta-analysis 
aimed at investigating the effects of RT on cognitive function in demented and non-demented 
older adults.  
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Materials and Methods  
We conducted a systematic review and meta-analysis of interventional studies to 
quantify the effects of RT on cognitive function in older adults. The study was fully performed 
by investigators and no librarian was part of the team. This study complies with the criteria of 
the Primary Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement 
[13] and Cochrane Handbook for Systematic Reviews and Interventions [14]. All data are 
available in the Open Science Framework at https:// doi 10.17605/OSF.IO/MVW4J 
 
Eligibility criteria 
The inclusion criteria of the present study consisted of: (a) experimental studies that 
investigated the chronic effects of RT in humans; (b) age of participants 60 years; (c) 
assessment of at least one cognitive domain via validated questionnaires and tests; (d) presence 
of a control group; € published studies (English, Italian, Portuguese, and Spanish languages). 
Studies that investigated demented and non-demented older adults were considered. To be 
included in the meta-analysis, in addition to the aforementioned inclusion criteria, 
investigations had to provide: (f) pre-post mean and standard deviation (SD) of each 
intervention arm. We excluded observational and quasi-experimental studies, acute 
interventions, or any investigation that combined RT with other interventions (e.g., aerobic 
exercise). Studies that evaluated cognition based on sub-domains of scales were also excluded. 
 
Search strategy and selection criteria 
Studies published on or before August 2019 were retrieved by two investigators 
(HJCJ, EM) from the following five electronic databases: (1) MEDLINE (PubMed interface) 
(2) Embase (EBSCO interface), (3) CINAHL (EBSCO interface), (4) SPORTDiscus (EBSCO 
interface), and (5) AgeLine (EBSCO interface). Reference lists for reviews (Supplementary 
File [SF] 1) and retrieved articles for additional studies were checked and citation searches in 
key articles were performed on Google Scholar and ResearchGate for additional reports. 
Initially, a search strategy was designed using keywords, MeSH terms, and free text words such 
as resistance training, cognitive function, older adults. Additionally, keywords and subject 
headings were exhaustively combined using Boolean operators. The complete search strategy 
used for the PubMed is shown in SF2. Only eligible full texts in English, Italian, Portuguese or 
Spanish languages were considered for review.  
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Data extraction and quality assessment  
Titles and abstracts of retrieved articles were screened for eligibility by two 
researchers (HJCJ, EM). If an abstract did not provide enough information for evaluation, the 
full-text was retrieved. Disagreements were solved by a third reviewer (MCU). Reviewers were 
not blinded to authors, institutions, or manuscript journals. Data extraction was independently 
performed by two reviews (HJCJ, EM) using a standardized coding form. Disagreements were 
solved by a third reviewer (MCU). Coded variables included methodological quality and the 
characteristics of the studies. The quality of reporting for each study was performed by two 
researchers (HJCJ, EM) using the Critical Appraisal Skills Programme (CASP) criteria for 
clinical trials [15]. The agreement rate for quality assessment between reviewers was κ=0.99. 
 
Statistical analysis 
The meta-analysis was conducted using Revman V.5. Effect sizes (ESs) were 
measured using mean and SD. Where SDs were not available from trial authors, they were 
calculated from t-values, confidence intervals or standard errors, where reported in articles 
(SF3). In addition, if a study included more than one cognitive test, or had more sub-domains 
in one test, all results were extracted. Pooled ES for: a) overall cognitive function, b) short-term 
memory, and c) concentration and attention was calculated based on standard mean difference 
(SMD), given that different tools were used to measure these cognitive domains. Mean 
difference (MD) was used when short-term memory was assessed with the digit span test of the 
Wechsler Adult Intelligence Scale III (WAIS III). Due to the different characteristics of the 
included studies, a random-effect model was used to calculate the pooled ES. Funnel plots were 
used to evaluate publication bias. Heterogeneity across studies was tested using the Q-statistics, 
while the I² index was used to assess inconsistency [14]. In addition, the I² index was classified 
as might not be important (0-40%), may represent moderate heterogeneity (30-60%), may 
represent substantial heterogeneity (50-90%), and represents considerable heterogeneity (75-
100%) [14]. Forest plots were used to illustrate summary statistics and the variation 
(heterogeneity) across studies. 
 
Results 
Literature search 
Of the 2490 registers recovered from electronic databases and hand search, 2440 
records were excluded based on duplicate data, title or abstract. Fifty studies were fully 
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reviewed and assessed for eligibility and 32 were excluded (SF4). Finally, 18 studies met the 
inclusion criteria (Figure 1). 
 
Figure 1. Flowchart of the study. 
 
Characteristics of included studies 
Table 1 provides a general description of included studies. Overall, community-
dwelling older adults from 10 different countries (Armenia, Brazil, Canada, Ireland, Korea, 
Netherland, Spain, Switzerland, Taiwan, and the United States of America) were investigated 
between 1998 and 2019. Eleven studies (61.1%) investigated non-demented community-
dwelling older adults [16–22], four studies (22.2%) investigated older adults with MCI [21,23–
25], three studies (16.6%) investigated prefrail and frail older adults [26–28], while older adults 
with memory complains [29] (5.6%) were investigated in one study. Mean ages ranged from 
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65.3 to 84.8 years. RT protocols included traditional RT (TRT) [16,19,29–33,20–27], high-
speed RT (HSRT) [24,28], circuit RT [18], and respiratory RT [17]. Sessions of exercise were 
performed once [33], twice [21,24,27,32,33], and third [16,17,31,18,19,22,25,26,28–30] 
weekly using 2-4 sets at low-to-moderate [16,18,22,31], moderate [32], moderate-to-high 
[24,25,28], and high intensities [21,23,24,30,31,33] for six to 36 weeks. Cognitive outcomes 
included overall cognitive function [16,18,21,25,26,29,30], short-term memory 
[17,19,31,33,20–23,25,27–29], long-term memory [31], attention and concentration 
[21,23,27,28,31,33], set-shifting [17,23,33], spatial awareness [32], reaction time [27,32], and 
verbal fluency [27,30].     
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Table 1. Main characteristics of the included studies. 
Study Country Sample Age 
Intervention 
duration 
Resistance training protocol 
Control 
group 
Cognitive outcomes 
Ansai et 
al., 2015 
Brazil 
Community-
dwelling 
older adults 
82.4 16 weeks 
3d/week; 3 sets of 10-12RM; 2s 
for CON and 2s for the ECC 
No 
intervention 
Overall cognitive 
function, verbal 
fluency 
Busse et 
al., 2008 
Brazil 
Older adults 
with memory 
impairment 
72.2 36 weeks 
3d/week; 3 sets of 8-12 reps; 3s 
for CON and 6s for the ECC 
— 
Overall cognitive 
function, short-term 
memory 
Cardalda 
et al., 2019 
Spain 
Frail older 
adults with 
MCI 
84.8 12 weeks 3d/week; 2-3 sets of 10-15 reps 
Social 
activities 
Overall cognitive 
function 
Cassilhas 
et al., 2007 
Brazil 
Community-
dwelling 
older adults 
~68.0 24 weeks 
3d/week; 2 sets of 8 reps at 50% 
1RM 
Stretching  
Short-term memory, 
long-term memory, 
attention and 
concentration 
Cassilhas 
et al., 2007 
Brazil 
Community-
dwelling 
older adults 
~68.0 24 weeks 
3d/week; 2 sets of 8 reps at 80% 
1RM 
Stretching  Short-term memory 
Ferreira et 
al., 2015 
Brazil 
Community-
dwelling 
older adults 
~67.0 24 weeks 
3d/week; 7 sets of breathing 
exercises and inspiratory muscle 
training 
Social 
activities 
Short-term memory, 
set-shifting 
Fragala et 
al., 2014 
Brazil 
Community-
dwelling 
older adults 
70.6 6 weeks 
2d/week; 3 sets of 10-15 
repetitions at moderate intensity 
— 
Spatial Awareness, 
reaction time 
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Hong et 
al., 2018 
Korea 
Community-
dwelling 
older adults 
75.5 12 weeks 
2d/week;  Resistance exercise at 
15 RM 
No 
intervention 
Overall cognitive 
function, short-term 
memory, attention and 
concentration 
Hong et 
al., 2018 
Korea 
Older adults 
with MCI 
75.5 12 weeks 
2d/week;  Resistance exercise at 
15 RM 
No 
intervention 
Overall cognitive 
function, short-term 
memory, attention and 
concentration 
Lachman 
et al., 2006 
USA 
Community-
dwelling 
older adults 
with 
disabilities 
60-
94 
24 weeks 
3d/week;  Resitance exercise 
with elastic bands 
No 
intervention 
Short-term memory 
Liu-
Ambrose 
et al., 2010 
Canada 
Community-
dwelling 
older women 
69.6 24 weeks 1d/week; 2 sets of 7RM 
Balance, 
core, and 
streching 
exercises 
Short-term memory, 
attention and 
concentration, set-
shifting 
Liu-
Ambrose 
et al., 2010 
Canada 
Community-
dwelling 
older women 
69.6 24 weeks 2d/week; 2 sets of 7RM 
Balance, 
core, and 
streching 
exercises 
Short-term memory, 
attention and 
concentration, set-
shifting 
Nagamatsu 
et al., 2013 
Canada 
Older adults 
with MCI 
~75.0 24 weeks 1-2d/week; 2 sets of 7RM 
Balance, 
core, and 
streching 
exercises 
Short-term memory, 
attention and 
concentration, set-
shifting 
351 
 
 
Perrig-
Chiello et 
al., 1998 
Switzerland 
Community-
dwelling 
older adults 
73.2 8 weeks 1d/week; 8 resistance exercises — Short-term memory 
Tsai et al., 
2019 
Taiwan 
Older adults 
with MCI 
~65.3 16 weeks 
3d/ week; 3 sets of 10 reps at 75% 
1RM 
Stretching  
Overall cognitive 
function, short-term 
memory 
Timmons 
et al., 2017 
Ireland 
Community-
dwelling 
older adults 
69.3 12 weeks 
3d/week; 6 exercise circuit at 
60% 1RM 
— 
Overall cognitive 
function 
Smolarek 
et al., 2016 
Brazil 
Community-
dwelling 
older adults 
65.8 12 weeks 
3d/week; 3 sets of 10 reps at 60-
70% 1RM 
No 
intervention 
Overall cognitive 
function 
Petrosyan, 
2013 
Armenia 
Community-
dwelling 
older men 
66.7 12 weeks 
3d/week; 2 sets of 6-8 reps at 50-
60% 1RM 
No 
intervention 
Short-term memory 
de Rest et 
al., 2014 
Netherlands 
Prefrail and 
frial older 
adults 
~79.0 24 weeks 
2d/week; 3-4 sets of 8-15 reps at 
50-75% 1RM 
— 
Short-term memory, 
attention and 
concentration, reaction 
time, verbal fluency 
Yoon et 
al., 2017 
Korea 
Older adults 
with MCI 
~76.3 12 weeks 
2d/week; 2-3 sets of 8-10 reps at 
hard intensity; 2s for CON and 2s 
for the ECC 
Stretching  
Overall cognitive 
function 
Yoon et 
al., 2017 
Korea 
Older adults 
with MCI 
~76.3 12 weeks 
2d/week; 2-3 sets of 12-15 reps at 
somewhat hard intensity; As 
quick as possible for CON and 2s 
for the ECC 
Stretching  
Overall cognitive 
function 
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Yoon et 
al., 2018 
Korea 
Prefrail and 
frial older 
adults 
~73.0 16 weeks 
3d/ week; 2-3 sets of 12-15 reps 
at somewhat hard intensity; As 
quick as possible for CON and 2s 
for the ECC 
— 
Short-term memory, 
attention and 
concentration 
CON= Concentric; ECC= Eccentric; MCI= Mild cognitive impairment; RM= Repetition maximum; USA= United States of America 
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Quality assessment 
The overall score of quality assessment of cross-sectional and longitudinal studies 
is shown in Table 2. Detailed quality assessment is available in SF5. All studies reported the 
item required by the CASP criteria in relation to the focus (item 1), equivalences in treatments 
(item 6), external validity (item 9), and advantages of benefits (item 11). No studies blinded 
participants or health workers (item 4). However, 55.6% did not consider a measure of overall 
cognitive function (item 10) [17,19–23,27,31–33], 33.3% failed to clearly report whether 
individuals were analyzed according to the intention-to-treat method (item 3)[18,19,28,31–33], 
16.6% investigated individuals who were not similar in the main variables at baseline (item 5) 
[22], and 5.6% did not clarify if participants were allocated to treatments randomly (item 2) 
[22].   
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Table 2. Study quality.  
  Item No 
Study 1 2 3 4 5 6 9 10 11 
Ansai et al., 2015 Y Y Y N Y Y Y Y Y 
Busse et al., 2008 Y Y Y N N Y Y Y Y 
Cardalda et al., 2019 Y Y Y N Y Y Y Y Y 
Cassilhas et al., 2007 Y Y CT N Y Y Y N Y 
Ferreira et al., 2015 Y Y Y N Y Y Y N Y 
Fragala et al., 2014 Y Y CT N Y Y Y N Y 
Hong et al., 2018 Y Y Y N Y Y Y N Y 
Lachman et al., 2006 Y Y CT N Y Y Y N Y 
Liu-Ambrose et al., 2010 Y Y Y N Y Y Y N Y 
Nagamatsu et al., 2012 Y Y CT N Y Y Y N Y 
Perrig-Chiello et al., 1998 Y Y Y N Y Y Y N Y 
Tsai et al., 2019 Y Y Y N Y Y Y Y Y 
Timmons et al., 2017 Y Y CT N Y Y Y Y Y 
Smolarek et al., 2016 Y Y Y N Y Y Y Y Y 
Petrosyan, 2013 Y CT Y N CT Y Y N Y 
de Rest et al., 2014 Y Y Y N Y Y Y N Y 
Yoon et al., 2017 Y Y Y N Y Y Y Y Y 
Yoon et al., 2018 Y Y CT N Y Y Y Y Y 
1. Did the trial address a clearly focused issue?; 2. Was the assignment of patients to treatments randomised?; 3. Were all of the patients who entered the 
trial properly accounted for at its conclusion?; 4. Were patients, health workers and study personnel ‘blind’ to treatment?; 5. Were the groups similar at the 
start of the trial; 6. Aside from the experimental intervention, were the groups treated equally?; 9. Can the results be applied to the local population, or in 
your context?; 10. Were all clinically important outcomes considered?; 11. Are the benefits worth the harms and costs?; CT= Can't tell; N= No; Y= Yes. 
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Effects of resistance training on cognitive function 
- Overall cognitive function  
Nine studies (five with non-demented and four with demented participants) 
investigated the effects of RT on overall cognitive function (Figure 2). Overall cognitive 
function was measured using the Montreal Cognitive Assessment (MoCA) in five 
studies [16,18,21,24,30], the Mini Mental State Examination (MMSE) in three studies 
[24–26], and the Cambridge Cognitive Examination (CAMCOG) in one study [29]. 
Yoon et al. [24] assessed overall cognitive function using both MMSE and MoCA and 
pooled analyses were performed accordingly. Results indicated a significant ES (SMD= 
0.65; 95% CI= 0.24 to 1.07, P=0.002) for the effects of RT using MMSE from Yoon et 
al. [24] in the combined sample. Substantial heterogeneity (χ2= 22.45, df= 8, P= 0.004, 
I²= 64%) was found across studies. When the sample size was stratified according to 
diagnosis of dementia, the effects of RT remained significant in demented (SMD= 1.02; 
95% CI= 0.22 to 1.82, P=0.01; χ2= 11.47, df= 3, P= 0.009, I²= 74%), but not in non-
demented older adults (SMD= 0.41; 95% CI= -0.02 to 0.84, P=0.06; χ2= 7.59, df= 4, 
P= 0.11, I²= 47%). Yoon et al. [24] included two intervention groups: TRT and HSRT, 
and further analyses were performed accordingly. Results were no longer significant 
when TRT was removed (SMD= 1.00; 95% CI= -0.09 to 2.10, P=0.07) from the pooled 
analysis and heterogeneity increased from "may represent substantial heterogeneity" 
(I²=74%) to "considerable heterogeneity" (I²=81%, χ2= 10.62, df= 2, P= 0.005). On the 
other hand, the exclusion of HSRT reduced ES (SMD= 0.62; 95% CI= 0.17 to 1.08, 
P=0.007), although it remained significant, and reduced heterogeneity classification 
from "may represent substantial heterogeneity" to "might not be important" (χ2= 2.40, 
df= 2, P= 0.30, I²= 17%).  
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Figure 2. Standard mean difference of the effects of RT on overall cognitive function in non-
demented and demented older adults. 
 
When pooled analysis was performed using MoCA from Yoon et al. [24], 
the effects of RT on cognitive function were no longer significant in the non-demented 
sample (SMD= 0.68; 95% CI= -0.07 to 1.44, P=0.01; χ2= 10.86, df= 3, P= 0.01, I²= 
72%) (SF6). 
 
- Short-term memory 
Short-term memory was assessed using immediate and delayed free recall 
in three studies [20,22,27] and Rey 15-Item Memory Test in two studies [21,28]. A non-
significant pooled ES was found in the whole sample (SMD= 0.19; 95% CI= -0.06 to 
0.45, P=0.14; χ2= 2.30, df= 6, P= 0.89, I²= 0%) and in the non-demented subset (SMD= 
0.18; 95% CI= -0.11 to 0.48, P=0.23; χ2= 0.49, df= 4, P= 0.49, I²= 0%) (SF7).  
Other four studies [17,21,31,33] assessed short-term memory using the digit 
span test. Overall ES indicated a significant effect of RT on digit span in the whole 
sample (MD= -0.15; 95% CI= -0.23 to -0.08, P<0.0001; I²= 0%, χ2= 3.97, df= 6, P= 
0.68) and in the non-demented subset (MD= -0.15; 95% CI= -0.23 to -0.08, P<0.0001; 
I²= 0%, χ2= 3.84, df= 5, P= 0.57) (Figure 3).  
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Figure 3. Mean difference of the effects of RT on digit span performance in the whole and non-
demented samples. 
 
- Concentration and attention 
Concentration and attention were assessed using the Stroop test in three 
studies [21,27,33] and the Toulouse-Pieron's concentration attention test in one study 
[31]. No significant pooled ES were found for the overall (SMD= -0.01; 95% CI= -0.29 
to 0.27, P=0.94; I²= 43%, χ2= 10.46, df= 6, P= 0.11) and non-demented samples (SMD= 
0.01; 95% CI= -0.31 to 0.33, P= 0.95; I²= 51%, χ2= 10.28, df = 5, P= 0.07) (Figure 4). 
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Figure 4. Standard mean difference of the effects of RT on concentration and attention in the 
whole and non-demented samples. 
 
Discussion 
The main findings of the present study indicate that RT improved overall 
cognitive function in demented, but not in non-demented older adults, while short-term 
memory, assessed by the digit span of the WAIS III, was only significantly increased 
in non-demented older adults. No effects of RT were observed for the concentration and 
attention domain. 
These results are in line with prior systematic reviews, which found that 
aerobic exercise improved overall cognitive function in demented older adults [12,34]. 
However, no other investigations reported improved overall cognitive function in older 
adults in response to RT. Our findings have substantial clinical relevance since MMSE 
and MoCA are routinely used in clinics and research for cognitive screening [35,36] 
and low scores in these tests are associated with numerous negative health-related 
outcomes, such as sedentary lifestyle, insomnia, loneliness, and dementia [37–40]. 
Notably, RT did not improve overall cognitive function in cognitively 
healthy older adults, while short-term memory was significantly increased in this 
population, but not in demented older adults. Although we are unable to explain the 
underlying mechanisms, these findings may indicate that different brain regions are 
affected by RT according to the progression of dementia. This proposition is supported 
by Hong et al. [21], who found an exclusive increase in alpha waves of the 
electroencephalogram (EEG) in demented older adults after 12 weeks of RT. However, 
there is a lack of empirical evidence comparing the underlying neural mechanisms 
elicited by RT in older adults with different cognitive levels.  
Regarding short-term memory, prior studies observed that hormonal levels 
(i.e., insulin-like growth factor-1 [IGF-1]) [41], EEG pattern (i.e., theta wave) [21], and 
brain morphology (i.e., brain volume) [33] were changed in parallel to improvements 
in short-term memory after RT in non-demented older adult. These adaptations may 
explain, at least partially, the findings of the present study.  
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It is important to mention that our quality assessment analysis identified a 
lack of important information, such as if enrollees were treated according to the 
intention to treat method, the inclusion of other measures in addition to hypothesis tests, 
and if all clinically important outcomes were considered. Particularly, the P-value may 
not sufficiently represent significance, ES, and clinical relevance of results, and the use 
of additional analyses is encouraged [42,43]. In addition, the absence of evaluation of 
global cognitive function limits the extrapolation of findings to public health program, 
given the prognostic value of this parameter.  
Future studies aimed at investigating the effects of RT on cognition in older 
adults should include evaluation of overall cognitive function to provide evidence for 
guidelines on exercise and mental health. These findings may be further explored 
through follow-up designs, which can identify if maintaining or improving overall 
cognitive function in demented older adults with RT may prevent the development of 
dementia. Although many cognitive domains were investigated, only few studies 
reported similar data to be included in the meta-analysis. In fact, improvements in 
overall cognitive function in demented older adults may not be explained by short-term 
memory or concentration and attention, suggesting that other cognitive domains may 
be improved after RT. Therefore, researchers should consider using already 
investigated tools to assess cognitive domains to facilitate comparisons among studies. 
Finally, a reduced ES was found when TRT of Yoon et al. [24] was 
removed, which may indicate that HSRT has limited impact on cognitive function. On 
the other hand, findings from quasi-experimental studies [44] and samples composed 
by young to middle age adults [44,45] suggest a positive impact of RT on cognition. 
However, the lack of evidence limited possible comparisons among TRT and HSRT. 
Thus, more studies investigating RT modalities other than TRT should be performed to 
allow comparisons among interventions.  
 
Conclusion 
Cognition is significantly improved after RT in older adults. However, 
different adaptations are observed according to cognitive levels. In fact, overall 
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cognitive function is only improved in cognitively healthy individuals, while 
amelioration of short-term memory was exclusively found in demented older adults. 
These findings encourage the use of RT as a tool to preserve mental health in the older 
population. 
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Patients 
Aged [MESH] 
Frail elderly [MESH] 
Older adults 
 
Intervention 
Plyometric exercise [MESH] 
Resistance Training [MESH] 
Circuit resistance training 
High-velocity resistance training 
Power training 
Strength training 
Weight-bearing training 
Weight-lifting training 
 
Outcomes 
cognition [MESH] 
cognitive function 
executive function 
problem solving 
memory 
attention 
language 
visual perception 
 
BOOLEAN OPERATORS 
AND, OR 
 
COMBINATIONS 
1- Plyometric exercise [MESH] AND Aged [MESH] AND cognition [MESH] 
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2- Resistance Training [MESH] AND Aged [MESH] AND cognition [MESH] 
3- Resistance Training [MESH][tw] AND Aged [MESH] AND cognition [MESH] 
4- Resistance Training AND Aged [MESH] AND cognition [MESH] 
5- Resistance Training AND Aged [MESH] AND cognition 
6- Circuit resistance training AND Aged [MESH] AND cognition [MESH] 
7- Circuit resistance training [tw] AND Aged [MESH] AND cognition [MESH] 
8- High-velocity resistance training [tw] AND Aged [MESH] AND cognition 
[MESH] 
9- Power training AND Aged [MESH] AND cognition [MESH] 
10- Power training [tw] AND Aged [MESH] AND cognition [MESH] 
11- Strength training [tw] AND Aged [MESH] AND cognition [MESH] 
12- Weight-bearing training AND Aged [MESH] AND cognition [MESH] 
13- Weight-bearing training [tw] AND Aged [MESH] AND cognition [MESH] 
14- Weight-lifting training AND Aged [MESH] AND cognition [MESH] 
15- Weight-lifting training [tw] AND Aged [MESH] AND cognition [MESH] 
16- Plyometric exercise [MESH] AND Frail elderly [MESH] AND cognition 
17- Resistance Training [MESH] AND Frail elderly [MESH] AND cognition 
[MESH] 
18- Resistance Training [MESH] AND Frail elderly [MESH] AND cognition 
[MESH] 
19- Resistance Training [MESH] AND Frail elderly [MESH] AND cognition 
20- Resistance Training [MESH][tw] AND Frail elderly [MESH] AND cognition 
21- Resistance Training AND Frail elderly [MESH] AND cognition 
22- Circuit resistance training AND Frail elderly [MESH] AND cognition [MESH] 
23- Circuit resistance training AND Frail elderly [MESH] AND cognition 
24- High-velocity resistance training AND Frail elderly [MESH] AND cognition 
[MESH] 
25- High-velocity resistance training AND Frail elderly [MESH] AND cognition 
26- Power training AND Frail elderly [MESH] AND cognition [MESH] 
27- Strength training AND Frail elderly [MESH] AND cognition [MESH] 
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28- Strength training [tw] AND Frail elderly [MESH] AND cognition [MESH] 
29- Weight-bearing training AND Frail elderly [MESH] AND cognition [MESH] 
30- Weight-lifting training AND Frail elderly [MESH] AND cognition [MESH] 
31- Plyometric exercise [MESH] AND older adults AND cognition [MESH] 
32- Resistance Training [MESH] AND older adults AND cognition [MESH] 
33- Resistance Training [MESH][tw] AND older adults AND cognition [MESH] 
34- Resistance Training [tw] AND older adults AND cognition [MESH] 
35- Circuit resistance training AND older adults AND cognition [MESH] 
36- High-velocity resistance training AND older adults AND cognition [MESH] 
37- Power training AND older adults AND cognition [MESH] 
38- Strength training AND older adults AND cognition [MESH] 
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memory [tw] OR attention [tw] OR language [tw] OR visual perception [tw]) 
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56- Resistance Training AND older adults AND (cognition [tw] OR cognitive 
function [tw] OR executive function [tw] OR problem solving [tw] OR memory [tw] 
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57- Circuit resistance training AND older adults AND (cognition [tw] OR cognitive 
function [tw] OR executive function [tw] OR problem solving [tw] OR memory [tw] 
OR attention [tw] OR language [tw] OR visual perception [tw]) 
58- High-velocity resistance training AND older adults AND (cognition [tw] OR 
cognitive function [tw] OR executive function [tw] OR problem solving [tw] OR 
memory [tw] OR attention [tw] OR language [tw] OR visual perception [tw]) 
59- Strength training AND older adults AND (cognition [tw] OR cognitive function 
[tw] OR executive function [tw] OR problem solving [tw] OR memory [tw] OR 
attention [tw] OR language [tw] OR visual perception [tw]) 
60- Strength training [tw] AND older adults AND (cognition [tw] OR cognitive 
function [tw] OR executive function [tw] OR problem solving [tw] OR memory [tw] 
OR attention [tw] OR language [tw] OR visual perception [tw]) 
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65- (Plyometric exercise [MESH] OR Resistance Training [MESH] OR Circuit 
resistance training OR High-velocity resistance training OR Power training OR 
Strength training OR Weight-bearing training OR Weight-lifting training) AND (Aged 
[MESH] OR Frail elderly [MESH] OR Older adults) AND (cognition [MESH] OR 
cognitive function OR executive function OR problem solving OR memory OR 
attention OR language OR visual perception);  
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66- (Plyometric exercise [MESH][tw] OR Resistance Training [MESH][tw] OR 
Circuit resistance training [tw] OR High-velocity resistance training [tw] OR Power 
training [tw] OR Strength training Weight-bearing training [tw] OR Weight-lifting 
training [tw]) AND (Aged [MESH] OR Frail elderly [MESH] OR Older adults) AND 
(cognition [MESH] OR cognitive function OR executive function OR problem solving 
OR memory OR attention OR language OR visual perception). 
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MocA 
       
Timmons et al., 
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Control 3,2 27,0 0,86 27,9 
  
A-Rey Figure 
       
Cassilhas et al., 
2007 High intensity 8,31 10,1 0,84 10,9 
  
 
Moderate 
intensity 8,38 11,3 0,94 12,2 
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WAIS-III 
       
Cassilhas et al., 
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Moderate 
intensity -0,12 4,1 0,00 4,1 
  
 
Control -0,14 4,3 
-
0,01 4,3 
  
369 
 
 
CONVERTION 
 
Supplementary material 4 
Excluded 
Aged <60 years old 
1- Anderson-Hanley, C., Nimon, J. P., & Westen, S. C. (2010). Cognitive health 
benefits of strengthening exercise for community-dwelling older adults. Journal of 
Clinical and Experimental Neuropsychology, 32(9), 996-1001. 
2-  Cherup, N., Roberson, K., Potiaumpai, M., Widdowson, K., Jaghab, A. M., 
Chowdhari, S., ... & Signorile, J. (2018). Improvements in cognition and associations 
with measures of aerobic fitness and muscular power following structured exercise. 
Experimental gerontology, 112, 76-87. 
        
        
WSM-R 
       
Cassilhas et al., 
2007 High intensity 0,95 4,1 0,04 4,1 
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Figure captions/Supplementary material  
 
Figure S6. Standard mean difference of the effects of RT on overall cognitive function in non-
demented and demented older adults based on MoCA. 
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Figure S7. Standard mean difference of the effects of RT on short-term memory in demented 
older adults. 
  
 
Figure SF8. Funnel plots: a) RT on overall cognitive function, b) RT on short-term memory, 
c) RT on digit span performance, and d) RT on concentration and attention. Funnel plots shows 
distributions of the SMD and SD in relation to standard error in the funnel plots were 
symmetrical, suggesting a low probability of study bias. 
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Article 14 
Acute Effects of Low- and High-Speed Resistance Exercise on the Cognitive 
Function of Institutionalized Frail Older Adults 
 
Abstract 
Aim: The present study aimed to investigate the acute effects of low-speed resistance 
exercise (LSRE) and high-speed resistance exercise (HSRE) on the cognitive function 
of frail older adults. Material and methods: This was a randomized crossover study. 
Eighteen institutionalized frail older women randomly performed LSRE, HSRE, and a 
control session (CS). Cognitive function was recorded before, over 1 h, and 24 h after 
the end of the experimental session. Exercise sessions were performed using 4 exercises 
for lower limbs. Particularly, LSRE was composed of 4 sets of 8-10 repetitions at 70%-
75% of 1-repetition maximum (1RM). The concentric and eccentric phases were carried 
out for 2-s. For HSRE, exercises were performed 8 times (sets) with 3-5 repetitions at 
70%-75% of 1RM. The concentric phase was performed as fast as possible and the 
eccentric phase was carried out for 2-s. Results: Both LSRE (P=0.01) and HSRE 
(P=0.001) increased VL scores IA the exercise session, but only LSRE (P=0.01) 
remained significant higher at 1h. At 24h, VL was significantly higher in CS in 
comparison to rest (P=0.001) and HSRE (P=0.01). No changes were observed in FS, 
IR, and DR in response to any session and no other differences were observed between-
group. Regarding STROOP, no significant effects of strength and power exercises were 
observed on the number of correct answers, while it was significantly reduced at 1h 
during the incongruent stimulus in CS. Conclusion: Our findings indicate that both 
power and strength exercises acutely increased VL, an indicative of verbal immediate 
memory, in frail older women. However, a different pattern was observed among the 
groups, given that VL remained improved during 1h after the LSRE, while it was only 
increased IA the HSRE. No acute effects of exercise were observed on STROOP 
performance. Nevertheless, the number of correct answers was significantly reduced in 
the CS during the incongruent stimulus. 
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INTRODUCTION 
The roman aphorism mens sana in corpore sano acknowledges the well-
recognized positive effects of physical exercise on brain function. This concept seems 
to be particularly important in older adults, give the age-related decline in cognitive 
function (1). Specifically, observational studies have found that frail older people are at 
higher risk for cognitive decline (2,3), which may indicate that exercise therapy may be 
an important tool in the management of frail patients.  
Low-Speed Resistance Exercise (LSRE), a type of exercise in which 
muscles work or hold against an applied force at low to moderate velocity, has been 
considered the first-line therapy to prevent age-related neuromuscular decline (4). 
Regarding cognition, an increasing number of evidence has found that an acute session 
of RE may cause transient improvements in cognitive function. However, most findings 
are based in clinical and non-clinical populations of older adults (5,6) and the few 
available studies are restricted to working memory (5–8).  
Hsieh et al. (5) found improved working memory 10 min following a 
session of LSRE in non-demented older men. Similarly, Naderi et al. (6) observed 
improved working memory in older women and men who performed RE at 40% 1RM 
and 70% 1RM.  
Notably, researchers (9) have argued that high-speed resistance exercise 
(HSRE), a type of resistance exercise in which muscle contractions are performed as 
fast as possible, should be included in resistance training programs for older adults that 
aim to improve physical function, given that some aspects of the neuromuscular 
function seem to be more dependent of high-speed muscle actions than on those 
performed with low speed (10,11). However, the effects of HSRE on the cognitive 
function are still unknown. 
Based on these premises, the present study investigated the acute effects of 
LSRE and HSRE on the cognitive function of frail older adults.  
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MATERIALS AND METHODS 
This is a randomized cross-over study that investigated the acute effects of 
two types of resistance exercise on cognitive parameters of non-demented frail older 
women. The protocol was approved by the Research Ethics Committee of the 
University of Campinas (UNICAMP, Campinas, Brazil). All study procedures were 
conducted in compliance with the Declaration of Helsinki and the Resolution 196/96 of 
the National Health Council. 
 
Participants 
Institutionalized older women (aged 72 to 99 years) were recruited from a 
public nursing home located in eastern region of São Paulo State, in southern Brazil. 
Individuals were eligible if they: a) aged 60 years or over; b) were frail according to 
Fried’s criteria(12); c) possessed sufficient physical and cognitive abilities to perform 
all exercises required by the protocol; and d) had a physician authorization to 
participate. Exclusion criteria included having participated in a structured physical 
exercise training program in the past six months, uncorrected visual deficit, color 
blindness, prescription of hormone replacement therapy and/or psychotropic drugs, any 
unstable cardiovascular event (e.g., myocardial infarction) or complication in the past 
6 months, and dementia according to the Mini-mental Mental State Examination 
(MMSE) scores adjusted by educational level (13,14).  
Enrollers were randomized by an independent researcher using a computer-
generated list of random numbers into low-speed resistance exercise (LSRE), high-
speed resistance exercise (HSRE), and control session (CS). 
All experiments were performed in the rehabilitation unit of the nursing 
home. Food consumption was maintained constant during the previous 48 h and 
enrollers consumed a standard breakfast 60–90 min before the being of the experimental 
sessions. Experimental sessions were separated by one week. 
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Ten repetition maximum test (10RM)  
Participants were familiarized with resistance exercises used in the present 
study prior to the ten-repetition maximum test (10RM). 10RM tests was performed in 
following three exercises: squat on the chair (until 90° knee flexion), seated unilateral 
hip flexion, and seated unilateral knee extension. Before the tests, enrollers performed 
a brief specific warm-up using light loads. Afterward, the 10RM load was determined 
up to 5 attempts, with a 3-minute interval between the attempts. The resistance was 
increased according to the capacity of the volunteer to perform more than one successful 
repetition maximum with the proper technique. The test was completed when 
participants were unable to perform more than 10 repetitions using proper technique 
(15). All trials were performed with participants using the full range of motion. 
Subsequently, the one-maximum repetition (1RM) was calculated based on the 
following formula: 
a) 1RM= (10RM/ (1.0278 -[0.0278 × 10])) (16). 
  
Experimental sessions 
Exercise sessions were performed in the mornings (08:00 am–12:00 am) 
under the supervision of at least two fitness instructors. After a brief warm-up, 
participants performed the following exercises using an adjustable weight vest and 
ankle weights (DOMYOS®, Shangai, China) : 1st) squat on the chair (until 90° knee 
flexion), 2nd) seated unilateral hip flexion, 3rd) seated unilateral knee extension, and 4th) 
bilateral calf raise. The total volume (sets x repetitions x load= ~ 172032000 sets * 
reps* kg) was equalized among the exercise sessions. However, LSRE and HSRE were 
designed according to the peculiarities of each type of resistance exercise (17). During 
LSRE, participants performed 4 sets of 8-10 repetitions at 70%-75% of 1RM. The 
concentric and eccentric phases should be carried out for 2-s. For HSRE, exercises were 
performed 8 times (sets) with 3-5 repetitions at 70%-75% of 1RM. The concentric phase 
was performed as fast as possible and the eccentric phase was carried out for 2-s. 
Bilateral calf raise was performed with the load of unilateral knee extension. A 
researcher was responsible for monitoring and ensuring that the velocity of muscle 
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contraction was according to the protocol. Particularly, verbal encouragement was 
provided in the HSRE. During CS, participants remained seated in a comfortable chair 
for approximately 30 min.  
 
Cognitive function 
All cognitive tests were performed before (rest), immediately after (IA), 1h 
and 24h after the end of the exercise session face-to-face in a private silent room by a 
trained researcher, and a familiarization trial was provided before testing.  
 
Rey's Auditory Verbal Learning Test (RALVT) 
RALVT is a neuropsychological tool widely for testing episodic memory 
(18–21) and its scores have been strongly associated with the atrophy of medial 
temporal lobe structures (e.g., hippocampus) responsible for memory formation and 
maintenance after learning (20). In addition, RALVT is useful to distinguish patients 
with and without dementia (18) and normative data according to gender and age have 
been provided to young, middle-aged and older adults (21,22) and patients with stroke, 
epilepsy, and neoplasm (19). The test consists in read aloud two lists (A and B) of 15 
substantives each (with a 1-s interval between each word). At the beginning of the test, 
the list A was read five consecutive times by a researcher. Then, participants were 
requested to recall as many words was possible after each trial (A1-A5). The list B, 
interference list, with new 15 substantives was read after A5 and words were retrieved 
(B1). Finally, participants were asked to recall the words from list A immediately after 
the interference list (A6, immediate recall) and after a delay of 20 minutes (A7, delayed 
recall), without listen the list A again (22). Eight different lists (4 lists A and 4 lists B) 
were provided in each session to avoid learning effects. Seven summary scores were 
used to the assess episodic memory, delayed memory, verbal learning, susceptibility to 
interference (22):    
a) Verbal learning (VL) score= ƩA1-A5 – (5 * A1); 
b) VL curve= A1, A2, A3, A4, A5; 
c) Forgetting speed (FS)= A7-A6; 
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d) Immediate recall (IR)= The sum of correct words retrieved in A6; 
e) Delayed recall (DR)= The sum of correct words retrivied in A7. 
 
Stroop test 
A computerized version of the Stroop test (TESTINPACSTM) was used to 
provide reaction time (ms) and the number of correct words in each stimulus (control, 
congruent, incongruent) (23,24). To the test, participants remained seated in front of a 
17-inch color monitor. The distance between the participant and the monitor was chosen 
according to participants’ vision needs. Stroop was divided into three phases. In the first 
phase, control stimulus, the monitor exhibited a rectangle painted in green, yellow, blue, 
or red. Two possible responses, corresponding or not to the color of the rectangle, were 
exhibited at the lower corners of the monitor, and participants were requested to tell the 
color corresponding to the rectangle. The second phase was called congruent stimulus 
and consisted in stimulus (i.e., name of a color) and responses (i.e., name of two colors, 
one corresponding to the first color and the other not) exhibited as words in white. The 
correct answer was telling which colors match. The third phase, incongruent stimulus, 
is called Stroop effect and consisted of four colors exhibited is an incompatible color. 
The participants were requested to tell the color corresponding to the letters and inhibit 
the response for the identity of the disclosed word. A total of 36 stimuli (12 attempts 
each phase) were randomly provided and the time was registered in milliseconds. After 
the participants’ response, a researcher was responsible to immediately press the 
corresponding key (←  or →). This protocol was established after a pilot study in which 
we observed that participants of the present study took too long or were not able to 
return the hand to the initial position, if they had to take it off, even if the keyboard was 
composed only by two keys. 
 
Statistical analysis 
Normality of data was tested using the Kormonov-Smirnov test. Intragroup 
and intergroup comparisons in the different periods for RALVT and Stroop variables 
were performed using two-way analysis of variance (ANOVA) followed by Dunnett’s 
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post-hoc test. The level of significance was 5% (P < 0.05) and all procedures were 
performed using Graphpad PRISM software (CA, USA). 
    
RESULTS 
Eighteen subjects were recruited for the present study and fifteen accepted 
to be evaluated for inclusion criteria. Of these, four had dementia according to MMSE 
scores and one left the study after the 10RM test, leaving a total ten older women. The 
main characteristics of the studied sample are shown in Table 1. Participants completed 
all experimental sessions. 
 
Table 1. Main characteristics of study participants 
 
Variables n= 10 
Age, years 86.2 ± 10.2 
BMI, kg/m² 23.5 ± 1.3 
Period of institutionalization, years 1.0 ± 0.0 
MMSE, points 16.4 ± 4.4 
    
Comorbidities (%)   
Hypertension 80 
Osteoarthritis 60 
Stroke 20 
Diabetes 20 
Data are presented as mean ± SD and %. BMI= Body mass index; MMSE= Mini mental state 
examination. 
 
The acute effects of resistance exercise on RAVLT are shown in Figures 1 
and 2. The point-by-point analysis indicated that VL increased linearly from A1 to A5 
IA the HSRE session (Figure 1; F=12.12; P<0.001). A significantly higher A5 was 
observed at rest (P=0.01), IA (P=0.001), and 1h after exercise (P=0.001) in LSRE. 
However, A4 was only improved 1h after the LSRE (Figure 1, P<0.001). Figure 2a 
shows the overall VL scores. Increased VL scores were observed IA both HSRE 
(P=0.001) and LSRE (P=0.01) than in CS, but only LSRE (P=0.01) remained significant 
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higher at 1h. At 24h, VL was significantly higher in CS in comparison to rest (P=0.001) 
and HSRE (P=0.01). No changes were observed in FS, IR, and DR in response to any 
session and no other differences were observed between-group.  
 
Figure 1. Point-by-point RALVT analysis. CS= Control session, LSRE= Low-speed resistance 
exercise; HSRE= High-speed resistance exercise. *P<0.05 vs A1.  
 
 
Figure 2. RALVT score. CS= Control session, LSRE= Low-speed resistance exercise; HSRE= 
High-speed resistance exercise; IA= Immediately after. *P<0.05 vs A1; aP<0.05 vs CS; 
bP<0.05 vs LSRE.  
 
The acute effects of resistance exercise on STROOP performance are 
shown in Figures 3 and 4. No significant effects of strength and power exercises were 
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observed on the number of correct answers (Figure 3b and 3c), while it was significantly 
reduced at 1h during the incongruent stimulus in CS (Figure 3a). No changes were 
observed in reaction time (Figure 4) and no other differences were observed between-
group. 
Figure 3. Correct answers on Stroop test. CS= Control session, LSRE= Low-speed resistance 
xercise; HSRE= High-speed resistance exercise; IA= Immediately after. *P<0.05 vs A1; 
aP<0.05 vs CS; bP<0.05 vs LSRE. 
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Figure 4. Reaction time on Stroop test. CS= Control session, LSRE= Low-speed resistance 
exercise; HSRE= High-speed resistance exercise; IA= Immediately after.  
 
DISCUSSION 
The main findings of the present study indicate that both power and strength 
exercises acutely increased VL, an indicative of verbal immediate memory, in frail older 
women. However, a different pattern was observed among the groups, given that VL 
remained improved during 1h after the LSRE, while it was only increased IA the HSRE. 
No acute effects of exercise were observed on STROOP performance. Nevertheless, the 
number of correct answers was significantly reduced in the CS during the incongruent 
stimulus. 
There is still a lack of evidence on the acute effects of resistance exercise 
on the individual’s capacity to store and subsequent retrieve information, and the few 
available studies are restricted to working memory (5–8). In older adults, Hsieh et al. 
(5) found improved working memory 10 min following a session of LSRE in non-
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demented older men. Similarly, Naderi et al. (6) observed improved working memory 
in older women and men who performed LSRE at 40% 1RM and 70% 1RM.  
In this context, our results provide a prima facie case for the differential 
effects of LSRE and HSRE on verbal memory in frail older women. Notably, LSRE 
elicited longer learning improvements in comparison to HSRE, although results seem 
to be greater IA HSRE than in LSRE. Taken together, these findings add to the existing 
literature indicating that the velocity of muscle contraction influences cognitive 
function in response to resistance exercise.   
Although is beyond the scope of this study to explain the possible bio-
physiological mechanisms underlying the improved verbal memory performance found 
following an acute bout of LSRE and HSRE, the contraction time could be a plausible 
explanation for our findings, given that the duration of muscle contractions during each 
set was about ~40 s in LSRE and ~ 12.5 s in HSRE, which might have caused different 
neuroendocrine responses (25).  
Insulin-like growth factor-1 (IGF-1), for example, is acutely increased in 
response to LSRE in older adults (26) and systemic IGF-1 levels are significantly 
associated with verbal memory and hippocampal perfusion and volume (27). In 
addition, acute improvements in IGF-1 levels in brain areas strongly associated with 
memory formation (e.g., hippocampus, cortex) (28) and seem to be critically involved 
in exercise-induced improvements in neuronal activation and cell proliferation (28,29).  
On the other hand, endocrine responses to HSRE are commonly lower in 
comparison to LSRE (25), which might indicate that other mechanisms may be 
associated with acute HSRE-induced transitory cognitive gains. Nitric oxide (NO) may 
be a possible candidate for improved verbal memory after HSRE, given that NO was 
improved after acute HSRE in older women (30) and infusion of NO precursor, L-
arginine, improved learning and memory, as well as increased the length of cortical 
capillaries in rats (31,32), while NO inhibition by L-NAME inhibited cognitive 
improvements (31,32).  
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Nevertheless, these speculations cover only some of the myriad of 
mechanisms that can be responsible for the acute effects of resistance exercise on 
cognition and future studies are required to better explore this issue.  
Notably, VL performance was significantly reduced 24 after HSRE session 
and significant increased after CS. Audiffrenn (33) proposed an inverted-U shaped 
curve to explain the relationship between exercise intensity and cognitive 
improvements in response to an acute session of exercise, so that low- and high-
intensity exercise sessions are expected to induce low transitory cognitive 
improvements, while greater changes may be observed after moderate-intensity 
exercise.  
One possible reason why this phenomenon was not observed in the current 
study may be that frail participants have high baseline cortisol levels (34). Although 
HSRE was performed at moderate-to-high intensity, frail patients may have reduced 
resiliency to physical stress, causing exaggerated hypercortisolemia during recovery 
and causing transient reduction in memory performance (35).  
The effects of resistance exercise on Stroop performance remain equivocal. 
In accordance with the present study, Alves et al. (36), Dunsky et al. (37) and Tsai et 
al. (26) did not observe improvements in Stroop performance post-LSRE in middle-
aged and older adults with mild-cognitive impairment. On the hand, Johnson et al. (38) 
found increased performance on the incongruent stimulus up to 1h post-resistance 
exercise. These findings are supported by a recent systematic review and meta-analysis 
that a unique session of LSRE may induce moderate improvements on inhibitory control 
(8).  
These abovementioned findings are hard to reconcile, but a possible 
explanation for these divergent results may be fact that Johnson et al. (38) used a circuit-
based resistance exercise, which has a significant aerobic component (39). In addition, 
differences on age and healthy status may also collaborated with the findings of the 
present study since healthy adults were investigated by Johnson et al (38) and Wilke et 
al. (8), while frail older women took part of the present study.   
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There are some limitations to mention in addition to the lack of 
mechanisms. First, our findings are limited to frail older adults and should be carefully 
extrapolated to non-institutionalized robust older adults. Second, our sample size was 
only composed by women. Third, reaction time was based on the researcher’s velocity 
response to participants stimulus.  
 
CONCLUSION 
Our findings indicate that both power and strength exercises acutely 
increased VL, an indicative of verbal immediate memory, in frail older women. 
However, a different pattern was observed among the groups, given that VL remained 
improved during 1h after the LSRE, while it was only increased IA the HSRE. No acute 
effects of exercise were observed on STROOP performance. Nevertheless, the number 
of correct answers was significantly reduced in the CS during the incongruent stimulus. 
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ARTICLE 15 
Acute Effects of Low- and High-Speed Resistance Exercise on Hemodynamic 
Parameters of Institutionalized Frail Older Adults 
 
Abstract 
Aim: The present study aimed to investigate the acute effects of low-speed resistance 
exercise (LSRE) and high-speed resistance exercise (HSRE) on the hemodynamic 
parameters of frail older adults. Material and methods: This was a randomized 
crossover study. Sixteen institutionalized frail older adults (81.0 ± 9.2 years, 23.2 ± 2.1 
kg/m²) randomly performed LSRE, HSRE, and a control session (CS). Blood pressure 
was recorded before, over 1 h, and 24 h after the end of the experimental session. 
Exercise sessions were performed using 4 exercises for lower limbs. Particularly, LSRE 
was composed of 4 sets of 8-10 repetitions at 70%-75% of 1-repetition maximum 
(1RM). The concentric and eccentric phases were carried out for 2-s. For HSRE, 
exercises were performed 8 times (sets) with 3-5 repetitions at 70%-75% of 1RM. The 
concentric phase was performed as fast as possible and the eccentric phase was carried 
out for 2-s. Results: Both LSRE and HSRE caused post-exercise hypotension. Notably, 
a longer reduction was observed in LSRE (over 1 hour) in comparison to HSRE (~20 
min) and an exclusive reduction in mean arterial pressure were observed after LSRE. 
Conclusion: Our findings suggest that resistance exercise caused post-exercise 
hypotension, regardless of the velocity of concentric muscle contraction. However, a 
longer reduction in systolic blood pressure and an exclusive decrease in mean arterial 
pressure were observed after LSRE. 
 
Key words: Power training, Resistance training, Blood pressure, Hypertension, Elderly 
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Introduction 
Frailty is a highly prevalent condition among older adults and is defined as 
a potentially reversible state of increased vulnerability to negative health-related 
outcomes [1]. Although the progression of frailty is commonly associated with physical 
and cognitive deterioration [2,3], cardiovascular diseases are highly prevalent among 
this population [4] and frequently lead to hospitalization due to inappropriate care [5]. 
In this sense, a recent report of the European Society of Hypertension-
European Union Geriatric Medicine Society (ESHEUGMS) Working Group proposed 
that special attention should be given in the antihypertensive treatment of frail older [6]. 
However, no guidelines or algorithms for the management of cardiovascular diseases 
in frail are available [4].   
Notably, many evidence [7–11] has supported the importance of exercise 
training as a non-pharmacological therapy to reduce blood pressure in older adults with 
different diagnosis, consequently reducing the cardiovascular risk in this population 
[12].  
However, the benefits of physical exercise on blood pressure are not 
exclusively found after training programs since an unique session of exercise may 
induce post-exercise hypotension (PEH), a phenomenon characterized by reduced 
blood pressure values to levels below to those reported either prior to exercise or on a 
control session [13]. PEH may occur up to 24 hours [14] and collaborates to lower 
cardiovascular risk during the performance of activities of daily living [15,16], besides 
predicting responders and non-responders to exercise therapy [17,18].  
A substantial body of evidence indicates that PEH may occur in response 
to different types of exercise, including low-speed resistance exercise (LSRE) [19–22], 
a type of exercise in which muscles work or hold against an applied force at low to 
moderate velocity. These observations are clinically important because resistance 
exercise is a well-stablished therapy to counteract the age-associated neuromuscular 
and osteoarticular deterioration [23]. Nevertheless, researchers [24,25] have argued that 
high-speed resistance exercise (HSRE), a type of resistance exercise in which muscle 
contractions are performed as fast as possible, should be included in resistance training 
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programs for older adults that aim to improve physical function, given that some aspects 
of the neuromuscular function seem to be more dependent of high-speed muscle actions 
than on those performed with low speed [26,27]. However, the effects of HSRE on 
hemodynamic parameters of older adults have been poorly explored.  
Indeed, just a few studies have investigated the effects of HSRE on blood 
pressure. Though, existing studies were based on healthy older women [28,29], blood 
pressure measured only immediately after the session of exercise [30], and not 
equalized exercise protocols [28].  
Therefore, the present study aimed at investigating the acute effects of 
LSRE and HSRE on hemodynamic parameters of institutionalized frail older adults. 
Our hypothesis is that HRSE may elicit longer and greater PEH than LSRE. 
 
Material and methods 
This is a randomized crossover study that investigated the acute effects of 
two different types of resistance exercise on hemodynamic parameters of frail older 
adults. The protocol was approved by the Research Ethics Committee of the University 
of Campinas (UNICAMP, Campinas, Brazil). All study procedures were conducted in 
compliance with the Declaration of Helsinki and the Resolution 196/96 of the National 
Health Council.  
Institutionalized older adults (aged 72 to 99 years) were recruited from a 
public nursing home located in eastern region of São Paulo State, in southern Brazil. 
Individuals were eligible if they: a) aged 60 years or over; b) were frail according to 
Fried’s criteria [31]; c) possessed sufficient physical and cognitive abilities to perform 
all exercises required by the protocol; and d) had a physician authorization to 
participate. Exclusion criteria included having participated in a structured physical 
exercise training program in the past six months, prescription of hormone replacement 
therapy and/or psychotropic drugs, and any unstable cardiovascular event (e.g., 
myocardial infarction) or complication in the past 6 months.  
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Enrollers were randomized by an independent researcher using a computer-
generated list of random numbers into low-speed resistance exercise (LSRE), high-
speed resistance exercise (HSRE), and control session (CS). 
The experimental design of the current study is shown in Figure 1. All 
experiments were performed in the rehabilitation unit of the nursing home. Food 
consumption was maintained constant during the previous 48 h and enrollers consumed 
a standard breakfast 60–90 min before the being of the experimental sessions. 
Experimental sessions were separated by one week.  
 
Figure 1. Experimental design of the present study. 10RM= 10-repetition maximum test; 
CS= Control session; HSRE= High-speed resistance exercise; LSRE= Low-speed resistance 
exercise. 
 
Ten repetition maximum test (10RM)  
Participants were familiarized with resistance exercises used in the present 
study prior to the 10-repetition maximum test (10RM). 10RM tests was performed in 
following three exercises: squat on the chair (until 90° knee flexion), seated unilateral 
hip flexion, and seated unilateral knee extension. Before the tests, individuals 
performed a brief specific warm-up using light loads. Afterward, the 10RM load was 
determined up to 5 attempts, with a 3-minute interval between the attempts. The 
resistance was increased according to the capacity of the volunteer to perform more 
than one successful repetition maximum with the proper technique. The test was 
completed when participants were unable to perform more than 10 repetitions using 
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proper technique [32]. All trials were performed with participants using the full range 
of motion. Subsequently, the one- repetition maximum (1RM) was calculated based on 
the following formula: 
a) 1RM= (10RM/ (1.0278 -[0.0278 × 10])) [33]. 
  
Experimental sessions 
Exercise sessions were performed in the mornings (08:00 am–12:00 am) 
under the supervision of at least two fitness instructors. After a brief warm-up, 
participants performed the following exercises using an adjustable weight vest and 
ankle weights (DOMYOS®, Shangai, China) : 1st) squat on the chair (until 90° knee 
flexion), 2nd) seated unilateral hip flexion, 3rd) seated unilateral knee extension, and 4th) 
bilateral calf raise. The total volume (sets x repetitions x load= ~ 172032000 sets * 
reps* kg) was equalized among the exercise sessions. However, LSRE and HSRE were 
designed according to the peculiarities of each type of resistance exercise [23]. During 
LSRE, participants performed 4 sets of 8-10 repetitions at 70%-75% of 1RM. The 
concentric and eccentric phases should be carried out for 2-s. For HSRE, exercises were 
performed 8 times (sets) with 3-5 repetitions at 70%-75% of 1RM. The concentric phase 
was performed as fast as possible and the eccentric phase was carried out for 2-s. 
Bilateral calf raise was performed with the load of unilateral knee extension. A 
researcher was responsible for monitoring and ensuring that the velocity of muscle 
contraction was according to the protocol. Particularly, verbal encouragement was 
provided in the HSRE. During CS, participants remained seated in a comfortable chair 
for approximately 30 min.  
  
Hemodynamic parameters 
Hemodynamic parameters were measured accordingly to the VII Joint 
National Committee of High Blood Pressure (JNC7) [34]. The baseline blood pressure 
of each session was based on the mean values measured in three consecutive visits. 
Participants remained seated in a comfortable chair in a room with artificial light for 
baseline and post-exercise blood pressure measurements. The hemodynamic parameters 
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were blindly measured in the left arm using an automated oscilometric equipment (BP 
3BT0A, Microlife AG, Widnau, Switzerland) [35] and were recorded immediately after 
(IA) (0 minute), and 10, 20, 30, 50, and 60 minutes, as well as 24 h after the exercise 
completion. At the end of each measurement, the equipment provided systolic blood 
pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR). Mean arterial 
pressure (MAP) was determined based on the formula: 
b) (SBP + [2*DBP])/3).  
 
Statistical analysis 
Normality of data was tested using the Kormonov-Smirnov test. Intragroup 
and intergroup comparisons in the different periods (i.e., baseline, 10’, 20’, 30’, 50’, 
60’ and 24h after the end of each session) for SBP, DBP, HR, and MAP were performed 
using two-way analysis of variance (ANOVA) followed by Dunnett’s post-hoc test. 
The level of significance was 5% (P < 0.05) and all procedures were performed using 
Graphpad PRISM software (CA, USA).  
 
Results 
Twenty-two subjects were recruited for the present study and twenty 
accepted to be evaluated for inclusion criteria. Of these, two had a clinical diagnosis of 
psychiatric diseases and two left the study after the 10RM test, leaving a total sixteen 
older adults. The main characteristics of the studied sample are shown in Table 1. 
Participants completed all experimental sessions.  
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Table 1. Main characteristics of study participants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are presented in mean ± SD and %. BMI= Body mass index; SBP= Systolic blood pressure; 
DBP= Diastolic blood pressure;MAP= Mean arterial pressure; HR= Heart rate; ACE= 
Angiotensin converting enzyme; ANG= Angiotensin 
 
 
Variables n= 16 
Age, years 81.0 ± 9.2 
BMI, kg/m² 23.2 ± 2.1 
Male, % 37.5 
Period of institutionalization, years 2.2 ± 3.4 
    
Hemodynamic parameters   
SBP, mmHg 128.8 ± 19.8 
DBP, mmHg 77.4 ± 12.2 
MAP, mmHg 77.4 ± 12.2 
HP, bpm 76.8 ± 12.1 
    
Comorbidities (%)   
Hypertension 87.5 
Osteoarthritis 37.5 
Stroke 37.5 
Diabetes 10.0 
Low-back pain 6.25 
Parkinson's disease 6.25 
    
Drug class (%)   
ACE inhibitor 75.0 
Diuretic 31.2 
ANG II receptor antagonista 25.0 
Proton-pump inhibitor 31.2 
Antihyperglycemic  12.5 
Alpha and beta-blockers 6.2 
Nonsteroidal anti-inflammatory drug 6.2 
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Hemodynamic parameters are shown on Figure 2 and Table 2. Both LSRE 
and HSRE caused systolic PEH (Figure 2a). However, different patters were observed 
among the sessions. SBP was significantly reduced at 30 and 50 min after HSRE and 
over the entire period after LSRE. Lower SBP were found at 10, 30, and 50 min in 
HSRE and at 20 in LSRE when compared to CS. MAP was only significantly reduced 
after LSRE at 10, 20, and 30 min (Figure 2d). In addition, lower MAP at 20 min was 
observed in LSRE in comparison to CS. No significant changes were observed in DBP 
and HR for any session and no differences were observed between the exercise groups 
(Figure 2b and 2d). 
 
 
Figure 2. Hemodynamic parameters in experimental sessions. CS= Control session; DBP= 
Diastolic blood pressure; HR= Heart rate; HSRE= High-speed resistance exercise; LSRE= 
Low-speed resistance exercise; MAP= Mean arterial pressure; SBP= Systolic blood pressure. 
 
Table 2. Hemodynamic parameters on experimental sessions. 
Variable   CS LSRE HSRE 
  Baseline 124.4 ± 17.8 126.3 ± 19.1 126.1 ± 17.9 
SBP 
IA 
123.6 ± 17.7 (-0.5, -
0.7) 
120.8 ± 21.8 (-4.2, -5.5)a 128.3 ± 21.5 (1.5, 2.1) 
10' 
123.6 ± 17.8 (-0.5, -
0.7) 
116.3 ± 17.6 (-7.6, -10.0)a 116.8 ± 17.8 (-7.3, -9.3)b 
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20' 124.8 ± 17.7 (0.3, 0.3) 113.7 ± 12.5 (-9.2, -12.6)ab 121.4 ± 17.6 (-3.2, -4.7) 
30' 
123.9 ± 16.7 (-0.2, -
0.5) 
116.1 ± 13.3 (-7.3, -10.1)a 114.6 ± 16.4 (-8.8, -11.5)ab 
50' 
123.3 ± 17.2 (-0.8, -
1.1) 
117.7 ± 13.7 (-5.8, -8.6)a 114.6 ± 16.4 (-8.5, -11.5)ab 
60' 
121.9 ± 20.7 (-2.3, -
2.5) 
116.4 ± 15.0 (-7.1, -9.8)a 118.8 ± 12.8 (-4.3, -7.3) 
24h 124.9 ± 19.0 (0.3, 0.5) 125.4 ± 13.0 (0.1, -0.9) 121.3 ± 14.2 (-3.3, -4.8) 
          
  Baseline 78.1 ± 20.8 77.7 ± 18.7 74.7 ± 11.1 
DBP 
IA 78.2 ± 20.7 (0.2, 0.1) 75.5 ± 11.9 (-0.5, -2.1) 80.1 ± 11.8  (7.7, 5.3) 
10' 79.7 ± 22.9 (1.6, 1.6) 72.5 ± 9.8 (-4.2, -5.1) 78.2 ± 10.1 (5.2, 3.5) 
20' 81.1 ± 23.4 (3.4, 3.0) 73.6 ± 9.8 (-3.0, -4.1) 74.6 ± 9.4 (0.6, -0.0) 
30' 80.7 ± 23.1 (3.0, 2.6) 72.6 ± 9.6 (-4.2, -5.1) 72.7 ± 8.7 (-1.5, 2.0) 
50' 81.2 ± 22.8 (3.7, 3.1) 76.1 ± 12.7 (0.3, -1.6) 73.8 ± 11.2 (-0.5, -0.9) 
60' 81.5 ± 23.2 (3.9, 3.3) 74.6 ± 8.9 (-1.1, -3.1) 77.3 ± 15.6 (4.9, 2.5) 
24h 78.3 ± 21.6 (0.1, 0.2) 76.7 ± 11.5 (1.6, 3.0) 74.8 ± 12.7 (0.1, 0.1) 
          
  Baseline 93.5 ± 17.4 93.9 ± 17.7 91.8 ± 12.5 
MAP 
IA 93.3 ± 17.1 (-0.1, -0.1) 90.6 ± 14.0 (-2.5, -3.3) 96.1 ± 14.1  (4.7, 4.2) 
10' 94.3 ± 19.1 (0.6, 0.8) 87.1 ± 10.6 (-6.0, -6.8)a 91.0 ± 11.5 (-0.6, -0.7) 
20' 95.6 ± 19.6 (2.0, 2.1) 86.9 ± 9.9 (-6.1, -6.9)ab 90.2 ± 10.8 (-1.2, -1.6) 
30' 95.1 ± 18.9 (1.5, 1.5) 87.1 ± 10.2 (-5.9, -6.8)a 86.7 ± 9.5 (-4.9, -5.1) 
50' 95.2 ± 19.2 (1.6, 1.7) 89.9 ± 11.1 (-2.5, -3.9) 87.4 ± 10.5 (-4.2, -4.4) 
60' 94.9 ± 20.4 (1.0, 1.4) 88.5 ± 9.6 (-4.1, -5.3) 91.1 ± 13.3 (0.7, -0.7) 
24h 93.8 ± 19.2 (0.0, 0.3) 92.9 ± 10.4 (0.7, -0.9) 90.3 ± 11.7 (-1.4, -1.5) 
          
  Baseline 77.5 ± 13.6 73.6 ± 13.3 75.2 ± 12.7 
HR 
IA 78.1 ± 13.1 (0.9, 0.6) 79.5 ± 16.9 (7.9, 5.8) 79.2 ± 12.1 (5.9, 4.0) 
10' 78.2 ± 14.3 (0.8, 0.7) 77.0 ± 14.9 (4.7, 3.3) 77.8  ± 12.3 (3.9, 2.5) 
20' 77.5 ± 14.5 (-0.1, 0.0) 74.9 ± 16.5 (1.6, 1.2) 76.1 ± 11.5 (1.8, 0.9) 
30' 78.5 ± 14.2 (1.1, 1.0) 72.2 ± 14.8 (-0.9, -1.4) 75.8 ± 14.1 (2.4, 0.5) 
50' 77.8 ± 13.5 (0.4, 0.3) 72.0 ± 14.8 (-1.3, -1.6) 74.5 ± 15.2 (-0.7, -0.6) 
60' 77.8 ± 14.3 (0.3, 0.3) 69.9 ± 13.9 (-4.1, -3.7) 72.1 ± 10.9 (-3.7, 3.0) 
24h 77.0 ± 14.3 (-0.7, -0.5) 72.9 ± 12.9  (0.0, -0.7) 72.6 ± 10.8 (-2.5, -2.6) 
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CS= Contral session; DBP= Diastolic blood pressure; HR= Heart rate; HSRE= High-speed 
resistance exercise; IA- Imediatelly after; LSRE= Low-speed resistance exercise; MAP= Mean 
arterial pressure; SBP= Systolic blood pressure. aP<0.05 vs Baseline; bP<0.05 vs CS. 
 
DISCUSSION 
The main findings of the preset study indicate that SBP is acutely reduced 
after LSRE and HSRE in frail older adults. However, LSRE caused longer PEH in 
comparison to HSRE, given that SBP was significantly reduced over the whole period 
after LSRE and only for approximately 20 min after HSRE. In addition, exclusive MAP 
reductions were observed after HSRE.  
Our findings are in line with prior investigations, which observed PEH after 
LSRE [19–22] and HSRE [28,30] in older adults with different conditions. However, 
for the best of our knowledge, this is the first study investigating the acute effects of 
two different types of resistance exercise on hemodynamic parameters of frail 
institutionalized older adults.  
In the last years, an increasing coupling body of evidence has investigated 
the acute effects of HSRE on blood pressure in older adults. Our group [28] found 
significant PEH after an acute session of HSRE in community-dwelling older adults, 
while no significant changes were observed after LSRE. On the other hand, Orsano et 
al. [29] did not observe significant effects of HSRE on blood pressure of community-
dwelling older women. Subsequently, Machado et al. [30]. reported lower SBP and 
DBP values after HSRE in older adults with type II diabetes mellitus. These 
controversial findings among trials may be at least partially attributed to differences in 
the exercise design (e.g., number of exercises), blood pressure measurement (e.g., only 
IA or for 1 h after the exercise session), and sample characteristics (e.g., hypertensive, 
frail, and older adults with type II diabetes mellitus).  
Contrarious to our initial hypothesis, LSRE elicited longer and greater PEH 
in comparison to HSRE. The time under tension could be a plausible explanation for 
our findings, given that the duration of muscle contractions in each set was about ~40 s 
during LSRE and ~ 12.5 s during HSRE. These premises are contrarious to the 
observation that interval and continuous trainings elicited similar blood pressure 
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responses [36] and may indicate that the time under tension is an important variable in 
the light of resistance exercise inducing PEH. In addition, we [28] previously observed 
a longer and greater PEH after HSRE performed at moderate intensity (3 on Borg scale 
adapted by Foster et al. [37]), which represents approximately 50% of 1RM. Thus, it is 
possible that HSRE protocols performed at low-to-moderate loads may elicit better 
acute cardiovascular benefits in comparison to HSRE at moderate-to-high loads. This 
hypothesis is supported by Figueredo et al. [20], who observed a longer PEH after 
resistance exercise performed at 70%1RM when compared to 80%1RM. Nevertheless, 
more studies are needed to confirm our inferences. 
The possible mechanisms underlying the effects of RT on blood pressure 
were not investigated in the present study which limits possible inferences. However, 
prior investigations observed transiently improvements in nitric oxide (NO) [28], 
bradykinin [19], and autonomic modulation [38] in response to an acute session of 
resistance exercise. 
There are some limitations to mention in addition to the lack of 
mechanisms. First, our findings are limited to frail older adults and should be carefully 
extrapolated to non-institutionalized robust older adults. Second, our sample size was 
prevalently composed by women. Third, the lack of ambulatory blood pressure 
monitoring may cover possible effects of LSRE and HSRE, given that researchers [39] 
found reduced night-time, but not daytime ambulatory blood pressure after an acute 
session of resistance exercise.   
 
Conclusion 
Our findings suggest that resistance exercise caused PEH, regardless of the 
velocity of concentric muscle contraction. However, a longer reduction in SBP and an 
exclusive decrease in MAP were observed after LSRE.  
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 ABSTRACT  
 Background and Purpose:   Cutoff points for physical 
function tests are commonly used in clinical practice for 
the evaluation, monitoring, and treatment of older 
adults. Previous studies have shown that, while age-
related patterns of muscle strength change are similar 
between ethnic groups, strength values differ signifi 
cantly independent of age. Whether the same applies to 
other physical function tests is presently unclear. This 
study investigated age- and gender-related changes of 
performance on a battery of physical function tests in 
Brazilian community dwellers.  Methods:  The study 
followed a cross-sectional design. Participants were 
community-dwelling adults. Candidates were 
considered eligible if they were 18 years or older, lived 
independently, and possessed suffi cient physical and 
cognitive abilities to perform all of the measurements 
required by the protocol. Physical function tests 
included isometric handgrip (IHG), 5 times sit-to-stand 
(5 × STS) test, Timed Up and Go, 1-leg stance, and 
walking speed (WS) at usual and fast pace.  Results:  
Two-thousand eight-hundred and four people were 
enrolled. Mean age was 68.0 (7.0) years (range 50-102 
years), and 2262 (80.7%) were women. Men displayed 
better IHG and balance, while women showed higher 
performance on the 5 × STS and WS tests. A gender-
specifi c pattern of decline in physical performance was 
observed. Specifi cally, women showed a linear age-
dependent decline in all tests. In men, only in the IHG, 
1-leg stance, and WS test at a fast pace was there a linear 
decline with age. In both genders, the lowest mean 
values of physical function tests were higher than the 
proposed cutoffs for sarcopenia. Discussion and 
Conclusions:  Our fi ndings indicate that the 
performance on different physical function tests 
decreases with advancing age in Brazilian adults, 
following a genderspecifi c pattern. In none of the tests 
did the lowest mean values reach the cutoffs for 
sarcopenia. This suggests that region-specifi c cutoffs 
might be necessary to identify older people at risk of 
adverse events.  
 Key Words:  balance ,  assessment,   mobility ,  muscle 
strength,   physical performance 
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INTRODUCTION  
The World Health Organization projections indicate that the absolute and relative 
number of older adults will increase exponentially in the next decades. 1 This phenomenon 
demands special attention, since aging is associated with risk of loss of independence and 
greater use of health care resources. 2 Among the numerous changes that accompany aging, the 
deterioration of physical function is especially concerning. Indeed, the preservation of physical 
performance is a core element for maintaining independence and remaining engaged in social 
activities. 3, 4  Conversely, reduced physical function levels have been associated with a wide 
range of poor outcomes, such as cognitive impairment, falls, disability, institutionalization, and 
mortality. 5-10  Several investigations have observed a common agerelated pattern of changes in 
upper and lower limb muscle strength, 11-13 lower limb muscle power, 11, 12  and mobility 11 
among people from Europe and Asia. However, muscle strength values were found to differ 
signifi cantly across ethnic groups, independent of age. 13 This suggests that region-specifi c 
muscle strength cutoffs may be needed to estimate the risk of adverse events in different 
populations. In addition, most studies have focused on the analysis of muscle strength, while 
other important parameters, such as mobility, have been less explored. As a consequence, it is 
currently unknown whether the pattern of age-related changes in other physical function tests, 
such as the 5 times sit-to-stand (5 × STS), the 1-leg stance, and the Timed Up and Go (TUG) 
tests, differ across ethnic groups.  
 This information is highly relevant to health care professionals, including physical 
therapists, given that cutoff values for physical function tests are commonly used for the 
evaluation, monitoring, and treatment of older adults. 14-16 The lack of a deeper understanding 
of age- and gender-dependent trajectories of physical function in specifi c populations might 
impact the interpretation of functional tests and the effects of interventions. Furthermore, 
popular physical function tests (eg, walking speed [WS] at usual pace over short tracks) may 
have a ceiling effect in the assessment of healthy older adults. 17, 18  This limitation may be 
overcome by testing multiple physical domains and through the use of more demanding tests 
(eg, WS at fast pace, maximal isokinetic handgrip [IHG] strength).  
 Based on these premises, the present study was undertaken to investigate the 
patterns of gender- and age-related changes in a comprehensive set of physical function tests in 
a convenience sample of Brazilian community-dwelling men and women across a wide age 
range.  
419 
 
 
 METHODS  
Design and Participants  
 This study had a cross-sectional design and was approved by the Research Ethics 
Committee of the University of Mogi das Cruzes (UMC, São Paulo, Brazil). All study 
procedures were conducted in compliance with the Declaration of Helsinki and the Resolution 
196/96 of the National Health Council. The article was prepared according to the Strengthening 
the Reporting of Observational Studies in Epidemiology criteria. 19  
 Participant recruitment took place between January 2015 and January 2018. 
Participants were recruited in a community senior center located in the metropolitan area of São 
Paulo, Poá, Brazil. The study was advertised through posters placed in public sites (eg, parks, 
city hall, public offi ces, bus stops, and train stations) as well as via local radio and newspapers. 
People were also invited to participate by direct contact. Candidates were considered eligible if 
they were 18 years or older, lived independently, and possessed suffi cient physical and 
cognitive abilities to perform all of the measurements required by the protocol.  
No other selection criteria were set. Written informed consent was obtained prior to inclusion 
from each participant for this study.  
 
Functional Assessments  
 All physical function tests were administered by 2 experienced exercise 
physiologists. One examiner was responsible for detailing the operational procedures, 
demonstrating the test before the assessment, quantifying performance, and evaluating motor 
patterns. The other examiner ensured participant safety by providing occasional verbal and/or 
tactile cueing, if needed, without interfering with the physical function tests. After the 
explanation and before each test, participants performed a familiarization trial to ensure they 
had fully understood each test. Except for the 1-leg stance test, participants performed all tests 
twice with the best result used for analysis. The tests were administered in a dedicated room 
within the senior center and were performed in a sequential order with a 1-minute rest between 
trials, as follows: (1) IHG, 20 (2) 5 × STS, 21 (3) TUG, 22 (4) 1-leg stance, 23 and (5) WS at usual 
and fast pace. 24 
  
Isometric Handgrip Strength  
 IHG strength of the dominant hand was measured using a Jamar handheld 
hydraulic dynamometer (Sammons Preston, Bolingbrook, Illinois). 20 To determine the 
dominant hand, participants were asked which of their hands was the strongest. The measure 
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was obtained while the participant was seated on a chair with the shoulder abducted, the elbow 
near the trunk and fl exed at 90 ° , and the wrist in a neutral position (thumbs up). The 
contralateral arm remained relaxed under the thigh. To measure handgrip strength, participants 
performed a maximal contraction during 4 seconds. The test reliability in the present study was 
0.8 or more ( κ  = 0.97). Results were recorded in kilogram.  
 
Five Times Sit-to-Stand Test  
 Participants rose from a chair 5 times as quick as possible with their arms folded 
across their chest. Timing began when participants raised their buttocks off the chair and was 
stopped when they were seated at the end of the fi fth stand. 21 The test reliability in the present 
study was 0.8 or more ( κ  = 0.97).  
 
Timed Up and Go Test  
 The TUG test involved getting up from a chair (total height: 87 cm; seat height: 45 
cm; width: 33 cm), walking 3 m around a cone placed on the fl oor, coming back to the same 
position, and sitting back on the chair. 22 Participants wore regular footwear, placed their back 
against the chair, rested their arms on the chair’s arms, and put their feet on the ground. A 
researcher instructed the participant to, on the word “go,” get up, walk 3 m as fast as possible 
without compromising safety, turn, walk 3 m back to the chair, and sit down. Timing began 
when the participant got up from the chair and was stopped when the participant’s back touched 
the backrest of the chair. The test reliability in the present study was 0.8 or more ( κ  = 0.93).  
 
One-Leg Stance Test  
 The 1-leg stance test was performed with the participant standing in a unipodal 
stance on the dominant lower limb, with the contralateral knee fl exed at 90 ° , arms folded 
across the chest, and head held straight. 23 Timing began when the participant raised the 
nondominant foot off the fl oor and was stopped when the foot touched the fl oor again. The 
maximum performance time was set at 30 seconds. 25  
 
Walking Speed Tests  
 WS was measured over 3 m. 24 This distance was chosen because of space 
limitations. However, high concordance has been observed between the results recorded on 3- 
and 6-m courses. 26 For the test, participants were required to walk 5 m (including 1-m 
acceleration and 1-m deceleration) at their usual and fastest possible pace (without running). 
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Before the evaluation, both feet of each participant were to remain on the starting line. Timing 
began when a foot reached the 1-m line and was stopped when a foot reached the 4-m line. The 
1-m intervals at the beginning and at the end of the course were used to avoid early acceleration 
and/or deceleration. The test reliability in the present study was 0.8 re more ( κ  = 0.98).  
 
Anthropometric Measurements  
 An analog weight scale with a Filizola (Brazil) stadiometer was used to measure 
body mass and height. The body mass index (BMI) was calculated as the ratio between body 
mass (kg) and the square of height (m²).  
 
Disease Conditions  
 Information pertaining to disease conditions was collected by 2 researchers 
(H.J.C.-J. and I.O.G.) through self-report and careful review of medical charts of the community 
senior center. Medical charts, which are updated every 6 months by a local physician, were 
reviewed to determine the prevalence of disease conditions that may impact physical 
performance (eg, osteoarthritis).  
 
Statistical Analysis  
 Normality of data was ascertained using the KolmogorovSmirnov test. 27 Data are 
presented as mean (standard deviation) or absolute numbers (percentages) for continuous and 
categorical variables, respectively. Differences in continuous variables among groups were 
assessed via 1-way analysis of variance. When appropriate, Bonferroni post hoc analyses were 
performed to determine whether there were signifi cant differences between groups. Posttests 
were performed to investigate whether or not there was a linear trend of decline in physical 
function in relation to age. Comparisons of categorical variables were performed by  χ ² 
statistics. Pearson correlations were used to explore the relationships between physical function 
tests and age. For all tests, the level of signifi cance was set at 5% ( P  < .05). All analyses were 
conducted using the IBM SPSS Statistics, version 20.0, software (IBM Corp, Armonk, New 
York).  
 
Physical Function Across Ages  
 Overall, performance on the various physical function tests declined linearly with 
advancing age in women (F igure1). On the other hand, only the performance on IHG, 1-leg 
stance, and WS at fast pace showed a linear age-associated decline in men (F igure 2 ).  
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Isometric handgrip strength  
 IHG performance was signifi cantly affected by age in women ( F1638 =  60.51;  P  
< .001). IHG strength in 80 + (20.0 [6.9] kg;  P  < .001) and 71 to 80 years’ groups (23.4 [6.9] 
kg;  P  < .001) was signifi cantly lower than in the 50 to 60 years’ group (27.6 [6.0] kg) (Figure 
1A ). Furthermore, the IHG strength recorded in the 80 + years’ group ( P  < .001), but not in 
the 71 to 80 years’ group, was signifi cantly lower than that observed in the 61 to 70 years’ 
group. In men, although IHG strength declined linearly with advancing age ( P for linear trend  
< .05;  Figure 2A ), no signifi cant differences were detected between age groups ( F 382=  2.202;  
P  = .08).  
 
Five times sit-to-stand test  
 5×  STS performance was signifi cantly affected by age in women ( F1696 =  41.74;  
P  < .001; F igure 1B ). The performance on the 5 × STS in 80 + (13.3 [4.0] seconds) and 71 to 
80 years’ groups (13.1 [3.5] seconds) was slower than that recorded in both 61 to 70 (11.9 [3.7] 
seconds;  P  < .001 for both) and 50 to 60 years’ groups (10.8 [3.1] seconds;  P  < .001 for both). 
In turn, participants in the 61 to 70 years’ group performed slower than the younger group ( P  
< .001). No effects of age were observed in men ( F383 =  1.400;  P  = .25;  Figure 2B) .  
 
Timed Up and Go test  
TUG performance was signifi cantly affected by age in women ( F1698 =  51.74;  P  
< .001;  Figure 1C)  and men (F  382=  5.98;  P  < .001; F igure 2C ). In women, the performance 
on the TUG test of 80 + (9.3 [5.6] seconds) and 71 to 80 years’ groups (7.6 [1.8] seconds) was 
worse than both 50 to 60 (6.5 [1.2] seconds;  P  < .001 for both) and 61 to 70 years’ groups (6.9 
[2.2] seconds;  P  < .001 for both). No differences were detected between participants in 50 to 
60 and 61 to 70 years’ groups. In men, participants in the 80 + years’ group showed worse 
performance than both 50 to 60 (6.2 [0.7] seconds;  P  = .01) and 61 to 70 years’ groups (6.5 
[1.6] seconds;  P  < .001). No differences were found in TUG performance between 80 + and 
71 to 80 years’ groups.  
 
 Table. Participant Characteristics According to Gender and Age Groups.  
Age Group  
Sample  
Size, n  
Age, y 
Mean (SD)  
BMI, kg/m²  
Mean (SD)  
HTN 
n (%)  
T1DM 
n (%)  
T2DM 
n (%)  
Osteoarthritis 
n (%)  
CVD 
n (%)  
Overall   
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Abbreviations: BMI, body mass index; CVD, cardiovascular disease; HTN, hypertension; SD, standard 
deviation; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellit  a P  < .05 vs. women. 
 
One-leg stance test  
 One-leg stance performance was signifi cantly affected by age in women (F1558 =  
51.59;  P  < .001; F igure 1D ). The performance on the 1-leg stance test in 80 + (12.6 [10.0] 
seconds) and 71 to 80 years’ groups (16.1 [11.0] seconds) was poorer than in both 50 to 60 
(23.8 [10.3] seconds;  P  < .001 for both) and 61 to 70 years’ groups (18.4 [12.2] seconds;  P  < 
.001 for both). In addition, participants in the 61 to 70 years’ group showed poorer performance 
than the youngest group (P  < .001). In men, although balance performance declined linearly 
with advancing age (P for linear trend  < .05), no signifi cant differences were detected between 
individual age groups ( F 347=  13.13;  P  = .08;  Figure 2D ). An additional analysis was 
performed to compare the distribution of participants able to achieve maximum performance 
on the 1-leg stance test (30 seconds) in the 2 genders across age groups. Results demonstrated 
a decreasing number of participants achieving maximum performance in both genders with 
advancing age (see Supplemental Digital Content, Figure S1, available at: h 
ttp://links.lww.com/JGPT/A38 ).  
 
 Range: 50-102  2804  68.0 (7.0)  27.9 (8.9)  1140 (40.7)  120 (4.3)  681 (24.3)  1532 (54.6)  216 (7.7)  
Women   
 All age groups  2262  67.1 (7.6)  26.9 (8.5)  1037 (46.5)  108 (4.8)  589 (26.4)  1300 (58.4)  189 (8.5)  
 50-60  448  56.7 (2.7)  25.5 (9.2)  223 (49.8)  41 (9.2)  155 (34.6)  183 (40.8)  27 (6.0)  
 61-70  1128  65.7 (2.7)  27.2 (9.0)  544 (48.2)  42 (3.7)  297 (25.9)  649 (57.5)  92 (8.2)  
 71-80  576  74.6 (2.8)  28.4 (6.5)  243 (42.2)  24 (4.2)  126 (21.9)  393 (68.2)  60 (10.4)  
  > 80  110  83.8 (2.4)  28.0 (6.9)  27 (24.5)  1 (0.9)  11 (10)  73 (66.4)  6 (5.5)  
Men   
 All age groups  542  71.5 (6.2)a   32.1 (9.2)a   103 (19)a   12 (2.2) a  92 (17.0) a  232 (42.8)a   27 (5.0) a  
 50-60  17  57.2 (2.7)  30.3 (4.7)a   9 (52.9)  2 (11.8)  3 (17.6) a  4 (23.5) a  2 (11.8)  
 61-70  187  65.9 (2.8)  31.1 (10.1)a   57 (30.5) a  4 (2.1)  16 (8.6) a  86 (46.0)  17 (9.1)  
 71-80  302  74.4 (2.7)  31.6 (9.0)a   20 (6.6) a  6 (2.0)  35 (11.6)  36 (11.9) a  6 (2.0) a  
  > 80  36  82.9 (1.6)  33.2 (10.5)a   3 (8.3) a  0 (0)  30 (8.3)  22 (61.1)  0 (0) a  
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Walking speed at usual pace  
 Walking speed at usual pace was signifi cantly affected by age in women (F 3364=  
51.01;  P  < .001;  Figure 1E)  and men ( F186 =  5.28;  P  = .01; F igure 2E ). In women, WS at 
usual pace in 80 + (1.06 [0.28] m/s) and 71 to 80 years’ groups (1.27 [0.28] m/s) was lower 
than in both 61 to 70 (1.35 [0.26] m/s;  P  < .001 for both) and 50 to 60 years’ groups (1.42 
[0.31] m/s;  P  < .001 for both). In addition, the 61 to 70 years’ group showed a slower WS at 
usual pace than the 50 to 60 years’ group ( P  < .001). In men, the slowest WS at usual pace 
was observed in the 71 to 80 years’ group (1.35 [0.24] m/s). Participants in this age group had 
a signifi cantly lower performance in comparison to the 61 to 70 years’ group (1.54 [0.33] m/s;  
P  = .01). No other signifi cant between-group differences were observed.  
Figure 1.  Upper limb muscle strength (A), lower limb muscle power (B), mobility (C, E, and F), and 
balance (D) across age groups in women. 5 × STS indicates 5 times sit-to-stand test; IHG, isometric 
handgrip strength; TUG, Timed Up and Go;  WS, walking speed. 
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Walking speed at fast pace  
 Walking speed at fast pace was signifi cantly affected by age in women ( F1267 =  
33.02;  P  < .001;  Figure 1F) . WS at fast pace in 80 + (1.41 [0.37] m/s) and 71 to 80 years’ 
groups (1.67 [0.36] m/s) was lower than in both 50 to 60 (1.88 [0.91] m/s;  P  < .001 for both) 
and 61 to 70 years’ groups (1.81 [0.44] m/s;  P  < .001 for both). In men, WS at fast pace showed 
a linear decline across ages ( P for linear trend <  .05), with no signifi cant differences between 
groups ( F 183=  2.94;  P  = .03;  Figure 2F) .  
 
Figure 2.  Upper limb muscle strength (A), lower limb muscle power (B), mobility (C, E, and F), and 
balance (D) across age groups in men. 5 × STS indicates 5 times sit-to-stand test; IHG, isometric 
handgrip strength; TUG, Timed Up and Go; WS,  walking speed. 
 
Physical Function Across Genders  
 Figure 3 compares the results of physical function tests in men and women across 
ages. A gender-specifi c pattern was observed in individual tests. Men showed greater IHG 
strength than women in all age groups ( P  < .001;  Figure 3A ).  
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Conversely, women performed better than men on the 5×  STS test at ages 61 to 70 
and 71 to 80 years ( P  < .001 for both; Figure 3B ). No significant differences in TUG 
performance were observed between genders in any age group (Figure 3C ). Men performed 
the 1-leg stance longer than women in 61 to 70 and 71 to 80 years’ groups ( P  < .001 for both; 
F igure 3D ). Finally, men had a slower WS at usual pace than women in 61 to 70 and 80 + 
years’ groups, as well as a reduced WS at fast pace in the 61 to 70 years’ group ( P  < .001 for 
both;  Figures 3E and 3 F ).  
Figure 3. Upper limb muscle strength (A), lower limb muscle power (B), mobility (C, E, F), and balance 
(D) in men and women across age groups. 5 × STS indicates 5 times sit-to-stand test; IHG, isometric 
handgrip strength; TUG, Timed Up  and Go; WS, walking speed. * P  < .05. 
 
Pearson’s Correlations  
 Pearson’s correlations were run to explore the relationship between physical 
function tests and age in the whole sample (Figure 4) and according to gender (see 
Supplemental Digital Content, Figures S2 and S3, available at:  http:// 
links.lww.com/JGPT/A39 and  http://links.lww.com/JGPT/ A40 ). In women, men, and in the 
whole sample, age was signifi cantly correlated with IHG (women  r  =  − 0.31,  P  < .001; men  
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r  =  − 0.14,  P  = .004; whole sample  r  =  − 0.24,  P  < .001), 5 × STS (women  r  = 0.33,  P  
< .001; men  r  = 0.15,  P  = .04; whole sample  r  = 0.31,  P  < .001), TUG (women  r  = 0.33, 
men  r  = 0.24, whole sample  r  = 0.30;  P  < .001 for all), WS at usual pace (women  r  =  − 
0.28, men  r  =  − 0.24, whole sample  r  =  − 0.26;  P  < .001 for all), and WS at fast pace 
(women  r  =  − 0.28, men  r  =  − 0.28, whole sample  r  =  − 0.26;  P  < .001 for all). These 
results further indicate that physical performance declines with advancing age in both genders.  
 
Figure 4.  Relationship between age and physical function in the whole study population. 5 × STS 
indicates 5 times sit-tostand test; IHG, isometric handgrip strength; TUG, Timed Up and Go; WS, 
walking speed. * P  < .05. 
 
DISCUSSION  
 The maintenance of physical function is a central component of successful aging. 
28 Conversely, declining physical performance is associated with a vast array of nega-tive 
health-related outcomes, including disability, 29 falls, 10 dementia, 30 institutionalization, 7 and 
mortality. 8 Poor performance on the IHG ( < 27 kg in men and  < 16 kg in women), TUG ( ≥ 
20 seconds), 5 × STS ( > 15 seconds), and WS at usual pace ( ≤ 0.8 m/s) is listed among the 
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items of the diagnostic algorithm of sarcopenia. 31 Yet, limited evidence exists on the impact of 
ethnicity on age-related declines in physical performance. 13  
 In the present study, a comprehensive set of physical function tests were 
administered to a large sample of community-dwelling Brazilian adults across a wide age 
spectrum to investigate how physical performance varied with age and gender. Our fi ndings 
indicate that performance on all physical function tests declines linearly with age in women 
(Figure 1 and Figure S2, available at:  http://links.lww.com/JGPT/ A39 ). In men, although all 
physical function tests were negatively correlated with age, only IHG, 1-leg stance, and WS at 
fast pace displayed linear age-related declines. Comparisons between genders showed that 
women walked faster and had greater lower limb muscle power, while men displayed greater 
upper limb muscle strength and better balance.  
 Our fi ndings are in line with prior investigations in European 11-13 and Asian 
people, 13 and add to existing knowledge by demonstrating that this phenomenon is also 
observed in community-dwelling Brazilians across different functional domains. In women, 
participants in their seventh and eighth decade of life showed lower physical function than those 
younger than 60 years, with the greater difference observed in the TUG test and 1-leg stance 
(43.0% and 48.3%, respectively). In men, 70- to 80-year-old participants showed a balance 
performance approximately 50% lower than those younger than 60 years, while WS at fast pace 
was reduced by around 69%.  
 Irrespective of the signifi cant age-related declines in physical function, mean IHG, 
TUG, 5 × STS, and WS values in men and women were higher than the proposed cutoffs for 
sarcopenia. 31 Regarding IHG, for example, the lowest mean values observed were 29.4 and 
20.0 kg, for men and women, respectively, while the recent revised European consensus on 
sarcopenia has set cutoff points at 27 kg for men and 16 kg for women. 31 These results could 
be expected since a recent systematic review and metaanalysis demonstrated a low prevalence 
of sarcopenia (17%) among Brazilian older adults. 32 However, the investigations included in 
the meta-analysis were based on different cutoffs (eg, Baumgartner’s criteria, populationbased) 
and the prevalence of sarcopenia ranged from 4% to 72.7%, 32 limiting comparison across 
studies.  
Although all participants of the present study were recruited from the same 
community senior center, a high rate of variability was observed in physical performance, 
which may explain its low correlation with age. This variability might be attributed to 
environmental and behavioral factors, including mid-life lifestyle, 33 neighborhood 
environment (eg, number of recreational facilities, community center, and criminality), 34, 35  
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protein intake, 36, 37  and street walkability. 38 However, these assumptions are only speculative 
and should be investigated further in future studies.  
 In contrast to upper limb muscle strength, lower extremity muscle power and WS 
were greater in women than in men. This result differs from a previous investigation showing 
that men performed better than women on the 5 ×STS from  middle age through senescence. 12 
A possible explanation for these fi ndings may be found in the different patterns of physical 
activity between participants enrolled in the 2 studies. In addition to a similar time spent in paid 
work, women typically spend more time in domestic work than men. 39-41 In some cases, the 
time spent doing domestic work by women may reach as many as 20 hours per week. 40 
Domestic work is commonly based on moving from one room to another, combined with 
numerous squats to collect objects from the ground, and standing periods to cook, clean, and 
organize. The physical function profi le observed in women may therefore refl ect an adaptation 
to a set of movements repetitively performed every day throughout life. In contrast, men’s 
domestic work is often restricted to strength-requiring tasks. Studies taking into consideration 
economic and social status, physical activity levels, and time spent in domestic work are 
necessary to validate our results. The existence of gender-specifi c patterns of physical function 
also calls for a comprehensive assessment of physical performance to capture its various 
domains (eg, mobility, upper limb muscle strength, lower limb muscle power, and balance).  
 As a practical application of our fi ndings, physical therapists should be cautious 
when using cutoffs for physical function tests to evaluate patients or to set rehabilitation goals 
and exercise programs for older adults. Indeed, the extrapolation of cutoffs to populations 
different from those in which they were established might lead to erroneous interpretations of 
a person’s condition and the effectiveness of physical interventions. Therefore, in the absence 
of region-specifi c cutoffs for physical function, the inclusion of other tools (eg, self-reported 
scales) may be advisable for the evaluation and treatment of community-dwelling older adults.  
 Our study presents some limitations that need to be discussed. First, the results 
shown in this work are derived from cross-sectional observations. The possibility cannot be 
ruled out that the differences in birth cohorts may have infl uenced some of the assessed 
parameters. A deeper understanding of age-dependent trajectories of physical function requires 
an analysis of prospective data that are not available at this stage for our study. Furthermore, 
neither objectively measured nor self-reported physical activity throughout life was collected. 
Hence, the impact of physical activity on functional tests across ages and genders could not be 
established. In addition, no measures of muscle mass were obtained, which prevented 
exploration of the relationship between muscle quantity and physical function. The relatively 
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small number of men enrolled may be viewed as a further limitation of this study, given that a 
small sample size increases the risk of type 2 statistical errors. However, according to the most 
recent report of the Brazilian Institute of Geography and Statistics, 42 the gender distribution of 
our study sample is comparable to that of the geographic area where participants were recruited. 
  
CONCLUSIONS  
 Findings of the present study indicate that performance decreases on different 
physical function tests with advancing age in Brazilian adults, following a gender-specifi c 
pattern. Remarkably, the lowest mean values of physical function tests recorded in our study 
population did not reach the cutoffs for sarcopenia recently proposed by the European Working 
Group on Sarcopenia in Older People 2. 31 This may suggest that region-specifi c cutoffs of 
physical function may be necessary to estimate the risk of adverse events in different 
populations. Therefore, health professionals, including physical therapists, should use caution 
when applying cutoffs for physical function tests in clinical practice. Unless region-specifi c 
reference values for physical function are available, other tools (eg, self-reported scales) should 
be adopted for the careful evaluation and treatment of community-dwelling older people.  
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CONCLUSION 
A) Prevalence of frailty in South America. Our findings suggest that prefrailty and frailty are 
highly prevalent in South American older adults, with rates higher than those observed in 
Europe and Asia. In the community, almost one-in-two are prefrail and one-in-five are frail, 
while institutionalized individuals are more frequently affected. These findings indicate the 
need for immediate attention to avoid frailty progression toward negative health outcomes. Our 
findings also highlight the need for specific guidelines for frailty in South America. 
 
B) The relationship between frailty status and protein intake, physical performance, and 
hypertension-related parameters using 4 different frailty instruments. Protein intake, 
regardless of the source, is significantly associated with physical function in older adults. The 
systematic review and metanalysis suggest that high protein consumption is negatively 
associated with frailty prevalence. When was compared the relationship between frailty status 
using 4 different instruments and many protein-related parameters, findings suggested that the 
results are tool-dependent. In addition, a lower consumption of protein and BCAA is observed 
in frail older adults. Similarly, frailty status is only related with physical function when frailty 
tools use performance-based measures to assess physical performance. Finally, no significant 
association between hypertension-related parameters and frailty status was observed.   
 
C) The effects of HSRT and LSRT on frailty status, physical performance, cognitive 
function, and blood pressure.  Both LSRT and HSRT reversed frailty status and improved 
physical performance in prefrail and frail older adults. However, different patterns of 
improvement were observed among RT protocols. Regarding frailty status, LSRT seemed to be 
more effective in reverse prefrailty and frailty when compared to HSRT. Greater improvements 
in muscle strength and power were also observed after LSRT, while HSRT caused greater 
improvements in mobility and dual-task performance. Finally, RT programs similarly improved 
verbal memory in prefrail. 
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APPENDIX 3- FRAILTY STATUS 
                                                                                                                         
                                                                                                                                                
NOME______________ ID___________ DATA___________ AVALIADOR_______ 
 
 PERDA DE PESO NÃO INTENCIONAL- (mais que 4.5 kg no último ano); 
 FRAQUEZA - (resultado abaixo de 20kgf para mulheres e abaixo de 30kgf para homem 
no teste de preensão manual);  
 FADIGA - O senhor(a) se sente cansado ao realizar as atividades da vida diária? 1) Nunca; 
2) Às vezes; 3) Frequentemente; 4) Sempre. Se 3 ou 4, assinale como SIM.   
 MOBILIDADE- Velocidade da marcha no teste de 10 metros (≤1.0 m/s); 
 Nível de atividade física – IPAQ para idosos. 
• Robusto: 0 
• Pré-frágil: 1-2 
• Frágil:≥3 
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  APPENDIX 4- MINI-MENTAL STATE EXAMINATION (MMSE)  
                                                                                                                         
Voluntário: ________________________________________________  
 
Data de avaliação: __________ Avaliador: ______________________  
 
Orientação  
 
1) Dia da Semana (1 ponto) ( )  
2) Dia do Mês (1 ponto) ( )  
3) Mês (1 ponto) ( )  
4) Ano (1 ponto) ( )  
5) Hora aproximada (1 ponto) ( )  
6) Local específico (andar ou setor) (1 ponto) ( )  
7) Instituição (residência, hospital, clínica) (1 ponto) ( )  
8) Bairro ou rua próxima (1 ponto) ( )  
9) Cidade (1 ponto) ( )  
10) Estado (1 ponto) ( )  
 
Memória Imediata  
 
Fale três palavras não relacionadas.  
Posteriormente pergunte ao paciente pelas 3 palavras.  
Dê 1 ponto para cada resposta correta. ( )  
Depois repita as palavras e certifique-se de que o paciente as aprendeu, pois mais adiante você 
irá perguntá-las novamente.  
 
Atenção e Cálculo  
 
(100-7) sucessivos, 5 vezes sucessivamente (93,86,79,72,65) (1 ponto para cada cálculo 
correto) ( )  
 
Evocação  
 
Pergunte pelas três palavras ditas anteriormente (1 ponto por palavra) ( ) 
 
Linguagem  
 
1) Nomear um relógio e uma caneta (2 pontos) ( )  
2) Repetir “nem aqui, nem ali, nem lá” (1 ponto) ( )  
3) Comando:”pegue este papel com a mão direita, dobre ao meio e coloque no chão (3 pontos) 
( )  
4) Ler e obedecer:”feche os olhos” (1 ponto) ( )  
5) Escrever uma frase (1 ponto) ( )  
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6) Copiar um desenho (1 ponto) ( )  
 
Resultado: ( / 30)  
 
COPIE O DESENHO 
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  APPENDIX 5- Rey's Auditory Verbal Learning Test (RAVLT) 
TESTE DE APRENDIZAGEM AUDITIVO-VERBAL (DE REY)- RAVLT 
 
Voluntário: ________________________________________________  
 
Data de avaliação: __________ Avaliador: ______________________  
 
 
  LISTA A A1 A2 A3 A4 A5 LISTA B B1 A6 A7 LISTA A 
1 Tambor           Carteira       Tambor 
2 Cortina           Guarda       Cortina 
3 Sino           Ave       Sino 
4 Café           Sapato       Café 
5 Escola           Forno       Escola 
6 Pai           Montanha       Pai 
7 Lua           Óculos       Lua 
8 Jardim           Toalha       Jardim 
9 Chapéu           Nuvem       Chapéu 
10 Cantor           Barco       Cantor 
11 Nariz           Carneiro       Nariz 
12 Peru           Canhão       Peru 
13 Cor           Lápis       Cor 
14 Casa           Igreja       Casa 
15 Rio           Peixe       Rio 
  TOTAL           TOTAL         
 
SINO (A)   LAR (SA)   TOALHA (B)   BARCO (B)   ÓCULOS (B)   
JANELA 
(SA)   PEIXE (B)   
CORTINA 
(A)   
ESTOLA 
(FA)   BOTA (SB)   
CHAPÉU 
(A)   LUA (A)   FLOR (SA)   PAI (A)   SAPATO (B)   
MÚSICA 
(SA)   PINO (FA)   COR (A)   ÁGUA (SA)   
PROFESSOR 
(SA)   
                    
GUARDA 
(B)   RUA (FA)   
CARTEIRA 
(B)   
CANTOR 
(A)   FORNO (B)   
NARIZ (A)   AVE (B)   CANHÃO (B)   BULE (SA)   NINHO (SB)   
CHUVA 
(SB)   
MONTANHA 
(B)   GIZ (SA)   NUVEM (B)   FILHO (SA)   
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ESCOLA 
(A)   CAFÉ (A)   IGREJA (B)   CASA (A)   TAMBOR (A)   
PAPEL (FA)   ASA (FA)   PERU (A)   FEIXE (FB)   RAPÉ (SA)   
LÁPIS (B)   RIO (A)   TORNO (FB)   JARDIM (A)   CARNEIRO (B)   
 
 
